Clinical	PMC3035602	0	8	O	-1	-1	0
Epidemiology	PMC3035602	9	21	O	-1	-1	0


	PMC3035602	21	23	O	-1	-1	0

Dovepress	PMC3035602	23	32	O	-1	-1	0
open	PMC3035602	33	37	O	-1	-1	0
access	PMC3035602	38	44	O	-1	-1	0
to	PMC3035602	45	47	O	-1	-1	0
scientific	PMC3035602	48	58	O	-1	-1	0
and	PMC3035602	59	62	O	-1	-1	0
medical	PMC3035602	63	70	O	-1	-1	0
research	PMC3035602	71	79	O	-1	-1	0


	PMC3035602	79	81	O	-1	-1	0

Review	PMC3035602	81	87	O	-1	-1	0


	PMC3035602	87	89	O	-1	-1	0

Open	PMC3035602	89	93	O	-1	-1	0
Access	PMC3035602	94	100	O	-1	-1	0
Full	PMC3035602	101	105	O	-1	-1	0
Text	PMC3035602	106	110	O	-1	-1	0
Article	PMC3035602	111	118	O	-1	-1	0


	PMC3035602	118	120	O	-1	-1	0

Birth	PMC3035602	120	125	O	-1	-1	0
outcome	PMC3035602	126	133	O	-1	-1	0
in	PMC3035602	134	136	O	-1	-1	0
women	PMC3035602	137	142	O	-1	-1	0
with	PMC3035602	143	147	O	-1	-1	0
breast	PMC3035602	148	154	O	-1	-1	0
cancer	PMC3035602	155	161	O	-1	-1	0
,	PMC3035602	161	162	O	-1	-1	0
cutaneous	PMC3035602	163	172	O	-1	-1	0
malignant	PMC3035602	173	182	O	-1	-1	0
melanoma	PMC3035602	183	191	O	-1	-1	0
,	PMC3035602	191	192	O	-1	-1	0
or	PMC3035602	193	195	O	-1	-1	0
Hodgkin	PMC3035602	196	203	O	-1	-1	0
’s	PMC3035602	203	205	O	-1	-1	0

disease	PMC3035602	206	213	O	-1	-1	0
:	PMC3035602	213	214	O	-1	-1	0

a	PMC3035602	215	216	O	-1	-1	0
review	PMC3035602	217	223	O	-1	-1	0

This	PMC3035602	224	228	O	-1	-1	0
article	PMC3035602	229	236	O	-1	-1	0
was	PMC3035602	237	240	O	-1	-1	0
published	PMC3035602	241	250	O	-1	-1	0
in	PMC3035602	251	253	O	-1	-1	0
the	PMC3035602	254	257	O	-1	-1	0
following	PMC3035602	258	267	O	-1	-1	0
Dove	PMC3035602	268	272	O	-1	-1	0
Press	PMC3035602	273	278	O	-1	-1	0
journal	PMC3035602	279	286	O	-1	-1	0
:	PMC3035602	286	287	O	-1	-1	0
Clinical	PMC3035602	288	296	O	-1	-1	0
Epidemiology	PMC3035602	297	309	O	-1	-1	0
23	PMC3035602	310	312	O	-1	-1	0
December	PMC3035602	313	321	O	-1	-1	0
2010	PMC3035602	322	326	O	-1	-1	0

Number	PMC3035602	327	333	O	-1	-1	0
of	PMC3035602	334	336	O	-1	-1	0
times	PMC3035602	337	342	O	-1	-1	0
this	PMC3035602	343	347	O	-1	-1	0
article	PMC3035602	348	355	O	-1	-1	0
has	PMC3035602	356	359	O	-1	-1	0
been	PMC3035602	360	364	O	-1	-1	0
viewed	PMC3035602	365	371	O	-1	-1	0


	PMC3035602	371	373	O	-1	-1	0
Vivian	PMC3035602	373	379	O	-1	-1	0
Langagergaard	PMC3035602	380	393	O	-1	-1	0
Department	PMC3035602	394	404	O	-1	-1	0
of	PMC3035602	405	407	O	-1	-1	0
Clinical	PMC3035602	408	416	O	-1	-1	0
Epidemiology	PMC3035602	417	429	O	-1	-1	0
,	PMC3035602	429	430	O	-1	-1	0

Aarhus	PMC3035602	431	437	O	-1	-1	0
University	PMC3035602	438	448	O	-1	-1	0
Hospital	PMC3035602	449	457	O	-1	-1	0
,	PMC3035602	457	458	O	-1	-1	0
Aarhus	PMC3035602	459	465	O	-1	-1	0
,	PMC3035602	465	466	O	-1	-1	0
Denmark	PMC3035602	467	474	O	-1	-1	0


	PMC3035602	474	476	O	-1	-1	0

Background	PMC3035602	476	486	O	-1	-1	0
:	PMC3035602	486	487	O	-1	-1	0

Data	PMC3035602	488	492	O	-1	-1	0
on	PMC3035602	493	495	O	-1	-1	0
birth	PMC3035602	496	501	O	-1	-1	0
outcome	PMC3035602	502	509	O	-1	-1	0
in	PMC3035602	510	512	O	-1	-1	0
women	PMC3035602	513	518	O	-1	-1	0
diagnosed	PMC3035602	519	528	O	-1	-1	0
with	PMC3035602	529	533	O	-1	-1	0
cancer	PMC3035602	534	540	O	-1	-1	0
before	PMC3035602	541	547	O	-1	-1	0
,	PMC3035602	547	548	O	-1	-1	0
during	PMC3035602	549	555	O	-1	-1	0
,	PMC3035602	555	556	O	-1	-1	0
or	PMC3035602	557	559	O	-1	-1	0
shortly	PMC3035602	560	567	O	-1	-1	0

after	PMC3035602	568	573	O	-1	-1	0
pregnancy	PMC3035602	574	583	O	-1	-1	0
are	PMC3035602	584	587	O	-1	-1	0
very	PMC3035602	588	592	O	-1	-1	0
sparse	PMC3035602	593	599	O	-1	-1	0
.	PMC3035602	599	600	O	-1	-1	0

The	PMC3035602	601	604	O	-1	-1	0
purpose	PMC3035602	605	612	O	-1	-1	0
of	PMC3035602	613	615	O	-1	-1	0
this	PMC3035602	616	620	O	-1	-1	0
review	PMC3035602	621	627	O	-1	-1	0
was	PMC3035602	628	631	O	-1	-1	0
to	PMC3035602	632	634	O	-1	-1	0
summarize	PMC3035602	635	644	O	-1	-1	0
the	PMC3035602	645	648	O	-1	-1	0
existing	PMC3035602	649	657	O	-1	-1	0
epidemiologic	PMC3035602	658	671	O	-1	-1	0
evidence	PMC3035602	672	680	O	-1	-1	0
of	PMC3035602	681	683	O	-1	-1	0
the	PMC3035602	684	687	O	-1	-1	0
adverse	PMC3035602	688	695	O	-1	-1	0
effect	PMC3035602	696	702	O	-1	-1	0
of	PMC3035602	703	705	O	-1	-1	0
breast	PMC3035602	706	712	O	-1	-1	0
cancer	PMC3035602	713	719	O	-1	-1	0
,	PMC3035602	719	720	O	-1	-1	0
cutaneous	PMC3035602	721	730	O	-1	-1	0
malignant	PMC3035602	731	740	O	-1	-1	0
melanoma	PMC3035602	741	749	O	-1	-1	0
,	PMC3035602	749	750	O	-1	-1	0
and	PMC3035602	751	754	O	-1	-1	0
Hodgkin	PMC3035602	755	762	O	-1	-1	0
’s	PMC3035602	762	764	O	-1	-1	0
disease	PMC3035602	765	772	O	-1	-1	0
on	PMC3035602	773	775	O	-1	-1	0
birth	PMC3035602	776	781	O	-1	-1	0
outcome	PMC3035602	782	789	O	-1	-1	0
.	PMC3035602	789	790	O	-1	-1	0

Methods	PMC3035602	791	798	O	-1	-1	0
:	PMC3035602	798	799	O	-1	-1	0

The	PMC3035602	800	803	O	-1	-1	0
MEDLINE	PMC3035602	804	811	O	-1	-1	0
database	PMC3035602	812	820	O	-1	-1	0
was	PMC3035602	821	824	O	-1	-1	0
used	PMC3035602	825	829	O	-1	-1	0
to	PMC3035602	830	832	O	-1	-1	0
review	PMC3035602	833	839	O	-1	-1	0
the	PMC3035602	840	843	O	-1	-1	0
literature	PMC3035602	844	854	O	-1	-1	0
systematically	PMC3035602	855	869	O	-1	-1	0
.	PMC3035602	869	870	O	-1	-1	0

Studies	PMC3035602	871	878	O	-1	-1	0

that	PMC3035602	879	883	O	-1	-1	0
examined	PMC3035602	884	892	O	-1	-1	0
the	PMC3035602	893	896	O	-1	-1	0
following	PMC3035602	897	906	O	-1	-1	0
outcomes	PMC3035602	907	915	O	-1	-1	0
were	PMC3035602	916	920	O	-1	-1	0
included	PMC3035602	921	929	O	-1	-1	0
:	PMC3035602	929	930	O	-1	-1	0
preterm	PMC3035602	931	938	O	-1	-1	0
birth	PMC3035602	939	944	O	-1	-1	0
,	PMC3035602	944	945	O	-1	-1	0
low	PMC3035602	946	949	O	-1	-1	0
birth	PMC3035602	950	955	O	-1	-1	0
weight	PMC3035602	956	962	O	-1	-1	0
,	PMC3035602	962	963	O	-1	-1	0
low	PMC3035602	964	967	O	-1	-1	0
birth	PMC3035602	968	973	O	-1	-1	0

weight	PMC3035602	974	980	O	-1	-1	0
at	PMC3035602	981	983	O	-1	-1	0
term	PMC3035602	984	988	O	-1	-1	0
,	PMC3035602	988	989	O	-1	-1	0
stillbirths	PMC3035602	990	1001	O	-1	-1	0
,	PMC3035602	1001	1002	O	-1	-1	0
congenital	PMC3035602	1003	1013	O	-1	-1	0
abnormalities	PMC3035602	1014	1027	O	-1	-1	0
,	PMC3035602	1027	1028	O	-1	-1	0
male	PMC3035602	1029	1033	O	-1	-1	0
proportion	PMC3035602	1034	1044	O	-1	-1	0
of	PMC3035602	1045	1047	O	-1	-1	0
newborns	PMC3035602	1048	1056	O	-1	-1	0
,	PMC3035602	1056	1057	O	-1	-1	0
and	PMC3035602	1058	1061	O	-1	-1	0
mean	PMC3035602	1062	1066	O	-1	-1	0

birth	PMC3035602	1067	1072	O	-1	-1	0
weight	PMC3035602	1073	1079	O	-1	-1	0
.	PMC3035602	1079	1080	O	-1	-1	0

Studies	PMC3035602	1081	1088	O	-1	-1	0
were	PMC3035602	1089	1093	O	-1	-1	0
grouped	PMC3035602	1094	1101	O	-1	-1	0
according	PMC3035602	1102	1111	O	-1	-1	0
to	PMC3035602	1112	1114	O	-1	-1	0
whether	PMC3035602	1115	1122	O	-1	-1	0
the	PMC3035602	1123	1126	O	-1	-1	0
woman	PMC3035602	1127	1132	O	-1	-1	0
had	PMC3035602	1133	1136	O	-1	-1	0
been	PMC3035602	1137	1141	O	-1	-1	0
diagnosed	PMC3035602	1142	1151	O	-1	-1	0
with	PMC3035602	1152	1156	O	-1	-1	0
the	PMC3035602	1157	1160	O	-1	-1	0
specific	PMC3035602	1161	1169	O	-1	-1	0
cancer	PMC3035602	1170	1176	O	-1	-1	0
before	PMC3035602	1177	1183	O	-1	-1	0
,	PMC3035602	1183	1184	O	-1	-1	0
during	PMC3035602	1185	1191	O	-1	-1	0
,	PMC3035602	1191	1192	O	-1	-1	0
or	PMC3035602	1193	1195	O	-1	-1	0
shortly	PMC3035602	1196	1203	O	-1	-1	0
after	PMC3035602	1204	1209	O	-1	-1	0
pregnancy	PMC3035602	1210	1219	O	-1	-1	0
.	PMC3035602	1219	1220	O	-1	-1	0

Results	PMC3035602	1221	1228	O	-1	-1	0

:	PMC3035602	1228	1229	O	-1	-1	0
Few	PMC3035602	1230	1233	O	-1	-1	0
data	PMC3035602	1234	1238	O	-1	-1	0
exist	PMC3035602	1239	1244	O	-1	-1	0
on	PMC3035602	1245	1247	O	-1	-1	0
birth	PMC3035602	1248	1253	O	-1	-1	0
outcome	PMC3035602	1254	1261	O	-1	-1	0
in	PMC3035602	1262	1264	O	-1	-1	0
women	PMC3035602	1265	1270	O	-1	-1	0
with	PMC3035602	1271	1275	O	-1	-1	0
breast	PMC3035602	1276	1282	O	-1	-1	0
cancer	PMC3035602	1283	1289	O	-1	-1	0
,	PMC3035602	1289	1290	O	-1	-1	0
melanoma	PMC3035602	1291	1299	O	-1	-1	0
,	PMC3035602	1299	1300	O	-1	-1	0
or	PMC3035602	1301	1303	O	-1	-1	0
Hodgkin	PMC3035602	1304	1311	O	-1	-1	0
’s	PMC3035602	1311	1313	O	-1	-1	0

disease	PMC3035602	1314	1321	O	-1	-1	0
.	PMC3035602	1321	1322	O	-1	-1	0

The	PMC3035602	1323	1326	O	-1	-1	0
overall	PMC3035602	1327	1334	O	-1	-1	0
results	PMC3035602	1335	1342	O	-1	-1	0
from	PMC3035602	1343	1347	O	-1	-1	0
the	PMC3035602	1348	1351	O	-1	-1	0
limited	PMC3035602	1352	1359	O	-1	-1	0
number	PMC3035602	1360	1366	O	-1	-1	0
of	PMC3035602	1367	1369	O	-1	-1	0
studies	PMC3035602	1370	1377	O	-1	-1	0
,	PMC3035602	1377	1378	O	-1	-1	0
which	PMC3035602	1379	1384	O	-1	-1	0
included	PMC3035602	1385	1393	O	-1	-1	0
a	PMC3035602	1394	1395	O	-1	-1	0
comparison	PMC3035602	1396	1406	O	-1	-1	0
group	PMC3035602	1407	1412	O	-1	-1	0
for	PMC3035602	1413	1416	O	-1	-1	0
birth	PMC3035602	1417	1422	O	-1	-1	0
outcome	PMC3035602	1423	1430	O	-1	-1	0
,	PMC3035602	1430	1431	O	-1	-1	0
were	PMC3035602	1432	1436	O	-1	-1	0
reassuring	PMC3035602	1437	1447	O	-1	-1	0
.	PMC3035602	1447	1448	O	-1	-1	0

However	PMC3035602	1449	1456	O	-1	-1	0
,	PMC3035602	1456	1457	O	-1	-1	0
for	PMC3035602	1458	1461	O	-1	-1	0
women	PMC3035602	1462	1467	O	-1	-1	0
diagnosed	PMC3035602	1468	1477	O	-1	-1	0
with	PMC3035602	1478	1482	O	-1	-1	0
breast	PMC3035602	1483	1489	O	-1	-1	0
cancer	PMC3035602	1490	1496	O	-1	-1	0
before	PMC3035602	1497	1503	O	-1	-1	0
pregnancy	PMC3035602	1504	1513	O	-1	-1	0
,	PMC3035602	1513	1514	O	-1	-1	0
the	PMC3035602	1515	1518	O	-1	-1	0
only	PMC3035602	1519	1523	O	-1	-1	0
2	PMC3035602	1524	1525	O	-1	-1	0
studies	PMC3035602	1526	1533	O	-1	-1	0
that	PMC3035602	1534	1538	O	-1	-1	0
included	PMC3035602	1539	1547	O	-1	-1	0
comparison	PMC3035602	1548	1558	O	-1	-1	0
groups	PMC3035602	1559	1565	O	-1	-1	0
for	PMC3035602	1566	1569	O	-1	-1	0
birth	PMC3035602	1570	1575	O	-1	-1	0
outcome	PMC3035602	1576	1583	O	-1	-1	0
had	PMC3035602	1584	1587	O	-1	-1	0
conflicting	PMC3035602	1588	1599	O	-1	-1	0
results	PMC3035602	1600	1607	O	-1	-1	0
regarding	PMC3035602	1608	1617	O	-1	-1	0
the	PMC3035602	1618	1621	O	-1	-1	0
risk	PMC3035602	1622	1626	O	-1	-1	0
of	PMC3035602	1627	1629	O	-1	-1	0
preterm	PMC3035602	1630	1637	O	-1	-1	0
birth	PMC3035602	1638	1643	O	-1	-1	0
and	PMC3035602	1644	1647	O	-1	-1	0
congenital	PMC3035602	1648	1658	O	-1	-1	0
abnormalities	PMC3035602	1659	1672	O	-1	-1	0
.	PMC3035602	1672	1673	O	-1	-1	0

­Furthermore	PMC3035602	1674	1686	O	-1	-1	0
,	PMC3035602	1686	1687	O	-1	-1	0

a	PMC3035602	1688	1689	O	-1	-1	0
recent	PMC3035602	1690	1696	O	-1	-1	0
cohort	PMC3035602	1697	1703	O	-1	-1	0
study	PMC3035602	1704	1709	O	-1	-1	0
of	PMC3035602	1710	1712	O	-1	-1	0
birth	PMC3035602	1713	1718	O	-1	-1	0
outcome	PMC3035602	1719	1726	O	-1	-1	0
in	PMC3035602	1727	1729	O	-1	-1	0
women	PMC3035602	1730	1735	O	-1	-1	0
who	PMC3035602	1736	1739	O	-1	-1	0
were	PMC3035602	1740	1744	O	-1	-1	0
diagnosed	PMC3035602	1745	1754	O	-1	-1	0
with	PMC3035602	1755	1759	O	-1	-1	0
Hodgkin	PMC3035602	1760	1767	O	-1	-1	0
’s	PMC3035602	1767	1769	O	-1	-1	0
disease	PMC3035602	1770	1777	O	-1	-1	0
before	PMC3035602	1778	1784	O	-1	-1	0
pregnancy	PMC3035602	1785	1794	O	-1	-1	0
indicated	PMC3035602	1795	1804	O	-1	-1	0
a	PMC3035602	1805	1806	O	-1	-1	0
slightly	PMC3035602	1807	1815	O	-1	-1	0
increased	PMC3035602	1816	1825	O	-1	-1	0
risk	PMC3035602	1826	1830	O	-1	-1	0
of	PMC3035602	1831	1833	O	-1	-1	0
congenital	PMC3035602	1834	1844	O	-1	-1	0
abnormalities	PMC3035602	1845	1858	O	-1	-1	0
among	PMC3035602	1859	1864	O	-1	-1	0
the	PMC3035602	1865	1868	O	-1	-1	0
newborns	PMC3035602	1869	1877	O	-1	-1	0
.	PMC3035602	1877	1878	O	-1	-1	0

Conclusion	PMC3035602	1879	1889	O	-1	-1	0
:	PMC3035602	1889	1890	O	-1	-1	0

Overall	PMC3035602	1891	1898	O	-1	-1	0
,	PMC3035602	1898	1899	O	-1	-1	0
the	PMC3035602	1900	1903	O	-1	-1	0
existing	PMC3035602	1904	1912	O	-1	-1	0
studies	PMC3035602	1913	1920	O	-1	-1	0
offer	PMC3035602	1921	1926	O	-1	-1	0
reassuring	PMC3035602	1927	1937	O	-1	-1	0
results	PMC3035602	1938	1945	O	-1	-1	0
concerning	PMC3035602	1946	1956	O	-1	-1	0
the	PMC3035602	1957	1960	O	-1	-1	0
risks	PMC3035602	1961	1966	O	-1	-1	0
of	PMC3035602	1967	1969	O	-1	-1	0
adverse	PMC3035602	1970	1977	O	-1	-1	0
birth	PMC3035602	1978	1983	O	-1	-1	0
outcome	PMC3035602	1984	1991	O	-1	-1	0
for	PMC3035602	1992	1995	O	-1	-1	0
women	PMC3035602	1996	2001	O	-1	-1	0
diagnosed	PMC3035602	2002	2011	O	-1	-1	0
with	PMC3035602	2012	2016	O	-1	-1	0
breast	PMC3035602	2017	2023	O	-1	-1	0
cancer	PMC3035602	2024	2030	O	-1	-1	0
,	PMC3035602	2030	2031	O	-1	-1	0
melanoma	PMC3035602	2032	2040	O	-1	-1	0
,	PMC3035602	2040	2041	O	-1	-1	0
or	PMC3035602	2042	2044	O	-1	-1	0
Hodgkin	PMC3035602	2045	2052	O	-1	-1	0
’s	PMC3035602	2052	2054	O	-1	-1	0
disease	PMC3035602	2055	2062	O	-1	-1	0
before	PMC3035602	2063	2069	O	-1	-1	0
,	PMC3035602	2069	2070	O	-1	-1	0
during	PMC3035602	2071	2077	O	-1	-1	0
or	PMC3035602	2078	2080	O	-1	-1	0
shortly	PMC3035602	2081	2088	O	-1	-1	0
after	PMC3035602	2089	2094	O	-1	-1	0
pregnancy	PMC3035602	2095	2104	O	-1	-1	0
.	PMC3035602	2104	2105	O	-1	-1	0

A	PMC3035602	2106	2107	O	-1	-1	0
limitation	PMC3035602	2108	2118	O	-1	-1	0
of	PMC3035602	2119	2121	O	-1	-1	0
most	PMC3035602	2122	2126	O	-1	-1	0
studies	PMC3035602	2127	2134	O	-1	-1	0
was	PMC3035602	2135	2138	O	-1	-1	0
the	PMC3035602	2139	2142	O	-1	-1	0
imprecise	PMC3035602	2143	2152	O	-1	-1	0
risk	PMC3035602	2153	2157	O	-1	-1	0

estimates	PMC3035602	2158	2167	O	-1	-1	0
caused	PMC3035602	2168	2174	O	-1	-1	0
by	PMC3035602	2175	2177	O	-1	-1	0
the	PMC3035602	2178	2181	O	-1	-1	0
small	PMC3035602	2182	2187	O	-1	-1	0
number	PMC3035602	2188	2194	O	-1	-1	0
of	PMC3035602	2195	2197	O	-1	-1	0
adverse	PMC3035602	2198	2205	O	-1	-1	0
birth	PMC3035602	2206	2211	O	-1	-1	0
outcomes	PMC3035602	2212	2220	O	-1	-1	0
and	PMC3035602	2221	2224	O	-1	-1	0
the	PMC3035602	2225	2228	O	-1	-1	0
lack	PMC3035602	2229	2233	O	-1	-1	0
of	PMC3035602	2234	2236	O	-1	-1	0
results	PMC3035602	2237	2244	O	-1	-1	0
stratified	PMC3035602	2245	2255	O	-1	-1	0
by	PMC3035602	2256	2258	O	-1	-1	0
treatment	PMC3035602	2259	2268	O	-1	-1	0
.	PMC3035602	2268	2269	O	-1	-1	0

Therefore	PMC3035602	2270	2279	O	-1	-1	0
,	PMC3035602	2279	2280	O	-1	-1	0
international	PMC3035602	2281	2294	O	-1	-1	0
collaboration	PMC3035602	2295	2308	O	-1	-1	0
is	PMC3035602	2309	2311	O	-1	-1	0
necessary	PMC3035602	2312	2321	O	-1	-1	0
in	PMC3035602	2322	2324	O	-1	-1	0
the	PMC3035602	2325	2328	O	-1	-1	0
future	PMC3035602	2329	2335	O	-1	-1	0
,	PMC3035602	2335	2336	O	-1	-1	0
to	PMC3035602	2337	2339	O	-1	-1	0
obtain	PMC3035602	2340	2346	O	-1	-1	0
more	PMC3035602	2347	2351	O	-1	-1	0
precise	PMC3035602	2352	2359	O	-1	-1	0
risk	PMC3035602	2360	2364	O	-1	-1	0
estimates	PMC3035602	2365	2374	O	-1	-1	0
for	PMC3035602	2375	2378	O	-1	-1	0
adverse	PMC3035602	2379	2386	O	-1	-1	0
birth	PMC3035602	2387	2392	O	-1	-1	0
outcomes	PMC3035602	2393	2401	O	-1	-1	0
,	PMC3035602	2401	2402	O	-1	-1	0
and	PMC3035602	2403	2406	O	-1	-1	0
to	PMC3035602	2407	2409	O	-1	-1	0
allow	PMC3035602	2410	2415	O	-1	-1	0
stratified	PMC3035602	2416	2426	O	-1	-1	0
analyses	PMC3035602	2427	2435	O	-1	-1	0
according	PMC3035602	2436	2445	O	-1	-1	0
to	PMC3035602	2446	2448	O	-1	-1	0
,	PMC3035602	2448	2449	O	-1	-1	0
for	PMC3035602	2450	2453	O	-1	-1	0
example	PMC3035602	2454	2461	O	-1	-1	0
,	PMC3035602	2461	2462	O	-1	-1	0
treatment	PMC3035602	2463	2472	O	-1	-1	0
.	PMC3035602	2472	2473	O	-1	-1	0

Keywords	PMC3035602	2474	2482	O	-1	-1	0
:	PMC3035602	2482	2483	O	-1	-1	0
epidemiology	PMC3035602	2484	2496	O	-1	-1	0
,	PMC3035602	2496	2497	O	-1	-1	0
breast	PMC3035602	2498	2504	O	-1	-1	0
cancer	PMC3035602	2505	2511	O	-1	-1	0
,	PMC3035602	2511	2512	O	-1	-1	0
melanoma	PMC3035602	2513	2521	O	-1	-1	0
,	PMC3035602	2521	2522	O	-1	-1	0
Hodgkin	PMC3035602	2523	2530	O	-1	-1	0
’s	PMC3035602	2530	2532	O	-1	-1	0
disease	PMC3035602	2533	2540	O	-1	-1	0
,	PMC3035602	2540	2541	O	-1	-1	0
birth	PMC3035602	2542	2547	O	-1	-1	0
outcome	PMC3035602	2548	2555	O	-1	-1	0


	PMC3035602	2555	2557	O	-1	-1	0

Introduction	PMC3035602	2557	2569	O	-1	-1	0


	PMC3035602	2569	2571	O	-1	-1	0

Correspondence	PMC3035602	2571	2585	O	-1	-1	0
:	PMC3035602	2585	2586	O	-1	-1	0
Vivian	PMC3035602	2587	2593	O	-1	-1	0
Langagergaard	PMC3035602	2594	2607	O	-1	-1	0
Department	PMC3035602	2608	2618	O	-1	-1	0
of	PMC3035602	2619	2621	O	-1	-1	0
Clinical	PMC3035602	2622	2630	O	-1	-1	0
Epidemiology	PMC3035602	2631	2643	O	-1	-1	0
,	PMC3035602	2643	2644	O	-1	-1	0

Aarhus	PMC3035602	2645	2651	O	-1	-1	0
University	PMC3035602	2652	2662	O	-1	-1	0
Hospital	PMC3035602	2663	2671	O	-1	-1	0
,	PMC3035602	2671	2672	O	-1	-1	0

Olof	PMC3035602	2673	2677	O	-1	-1	0
Palmes	PMC3035602	2678	2684	O	-1	-1	0
Alle	PMC3035602	2685	2689	O	-1	-1	0
43	PMC3035602	2690	2692	O	-1	-1	0
-	PMC3035602	2692	2693	O	-1	-1	0
45	PMC3035602	2693	2695	O	-1	-1	0
,	PMC3035602	2695	2696	O	-1	-1	0
DK-8200	PMC3035602	2697	2704	O	-1	-1	0

Aarhus	PMC3035602	2705	2711	O	-1	-1	0
N.	PMC3035602	2712	2714	O	-1	-1	0
,	PMC3035602	2714	2715	O	-1	-1	0
Denmark	PMC3035602	2716	2723	O	-1	-1	0

Tel	PMC3035602	2724	2727	O	-1	-1	0
+45	PMC3035602	2728	2731	O	-1	-1	0
8942	PMC3035602	2732	2736	O	-1	-1	0
4800	PMC3035602	2737	2741	O	-1	-1	0

Fax	PMC3035602	2742	2745	O	-1	-1	0
+45	PMC3035602	2746	2749	O	-1	-1	0
8942	PMC3035602	2750	2754	O	-1	-1	0

4801	PMC3035602	2755	2759	O	-1	-1	0

Email	PMC3035602	2760	2765	O	-1	-1	0
vl@dce.au.dk	PMC3035602	2766	2778	O	-1	-1	0


	PMC3035602	2778	2780	O	-1	-1	0
submit	PMC3035602	2780	2786	O	-1	-1	0
your	PMC3035602	2787	2791	O	-1	-1	0
manuscript	PMC3035602	2792	2802	O	-1	-1	0

|	PMC3035602	2803	2804	O	-1	-1	0

www.dovepress.com	PMC3035602	2805	2822	O	-1	-1	0


	PMC3035602	2822	2824	O	-1	-1	0

Dovepress	PMC3035602	2824	2833	O	-1	-1	0
DOI	PMC3035602	2834	2837	O	-1	-1	0
:	PMC3035602	2837	2838	O	-1	-1	0

10.2147	PMC3035602	2839	2846	O	-1	-1	0
/	PMC3035602	2846	2847	O	-1	-1	0
CLEP.S12190	PMC3035602	2847	2858	O	-1	-1	0


	PMC3035602	2858	2860	O	-1	-1	0

In	PMC3035602	2860	2862	O	-1	-1	0
Western	PMC3035602	2863	2870	O	-1	-1	0
countries	PMC3035602	2871	2880	O	-1	-1	0
women	PMC3035602	2881	2886	O	-1	-1	0
often	PMC3035602	2887	2892	O	-1	-1	0
postpone	PMC3035602	2893	2901	O	-1	-1	0
childbearing	PMC3035602	2902	2914	O	-1	-1	0
for	PMC3035602	2915	2918	O	-1	-1	0
personal	PMC3035602	2919	2927	O	-1	-1	0
or	PMC3035602	2928	2930	O	-1	-1	0
professional	PMC3035602	2931	2943	O	-1	-1	0
reasons.1	PMC3035602	2944	2953	O	-1	-1	0

The	PMC3035602	2954	2957	O	-1	-1	0
average	PMC3035602	2958	2965	O	-1	-1	0
age	PMC3035602	2966	2969	O	-1	-1	0
of	PMC3035602	2970	2972	O	-1	-1	0
Danish	PMC3035602	2973	2979	O	-1	-1	0
women	PMC3035602	2980	2985	O	-1	-1	0
at	PMC3035602	2986	2988	O	-1	-1	0
their	PMC3035602	2989	2994	O	-1	-1	0
first	PMC3035602	2995	3000	O	-1	-1	0
delivery	PMC3035602	3001	3009	O	-1	-1	0
has	PMC3035602	3010	3013	O	-1	-1	0
gradually	PMC3035602	3014	3023	O	-1	-1	0
increased	PMC3035602	3024	3033	O	-1	-1	0
from	PMC3035602	3034	3038	O	-1	-1	0
23	PMC3035602	3039	3041	O	-1	-1	0
years	PMC3035602	3042	3047	O	-1	-1	0
in	PMC3035602	3048	3050	O	-1	-1	0
the	PMC3035602	3051	3054	O	-1	-1	0
1960s	PMC3035602	3055	3060	O	-1	-1	0
to	PMC3035602	3061	3063	O	-1	-1	0
29	PMC3035602	3064	3066	O	-1	-1	0
years	PMC3035602	3067	3072	O	-1	-1	0
in	PMC3035602	3073	3075	O	-1	-1	0
2008.2	PMC3035602	3076	3082	O	-1	-1	0
Because	PMC3035602	3083	3090	O	-1	-1	0
the	PMC3035602	3091	3094	O	-1	-1	0
incidence	PMC3035602	3095	3104	O	-1	-1	0
rates	PMC3035602	3105	3110	O	-1	-1	0
of	PMC3035602	3111	3113	O	-1	-1	0
most	PMC3035602	3114	3118	O	-1	-1	0
cancers	PMC3035602	3119	3126	O	-1	-1	0
increase	PMC3035602	3127	3135	O	-1	-1	0
with	PMC3035602	3136	3140	O	-1	-1	0
advancing	PMC3035602	3141	3150	O	-1	-1	0
age3	PMC3035602	3151	3155	O	-1	-1	0
more	PMC3035602	3156	3160	O	-1	-1	0
women	PMC3035602	3161	3166	O	-1	-1	0
can	PMC3035602	3167	3170	O	-1	-1	0
be	PMC3035602	3171	3173	O	-1	-1	0
expected	PMC3035602	3174	3182	O	-1	-1	0
to	PMC3035602	3183	3185	O	-1	-1	0
be	PMC3035602	3186	3188	O	-1	-1	0
diagnosed	PMC3035602	3189	3198	O	-1	-1	0
with	PMC3035602	3199	3203	O	-1	-1	0
cancer	PMC3035602	3204	3210	O	-1	-1	0
before	PMC3035602	3211	3217	O	-1	-1	0
childbearing	PMC3035602	3218	3230	O	-1	-1	0
,	PMC3035602	3230	3231	O	-1	-1	0
during	PMC3035602	3232	3238	O	-1	-1	0
pregnancy	PMC3035602	3239	3248	O	-1	-1	0
,	PMC3035602	3248	3249	O	-1	-1	0
or	PMC3035602	3250	3252	O	-1	-1	0
shortly	PMC3035602	3253	3260	O	-1	-1	0
after	PMC3035602	3261	3266	O	-1	-1	0
giving	PMC3035602	3267	3273	O	-1	-1	0
birth	PMC3035602	3274	3279	O	-1	-1	0
.	PMC3035602	3279	3280	O	-1	-1	0

In	PMC3035602	3281	3283	O	-1	-1	0
Denmark	PMC3035602	3284	3291	B-Location	-1	-1	0
,	PMC3035602	3291	3292	O	-1	-1	0
the	PMC3035602	3293	3296	O	-1	-1	0
most	PMC3035602	3297	3301	O	-1	-1	0
common	PMC3035602	3302	3308	O	-1	-1	0
malignancy	PMC3035602	3309	3319	O	-1	-1	0
affecting	PMC3035602	3320	3329	O	-1	-1	0
women	PMC3035602	3330	3335	O	-1	-1	0
of	PMC3035602	3336	3338	O	-1	-1	0
childbearing	PMC3035602	3339	3351	O	-1	-1	0
age	PMC3035602	3352	3355	O	-1	-1	0
is	PMC3035602	3356	3358	O	-1	-1	0
breast	PMC3035602	3359	3365	O	-1	-1	0
cancer	PMC3035602	3366	3372	O	-1	-1	0
,	PMC3035602	3372	3373	O	-1	-1	0
and	PMC3035602	3374	3377	O	-1	-1	0
the	PMC3035602	3378	3381	O	-1	-1	0
second	PMC3035602	3382	3388	O	-1	-1	0
most	PMC3035602	3389	3393	O	-1	-1	0
common	PMC3035602	3394	3400	O	-1	-1	0
one	PMC3035602	3401	3404	O	-1	-1	0
is	PMC3035602	3405	3407	O	-1	-1	0
cutaneous	PMC3035602	3408	3417	O	-1	-1	0
malignant	PMC3035602	3418	3427	O	-1	-1	0
melanoma	PMC3035602	3428	3436	O	-1	-1	0

(	PMC3035602	3437	3438	O	-1	-1	0
excluding	PMC3035602	3438	3447	O	-1	-1	0
nonmelanoma	PMC3035602	3448	3459	O	-1	-1	0
skin	PMC3035602	3460	3464	O	-1	-1	0
cancer).3	PMC3035602	3465	3474	O	-1	-1	0
Hodgkin	PMC3035602	3475	3482	O	-1	-1	0
’s	PMC3035602	3482	3484	O	-1	-1	0
disease	PMC3035602	3485	3492	O	-1	-1	0
,	PMC3035602	3492	3493	O	-1	-1	0
whose	PMC3035602	3494	3499	O	-1	-1	0
incidence	PMC3035602	3500	3509	O	-1	-1	0
peaks	PMC3035602	3510	3515	O	-1	-1	0
in	PMC3035602	3516	3518	O	-1	-1	0
early	PMC3035602	3519	3524	O	-1	-1	0
adulthood	PMC3035602	3525	3534	O	-1	-1	0
and	PMC3035602	3535	3538	O	-1	-1	0
thus	PMC3035602	3539	3543	O	-1	-1	0
also	PMC3035602	3544	3548	O	-1	-1	0
affects	PMC3035602	3549	3556	O	-1	-1	0
women	PMC3035602	3557	3562	O	-1	-1	0
of	PMC3035602	3563	3565	O	-1	-1	0
childbearing	PMC3035602	3566	3578	O	-1	-1	0
age	PMC3035602	3579	3582	O	-1	-1	0
,	PMC3035602	3582	3583	O	-1	-1	0
belongs	PMC3035602	3584	3591	O	-1	-1	0
to	PMC3035602	3592	3594	O	-1	-1	0
cancers	PMC3035602	3595	3602	O	-1	-1	0
Clinical	PMC3035602	3603	3611	O	-1	-1	0
Epidemiology	PMC3035602	3612	3624	O	-1	-1	0
2011:3	PMC3035602	3625	3631	O	-1	-1	0
7–19	PMC3035602	3632	3636	O	-1	-1	0

©	PMC3035602	3637	3638	O	-1	-1	0
2011	PMC3035602	3639	3643	O	-1	-1	0

Langagergaard	PMC3035602	3644	3657	O	-1	-1	0
,	PMC3035602	3657	3658	O	-1	-1	0
publisher	PMC3035602	3659	3668	O	-1	-1	0
and	PMC3035602	3669	3672	O	-1	-1	0

licensee	PMC3035602	3673	3681	O	-1	-1	0
Dove	PMC3035602	3682	3686	O	-1	-1	0
Medical	PMC3035602	3687	3694	O	-1	-1	0
Press	PMC3035602	3695	3700	O	-1	-1	0
Ltd.	PMC3035602	3701	3705	O	-1	-1	0
This	PMC3035602	3706	3710	O	-1	-1	0
is	PMC3035602	3711	3713	O	-1	-1	0
an	PMC3035602	3714	3716	O	-1	-1	0
Open	PMC3035602	3717	3721	O	-1	-1	0
Access	PMC3035602	3722	3728	O	-1	-1	0
article	PMC3035602	3729	3736	O	-1	-1	0
which	PMC3035602	3737	3742	O	-1	-1	0
permits	PMC3035602	3743	3750	O	-1	-1	0
unrestricted	PMC3035602	3751	3763	O	-1	-1	0
noncommercial	PMC3035602	3764	3777	O	-1	-1	0
use	PMC3035602	3778	3781	O	-1	-1	0
,	PMC3035602	3781	3782	O	-1	-1	0
provided	PMC3035602	3783	3791	O	-1	-1	0
the	PMC3035602	3792	3795	O	-1	-1	0
original	PMC3035602	3796	3804	O	-1	-1	0
work	PMC3035602	3805	3809	O	-1	-1	0
is	PMC3035602	3810	3812	O	-1	-1	0
properly	PMC3035602	3813	3821	O	-1	-1	0
cited	PMC3035602	3822	3827	O	-1	-1	0
.	PMC3035602	3827	3828	O	-1	-1	0


	PMC3035602	3828	3830	O	-1	-1	0

7	PMC3035602	3830	3831	O	-1	-1	0


	PMC3035602	3831	3833	O	-1	-1	0

Dovepress	PMC3035602	3833	3842	O	-1	-1	0


	PMC3035602	3842	3844	O	-1	-1	0

Langagergaard	PMC3035602	3844	3857	O	-1	-1	0


	PMC3035602	3857	3859	O	-1	-1	0
with	PMC3035602	3859	3863	O	-1	-1	0
a	PMC3035602	3864	3865	O	-1	-1	0
good	PMC3035602	3866	3870	O	-1	-1	0

prognosis.4	PMC3035602	3871	3882	O	-1	-1	0

While	PMC3035602	3883	3888	O	-1	-1	0
in	PMC3035602	3889	3891	O	-1	-1	0
previous	PMC3035602	3892	3900	O	-1	-1	0
decades	PMC3035602	3901	3908	O	-1	-1	0
­pregnancy	PMC3035602	3909	3919	O	-1	-1	0
in	PMC3035602	3920	3922	O	-1	-1	0
patients	PMC3035602	3923	3931	O	-1	-1	0
with	PMC3035602	3932	3936	O	-1	-1	0
a	PMC3035602	3937	3938	O	-1	-1	0
history	PMC3035602	3939	3946	O	-1	-1	0
of	PMC3035602	3947	3949	O	-1	-1	0
cancer	PMC3035602	3950	3956	O	-1	-1	0
was	PMC3035602	3957	3960	O	-1	-1	0
discouraged,5	PMC3035602	3961	3974	O	-1	-1	0

currently	PMC3035602	3975	3984	O	-1	-1	0
such	PMC3035602	3985	3989	O	-1	-1	0
pregnancies	PMC3035602	3990	4001	O	-1	-1	0
are	PMC3035602	4002	4005	O	-1	-1	0
treated	PMC3035602	4006	4013	O	-1	-1	0
with	PMC3035602	4014	4018	O	-1	-1	0
more	PMC3035602	4019	4023	O	-1	-1	0
optimism	PMC3035602	4024	4032	O	-1	-1	0
,	PMC3035602	4032	4033	O	-1	-1	0
partly	PMC3035602	4034	4040	O	-1	-1	0
owing	PMC3035602	4041	4046	O	-1	-1	0
to	PMC3035602	4047	4049	O	-1	-1	0
the	PMC3035602	4050	4053	O	-1	-1	0
improved	PMC3035602	4054	4062	O	-1	-1	0
prognosis	PMC3035602	4063	4072	O	-1	-1	0
for	PMC3035602	4073	4076	O	-1	-1	0
several	PMC3035602	4077	4084	O	-1	-1	0
cancers,6	PMC3035602	4085	4094	O	-1	-1	0
and	PMC3035602	4095	4098	O	-1	-1	0
partly	PMC3035602	4099	4105	O	-1	-1	0
because	PMC3035602	4106	4113	O	-1	-1	0
pregnancies	PMC3035602	4114	4125	O	-1	-1	0
subsequent	PMC3035602	4126	4136	O	-1	-1	0
to	PMC3035602	4137	4139	O	-1	-1	0
breast	PMC3035602	4140	4146	O	-1	-1	0
cancer	PMC3035602	4147	4153	O	-1	-1	0
,	PMC3035602	4153	4154	O	-1	-1	0

for	PMC3035602	4155	4158	O	-1	-1	0
example	PMC3035602	4159	4166	O	-1	-1	0
,	PMC3035602	4166	4167	O	-1	-1	0
do	PMC3035602	4168	4170	O	-1	-1	0
not	PMC3035602	4171	4174	O	-1	-1	0
seem	PMC3035602	4175	4179	O	-1	-1	0
to	PMC3035602	4180	4182	O	-1	-1	0
adversely	PMC3035602	4183	4192	O	-1	-1	0
affect	PMC3035602	4193	4199	O	-1	-1	0
maternal	PMC3035602	4200	4208	O	-1	-1	0
life	PMC3035602	4209	4213	O	-1	-1	0

expectancy.7–9	PMC3035602	4214	4228	O	-1	-1	0

Because	PMC3035602	4229	4236	O	-1	-1	0
of	PMC3035602	4237	4239	O	-1	-1	0
a	PMC3035602	4240	4241	O	-1	-1	0
growing	PMC3035602	4242	4249	O	-1	-1	0
population	PMC3035602	4250	4260	O	-1	-1	0
of	PMC3035602	4261	4263	O	-1	-1	0
young	PMC3035602	4264	4269	O	-1	-1	0
­cancer	PMC3035602	4270	4277	O	-1	-1	0
survivors	PMC3035602	4278	4287	O	-1	-1	0
,	PMC3035602	4287	4288	O	-1	-1	0
however	PMC3035602	4289	4296	O	-1	-1	0
,	PMC3035602	4296	4297	O	-1	-1	0
concerns	PMC3035602	4298	4306	O	-1	-1	0
have	PMC3035602	4307	4311	O	-1	-1	0
been	PMC3035602	4312	4316	O	-1	-1	0
raised	PMC3035602	4317	4323	O	-1	-1	0
about	PMC3035602	4324	4329	O	-1	-1	0
the	PMC3035602	4330	4333	O	-1	-1	0
adverse	PMC3035602	4334	4341	O	-1	-1	0
effects	PMC3035602	4342	4349	O	-1	-1	0
of	PMC3035602	4350	4352	O	-1	-1	0
cancer	PMC3035602	4353	4359	O	-1	-1	0
and	PMC3035602	4360	4363	O	-1	-1	0
cancer	PMC3035602	4364	4370	O	-1	-1	0
therapy	PMC3035602	4371	4378	O	-1	-1	0
on	PMC3035602	4379	4381	O	-1	-1	0
the	PMC3035602	4382	4385	O	-1	-1	0
offspring	PMC3035602	4386	4395	O	-1	-1	0
of	PMC3035602	4396	4398	O	-1	-1	0
the	PMC3035602	4399	4402	O	-1	-1	0
treated	PMC3035602	4403	4410	O	-1	-1	0
individuals.10	PMC3035602	4411	4425	O	-1	-1	0
Offspring	PMC3035602	4426	4435	O	-1	-1	0
include	PMC3035602	4436	4443	O	-1	-1	0
those	PMC3035602	4444	4449	O	-1	-1	0
conceived	PMC3035602	4450	4459	O	-1	-1	0
after	PMC3035602	4460	4465	O	-1	-1	0
completion	PMC3035602	4466	4476	O	-1	-1	0
of	PMC3035602	4477	4479	O	-1	-1	0
treatment	PMC3035602	4480	4489	O	-1	-1	0
,	PMC3035602	4489	4490	O	-1	-1	0
and	PMC3035602	4491	4494	O	-1	-1	0
fetuses	PMC3035602	4495	4502	O	-1	-1	0
exposed	PMC3035602	4503	4510	O	-1	-1	0
to	PMC3035602	4511	4513	O	-1	-1	0
cancer	PMC3035602	4514	4520	O	-1	-1	0
therapy	PMC3035602	4521	4528	O	-1	-1	0
in	PMC3035602	4529	4531	O	-1	-1	0
utero	PMC3035602	4532	4537	O	-1	-1	0
.	PMC3035602	4537	4538	O	-1	-1	0

Data	PMC3035602	4539	4543	O	-1	-1	0
on	PMC3035602	4544	4546	O	-1	-1	0
birth	PMC3035602	4547	4552	O	-1	-1	0
outcome	PMC3035602	4553	4560	O	-1	-1	0
in	PMC3035602	4561	4563	O	-1	-1	0
women	PMC3035602	4564	4569	O	-1	-1	0
diagnosed	PMC3035602	4570	4579	O	-1	-1	0
with	PMC3035602	4580	4584	O	-1	-1	0
cancer	PMC3035602	4585	4591	O	-1	-1	0
before	PMC3035602	4592	4598	O	-1	-1	0
,	PMC3035602	4598	4599	O	-1	-1	0
during	PMC3035602	4600	4606	O	-1	-1	0
,	PMC3035602	4606	4607	O	-1	-1	0
or	PMC3035602	4608	4610	O	-1	-1	0
shortly	PMC3035602	4611	4618	O	-1	-1	0
after	PMC3035602	4619	4624	O	-1	-1	0
pregnancy	PMC3035602	4625	4634	O	-1	-1	0
are	PMC3035602	4635	4638	O	-1	-1	0
very	PMC3035602	4639	4643	O	-1	-1	0
sparse	PMC3035602	4644	4650	O	-1	-1	0
.	PMC3035602	4650	4651	O	-1	-1	0

Thus	PMC3035602	4652	4656	O	-1	-1	0
the	PMC3035602	4657	4660	O	-1	-1	0
purpose	PMC3035602	4661	4668	O	-1	-1	0
of	PMC3035602	4669	4671	O	-1	-1	0
this	PMC3035602	4672	4676	O	-1	-1	0
review	PMC3035602	4677	4683	O	-1	-1	0
was	PMC3035602	4684	4687	O	-1	-1	0
to	PMC3035602	4688	4690	O	-1	-1	0
summarize	PMC3035602	4691	4700	O	-1	-1	0
the	PMC3035602	4701	4704	O	-1	-1	0
existing	PMC3035602	4705	4713	O	-1	-1	0
epidemiologic	PMC3035602	4714	4727	O	-1	-1	0
evidence	PMC3035602	4728	4736	O	-1	-1	0
of	PMC3035602	4737	4739	O	-1	-1	0
the	PMC3035602	4740	4743	O	-1	-1	0
adverse	PMC3035602	4744	4751	O	-1	-1	0
effect	PMC3035602	4752	4758	O	-1	-1	0
of	PMC3035602	4759	4761	O	-1	-1	0
breast	PMC3035602	4762	4768	O	-1	-1	0
cancer	PMC3035602	4769	4775	O	-1	-1	0
,	PMC3035602	4775	4776	O	-1	-1	0
cutaneous	PMC3035602	4777	4786	O	-1	-1	0
malignant	PMC3035602	4787	4796	O	-1	-1	0
melanoma	PMC3035602	4797	4805	O	-1	-1	0
,	PMC3035602	4805	4806	O	-1	-1	0
and	PMC3035602	4807	4810	O	-1	-1	0
Hodgkin	PMC3035602	4811	4818	O	-1	-1	0
’s	PMC3035602	4818	4820	O	-1	-1	0
disease	PMC3035602	4821	4828	O	-1	-1	0
on	PMC3035602	4829	4831	O	-1	-1	0
birth	PMC3035602	4832	4837	O	-1	-1	0
outcome	PMC3035602	4838	4845	O	-1	-1	0
.	PMC3035602	4845	4846	O	-1	-1	0


	PMC3035602	4846	4848	O	-1	-1	0

Incidence	PMC3035602	4848	4857	O	-1	-1	0
of	PMC3035602	4858	4860	O	-1	-1	0
breast	PMC3035602	4861	4867	O	-1	-1	0
cancer	PMC3035602	4868	4874	O	-1	-1	0
,	PMC3035602	4874	4875	O	-1	-1	0
cutaneous	PMC3035602	4876	4885	O	-1	-1	0
malignant	PMC3035602	4886	4895	O	-1	-1	0
melanoma	PMC3035602	4896	4904	O	-1	-1	0
,	PMC3035602	4904	4905	O	-1	-1	0
and	PMC3035602	4906	4909	O	-1	-1	0
Hodgkin	PMC3035602	4910	4917	O	-1	-1	0
’s	PMC3035602	4917	4919	O	-1	-1	0

disease	PMC3035602	4920	4927	O	-1	-1	0
in	PMC3035602	4928	4930	O	-1	-1	0
women	PMC3035602	4931	4936	O	-1	-1	0
of	PMC3035602	4937	4939	O	-1	-1	0
childbearing	PMC3035602	4940	4952	O	-1	-1	0
age	PMC3035602	4953	4956	O	-1	-1	0

Breast	PMC3035602	4957	4963	O	-1	-1	0
cancer	PMC3035602	4964	4970	O	-1	-1	0

Breast	PMC3035602	4971	4977	O	-1	-1	0
cancer	PMC3035602	4978	4984	O	-1	-1	0
is	PMC3035602	4985	4987	O	-1	-1	0
the	PMC3035602	4988	4991	O	-1	-1	0
most	PMC3035602	4992	4996	O	-1	-1	0
common	PMC3035602	4997	5003	O	-1	-1	0
female	PMC3035602	5004	5010	O	-1	-1	0
cancer	PMC3035602	5011	5017	O	-1	-1	0
in	PMC3035602	5018	5020	O	-1	-1	0
­Denmark	PMC3035602	5021	5029	O	-1	-1	0

with	PMC3035602	5030	5034	O	-1	-1	0
more	PMC3035602	5035	5039	O	-1	-1	0
than	PMC3035602	5040	5044	O	-1	-1	0
4000	PMC3035602	5045	5049	O	-1	-1	0
women	PMC3035602	5050	5055	O	-1	-1	0
diagnosed	PMC3035602	5056	5065	O	-1	-1	0
every	PMC3035602	5066	5071	O	-1	-1	0
year	PMC3035602	5072	5076	O	-1	-1	0
(	PMC3035602	5077	5078	O	-1	-1	0
approximately	PMC3035602	5078	5091	O	-1	-1	0
400	PMC3035602	5092	5095	O	-1	-1	0
women	PMC3035602	5096	5101	O	-1	-1	0
are	PMC3035602	5102	5105	O	-1	-1	0
younger	PMC3035602	5106	5113	O	-1	-1	0
than	PMC3035602	5114	5118	O	-1	-1	0
45	PMC3035602	5119	5121	O	-1	-1	0
years	PMC3035602	5122	5127	O	-1	-1	0
of	PMC3035602	5128	5130	O	-1	-1	0
age	PMC3035602	5131	5134	O	-1	-1	0
at	PMC3035602	5135	5137	O	-1	-1	0
the	PMC3035602	5138	5141	O	-1	-1	0
time	PMC3035602	5142	5146	O	-1	-1	0
of	PMC3035602	5147	5149	O	-1	-1	0
diagnosis).3	PMC3035602	5150	5162	O	-1	-1	0

The	PMC3035602	5163	5166	O	-1	-1	0
age	PMC3035602	5167	5170	O	-1	-1	0
-	PMC3035602	5170	5171	O	-1	-1	0
standardized	PMC3035602	5171	5183	O	-1	-1	0
­incidence	PMC3035602	5184	5194	O	-1	-1	0
rate	PMC3035602	5195	5199	O	-1	-1	0
of	PMC3035602	5200	5202	O	-1	-1	0
breast	PMC3035602	5203	5209	O	-1	-1	0
cancer	PMC3035602	5210	5216	O	-1	-1	0
has	PMC3035602	5217	5220	O	-1	-1	0
almost	PMC3035602	5221	5227	O	-1	-1	0
doubled	PMC3035602	5228	5235	O	-1	-1	0
over	PMC3035602	5236	5240	O	-1	-1	0
the	PMC3035602	5241	5244	O	-1	-1	0
last	PMC3035602	5245	5249	O	-1	-1	0
4	PMC3035602	5250	5251	O	-1	-1	0
decades	PMC3035602	5252	5259	O	-1	-1	0
,	PMC3035602	5259	5260	O	-1	-1	0
but	PMC3035602	5261	5264	O	-1	-1	0
this	PMC3035602	5265	5269	O	-1	-1	0
increase	PMC3035602	5270	5278	O	-1	-1	0
is	PMC3035602	5279	5281	O	-1	-1	0
mainly	PMC3035602	5282	5288	O	-1	-1	0
confined	PMC3035602	5289	5297	O	-1	-1	0
to	PMC3035602	5298	5300	O	-1	-1	0
women	PMC3035602	5301	5306	O	-1	-1	0
aged	PMC3035602	5307	5311	O	-1	-1	0
between	PMC3035602	5312	5319	O	-1	-1	0
45	PMC3035602	5320	5322	O	-1	-1	0
and	PMC3035602	5323	5326	O	-1	-1	0
75	PMC3035602	5327	5329	O	-1	-1	0
years.11	PMC3035602	5330	5338	O	-1	-1	0

The	PMC3035602	5339	5342	O	-1	-1	0
incidence	PMC3035602	5343	5352	O	-1	-1	0
of	PMC3035602	5353	5355	O	-1	-1	0
breast	PMC3035602	5356	5362	O	-1	-1	0
cancer	PMC3035602	5363	5369	O	-1	-1	0
in	PMC3035602	5370	5372	O	-1	-1	0
­pregnancy	PMC3035602	5373	5383	O	-1	-1	0
is	PMC3035602	5384	5386	O	-1	-1	0
unknown	PMC3035602	5387	5394	O	-1	-1	0
,	PMC3035602	5394	5395	O	-1	-1	0
but	PMC3035602	5396	5399	O	-1	-1	0
is	PMC3035602	5400	5402	O	-1	-1	0
estimated	PMC3035602	5403	5412	O	-1	-1	0
to	PMC3035602	5413	5415	O	-1	-1	0
range	PMC3035602	5416	5421	O	-1	-1	0
from	PMC3035602	5422	5426	O	-1	-1	0
1	PMC3035602	5427	5428	O	-1	-1	0
in	PMC3035602	5429	5431	O	-1	-1	0
3000	PMC3035602	5432	5436	O	-1	-1	0
to	PMC3035602	5437	5439	O	-1	-1	0
1	PMC3035602	5440	5441	O	-1	-1	0
in	PMC3035602	5442	5444	O	-1	-1	0
10,000	PMC3035602	5445	5451	O	-1	-1	0
pregnancies.12	PMC3035602	5452	5466	O	-1	-1	0


	PMC3035602	5466	5468	O	-1	-1	0

Cutaneous	PMC3035602	5468	5477	O	-1	-1	0
malignant	PMC3035602	5478	5487	O	-1	-1	0
melanoma	PMC3035602	5488	5496	O	-1	-1	0

For	PMC3035602	5497	5500	O	-1	-1	0
decades	PMC3035602	5501	5508	O	-1	-1	0
,	PMC3035602	5508	5509	O	-1	-1	0
the	PMC3035602	5510	5513	O	-1	-1	0
incidence	PMC3035602	5514	5523	O	-1	-1	0
of	PMC3035602	5524	5526	O	-1	-1	0
cutaneous	PMC3035602	5527	5536	O	-1	-1	0
malignant	PMC3035602	5537	5546	O	-1	-1	0
melanoma	PMC3035602	5547	5555	O	-1	-1	0
has	PMC3035602	5556	5559	O	-1	-1	0
been	PMC3035602	5560	5564	O	-1	-1	0
rising	PMC3035602	5565	5571	O	-1	-1	0
in	PMC3035602	5572	5574	O	-1	-1	0
most	PMC3035602	5575	5579	O	-1	-1	0
white	PMC3035602	5580	5585	O	-1	-1	0
populations	PMC3035602	5586	5597	O	-1	-1	0
around	PMC3035602	5598	5604	O	-1	-1	0
the	PMC3035602	5605	5608	O	-1	-1	0
world.13	PMC3035602	5609	5617	O	-1	-1	0

In	PMC3035602	5618	5620	O	-1	-1	0
Denmark	PMC3035602	5621	5628	B-Location	-1	-1	0
,	PMC3035602	5628	5629	O	-1	-1	0
the	PMC3035602	5630	5633	O	-1	-1	0
incidence	PMC3035602	5634	5643	O	-1	-1	0
of	PMC3035602	5644	5646	O	-1	-1	0
melanoma	PMC3035602	5647	5655	O	-1	-1	0
for	PMC3035602	5656	5659	O	-1	-1	0
women	PMC3035602	5660	5665	O	-1	-1	0
aged	PMC3035602	5666	5670	O	-1	-1	0
15	PMC3035602	5671	5673	O	-1	-1	0
to	PMC3035602	5674	5676	O	-1	-1	0
34	PMC3035602	5677	5679	O	-1	-1	0
years	PMC3035602	5680	5685	O	-1	-1	0
increased	PMC3035602	5686	5695	O	-1	-1	0
,	PMC3035602	5695	5696	O	-1	-1	0
on	PMC3035602	5697	5699	O	-1	-1	0
average	PMC3035602	5700	5707	O	-1	-1	0
,	PMC3035602	5707	5708	O	-1	-1	0
by	PMC3035602	5709	5711	O	-1	-1	0
4.3	PMC3035602	5712	5715	O	-1	-1	0
%	PMC3035602	5715	5716	O	-1	-1	0
annually	PMC3035602	5717	5725	O	-1	-1	0
from	PMC3035602	5726	5730	O	-1	-1	0
1970	PMC3035602	5731	5735	O	-1	-1	0
to	PMC3035602	5736	5738	O	-1	-1	0
1999,14	PMC3035602	5739	5746	O	-1	-1	0
and	PMC3035602	5747	5750	O	-1	-1	0
in	PMC3035602	5751	5753	O	-1	-1	0
recent	PMC3035602	5754	5760	O	-1	-1	0
years	PMC3035602	5761	5766	O	-1	-1	0
,	PMC3035602	5766	5767	O	-1	-1	0
approximately	PMC3035602	5768	5781	O	-1	-1	0
270	PMC3035602	5782	5785	O	-1	-1	0
Danish	PMC3035602	5786	5792	O	-1	-1	0
women	PMC3035602	5793	5798	O	-1	-1	0
younger	PMC3035602	5799	5806	O	-1	-1	0
than	PMC3035602	5807	5811	O	-1	-1	0
45	PMC3035602	5812	5814	O	-1	-1	0
years	PMC3035602	5815	5820	O	-1	-1	0
have	PMC3035602	5821	5825	O	-1	-1	0
been	PMC3035602	5826	5830	O	-1	-1	0
­diagnosed	PMC3035602	5831	5841	O	-1	-1	0
annually	PMC3035602	5842	5850	O	-1	-1	0
with	PMC3035602	5851	5855	O	-1	-1	0
melanoma	PMC3035602	5856	5864	O	-1	-1	0
.	PMC3035602	5864	5865	O	-1	-1	0

3	PMC3035602	5866	5867	O	-1	-1	0

It	PMC3035602	5868	5870	O	-1	-1	0
has	PMC3035602	5871	5874	O	-1	-1	0
been	PMC3035602	5875	5879	O	-1	-1	0
estimated	PMC3035602	5880	5889	O	-1	-1	0
that	PMC3035602	5890	5894	O	-1	-1	0
melanoma	PMC3035602	5895	5903	O	-1	-1	0
represents	PMC3035602	5904	5914	O	-1	-1	0
approximately	PMC3035602	5915	5928	O	-1	-1	0
8	PMC3035602	5929	5930	O	-1	-1	0
%	PMC3035602	5930	5931	O	-1	-1	0
of	PMC3035602	5932	5934	O	-1	-1	0
malignancies	PMC3035602	5935	5947	O	-1	-1	0
diagnosed	PMC3035602	5948	5957	O	-1	-1	0
during	PMC3035602	5958	5964	O	-1	-1	0
pregnancy.15	PMC3035602	5965	5977	O	-1	-1	0


	PMC3035602	5977	5979	O	-1	-1	0

Hodgkin	PMC3035602	5979	5986	O	-1	-1	0
’s	PMC3035602	5986	5988	O	-1	-1	0

disease	PMC3035602	5989	5996	O	-1	-1	0

Hodgkin	PMC3035602	5997	6004	O	-1	-1	0
’s	PMC3035602	6004	6006	O	-1	-1	0
disease	PMC3035602	6007	6014	O	-1	-1	0
is	PMC3035602	6015	6017	O	-1	-1	0
characterized	PMC3035602	6018	6031	O	-1	-1	0
by	PMC3035602	6032	6034	O	-1	-1	0
a	PMC3035602	6035	6036	O	-1	-1	0
bimodal	PMC3035602	6037	6044	O	-1	-1	0
age	PMC3035602	6045	6048	O	-1	-1	0
­incidence	PMC3035602	6049	6059	O	-1	-1	0
curve	PMC3035602	6060	6065	O	-1	-1	0
,	PMC3035602	6065	6066	O	-1	-1	0
with	PMC3035602	6067	6071	O	-1	-1	0
the	PMC3035602	6072	6075	O	-1	-1	0
first	PMC3035602	6076	6081	O	-1	-1	0
peak	PMC3035602	6082	6086	O	-1	-1	0
in	PMC3035602	6087	6089	O	-1	-1	0
young	PMC3035602	6090	6095	O	-1	-1	0
adults	PMC3035602	6096	6102	O	-1	-1	0
and	PMC3035602	6103	6106	O	-1	-1	0
the	PMC3035602	6107	6110	O	-1	-1	0
second	PMC3035602	6111	6117	O	-1	-1	0
in	PMC3035602	6118	6120	O	-1	-1	0
old	PMC3035602	6121	6124	O	-1	-1	0
-	PMC3035602	6124	6125	O	-1	-1	0
age	PMC3035602	6125	6128	O	-1	-1	0
groups.16	PMC3035602	6129	6138	O	-1	-1	0

While	PMC3035602	6139	6144	O	-1	-1	0
age	PMC3035602	6145	6148	O	-1	-1	0
standardized	PMC3035602	6149	6161	O	-1	-1	0
incidence	PMC3035602	6162	6171	O	-1	-1	0
of	PMC3035602	6172	6174	O	-1	-1	0
Hodgkin	PMC3035602	6175	6182	O	-1	-1	0

’s	PMC3035602	6182	6184	O	-1	-1	0
disease	PMC3035602	6185	6192	O	-1	-1	0
has	PMC3035602	6193	6196	O	-1	-1	0
been	PMC3035602	6197	6201	O	-1	-1	0
declining	PMC3035602	6202	6211	O	-1	-1	0
slightly	PMC3035602	6212	6220	O	-1	-1	0
over	PMC3035602	6221	6225	O	-1	-1	0
time	PMC3035602	6226	6230	O	-1	-1	0
,	PMC3035602	6230	6231	O	-1	-1	0

the	PMC3035602	6232	6235	O	-1	-1	0


	PMC3035602	6235	6237	O	-1	-1	0
8	PMC3035602	6237	6238	O	-1	-1	0


	PMC3035602	6238	6240	O	-1	-1	0
submit	PMC3035602	6240	6246	O	-1	-1	0
your	PMC3035602	6247	6251	O	-1	-1	0
manuscript	PMC3035602	6252	6262	O	-1	-1	0

|	PMC3035602	6263	6264	O	-1	-1	0

www.dovepress.com	PMC3035602	6265	6282	O	-1	-1	0


	PMC3035602	6282	6284	O	-1	-1	0

Dovepress	PMC3035602	6284	6293	O	-1	-1	0


	PMC3035602	6293	6295	O	-1	-1	0

true	PMC3035602	6295	6299	O	-1	-1	0
incidence	PMC3035602	6300	6309	O	-1	-1	0
in	PMC3035602	6310	6312	O	-1	-1	0
older	PMC3035602	6313	6318	O	-1	-1	0
age	PMC3035602	6319	6322	O	-1	-1	0
groups	PMC3035602	6323	6329	O	-1	-1	0
has	PMC3035602	6330	6333	O	-1	-1	0
in	PMC3035602	6334	6336	O	-1	-1	0
fact	PMC3035602	6337	6341	O	-1	-1	0
decreased	PMC3035602	6342	6351	O	-1	-1	0
substantially	PMC3035602	6352	6365	O	-1	-1	0
,	PMC3035602	6365	6366	O	-1	-1	0
whilst	PMC3035602	6367	6373	O	-1	-1	0
among	PMC3035602	6374	6379	O	-1	-1	0
young	PMC3035602	6380	6385	O	-1	-1	0
adults	PMC3035602	6386	6392	O	-1	-1	0
in	PMC3035602	6393	6395	O	-1	-1	0
industrialized	PMC3035602	6396	6410	O	-1	-1	0
countries	PMC3035602	6411	6420	O	-1	-1	0
increases	PMC3035602	6421	6430	O	-1	-1	0
have	PMC3035602	6431	6435	O	-1	-1	0
been	PMC3035602	6436	6440	O	-1	-1	0
documented.16	PMC3035602	6441	6454	O	-1	-1	0
In	PMC3035602	6455	6457	O	-1	-1	0
2000	PMC3035602	6458	6462	O	-1	-1	0
,	PMC3035602	6462	6463	O	-1	-1	0

29	PMC3035602	6464	6466	O	-1	-1	0
women	PMC3035602	6467	6472	O	-1	-1	0
younger	PMC3035602	6473	6480	O	-1	-1	0
than	PMC3035602	6481	6485	O	-1	-1	0
45	PMC3035602	6486	6488	O	-1	-1	0
years	PMC3035602	6489	6494	O	-1	-1	0
of	PMC3035602	6495	6497	O	-1	-1	0
age	PMC3035602	6498	6501	O	-1	-1	0
were	PMC3035602	6502	6506	O	-1	-1	0
diagnosed	PMC3035602	6507	6516	O	-1	-1	0
with	PMC3035602	6517	6521	O	-1	-1	0
Hodgkin	PMC3035602	6522	6529	O	-1	-1	0
’s	PMC3035602	6529	6531	O	-1	-1	0
disease	PMC3035602	6532	6539	O	-1	-1	0
in	PMC3035602	6540	6542	O	-1	-1	0
Denmark.17	PMC3035602	6543	6553	B-Location	-1	-1	0
Hodgkin	PMC3035602	6554	6561	O	-1	-1	0

’s	PMC3035602	6561	6563	O	-1	-1	0
disease	PMC3035602	6564	6571	O	-1	-1	0
during	PMC3035602	6572	6578	O	-1	-1	0
pregnancy	PMC3035602	6579	6588	O	-1	-1	0
has	PMC3035602	6589	6592	O	-1	-1	0
a	PMC3035602	6593	6594	O	-1	-1	0
reported	PMC3035602	6595	6603	O	-1	-1	0
incidence	PMC3035602	6604	6613	O	-1	-1	0
ranging	PMC3035602	6614	6621	O	-1	-1	0
from	PMC3035602	6622	6626	O	-1	-1	0
1	PMC3035602	6627	6628	O	-1	-1	0
per	PMC3035602	6629	6632	O	-1	-1	0
100,000	PMC3035602	6633	6640	O	-1	-1	0
to	PMC3035602	6641	6643	O	-1	-1	0
1	PMC3035602	6644	6645	O	-1	-1	0
per	PMC3035602	6646	6649	O	-1	-1	0
6000	PMC3035602	6650	6654	O	-1	-1	0
deliveries.18,19	PMC3035602	6655	6671	O	-1	-1	0


	PMC3035602	6671	6673	O	-1	-1	0
Definition	PMC3035602	6673	6683	O	-1	-1	0
of	PMC3035602	6684	6686	O	-1	-1	0
birth	PMC3035602	6687	6692	O	-1	-1	0
outcomes	PMC3035602	6693	6701	O	-1	-1	0

This	PMC3035602	6702	6706	O	-1	-1	0
review	PMC3035602	6707	6713	O	-1	-1	0
focuses	PMC3035602	6714	6721	O	-1	-1	0
on	PMC3035602	6722	6724	O	-1	-1	0
the	PMC3035602	6725	6728	O	-1	-1	0
prevalence	PMC3035602	6729	6739	O	-1	-1	0
of	PMC3035602	6740	6742	O	-1	-1	0
specific	PMC3035602	6743	6751	O	-1	-1	0
birth	PMC3035602	6752	6757	O	-1	-1	0
outcomes	PMC3035602	6758	6766	O	-1	-1	0
for	PMC3035602	6767	6770	O	-1	-1	0
children	PMC3035602	6771	6779	O	-1	-1	0
of	PMC3035602	6780	6782	O	-1	-1	0
cancer	PMC3035602	6783	6789	O	-1	-1	0
patients	PMC3035602	6790	6798	O	-1	-1	0
.	PMC3035602	6798	6799	O	-1	-1	0

It	PMC3035602	6800	6802	O	-1	-1	0
does	PMC3035602	6803	6807	O	-1	-1	0
not	PMC3035602	6808	6811	O	-1	-1	0
examine	PMC3035602	6812	6819	O	-1	-1	0
the	PMC3035602	6820	6823	O	-1	-1	0
risk	PMC3035602	6824	6828	O	-1	-1	0
of	PMC3035602	6829	6831	O	-1	-1	0
spontaneous	PMC3035602	6832	6843	O	-1	-1	0
or	PMC3035602	6844	6846	O	-1	-1	0
induced	PMC3035602	6847	6854	O	-1	-1	0
abortions	PMC3035602	6855	6864	O	-1	-1	0
,	PMC3035602	6864	6865	O	-1	-1	0
or	PMC3035602	6866	6868	O	-1	-1	0
diseases	PMC3035602	6869	6877	O	-1	-1	0
diagnosed	PMC3035602	6878	6887	O	-1	-1	0
later	PMC3035602	6888	6893	O	-1	-1	0
in	PMC3035602	6894	6896	O	-1	-1	0
life	PMC3035602	6897	6901	O	-1	-1	0
.	PMC3035602	6901	6902	O	-1	-1	0

The	PMC3035602	6903	6906	O	-1	-1	0
birth	PMC3035602	6907	6912	O	-1	-1	0
outcomes	PMC3035602	6913	6921	O	-1	-1	0
examined	PMC3035602	6922	6930	O	-1	-1	0
are	PMC3035602	6931	6934	O	-1	-1	0
defined	PMC3035602	6935	6942	O	-1	-1	0
below	PMC3035602	6943	6948	O	-1	-1	0
:	PMC3035602	6948	6949	O	-1	-1	0


	PMC3035602	6949	6951	O	-1	-1	0

Preterm	PMC3035602	6951	6958	O	-1	-1	0
birth	PMC3035602	6959	6964	O	-1	-1	0

Preterm	PMC3035602	6965	6972	O	-1	-1	0
birth	PMC3035602	6973	6978	O	-1	-1	0
is	PMC3035602	6979	6981	O	-1	-1	0
defined	PMC3035602	6982	6989	O	-1	-1	0
as	PMC3035602	6990	6992	O	-1	-1	0
delivery	PMC3035602	6993	7001	O	-1	-1	0
before	PMC3035602	7002	7008	O	-1	-1	0
37	PMC3035602	7009	7011	O	-1	-1	0
completed	PMC3035602	7012	7021	O	-1	-1	0
weeks	PMC3035602	7022	7027	O	-1	-1	0
of	PMC3035602	7028	7030	O	-1	-1	0
gestation	PMC3035602	7031	7040	O	-1	-1	0
.	PMC3035602	7040	7041	O	-1	-1	0

The	PMC3035602	7042	7045	O	-1	-1	0
time	PMC3035602	7046	7050	O	-1	-1	0
of	PMC3035602	7051	7053	O	-1	-1	0
delivery	PMC3035602	7054	7062	O	-1	-1	0
depends	PMC3035602	7063	7070	O	-1	-1	0
both	PMC3035602	7071	7075	O	-1	-1	0
on	PMC3035602	7076	7078	O	-1	-1	0
the	PMC3035602	7079	7082	O	-1	-1	0
natural	PMC3035602	7083	7090	O	-1	-1	0
course	PMC3035602	7091	7097	O	-1	-1	0
of	PMC3035602	7098	7100	O	-1	-1	0
the	PMC3035602	7101	7104	O	-1	-1	0
pregnancy	PMC3035602	7105	7114	O	-1	-1	0
and	PMC3035602	7115	7118	O	-1	-1	0
on	PMC3035602	7119	7121	O	-1	-1	0
clinical	PMC3035602	7122	7130	O	-1	-1	0
­interventions	PMC3035602	7131	7145	O	-1	-1	0
,	PMC3035602	7145	7146	O	-1	-1	0
which	PMC3035602	7147	7152	O	-1	-1	0
may	PMC3035602	7153	7156	O	-1	-1	0
either	PMC3035602	7157	7163	O	-1	-1	0
shorten	PMC3035602	7164	7171	O	-1	-1	0
or	PMC3035602	7172	7174	O	-1	-1	0
prolong	PMC3035602	7175	7182	O	-1	-1	0
­gestation	PMC3035602	7183	7193	O	-1	-1	0
.	PMC3035602	7193	7194	O	-1	-1	0

Given	PMC3035602	7195	7200	O	-1	-1	0
this	PMC3035602	7201	7205	O	-1	-1	0
mixture	PMC3035602	7206	7213	O	-1	-1	0
of	PMC3035602	7214	7216	O	-1	-1	0
spontaneous	PMC3035602	7217	7228	O	-1	-1	0
events	PMC3035602	7229	7235	O	-1	-1	0
and	PMC3035602	7236	7239	O	-1	-1	0
effects	PMC3035602	7240	7247	O	-1	-1	0
of	PMC3035602	7248	7250	O	-1	-1	0
medical	PMC3035602	7251	7258	O	-1	-1	0
interventions	PMC3035602	7259	7272	O	-1	-1	0
,	PMC3035602	7272	7273	O	-1	-1	0
the	PMC3035602	7274	7277	O	-1	-1	0
outcome	PMC3035602	7278	7285	O	-1	-1	0
of	PMC3035602	7286	7288	O	-1	-1	0
preterm	PMC3035602	7289	7296	O	-1	-1	0
birth	PMC3035602	7297	7302	O	-1	-1	0
itself	PMC3035602	7303	7309	O	-1	-1	0
is	PMC3035602	7310	7312	O	-1	-1	0
heterogeneous.20	PMC3035602	7313	7329	O	-1	-1	0


	PMC3035602	7329	7331	O	-1	-1	0

Low	PMC3035602	7331	7334	O	-1	-1	0
birth	PMC3035602	7335	7340	O	-1	-1	0
weight	PMC3035602	7341	7347	O	-1	-1	0

Low	PMC3035602	7348	7351	O	-1	-1	0
birth	PMC3035602	7352	7357	O	-1	-1	0
weight	PMC3035602	7358	7364	O	-1	-1	0
(	PMC3035602	7365	7366	O	-1	-1	0
LBW	PMC3035602	7366	7369	O	-1	-1	0
)	PMC3035602	7369	7370	O	-1	-1	0
is	PMC3035602	7371	7373	O	-1	-1	0
defined	PMC3035602	7374	7381	O	-1	-1	0
as	PMC3035602	7382	7384	O	-1	-1	0
birth	PMC3035602	7385	7390	O	-1	-1	0
weight	PMC3035602	7391	7397	O	-1	-1	0
of	PMC3035602	7398	7400	O	-1	-1	0
less	PMC3035602	7401	7405	O	-1	-1	0
than	PMC3035602	7406	7410	O	-1	-1	0

2500	PMC3035602	7411	7415	O	-1	-1	0
g.	PMC3035602	7416	7418	O	-1	-1	0
Children	PMC3035602	7419	7427	O	-1	-1	0
in	PMC3035602	7428	7430	O	-1	-1	0
this	PMC3035602	7431	7435	O	-1	-1	0
group	PMC3035602	7436	7441	O	-1	-1	0
represent	PMC3035602	7442	7451	O	-1	-1	0
a	PMC3035602	7452	7453	O	-1	-1	0
mix	PMC3035602	7454	7457	O	-1	-1	0
of	PMC3035602	7458	7460	O	-1	-1	0
newborns	PMC3035602	7461	7469	O	-1	-1	0
whose	PMC3035602	7470	7475	O	-1	-1	0
growth	PMC3035602	7476	7482	O	-1	-1	0
is	PMC3035602	7483	7485	O	-1	-1	0
suboptimal	PMC3035602	7486	7496	O	-1	-1	0
,	PMC3035602	7496	7497	O	-1	-1	0
newborns	PMC3035602	7498	7506	O	-1	-1	0
delivered	PMC3035602	7507	7516	O	-1	-1	0
early	PMC3035602	7517	7522	O	-1	-1	0
,	PMC3035602	7522	7523	O	-1	-1	0
and	PMC3035602	7524	7527	O	-1	-1	0
newborns	PMC3035602	7528	7536	O	-1	-1	0
who	PMC3035602	7537	7540	O	-1	-1	0
are	PMC3035602	7541	7544	O	-1	-1	0
small	PMC3035602	7545	7550	O	-1	-1	0
for	PMC3035602	7551	7554	O	-1	-1	0
genetic	PMC3035602	7555	7562	O	-1	-1	0
reasons.20	PMC3035602	7563	7573	O	-1	-1	0

As	PMC3035602	7574	7576	O	-1	-1	0
an	PMC3035602	7577	7579	O	-1	-1	0
alternative	PMC3035602	7580	7591	O	-1	-1	0
,	PMC3035602	7591	7592	O	-1	-1	0
some	PMC3035602	7593	7597	O	-1	-1	0
studies	PMC3035602	7598	7605	O	-1	-1	0
use	PMC3035602	7606	7609	O	-1	-1	0
“	PMC3035602	7610	7611	O	-1	-1	0
LBW	PMC3035602	7611	7614	O	-1	-1	0
at	PMC3035602	7615	7617	O	-1	-1	0
term	PMC3035602	7618	7622	O	-1	-1	0
”	PMC3035602	7622	7623	O	-1	-1	0

(	PMC3035602	7624	7625	O	-1	-1	0
defined	PMC3035602	7625	7632	O	-1	-1	0
as	PMC3035602	7633	7635	O	-1	-1	0
birth	PMC3035602	7636	7641	O	-1	-1	0
weight	PMC3035602	7642	7648	O	-1	-1	0

less	PMC3035602	7649	7653	O	-1	-1	0
than	PMC3035602	7654	7658	O	-1	-1	0
2500	PMC3035602	7659	7663	O	-1	-1	0
g	PMC3035602	7664	7665	O	-1	-1	0
in	PMC3035602	7666	7668	O	-1	-1	0
those	PMC3035602	7669	7674	O	-1	-1	0
born	PMC3035602	7675	7679	O	-1	-1	0
at	PMC3035602	7680	7682	O	-1	-1	0
least	PMC3035602	7683	7688	O	-1	-1	0
37	PMC3035602	7689	7691	O	-1	-1	0
weeks	PMC3035602	7692	7697	O	-1	-1	0

after	PMC3035602	7698	7703	O	-1	-1	0
conception	PMC3035602	7704	7714	O	-1	-1	0
)	PMC3035602	7714	7715	O	-1	-1	0
,	PMC3035602	7715	7716	O	-1	-1	0
which	PMC3035602	7717	7722	O	-1	-1	0
suggests	PMC3035602	7723	7731	O	-1	-1	0
that	PMC3035602	7732	7736	O	-1	-1	0
the	PMC3035602	7737	7740	O	-1	-1	0
child	PMC3035602	7741	7746	O	-1	-1	0
remains	PMC3035602	7747	7754	O	-1	-1	0
small	PMC3035602	7755	7760	O	-1	-1	0
despite	PMC3035602	7761	7768	O	-1	-1	0
having	PMC3035602	7769	7775	O	-1	-1	0
had	PMC3035602	7776	7779	O	-1	-1	0
adequate	PMC3035602	7780	7788	O	-1	-1	0
time	PMC3035602	7789	7793	O	-1	-1	0
for	PMC3035602	7794	7797	O	-1	-1	0
growth.20	PMC3035602	7798	7807	O	-1	-1	0

The	PMC3035602	7808	7811	O	-1	-1	0
presumption	PMC3035602	7812	7823	O	-1	-1	0
is	PMC3035602	7824	7826	O	-1	-1	0
that	PMC3035602	7827	7831	O	-1	-1	0
a	PMC3035602	7832	7833	O	-1	-1	0
child	PMC3035602	7834	7839	O	-1	-1	0
with	PMC3035602	7840	7844	O	-1	-1	0
LBW	PMC3035602	7845	7848	O	-1	-1	0
at	PMC3035602	7849	7851	O	-1	-1	0
term	PMC3035602	7852	7856	O	-1	-1	0
is	PMC3035602	7857	7859	O	-1	-1	0
likely	PMC3035602	7860	7866	O	-1	-1	0
to	PMC3035602	7867	7869	O	-1	-1	0
be	PMC3035602	7870	7872	O	-1	-1	0
growth	PMC3035602	7873	7879	O	-1	-1	0
retarded	PMC3035602	7880	7888	O	-1	-1	0
.	PMC3035602	7888	7889	O	-1	-1	0


	PMC3035602	7889	7891	O	-1	-1	0

Stillbirth	PMC3035602	7891	7901	O	-1	-1	0

In	PMC3035602	7902	7904	O	-1	-1	0
Denmark	PMC3035602	7905	7912	B-Location	-1	-1	0
stillbirth	PMC3035602	7913	7923	O	-1	-1	0
is	PMC3035602	7924	7926	O	-1	-1	0
defined	PMC3035602	7927	7934	O	-1	-1	0
as	PMC3035602	7935	7937	O	-1	-1	0
antepartum	PMC3035602	7938	7948	O	-1	-1	0
or	PMC3035602	7949	7951	O	-1	-1	0
intrapartum	PMC3035602	7952	7963	O	-1	-1	0
fetal	PMC3035602	7964	7969	O	-1	-1	0
death	PMC3035602	7970	7975	O	-1	-1	0
after	PMC3035602	7976	7981	O	-1	-1	0
22	PMC3035602	7982	7984	O	-1	-1	0
completed	PMC3035602	7985	7994	O	-1	-1	0
weeks	PMC3035602	7995	8000	O	-1	-1	0
of	PMC3035602	8001	8003	O	-1	-1	0
pregnancy	PMC3035602	8004	8013	O	-1	-1	0
.	PMC3035602	8013	8014	O	-1	-1	0

Before	PMC3035602	8015	8021	O	-1	-1	0
2004	PMC3035602	8022	8026	O	-1	-1	0
only	PMC3035602	8027	8031	O	-1	-1	0
fetal	PMC3035602	8032	8037	O	-1	-1	0
deaths	PMC3035602	8038	8044	O	-1	-1	0
after	PMC3035602	8045	8050	O	-1	-1	0
28	PMC3035602	8051	8053	O	-1	-1	0
completed	PMC3035602	8054	8063	O	-1	-1	0
weeks	PMC3035602	8064	8069	O	-1	-1	0
of	PMC3035602	8070	8072	O	-1	-1	0
pregnancy	PMC3035602	8073	8082	O	-1	-1	0
were	PMC3035602	8083	8087	O	-1	-1	0
considered	PMC3035602	8088	8098	O	-1	-1	0
stillbirths	PMC3035602	8099	8110	O	-1	-1	0
.	PMC3035602	8110	8111	O	-1	-1	0


	PMC3035602	8111	8113	O	-1	-1	0

Congenital	PMC3035602	8113	8123	O	-1	-1	0
abnormalities	PMC3035602	8124	8137	O	-1	-1	0

Congenital	PMC3035602	8138	8148	O	-1	-1	0
abnormalities	PMC3035602	8149	8162	O	-1	-1	0
occur	PMC3035602	8163	8168	O	-1	-1	0
in	PMC3035602	8169	8171	O	-1	-1	0
3	PMC3035602	8172	8173	O	-1	-1	0
%	PMC3035602	8173	8174	O	-1	-1	0
to	PMC3035602	8175	8177	O	-1	-1	0
5	PMC3035602	8178	8179	O	-1	-1	0
%	PMC3035602	8179	8180	O	-1	-1	0
of	PMC3035602	8181	8183	O	-1	-1	0
all	PMC3035602	8184	8187	O	-1	-1	0
livebirths	PMC3035602	8188	8198	O	-1	-1	0
.	PMC3035602	8198	8199	O	-1	-1	0
20	PMC3035602	8200	8202	O	-1	-1	0

However	PMC3035602	8203	8210	O	-1	-1	0
,	PMC3035602	8210	8211	O	-1	-1	0
each	PMC3035602	8212	8216	O	-1	-1	0
individual	PMC3035602	8217	8227	O	-1	-1	0
type	PMC3035602	8228	8232	O	-1	-1	0
of	PMC3035602	8233	8235	O	-1	-1	0
congenital	PMC3035602	8236	8246	O	-1	-1	0
abnormality	PMC3035602	8247	8258	O	-1	-1	0
is	PMC3035602	8259	8261	O	-1	-1	0
rare	PMC3035602	8262	8266	O	-1	-1	0
,	PMC3035602	8266	8267	O	-1	-1	0
with	PMC3035602	8268	8272	O	-1	-1	0
the	PMC3035602	8273	8276	O	-1	-1	0
most	PMC3035602	8277	8281	O	-1	-1	0
common	PMC3035602	8282	8288	O	-1	-1	0
occurring	PMC3035602	8289	8298	O	-1	-1	0
in	PMC3035602	8299	8301	O	-1	-1	0
about	PMC3035602	8302	8307	O	-1	-1	0
1/1000	PMC3035602	8308	8314	O	-1	-1	0

live	PMC3035602	8315	8319	O	-1	-1	0
births.20	PMC3035602	8320	8329	O	-1	-1	0

The	PMC3035602	8330	8333	O	-1	-1	0
etiologic	PMC3035602	8334	8343	O	-1	-1	0
events	PMC3035602	8344	8350	O	-1	-1	0
that	PMC3035602	8351	8355	O	-1	-1	0
generate	PMC3035602	8356	8364	O	-1	-1	0
structural	PMC3035602	8365	8375	O	-1	-1	0
abnormalities	PMC3035602	8376	8389	O	-1	-1	0
typically	PMC3035602	8390	8399	O	-1	-1	0
occur	PMC3035602	8400	8405	O	-1	-1	0
within	PMC3035602	8406	8412	O	-1	-1	0
the	PMC3035602	8413	8416	O	-1	-1	0
first	PMC3035602	8417	8422	O	-1	-1	0


	PMC3035602	8422	8424	O	-1	-1	0
Clinical	PMC3035602	8424	8432	O	-1	-1	0
Epidemiology	PMC3035602	8433	8445	O	-1	-1	0
2011:3	PMC3035602	8446	8452	O	-1	-1	0


	PMC3035602	8452	8454	O	-1	-1	0

Dovepress	PMC3035602	8454	8463	O	-1	-1	0


	PMC3035602	8463	8465	O	-1	-1	0
2	PMC3035602	8465	8466	O	-1	-1	0
to	PMC3035602	8467	8469	O	-1	-1	0
8	PMC3035602	8470	8471	O	-1	-1	0
weeks	PMC3035602	8472	8477	O	-1	-1	0
post	PMC3035602	8478	8482	O	-1	-1	0
-	PMC3035602	8482	8483	O	-1	-1	0
conception	PMC3035602	8483	8493	O	-1	-1	0
,	PMC3035602	8493	8494	O	-1	-1	0
but	PMC3035602	8495	8498	O	-1	-1	0
the	PMC3035602	8499	8502	O	-1	-1	0
recognition	PMC3035602	8503	8514	O	-1	-1	0
of	PMC3035602	8515	8517	O	-1	-1	0
the	PMC3035602	8518	8521	O	-1	-1	0
abnormality	PMC3035602	8522	8533	O	-1	-1	0
may	PMC3035602	8534	8537	O	-1	-1	0
not	PMC3035602	8538	8541	O	-1	-1	0
occur	PMC3035602	8542	8547	O	-1	-1	0
until	PMC3035602	8548	8553	O	-1	-1	0
later	PMC3035602	8554	8559	O	-1	-1	0
in	PMC3035602	8560	8562	O	-1	-1	0
pregnancy	PMC3035602	8563	8572	O	-1	-1	0
(	PMC3035602	8573	8574	O	-1	-1	0
during	PMC3035602	8574	8580	O	-1	-1	0
ultrasound	PMC3035602	8581	8591	O	-1	-1	0
evaluation	PMC3035602	8592	8602	O	-1	-1	0
)	PMC3035602	8602	8603	O	-1	-1	0
,	PMC3035602	8603	8604	O	-1	-1	0
at	PMC3035602	8605	8607	O	-1	-1	0
birth	PMC3035602	8608	8613	O	-1	-1	0
,	PMC3035602	8613	8614	O	-1	-1	0
in	PMC3035602	8615	8617	O	-1	-1	0
early	PMC3035602	8618	8623	O	-1	-1	0
childhood	PMC3035602	8624	8633	O	-1	-1	0
,	PMC3035602	8633	8634	O	-1	-1	0
or	PMC3035602	8635	8637	O	-1	-1	0
in	PMC3035602	8638	8640	O	-1	-1	0
adulthood	PMC3035602	8641	8650	O	-1	-1	0
,	PMC3035602	8650	8651	O	-1	-1	0
or	PMC3035602	8652	8654	O	-1	-1	0
the	PMC3035602	8655	8658	O	-1	-1	0
abnormality	PMC3035602	8659	8670	O	-1	-1	0
may	PMC3035602	8671	8674	O	-1	-1	0
never	PMC3035602	8675	8680	O	-1	-1	0
be	PMC3035602	8681	8683	O	-1	-1	0
recognized	PMC3035602	8684	8694	O	-1	-1	0
.	PMC3035602	8694	8695	O	-1	-1	0


	PMC3035602	8695	8697	O	-1	-1	0

Male	PMC3035602	8697	8701	O	-1	-1	0
proportion	PMC3035602	8702	8712	O	-1	-1	0
of	PMC3035602	8713	8715	O	-1	-1	0
newborns	PMC3035602	8716	8724	O	-1	-1	0

Approximately	PMC3035602	8725	8738	O	-1	-1	0
51	PMC3035602	8739	8741	O	-1	-1	0
%	PMC3035602	8741	8742	O	-1	-1	0
of	PMC3035602	8743	8745	O	-1	-1	0
live	PMC3035602	8746	8750	O	-1	-1	0
-	PMC3035602	8750	8751	O	-1	-1	0
born	PMC3035602	8751	8755	O	-1	-1	0
children	PMC3035602	8756	8764	O	-1	-1	0
in	PMC3035602	8765	8767	O	-1	-1	0
Denmark	PMC3035602	8768	8775	B-Location	-1	-1	0
are	PMC3035602	8776	8779	O	-1	-1	0
boys	PMC3035602	8780	8784	O	-1	-1	0
.	PMC3035602	8784	8785	O	-1	-1	0


	PMC3035602	8785	8787	O	-1	-1	0

Methods	PMC3035602	8787	8794	O	-1	-1	0

The	PMC3035602	8795	8798	O	-1	-1	0
epidemiologic	PMC3035602	8799	8812	O	-1	-1	0
evidence	PMC3035602	8813	8821	O	-1	-1	0
of	PMC3035602	8822	8824	O	-1	-1	0
the	PMC3035602	8825	8828	O	-1	-1	0
possible	PMC3035602	8829	8837	O	-1	-1	0
adverse	PMC3035602	8838	8845	O	-1	-1	0
effect	PMC3035602	8846	8852	O	-1	-1	0
of	PMC3035602	8853	8855	O	-1	-1	0
maternal	PMC3035602	8856	8864	O	-1	-1	0
breast	PMC3035602	8865	8871	O	-1	-1	0
cancer	PMC3035602	8872	8878	O	-1	-1	0
,	PMC3035602	8878	8879	O	-1	-1	0
melanoma	PMC3035602	8880	8888	O	-1	-1	0
,	PMC3035602	8888	8889	O	-1	-1	0
and	PMC3035602	8890	8893	O	-1	-1	0
Hodgkin	PMC3035602	8894	8901	O	-1	-1	0
’s	PMC3035602	8901	8903	O	-1	-1	0
disease	PMC3035602	8904	8911	O	-1	-1	0
on	PMC3035602	8912	8914	O	-1	-1	0
birth	PMC3035602	8915	8920	O	-1	-1	0
outcome	PMC3035602	8921	8928	O	-1	-1	0
was	PMC3035602	8929	8932	O	-1	-1	0
examined	PMC3035602	8933	8941	O	-1	-1	0
via	PMC3035602	8942	8945	O	-1	-1	0
a	PMC3035602	8946	8947	O	-1	-1	0
systematic	PMC3035602	8948	8958	O	-1	-1	0
literature	PMC3035602	8959	8969	O	-1	-1	0
review	PMC3035602	8970	8976	O	-1	-1	0
,	PMC3035602	8976	8977	O	-1	-1	0
including	PMC3035602	8978	8987	O	-1	-1	0
studies	PMC3035602	8988	8995	O	-1	-1	0
published	PMC3035602	8996	9005	O	-1	-1	0
before	PMC3035602	9006	9012	O	-1	-1	0
January	PMC3035602	9013	9020	O	-1	-1	0
2010	PMC3035602	9021	9025	O	-1	-1	0
.	PMC3035602	9025	9026	O	-1	-1	0

To	PMC3035602	9027	9029	O	-1	-1	0
review	PMC3035602	9030	9036	O	-1	-1	0
the	PMC3035602	9037	9040	O	-1	-1	0
literature	PMC3035602	9041	9051	O	-1	-1	0
,	PMC3035602	9051	9052	O	-1	-1	0
I	PMC3035602	9053	9054	O	-1	-1	0
searched	PMC3035602	9055	9063	O	-1	-1	0
the	PMC3035602	9064	9067	O	-1	-1	0
MEDLINE	PMC3035602	9068	9075	O	-1	-1	0
database	PMC3035602	9076	9084	O	-1	-1	0
and	PMC3035602	9085	9088	O	-1	-1	0
used	PMC3035602	9089	9093	O	-1	-1	0
the	PMC3035602	9094	9097	O	-1	-1	0
MeSH	PMC3035602	9098	9102	O	-1	-1	0
(	PMC3035602	9103	9104	O	-1	-1	0
Medical	PMC3035602	9104	9111	O	-1	-1	0
Subject	PMC3035602	9112	9119	O	-1	-1	0
Heading	PMC3035602	9120	9127	O	-1	-1	0
)	PMC3035602	9127	9128	O	-1	-1	0
terms	PMC3035602	9129	9134	O	-1	-1	0
“	PMC3035602	9135	9136	O	-1	-1	0
breast	PMC3035602	9136	9142	O	-1	-1	0
neoplasms	PMC3035602	9143	9152	O	-1	-1	0
”	PMC3035602	9152	9153	O	-1	-1	0
,	PMC3035602	9153	9154	O	-1	-1	0
“	PMC3035602	9155	9156	O	-1	-1	0
melanoma	PMC3035602	9156	9164	O	-1	-1	0
”	PMC3035602	9164	9165	O	-1	-1	0
,	PMC3035602	9165	9166	O	-1	-1	0
and	PMC3035602	9167	9170	O	-1	-1	0
“	PMC3035602	9171	9172	O	-1	-1	0
Hodgkin	PMC3035602	9172	9179	O	-1	-1	0
disease	PMC3035602	9180	9187	O	-1	-1	0
”	PMC3035602	9187	9188	O	-1	-1	0

[	PMC3035602	9189	9190	O	-1	-1	0
MAJR	PMC3035602	9190	9194	O	-1	-1	0
]	PMC3035602	9194	9195	O	-1	-1	0

(	PMC3035602	9196	9197	O	-1	-1	0
Major	PMC3035602	9197	9202	O	-1	-1	0
Topic	PMC3035602	9203	9208	O	-1	-1	0
headings	PMC3035602	9209	9217	O	-1	-1	0
only	PMC3035602	9218	9222	O	-1	-1	0
)	PMC3035602	9222	9223	O	-1	-1	0
,	PMC3035602	9223	9224	O	-1	-1	0
respectively	PMC3035602	9225	9237	O	-1	-1	0
,	PMC3035602	9237	9238	O	-1	-1	0
in	PMC3035602	9239	9241	O	-1	-1	0
combination	PMC3035602	9242	9253	O	-1	-1	0
with	PMC3035602	9254	9258	O	-1	-1	0
“	PMC3035602	9259	9260	O	-1	-1	0
pregnancy	PMC3035602	9260	9269	O	-1	-1	0
”	PMC3035602	9269	9270	O	-1	-1	0
[	PMC3035602	9271	9272	O	-1	-1	0
MAJR	PMC3035602	9272	9276	O	-1	-1	0
]	PMC3035602	9276	9277	O	-1	-1	0
,	PMC3035602	9277	9278	O	-1	-1	0
limiting	PMC3035602	9279	9287	O	-1	-1	0
the	PMC3035602	9288	9291	O	-1	-1	0
search	PMC3035602	9292	9298	O	-1	-1	0
to	PMC3035602	9299	9301	O	-1	-1	0
include	PMC3035602	9302	9309	O	-1	-1	0
only	PMC3035602	9310	9314	O	-1	-1	0
studies	PMC3035602	9315	9322	O	-1	-1	0
on	PMC3035602	9323	9325	O	-1	-1	0
human	PMC3035602	9326	9331	O	-1	-1	0
females	PMC3035602	9332	9339	O	-1	-1	0
,	PMC3035602	9339	9340	O	-1	-1	0
in	PMC3035602	9341	9343	O	-1	-1	0
English	PMC3035602	9344	9351	O	-1	-1	0
,	PMC3035602	9351	9352	O	-1	-1	0
and	PMC3035602	9353	9356	O	-1	-1	0
with	PMC3035602	9357	9361	O	-1	-1	0
an	PMC3035602	9362	9364	O	-1	-1	0
abstract	PMC3035602	9365	9373	O	-1	-1	0
.	PMC3035602	9373	9374	O	-1	-1	0

More	PMC3035602	9375	9379	O	-1	-1	0
studies	PMC3035602	9380	9387	O	-1	-1	0
were	PMC3035602	9388	9392	O	-1	-1	0
identified	PMC3035602	9393	9403	O	-1	-1	0
through	PMC3035602	9404	9411	O	-1	-1	0
communication	PMC3035602	9412	9425	O	-1	-1	0
with	PMC3035602	9426	9430	O	-1	-1	0
other	PMC3035602	9431	9436	O	-1	-1	0
researchers	PMC3035602	9437	9448	O	-1	-1	0
and	PMC3035602	9449	9452	O	-1	-1	0
by	PMC3035602	9453	9455	O	-1	-1	0
reviewing	PMC3035602	9456	9465	O	-1	-1	0
the	PMC3035602	9466	9469	O	-1	-1	0
reference	PMC3035602	9470	9479	O	-1	-1	0
lists	PMC3035602	9480	9485	O	-1	-1	0
of	PMC3035602	9486	9488	O	-1	-1	0
relevant	PMC3035602	9489	9497	O	-1	-1	0
articles	PMC3035602	9498	9506	O	-1	-1	0
.	PMC3035602	9506	9507	O	-1	-1	0

Studies	PMC3035602	9508	9515	O	-1	-1	0
were	PMC3035602	9516	9520	O	-1	-1	0
classified	PMC3035602	9521	9531	O	-1	-1	0
as	PMC3035602	9532	9534	O	-1	-1	0
case	PMC3035602	9535	9539	O	-1	-1	0
-	PMC3035602	9539	9540	O	-1	-1	0
series	PMC3035602	9540	9546	O	-1	-1	0
,	PMC3035602	9546	9547	O	-1	-1	0
if	PMC3035602	9548	9550	O	-1	-1	0
they	PMC3035602	9551	9555	O	-1	-1	0
reported	PMC3035602	9556	9564	O	-1	-1	0
birth	PMC3035602	9565	9570	O	-1	-1	0
outcome	PMC3035602	9571	9578	O	-1	-1	0
in	PMC3035602	9579	9581	O	-1	-1	0
a	PMC3035602	9582	9583	O	-1	-1	0
cohort	PMC3035602	9584	9590	O	-1	-1	0
of	PMC3035602	9591	9593	O	-1	-1	0
women	PMC3035602	9594	9599	O	-1	-1	0
with	PMC3035602	9600	9604	O	-1	-1	0
cancer	PMC3035602	9605	9611	O	-1	-1	0
without	PMC3035602	9612	9619	O	-1	-1	0
comparing	PMC3035602	9620	9629	O	-1	-1	0
it	PMC3035602	9630	9632	O	-1	-1	0
with	PMC3035602	9633	9637	O	-1	-1	0
the	PMC3035602	9638	9641	O	-1	-1	0
outcome	PMC3035602	9642	9649	O	-1	-1	0
of	PMC3035602	9650	9652	O	-1	-1	0
a	PMC3035602	9653	9654	O	-1	-1	0
comparison	PMC3035602	9655	9665	O	-1	-1	0
group	PMC3035602	9666	9671	O	-1	-1	0
.	PMC3035602	9671	9672	O	-1	-1	0

However	PMC3035602	9673	9680	O	-1	-1	0
,	PMC3035602	9680	9681	O	-1	-1	0
if	PMC3035602	9682	9684	O	-1	-1	0
the	PMC3035602	9685	9688	O	-1	-1	0
authors	PMC3035602	9689	9696	O	-1	-1	0
computed	PMC3035602	9697	9705	O	-1	-1	0
risk	PMC3035602	9706	9710	O	-1	-1	0
estimates	PMC3035602	9711	9720	O	-1	-1	0
for	PMC3035602	9721	9724	O	-1	-1	0
adverse	PMC3035602	9725	9732	O	-1	-1	0
birth	PMC3035602	9733	9738	O	-1	-1	0
outcome	PMC3035602	9739	9746	O	-1	-1	0
in	PMC3035602	9747	9749	O	-1	-1	0
comparison	PMC3035602	9750	9760	O	-1	-1	0
with	PMC3035602	9761	9765	O	-1	-1	0
the	PMC3035602	9766	9769	O	-1	-1	0
general	PMC3035602	9770	9777	O	-1	-1	0
population	PMC3035602	9778	9788	O	-1	-1	0
,	PMC3035602	9788	9789	O	-1	-1	0
the	PMC3035602	9790	9793	O	-1	-1	0
study	PMC3035602	9794	9799	O	-1	-1	0
was	PMC3035602	9800	9803	O	-1	-1	0
classified	PMC3035602	9804	9814	O	-1	-1	0
as	PMC3035602	9815	9817	O	-1	-1	0
a	PMC3035602	9818	9819	O	-1	-1	0
cohort	PMC3035602	9820	9826	O	-1	-1	0
study	PMC3035602	9827	9832	O	-1	-1	0
.	PMC3035602	9832	9833	O	-1	-1	0

The	PMC3035602	9834	9837	O	-1	-1	0
studies	PMC3035602	9838	9845	O	-1	-1	0
listed	PMC3035602	9846	9852	O	-1	-1	0
in	PMC3035602	9853	9855	O	-1	-1	0
Tables	PMC3035602	9856	9862	O	-1	-1	0
1	PMC3035602	9863	9864	O	-1	-1	0
,	PMC3035602	9864	9865	O	-1	-1	0
2	PMC3035602	9866	9867	O	-1	-1	0
,	PMC3035602	9867	9868	O	-1	-1	0
and	PMC3035602	9869	9872	O	-1	-1	0
3	PMC3035602	9873	9874	O	-1	-1	0
were	PMC3035602	9875	9879	O	-1	-1	0
selected	PMC3035602	9880	9888	O	-1	-1	0
according	PMC3035602	9889	9898	O	-1	-1	0
to	PMC3035602	9899	9901	O	-1	-1	0
these	PMC3035602	9902	9907	O	-1	-1	0
criteria	PMC3035602	9908	9916	O	-1	-1	0
:	PMC3035602	9916	9917	O	-1	-1	0
studies	PMC3035602	9918	9925	O	-1	-1	0
of	PMC3035602	9926	9928	O	-1	-1	0
birth	PMC3035602	9929	9934	O	-1	-1	0
outcome	PMC3035602	9935	9942	O	-1	-1	0
in	PMC3035602	9943	9945	O	-1	-1	0
women	PMC3035602	9946	9951	O	-1	-1	0
who	PMC3035602	9952	9955	O	-1	-1	0
were	PMC3035602	9956	9960	O	-1	-1	0
diagnosed	PMC3035602	9961	9970	O	-1	-1	0
with	PMC3035602	9971	9975	O	-1	-1	0
breast	PMC3035602	9976	9982	O	-1	-1	0
cancer	PMC3035602	9983	9989	O	-1	-1	0
,	PMC3035602	9989	9990	O	-1	-1	0
melanoma	PMC3035602	9991	9999	O	-1	-1	0
,	PMC3035602	9999	10000	O	-1	-1	0
or	PMC3035602	10001	10003	O	-1	-1	0
Hodgkin	PMC3035602	10004	10011	O	-1	-1	0
’s	PMC3035602	10011	10013	O	-1	-1	0

disease	PMC3035602	10014	10021	O	-1	-1	0
at	PMC3035602	10022	10024	O	-1	-1	0
any	PMC3035602	10025	10028	O	-1	-1	0
time	PMC3035602	10029	10033	O	-1	-1	0
before	PMC3035602	10034	10040	O	-1	-1	0
pregnenancy	PMC3035602	10041	10052	O	-1	-1	0
(	PMC3035602	10053	10054	O	-1	-1	0
including	PMC3035602	10054	10063	O	-1	-1	0
childhood	PMC3035602	10064	10073	O	-1	-1	0
)	PMC3035602	10073	10074	O	-1	-1	0
,	PMC3035602	10074	10075	O	-1	-1	0
during	PMC3035602	10076	10082	O	-1	-1	0
pregnancy	PMC3035602	10083	10092	O	-1	-1	0
,	PMC3035602	10092	10093	O	-1	-1	0
or	PMC3035602	10094	10096	O	-1	-1	0
within	PMC3035602	10097	10103	O	-1	-1	0
2	PMC3035602	10104	10105	O	-1	-1	0
years	PMC3035602	10106	10111	O	-1	-1	0
after	PMC3035602	10112	10117	O	-1	-1	0
delivery	PMC3035602	10118	10126	O	-1	-1	0
were	PMC3035602	10127	10131	O	-1	-1	0
included	PMC3035602	10132	10140	O	-1	-1	0
.	PMC3035602	10140	10141	O	-1	-1	0

I	PMC3035602	10142	10143	O	-1	-1	0
selected	PMC3035602	10144	10152	O	-1	-1	0
only	PMC3035602	10153	10157	O	-1	-1	0
studies	PMC3035602	10158	10165	O	-1	-1	0
that	PMC3035602	10166	10170	O	-1	-1	0
examined	PMC3035602	10171	10179	O	-1	-1	0
preterm	PMC3035602	10180	10187	O	-1	-1	0
birth	PMC3035602	10188	10193	O	-1	-1	0
,	PMC3035602	10193	10194	O	-1	-1	0
LBW	PMC3035602	10195	10198	O	-1	-1	0
(	PMC3035602	10199	10200	O	-1	-1	0
or	PMC3035602	10200	10202	O	-1	-1	0
LBW	PMC3035602	10203	10206	O	-1	-1	0
at	PMC3035602	10207	10209	O	-1	-1	0
term	PMC3035602	10210	10214	O	-1	-1	0
)	PMC3035602	10214	10215	O	-1	-1	0
,	PMC3035602	10215	10216	O	-1	-1	0
stillbirths	PMC3035602	10217	10228	O	-1	-1	0
,	PMC3035602	10228	10229	O	-1	-1	0
congenital	PMC3035602	10230	10240	O	-1	-1	0
abnormalities	PMC3035602	10241	10254	O	-1	-1	0
,	PMC3035602	10254	10255	O	-1	-1	0
male	PMC3035602	10256	10260	O	-1	-1	0
proportion	PMC3035602	10261	10271	O	-1	-1	0
of	PMC3035602	10272	10274	O	-1	-1	0
newborns	PMC3035602	10275	10283	O	-1	-1	0
,	PMC3035602	10283	10284	O	-1	-1	0

and/or	PMC3035602	10285	10291	O	-1	-1	0
mean	PMC3035602	10292	10296	O	-1	-1	0

birth	PMC3035602	10297	10302	O	-1	-1	0
weight	PMC3035602	10303	10309	O	-1	-1	0
.	PMC3035602	10309	10310	O	-1	-1	0

I	PMC3035602	10311	10312	O	-1	-1	0
excluded	PMC3035602	10313	10321	O	-1	-1	0
studies	PMC3035602	10322	10329	O	-1	-1	0
that	PMC3035602	10330	10334	O	-1	-1	0
reported	PMC3035602	10335	10343	O	-1	-1	0
overall	PMC3035602	10344	10351	O	-1	-1	0
risks	PMC3035602	10352	10357	O	-1	-1	0
of	PMC3035602	10358	10360	O	-1	-1	0
adverse	PMC3035602	10361	10368	O	-1	-1	0
birth	PMC3035602	10369	10374	O	-1	-1	0
outcome	PMC3035602	10375	10382	O	-1	-1	0
for	PMC3035602	10383	10386	O	-1	-1	0
survivors	PMC3035602	10387	10396	O	-1	-1	0
of	PMC3035602	10397	10399	O	-1	-1	0
different	PMC3035602	10400	10409	O	-1	-1	0
cancers	PMC3035602	10410	10417	O	-1	-1	0
combined	PMC3035602	10418	10426	O	-1	-1	0
.	PMC3035602	10426	10427	O	-1	-1	0

In	PMC3035602	10428	10430	O	-1	-1	0
addition	PMC3035602	10431	10439	O	-1	-1	0
,	PMC3035602	10439	10440	O	-1	-1	0
I	PMC3035602	10441	10442	O	-1	-1	0
excluded	PMC3035602	10443	10451	O	-1	-1	0
reviews	PMC3035602	10452	10459	O	-1	-1	0
,	PMC3035602	10459	10460	O	-1	-1	0
case	PMC3035602	10461	10465	O	-1	-1	0
-	PMC3035602	10465	10466	O	-1	-1	0
reports	PMC3035602	10466	10473	O	-1	-1	0
,	PMC3035602	10473	10474	O	-1	-1	0
case	PMC3035602	10475	10479	O	-1	-1	0
-	PMC3035602	10479	10480	O	-1	-1	0
series	PMC3035602	10480	10486	O	-1	-1	0
,	PMC3035602	10486	10487	O	-1	-1	0
and	PMC3035602	10488	10491	O	-1	-1	0
comments	PMC3035602	10492	10500	O	-1	-1	0
from	PMC3035602	10501	10505	O	-1	-1	0
the	PMC3035602	10506	10509	O	-1	-1	0
tables	PMC3035602	10510	10516	O	-1	-1	0
.	PMC3035602	10516	10517	O	-1	-1	0

However	PMC3035602	10518	10525	O	-1	-1	0
,	PMC3035602	10525	10526	O	-1	-1	0
given	PMC3035602	10527	10532	O	-1	-1	0
that	PMC3035602	10533	10537	O	-1	-1	0
the	PMC3035602	10538	10541	O	-1	-1	0
overall	PMC3035602	10542	10549	O	-1	-1	0
evidence	PMC3035602	10550	10558	O	-1	-1	0
on	PMC3035602	10559	10561	O	-1	-1	0
the	PMC3035602	10562	10565	O	-1	-1	0
topic	PMC3035602	10566	10571	O	-1	-1	0
is	PMC3035602	10572	10574	O	-1	-1	0
sparse	PMC3035602	10575	10581	O	-1	-1	0
,	PMC3035602	10581	10582	O	-1	-1	0
there	PMC3035602	10583	10588	O	-1	-1	0
are	PMC3035602	10589	10592	O	-1	-1	0
some	PMC3035602	10593	10597	O	-1	-1	0
references	PMC3035602	10598	10608	O	-1	-1	0
to	PMC3035602	10609	10611	O	-1	-1	0
case	PMC3035602	10612	10616	O	-1	-1	0
-	PMC3035602	10616	10617	O	-1	-1	0
series	PMC3035602	10617	10623	O	-1	-1	0
in	PMC3035602	10624	10626	O	-1	-1	0
the	PMC3035602	10627	10630	O	-1	-1	0
text	PMC3035602	10631	10635	O	-1	-1	0
.	PMC3035602	10635	10636	O	-1	-1	0


	PMC3035602	10636	10638	O	-1	-1	0

Results	PMC3035602	10638	10645	O	-1	-1	0

Below	PMC3035602	10646	10651	O	-1	-1	0
is	PMC3035602	10652	10654	O	-1	-1	0
a	PMC3035602	10655	10656	O	-1	-1	0
summary	PMC3035602	10657	10664	O	-1	-1	0
of	PMC3035602	10665	10667	O	-1	-1	0
the	PMC3035602	10668	10671	O	-1	-1	0
existing	PMC3035602	10672	10680	O	-1	-1	0
epidemiologic	PMC3035602	10681	10694	O	-1	-1	0
evidence	PMC3035602	10695	10703	O	-1	-1	0
of	PMC3035602	10704	10706	O	-1	-1	0
the	PMC3035602	10707	10710	O	-1	-1	0
adverse	PMC3035602	10711	10718	O	-1	-1	0
effect	PMC3035602	10719	10725	O	-1	-1	0
of	PMC3035602	10726	10728	O	-1	-1	0
maternal	PMC3035602	10729	10737	O	-1	-1	0
breast	PMC3035602	10738	10744	O	-1	-1	0
cancer	PMC3035602	10745	10751	O	-1	-1	0
,	PMC3035602	10751	10752	O	-1	-1	0
melanoma	PMC3035602	10753	10761	O	-1	-1	0
,	PMC3035602	10761	10762	O	-1	-1	0
and	PMC3035602	10763	10766	O	-1	-1	0
Hodgkin	PMC3035602	10767	10774	O	-1	-1	0
’s	PMC3035602	10774	10776	O	-1	-1	0
disease	PMC3035602	10777	10784	O	-1	-1	0
on	PMC3035602	10785	10787	O	-1	-1	0
birth	PMC3035602	10788	10793	O	-1	-1	0
outcome	PMC3035602	10794	10801	O	-1	-1	0
.	PMC3035602	10801	10802	O	-1	-1	0

The	PMC3035602	10803	10806	O	-1	-1	0
studies	PMC3035602	10807	10814	O	-1	-1	0
of	PMC3035602	10815	10817	O	-1	-1	0
birth	PMC3035602	10818	10823	O	-1	-1	0
outcome	PMC3035602	10824	10831	O	-1	-1	0
in	PMC3035602	10832	10834	O	-1	-1	0
women	PMC3035602	10835	10840	O	-1	-1	0
with	PMC3035602	10841	10845	O	-1	-1	0
,	PMC3035602	10845	10846	O	-1	-1	0
respectively	PMC3035602	10847	10859	O	-1	-1	0
,	PMC3035602	10859	10860	O	-1	-1	0
breast	PMC3035602	10861	10867	O	-1	-1	0
cancer	PMC3035602	10868	10874	O	-1	-1	0
,	PMC3035602	10874	10875	O	-1	-1	0
melanoma	PMC3035602	10876	10884	O	-1	-1	0
,	PMC3035602	10884	10885	O	-1	-1	0


	PMC3035602	10885	10887	O	-1	-1	0

Clinical	PMC3035602	10887	10895	O	-1	-1	0
Epidemiology	PMC3035602	10896	10908	O	-1	-1	0
2011:3	PMC3035602	10909	10915	O	-1	-1	0


	PMC3035602	10915	10917	O	-1	-1	0

Birth	PMC3035602	10917	10922	O	-1	-1	0
outcome	PMC3035602	10923	10930	O	-1	-1	0
in	PMC3035602	10931	10933	O	-1	-1	0
women	PMC3035602	10934	10939	O	-1	-1	0
with	PMC3035602	10940	10944	O	-1	-1	0
cancer	PMC3035602	10945	10951	O	-1	-1	0


	PMC3035602	10951	10953	O	-1	-1	0
and	PMC3035602	10953	10956	O	-1	-1	0
Hodgkin	PMC3035602	10957	10964	O	-1	-1	0
’s	PMC3035602	10964	10966	O	-1	-1	0
disease	PMC3035602	10967	10974	O	-1	-1	0

(	PMC3035602	10975	10976	O	-1	-1	0
Tables	PMC3035602	10976	10982	O	-1	-1	0
1	PMC3035602	10983	10984	O	-1	-1	0
,	PMC3035602	10984	10985	O	-1	-1	0
2	PMC3035602	10986	10987	O	-1	-1	0
,	PMC3035602	10987	10988	O	-1	-1	0
and	PMC3035602	10989	10992	O	-1	-1	0
3	PMC3035602	10993	10994	O	-1	-1	0
)	PMC3035602	10994	10995	O	-1	-1	0
were	PMC3035602	10996	11000	O	-1	-1	0
selected	PMC3035602	11001	11009	O	-1	-1	0
according	PMC3035602	11010	11019	O	-1	-1	0
to	PMC3035602	11020	11022	O	-1	-1	0
the	PMC3035602	11023	11026	O	-1	-1	0
inclusion	PMC3035602	11027	11036	O	-1	-1	0
criteria	PMC3035602	11037	11045	O	-1	-1	0
described	PMC3035602	11046	11055	O	-1	-1	0
under	PMC3035602	11056	11061	O	-1	-1	0
Methods	PMC3035602	11062	11069	O	-1	-1	0
.	PMC3035602	11069	11070	O	-1	-1	0

No	PMC3035602	11071	11073	O	-1	-1	0
case	PMC3035602	11074	11078	O	-1	-1	0
-	PMC3035602	11078	11079	O	-1	-1	0
control	PMC3035602	11079	11086	O	-1	-1	0
study	PMC3035602	11087	11092	O	-1	-1	0
fulfilled	PMC3035602	11093	11102	O	-1	-1	0
the	PMC3035602	11103	11106	O	-1	-1	0
inclusion	PMC3035602	11107	11116	O	-1	-1	0
criteria	PMC3035602	11117	11125	O	-1	-1	0
.	PMC3035602	11125	11126	O	-1	-1	0


	PMC3035602	11126	11128	O	-1	-1	0

Birth	PMC3035602	11128	11133	O	-1	-1	0
outcome	PMC3035602	11134	11141	O	-1	-1	0
in	PMC3035602	11142	11144	O	-1	-1	0
women	PMC3035602	11145	11150	O	-1	-1	0
with	PMC3035602	11151	11155	O	-1	-1	0
breast	PMC3035602	11156	11162	O	-1	-1	0
cancer	PMC3035602	11163	11169	O	-1	-1	0

Data	PMC3035602	11170	11174	O	-1	-1	0
on	PMC3035602	11175	11177	O	-1	-1	0
birth	PMC3035602	11178	11183	O	-1	-1	0
outcome	PMC3035602	11184	11191	O	-1	-1	0
in	PMC3035602	11192	11194	O	-1	-1	0
women	PMC3035602	11195	11200	O	-1	-1	0
diagnosed	PMC3035602	11201	11210	O	-1	-1	0
with	PMC3035602	11211	11215	O	-1	-1	0
breast	PMC3035602	11216	11222	O	-1	-1	0

­cancer	PMC3035602	11223	11230	O	-1	-1	0

before	PMC3035602	11231	11237	O	-1	-1	0
pregnancy	PMC3035602	11238	11247	O	-1	-1	0
are	PMC3035602	11248	11251	O	-1	-1	0
very	PMC3035602	11252	11256	O	-1	-1	0
sparse	PMC3035602	11257	11263	O	-1	-1	0
.	PMC3035602	11263	11264	O	-1	-1	0

Small	PMC3035602	11265	11270	O	-1	-1	0
case	PMC3035602	11271	11275	O	-1	-1	0
series	PMC3035602	11276	11282	O	-1	-1	0
have	PMC3035602	11283	11287	O	-1	-1	0
reported	PMC3035602	11288	11296	O	-1	-1	0
births	PMC3035602	11297	11303	O	-1	-1	0
of	PMC3035602	11304	11306	O	-1	-1	0
healthy	PMC3035602	11307	11314	O	-1	-1	0
children	PMC3035602	11315	11323	O	-1	-1	0
to	PMC3035602	11324	11326	O	-1	-1	0
women	PMC3035602	11327	11332	O	-1	-1	0
who	PMC3035602	11333	11336	O	-1	-1	0
became	PMC3035602	11337	11343	O	-1	-1	0
pregnant	PMC3035602	11344	11352	O	-1	-1	0
after	PMC3035602	11353	11358	O	-1	-1	0
being	PMC3035602	11359	11364	O	-1	-1	0
diagnosed	PMC3035602	11365	11374	O	-1	-1	0
with	PMC3035602	11375	11379	O	-1	-1	0
breast	PMC3035602	11380	11386	O	-1	-1	0
cancer.21,22	PMC3035602	11387	11399	O	-1	-1	0

The	PMC3035602	11400	11403	O	-1	-1	0
only	PMC3035602	11404	11408	O	-1	-1	0
2	PMC3035602	11409	11410	O	-1	-1	0
studies	PMC3035602	11411	11418	O	-1	-1	0
with	PMC3035602	11419	11423	O	-1	-1	0
a	PMC3035602	11424	11425	O	-1	-1	0
comparison	PMC3035602	11426	11436	O	-1	-1	0
group	PMC3035602	11437	11442	O	-1	-1	0
for	PMC3035602	11443	11446	O	-1	-1	0
birth	PMC3035602	11447	11452	O	-1	-1	0
outcome	PMC3035602	11453	11460	O	-1	-1	0

that	PMC3035602	11461	11465	O	-1	-1	0
have	PMC3035602	11466	11470	O	-1	-1	0
been	PMC3035602	11471	11475	O	-1	-1	0
published	PMC3035602	11476	11485	O	-1	-1	0
,	PMC3035602	11485	11486	O	-1	-1	0
however	PMC3035602	11487	11494	O	-1	-1	0
,	PMC3035602	11494	11495	O	-1	-1	0
had	PMC3035602	11496	11499	O	-1	-1	0
conflicting	PMC3035602	11500	11511	O	-1	-1	0
results	PMC3035602	11512	11519	O	-1	-1	0
on	PMC3035602	11520	11522	O	-1	-1	0
the	PMC3035602	11523	11526	O	-1	-1	0
risk	PMC3035602	11527	11531	O	-1	-1	0
of	PMC3035602	11532	11534	O	-1	-1	0
preterm	PMC3035602	11535	11542	O	-1	-1	0
birth	PMC3035602	11543	11548	O	-1	-1	0
and	PMC3035602	11549	11552	O	-1	-1	0
congenital	PMC3035602	11553	11563	O	-1	-1	0
abnormalities	PMC3035602	11564	11577	O	-1	-1	0
after	PMC3035602	11578	11583	O	-1	-1	0
breast	PMC3035602	11584	11590	O	-1	-1	0
cancer	PMC3035602	11591	11597	O	-1	-1	0
(	PMC3035602	11598	11599	O	-1	-1	0
Table	PMC3035602	11599	11604	O	-1	-1	0
1).23,24	PMC3035602	11605	11613	O	-1	-1	0

In	PMC3035602	11614	11616	O	-1	-1	0
a	PMC3035602	11617	11618	O	-1	-1	0
registry	PMC3035602	11619	11627	O	-1	-1	0
-	PMC3035602	11627	11628	O	-1	-1	0
based	PMC3035602	11628	11633	O	-1	-1	0
cohort	PMC3035602	11634	11640	O	-1	-1	0
study	PMC3035602	11641	11646	O	-1	-1	0
from	PMC3035602	11647	11651	O	-1	-1	0
Sweden	PMC3035602	11652	11658	B-Location	-1	-1	0
,	PMC3035602	11658	11659	O	-1	-1	0
Dalberg	PMC3035602	11660	11667	O	-1	-1	0
et	PMC3035602	11668	11670	O	-1	-1	0
al	PMC3035602	11671	11673	O	-1	-1	0
examined	PMC3035602	11674	11682	O	-1	-1	0
331	PMC3035602	11683	11686	O	-1	-1	0
births	PMC3035602	11687	11693	O	-1	-1	0
from	PMC3035602	11694	11698	O	-1	-1	0
1973	PMC3035602	11699	11703	O	-1	-1	0
to	PMC3035602	11704	11706	O	-1	-1	0
2002	PMC3035602	11707	11711	O	-1	-1	0
,	PMC3035602	11711	11712	O	-1	-1	0
to	PMC3035602	11713	11715	O	-1	-1	0
women	PMC3035602	11716	11721	O	-1	-1	0
who	PMC3035602	11722	11725	O	-1	-1	0
were	PMC3035602	11726	11730	O	-1	-1	0
diagnosed	PMC3035602	11731	11740	O	-1	-1	0
with	PMC3035602	11741	11745	O	-1	-1	0
breast	PMC3035602	11746	11752	O	-1	-1	0
cancer	PMC3035602	11753	11759	O	-1	-1	0
before	PMC3035602	11760	11766	O	-1	-1	0
pregnancy.24	PMC3035602	11767	11779	O	-1	-1	0
Dalberg	PMC3035602	11780	11787	O	-1	-1	0

et	PMC3035602	11788	11790	O	-1	-1	0
al	PMC3035602	11791	11793	O	-1	-1	0
found	PMC3035602	11794	11799	O	-1	-1	0
that	PMC3035602	11800	11804	O	-1	-1	0
a	PMC3035602	11805	11806	O	-1	-1	0
large	PMC3035602	11807	11812	O	-1	-1	0
majority	PMC3035602	11813	11821	O	-1	-1	0
of	PMC3035602	11822	11824	O	-1	-1	0
these	PMC3035602	11825	11830	O	-1	-1	0
births	PMC3035602	11831	11837	O	-1	-1	0
were	PMC3035602	11838	11842	O	-1	-1	0
free	PMC3035602	11843	11847	O	-1	-1	0
of	PMC3035602	11848	11850	O	-1	-1	0
adverse	PMC3035602	11851	11858	O	-1	-1	0
events	PMC3035602	11859	11865	O	-1	-1	0
,	PMC3035602	11865	11866	O	-1	-1	0
and	PMC3035602	11867	11870	O	-1	-1	0
reported	PMC3035602	11871	11879	O	-1	-1	0
no	PMC3035602	11880	11882	O	-1	-1	0
increased	PMC3035602	11883	11892	O	-1	-1	0
risk	PMC3035602	11893	11897	O	-1	-1	0
of	PMC3035602	11898	11900	O	-1	-1	0
stillbirth	PMC3035602	11901	11911	O	-1	-1	0
or	PMC3035602	11912	11914	O	-1	-1	0
reduced	PMC3035602	11915	11922	O	-1	-1	0
birth	PMC3035602	11923	11928	O	-1	-1	0
weight	PMC3035602	11929	11935	O	-1	-1	0
for	PMC3035602	11936	11939	O	-1	-1	0
gestational	PMC3035602	11940	11951	O	-1	-1	0
age	PMC3035602	11952	11955	O	-1	-1	0
.	PMC3035602	11955	11956	O	-1	-1	0

However	PMC3035602	11957	11964	O	-1	-1	0
,	PMC3035602	11964	11965	O	-1	-1	0
the	PMC3035602	11966	11969	O	-1	-1	0
study	PMC3035602	11970	11975	O	-1	-1	0
also	PMC3035602	11976	11980	O	-1	-1	0
reported	PMC3035602	11981	11989	O	-1	-1	0
an	PMC3035602	11990	11992	O	-1	-1	0
increased	PMC3035602	11993	12002	O	-1	-1	0
risk	PMC3035602	12003	12007	O	-1	-1	0
of	PMC3035602	12008	12010	O	-1	-1	0
very	PMC3035602	12011	12015	O	-1	-1	0
preterm	PMC3035602	12016	12023	O	-1	-1	0
birth	PMC3035602	12024	12029	O	-1	-1	0
(	PMC3035602	12030	12031	O	-1	-1	0
,	PMC3035602	12031	12032	O	-1	-1	0
32	PMC3035602	12032	12034	O	-1	-1	0
weeks	PMC3035602	12035	12040	O	-1	-1	0
)	PMC3035602	12040	12041	O	-1	-1	0

(	PMC3035602	12042	12043	O	-1	-1	0
odds	PMC3035602	12043	12047	O	-1	-1	0
ratio	PMC3035602	12048	12053	O	-1	-1	0
[	PMC3035602	12054	12055	O	-1	-1	0
OR	PMC3035602	12055	12057	O	-1	-1	0
]	PMC3035602	12057	12058	O	-1	-1	0

=	PMC3035602	12059	12060	O	-1	-1	0
3.2	PMC3035602	12061	12064	O	-1	-1	0
;	PMC3035602	12064	12065	O	-1	-1	0
95	PMC3035602	12066	12068	O	-1	-1	0
%	PMC3035602	12068	12069	O	-1	-1	0
confidence	PMC3035602	12070	12080	O	-1	-1	0
interval	PMC3035602	12081	12089	O	-1	-1	0
[	PMC3035602	12090	12091	O	-1	-1	0
95	PMC3035602	12091	12093	O	-1	-1	0
%	PMC3035602	12093	12094	O	-1	-1	0
CI	PMC3035602	12095	12097	O	-1	-1	0
]	PMC3035602	12097	12098	O	-1	-1	0
:	PMC3035602	12098	12099	O	-1	-1	0
1.7–6.0	PMC3035602	12100	12107	O	-1	-1	0
)	PMC3035602	12107	12108	O	-1	-1	0
and	PMC3035602	12109	12112	O	-1	-1	0
LBW	PMC3035602	12113	12116	O	-1	-1	0
(	PMC3035602	12117	12118	O	-1	-1	0
,	PMC3035602	12118	12119	O	-1	-1	0
1500	PMC3035602	12119	12123	O	-1	-1	0
g	PMC3035602	12124	12125	O	-1	-1	0
)	PMC3035602	12125	12126	O	-1	-1	0
(	PMC3035602	12127	12128	O	-1	-1	0

OR	PMC3035602	12128	12130	O	-1	-1	0
=	PMC3035602	12131	12132	O	-1	-1	0
2.9	PMC3035602	12133	12136	O	-1	-1	0
;	PMC3035602	12136	12137	O	-1	-1	0
95	PMC3035602	12138	12140	O	-1	-1	0
%	PMC3035602	12140	12141	O	-1	-1	0
CI	PMC3035602	12142	12144	O	-1	-1	0
:	PMC3035602	12144	12145	O	-1	-1	0
1.4–5.8	PMC3035602	12146	12153	O	-1	-1	0
)	PMC3035602	12153	12154	O	-1	-1	0
and	PMC3035602	12155	12158	O	-1	-1	0
an	PMC3035602	12159	12161	O	-1	-1	0
increased	PMC3035602	12162	12171	O	-1	-1	0
risk	PMC3035602	12172	12176	O	-1	-1	0
of	PMC3035602	12177	12179	O	-1	-1	0
congenital	PMC3035602	12180	12190	O	-1	-1	0
abnormalities	PMC3035602	12191	12204	O	-1	-1	0
(	PMC3035602	12205	12206	O	-1	-1	0
OR	PMC3035602	12206	12208	O	-1	-1	0
=	PMC3035602	12209	12210	O	-1	-1	0
1.7	PMC3035602	12211	12214	O	-1	-1	0
;	PMC3035602	12214	12215	O	-1	-1	0
95	PMC3035602	12216	12218	O	-1	-1	0
%	PMC3035602	12218	12219	O	-1	-1	0
CI	PMC3035602	12220	12222	O	-1	-1	0
:	PMC3035602	12222	12223	O	-1	-1	0
1.1–2.5	PMC3035602	12224	12231	O	-1	-1	0
)	PMC3035602	12231	12232	O	-1	-1	0
among	PMC3035602	12233	12238	O	-1	-1	0
children	PMC3035602	12239	12247	O	-1	-1	0
of	PMC3035602	12248	12250	O	-1	-1	0
breast	PMC3035602	12251	12257	O	-1	-1	0
cancer	PMC3035602	12258	12264	O	-1	-1	0
survivors	PMC3035602	12265	12274	O	-1	-1	0
,	PMC3035602	12274	12275	O	-1	-1	0
compared	PMC3035602	12276	12284	O	-1	-1	0
with	PMC3035602	12285	12289	O	-1	-1	0
the	PMC3035602	12290	12293	O	-1	-1	0
general	PMC3035602	12294	12301	O	-1	-1	0
population	PMC3035602	12302	12312	O	-1	-1	0
.	PMC3035602	12312	12313	O	-1	-1	0

The	PMC3035602	12314	12317	O	-1	-1	0
increased	PMC3035602	12318	12327	O	-1	-1	0
risk	PMC3035602	12328	12332	O	-1	-1	0
of	PMC3035602	12333	12335	O	-1	-1	0
congenital	PMC3035602	12336	12346	O	-1	-1	0
abnormalities	PMC3035602	12347	12360	O	-1	-1	0
was	PMC3035602	12361	12364	O	-1	-1	0
seen	PMC3035602	12365	12369	O	-1	-1	0
especially	PMC3035602	12370	12380	O	-1	-1	0
in	PMC3035602	12381	12383	O	-1	-1	0
the	PMC3035602	12384	12387	O	-1	-1	0
births	PMC3035602	12388	12394	O	-1	-1	0
occurring	PMC3035602	12395	12404	O	-1	-1	0
in	PMC3035602	12405	12407	O	-1	-1	0
1988	PMC3035602	12408	12412	O	-1	-1	0
to	PMC3035602	12413	12415	O	-1	-1	0
2002	PMC3035602	12416	12420	O	-1	-1	0
(	PMC3035602	12421	12422	O	-1	-1	0
OR	PMC3035602	12422	12424	O	-1	-1	0
=	PMC3035602	12425	12426	O	-1	-1	0
2.1	PMC3035602	12427	12430	O	-1	-1	0
;	PMC3035602	12430	12431	O	-1	-1	0
95	PMC3035602	12432	12434	O	-1	-1	0
%	PMC3035602	12434	12435	O	-1	-1	0
CI	PMC3035602	12436	12438	O	-1	-1	0
:	PMC3035602	12438	12439	O	-1	-1	0
1.2–3.7	PMC3035602	12440	12447	O	-1	-1	0
)	PMC3035602	12447	12448	O	-1	-1	0
,	PMC3035602	12448	12449	O	-1	-1	0
which	PMC3035602	12450	12455	O	-1	-1	0
the	PMC3035602	12456	12459	O	-1	-1	0
authors	PMC3035602	12460	12467	O	-1	-1	0
explained	PMC3035602	12468	12477	O	-1	-1	0
by	PMC3035602	12478	12480	O	-1	-1	0
an	PMC3035602	12481	12483	O	-1	-1	0
increased	PMC3035602	12484	12493	O	-1	-1	0
use	PMC3035602	12494	12497	O	-1	-1	0
of	PMC3035602	12498	12500	O	-1	-1	0
chemotherapy	PMC3035602	12501	12513	O	-1	-1	0
in	PMC3035602	12514	12516	O	-1	-1	0
younger	PMC3035602	12517	12524	O	-1	-1	0
patients	PMC3035602	12525	12533	O	-1	-1	0
.	PMC3035602	12533	12534	O	-1	-1	0

The	PMC3035602	12535	12538	O	-1	-1	0
study	PMC3035602	12539	12544	O	-1	-1	0
,	PMC3035602	12544	12545	O	-1	-1	0
however	PMC3035602	12546	12553	O	-1	-1	0
,	PMC3035602	12553	12554	O	-1	-1	0
had	PMC3035602	12555	12558	O	-1	-1	0
no	PMC3035602	12559	12561	O	-1	-1	0
data	PMC3035602	12562	12566	O	-1	-1	0
on	PMC3035602	12567	12569	O	-1	-1	0
the	PMC3035602	12570	12573	O	-1	-1	0
treatment	PMC3035602	12574	12583	O	-1	-1	0
of	PMC3035602	12584	12586	O	-1	-1	0
women	PMC3035602	12587	12592	O	-1	-1	0
with	PMC3035602	12593	12597	O	-1	-1	0
breast	PMC3035602	12598	12604	O	-1	-1	0
cancer	PMC3035602	12605	12611	O	-1	-1	0
.	PMC3035602	12611	12612	O	-1	-1	0

In	PMC3035602	12613	12615	O	-1	-1	0
contrast	PMC3035602	12616	12624	O	-1	-1	0
,	PMC3035602	12624	12625	O	-1	-1	0
a	PMC3035602	12626	12627	O	-1	-1	0
nationwide	PMC3035602	12628	12638	O	-1	-1	0
Danish	PMC3035602	12639	12645	O	-1	-1	0
cohort	PMC3035602	12646	12652	O	-1	-1	0
study	PMC3035602	12653	12658	O	-1	-1	0
of	PMC3035602	12659	12661	O	-1	-1	0
216	PMC3035602	12662	12665	O	-1	-1	0
newborns	PMC3035602	12666	12674	O	-1	-1	0
of	PMC3035602	12675	12677	O	-1	-1	0
women	PMC3035602	12678	12683	O	-1	-1	0
diagnosed	PMC3035602	12684	12693	O	-1	-1	0
with	PMC3035602	12694	12698	O	-1	-1	0
breast	PMC3035602	12699	12705	O	-1	-1	0
cancer	PMC3035602	12706	12712	O	-1	-1	0
before	PMC3035602	12713	12719	O	-1	-1	0
pregnancy	PMC3035602	12720	12729	O	-1	-1	0
found	PMC3035602	12730	12735	O	-1	-1	0
no	PMC3035602	12736	12738	O	-1	-1	0
increased	PMC3035602	12739	12748	O	-1	-1	0
risk	PMC3035602	12749	12753	O	-1	-1	0
with	PMC3035602	12754	12758	O	-1	-1	0
respect	PMC3035602	12759	12766	O	-1	-1	0
to	PMC3035602	12767	12769	O	-1	-1	0
preterm	PMC3035602	12770	12777	O	-1	-1	0
birth	PMC3035602	12778	12783	O	-1	-1	0
,	PMC3035602	12783	12784	O	-1	-1	0
LBW	PMC3035602	12785	12788	O	-1	-1	0
at	PMC3035602	12789	12791	O	-1	-1	0
term	PMC3035602	12792	12796	O	-1	-1	0
,	PMC3035602	12796	12797	O	-1	-1	0
stillbirth	PMC3035602	12798	12808	O	-1	-1	0
,	PMC3035602	12808	12809	O	-1	-1	0
and	PMC3035602	12810	12813	O	-1	-1	0
congenital	PMC3035602	12814	12824	O	-1	-1	0
abnormalities	PMC3035602	12825	12838	O	-1	-1	0
as	PMC3035602	12839	12841	O	-1	-1	0
well	PMC3035602	12842	12846	O	-1	-1	0
as	PMC3035602	12847	12849	O	-1	-1	0

mean	PMC3035602	12850	12854	O	-1	-1	0
birth	PMC3035602	12855	12860	O	-1	-1	0
weight	PMC3035602	12861	12867	O	-1	-1	0
,	PMC3035602	12867	12868	O	-1	-1	0
compared	PMC3035602	12869	12877	O	-1	-1	0
with	PMC3035602	12878	12882	O	-1	-1	0
the	PMC3035602	12883	12886	O	-1	-1	0
outcomes	PMC3035602	12887	12895	O	-1	-1	0
of	PMC3035602	12896	12898	O	-1	-1	0
33,443	PMC3035602	12899	12905	O	-1	-1	0
births	PMC3035602	12906	12912	O	-1	-1	0
from	PMC3035602	12913	12917	O	-1	-1	0
unaffected	PMC3035602	12918	12928	O	-1	-1	0
mothers	PMC3035602	12929	12936	O	-1	-1	0
,	PMC3035602	12936	12937	O	-1	-1	0
and	PMC3035602	12938	12941	O	-1	-1	0
with	PMC3035602	12942	12946	O	-1	-1	0
results	PMC3035602	12947	12954	O	-1	-1	0
unaltered	PMC3035602	12955	12964	O	-1	-1	0
by	PMC3035602	12965	12967	O	-1	-1	0
stratification	PMC3035602	12968	12982	O	-1	-1	0
by	PMC3035602	12983	12985	O	-1	-1	0
a	PMC3035602	12986	12987	O	-1	-1	0
treatment	PMC3035602	12988	12997	O	-1	-1	0
variable.23	PMC3035602	12998	13009	O	-1	-1	0
As	PMC3035602	13010	13012	O	-1	-1	0
suggested	PMC3035602	13013	13022	O	-1	-1	0
by	PMC3035602	13023	13025	O	-1	-1	0
Dalberg	PMC3035602	13026	13033	O	-1	-1	0
et	PMC3035602	13034	13036	O	-1	-1	0
al	PMC3035602	13037	13039	O	-1	-1	0

the	PMC3035602	13040	13043	O	-1	-1	0
different	PMC3035602	13044	13053	O	-1	-1	0
results	PMC3035602	13054	13061	O	-1	-1	0
in	PMC3035602	13062	13064	O	-1	-1	0
the	PMC3035602	13065	13068	O	-1	-1	0
Swedish	PMC3035602	13069	13076	O	-1	-1	0
and	PMC3035602	13077	13080	O	-1	-1	0
the	PMC3035602	13081	13084	O	-1	-1	0
Danish	PMC3035602	13085	13091	O	-1	-1	0
cohorts	PMC3035602	13092	13099	O	-1	-1	0
may	PMC3035602	13100	13103	O	-1	-1	0
be	PMC3035602	13104	13106	O	-1	-1	0
caused	PMC3035602	13107	13113	O	-1	-1	0
by	PMC3035602	13114	13116	O	-1	-1	0
different	PMC3035602	13117	13126	O	-1	-1	0
degrees	PMC3035602	13127	13134	O	-1	-1	0
of	PMC3035602	13135	13137	O	-1	-1	0
misclassification	PMC3035602	13138	13155	O	-1	-1	0
of	PMC3035602	13156	13158	O	-1	-1	0
the	PMC3035602	13159	13162	O	-1	-1	0
outcome	PMC3035602	13163	13170	O	-1	-1	0
variables	PMC3035602	13171	13180	O	-1	-1	0
between	PMC3035602	13181	13188	O	-1	-1	0
the	PMC3035602	13189	13192	O	-1	-1	0
registries	PMC3035602	13193	13203	O	-1	-1	0
or	PMC3035602	13204	13206	O	-1	-1	0
differences	PMC3035602	13207	13218	O	-1	-1	0
in	PMC3035602	13219	13221	O	-1	-1	0
the	PMC3035602	13222	13225	O	-1	-1	0
use	PMC3035602	13226	13229	O	-1	-1	0
of	PMC3035602	13230	13232	O	-1	-1	0
adjuvant	PMC3035602	13233	13241	O	-1	-1	0
radiotherapy	PMC3035602	13242	13254	O	-1	-1	0
or	PMC3035602	13255	13257	O	-1	-1	0
systemic	PMC3035602	13258	13266	O	-1	-1	0
treatments	PMC3035602	13267	13277	O	-1	-1	0
after	PMC3035602	13278	13283	O	-1	-1	0
breast	PMC3035602	13284	13290	O	-1	-1	0
cancer	PMC3035602	13291	13297	O	-1	-1	0
.	PMC3035602	13297	13298	O	-1	-1	0

The	PMC3035602	13299	13302	O	-1	-1	0
Danish	PMC3035602	13303	13309	O	-1	-1	0
cohort	PMC3035602	13310	13316	O	-1	-1	0
study	PMC3035602	13317	13322	O	-1	-1	0
also	PMC3035602	13323	13327	O	-1	-1	0
observed	PMC3035602	13328	13336	O	-1	-1	0
an	PMC3035602	13337	13339	O	-1	-1	0
8-fold	PMC3035602	13340	13346	O	-1	-1	0
increased	PMC3035602	13347	13356	O	-1	-1	0
risk	PMC3035602	13357	13361	O	-1	-1	0
of	PMC3035602	13362	13364	O	-1	-1	0
preterm	PMC3035602	13365	13372	O	-1	-1	0
delivery	PMC3035602	13373	13381	O	-1	-1	0
among	PMC3035602	13382	13387	O	-1	-1	0
37	PMC3035602	13388	13390	O	-1	-1	0
women	PMC3035602	13391	13396	O	-1	-1	0
diagnosed	PMC3035602	13397	13406	O	-1	-1	0
with	PMC3035602	13407	13411	O	-1	-1	0
breast	PMC3035602	13412	13418	O	-1	-1	0
cancer	PMC3035602	13419	13425	O	-1	-1	0
during	PMC3035602	13426	13432	O	-1	-1	0
pregnancy	PMC3035602	13433	13442	O	-1	-1	0
,	PMC3035602	13442	13443	O	-1	-1	0
which	PMC3035602	13444	13449	O	-1	-1	0
reflected	PMC3035602	13450	13459	O	-1	-1	0
a	PMC3035602	13460	13461	O	-1	-1	0
higher	PMC3035602	13462	13468	O	-1	-1	0
rate	PMC3035602	13469	13473	O	-1	-1	0
of	PMC3035602	13474	13476	O	-1	-1	0
elective	PMC3035602	13477	13485	O	-1	-1	0
early	PMC3035602	13486	13491	O	-1	-1	0
delivery	PMC3035602	13492	13500	O	-1	-1	0
,	PMC3035602	13500	13501	O	-1	-1	0
probably	PMC3035602	13502	13510	O	-1	-1	0
to	PMC3035602	13511	13513	O	-1	-1	0
allow	PMC3035602	13514	13519	O	-1	-1	0
an	PMC3035602	13520	13522	O	-1	-1	0
early	PMC3035602	13523	13528	O	-1	-1	0
start	PMC3035602	13529	13534	O	-1	-1	0
to	PMC3035602	13535	13537	O	-1	-1	0
cancer	PMC3035602	13538	13544	O	-1	-1	0
therapy	PMC3035602	13545	13552	O	-1	-1	0
.	PMC3035602	13552	13553	O	-1	-1	0

After	PMC3035602	13554	13559	O	-1	-1	0
adjustment	PMC3035602	13560	13570	O	-1	-1	0
for	PMC3035602	13571	13574	O	-1	-1	0
gestational	PMC3035602	13575	13586	O	-1	-1	0


	PMC3035602	13586	13588	O	-1	-1	0
submit	PMC3035602	13588	13594	O	-1	-1	0
your	PMC3035602	13595	13599	O	-1	-1	0
manuscript	PMC3035602	13600	13610	O	-1	-1	0
|	PMC3035602	13611	13612	O	-1	-1	0

www.dovepress.com	PMC3035602	13613	13630	O	-1	-1	0


	PMC3035602	13630	13632	O	-1	-1	0

Dovepress	PMC3035602	13632	13641	O	-1	-1	0


	PMC3035602	13641	13643	O	-1	-1	0

9	PMC3035602	13643	13644	O	-1	-1	0


	PMC3035602	13644	13646	O	-1	-1	0

10	PMC3035602	13646	13648	O	-1	-1	0


	PMC3035602	13648	13650	O	-1	-1	0

Period	PMC3035602	13650	13656	O	-1	-1	0
of	PMC3035602	13657	13659	O	-1	-1	0
cancer	PMC3035602	13660	13666	O	-1	-1	0

diagnosis	PMC3035602	13667	13676	O	-1	-1	0


	PMC3035602	13676	13678	O	-1	-1	0

Design	PMC3035602	13678	13684	O	-1	-1	0


	PMC3035602	13684	13686	O	-1	-1	0
submit	PMC3035602	13686	13692	O	-1	-1	0
your	PMC3035602	13693	13697	O	-1	-1	0
manuscript	PMC3035602	13698	13708	O	-1	-1	0

|	PMC3035602	13709	13710	O	-1	-1	0

www.dovepress.com	PMC3035602	13711	13728	O	-1	-1	0


	PMC3035602	13728	13730	O	-1	-1	0

Dovepress	PMC3035602	13730	13739	O	-1	-1	0


	PMC3035602	13739	13741	O	-1	-1	0
Not	PMC3035602	13741	13744	O	-1	-1	0
stated	PMC3035602	13745	13751	O	-1	-1	0


	PMC3035602	13751	13753	O	-1	-1	0

Cohort	PMC3035602	13753	13759	O	-1	-1	0
study	PMC3035602	13760	13765	O	-1	-1	0

Comparison	PMC3035602	13766	13776	O	-1	-1	0
:	PMC3035602	13776	13777	O	-1	-1	0
birth	PMC3035602	13778	13783	O	-1	-1	0
outcome	PMC3035602	13784	13791	O	-1	-1	0
in	PMC3035602	13792	13794	O	-1	-1	0
the	PMC3035602	13795	13798	O	-1	-1	0
general	PMC3035602	13799	13806	O	-1	-1	0
population	PMC3035602	13807	13817	O	-1	-1	0


	PMC3035602	13817	13819	O	-1	-1	0

331	PMC3035602	13819	13822	O	-1	-1	0
births	PMC3035602	13823	13829	O	-1	-1	0
by	PMC3035602	13830	13832	O	-1	-1	0
women	PMC3035602	13833	13838	O	-1	-1	0
with	PMC3035602	13839	13843	O	-1	-1	0
previous	PMC3035602	13844	13852	O	-1	-1	0
breast	PMC3035602	13853	13859	O	-1	-1	0
cancer	PMC3035602	13860	13866	O	-1	-1	0


	PMC3035602	13866	13868	O	-1	-1	0

216	PMC3035602	13868	13871	O	-1	-1	0
births	PMC3035602	13872	13878	O	-1	-1	0
by	PMC3035602	13879	13881	O	-1	-1	0
women	PMC3035602	13882	13887	O	-1	-1	0
with	PMC3035602	13888	13892	O	-1	-1	0
previous	PMC3035602	13893	13901	O	-1	-1	0
breast	PMC3035602	13902	13908	O	-1	-1	0
cancer	PMC3035602	13909	13915	O	-1	-1	0


	PMC3035602	13915	13917	O	-1	-1	0

Number	PMC3035602	13917	13923	O	-1	-1	0


	PMC3035602	13923	13925	O	-1	-1	0

Breast	PMC3035602	13925	13931	O	-1	-1	0
cancer	PMC3035602	13932	13938	O	-1	-1	0
diagnosed	PMC3035602	13939	13948	O	-1	-1	0
during	PMC3035602	13949	13955	O	-1	-1	0
or	PMC3035602	13956	13958	O	-1	-1	0
shortly	PMC3035602	13959	13966	O	-1	-1	0
after	PMC3035602	13967	13972	O	-1	-1	0
pregnancy	PMC3035602	13973	13982	O	-1	-1	0

Zemlickis	PMC3035602	13983	13992	O	-1	-1	0
et	PMC3035602	13993	13995	O	-1	-1	0

al25	PMC3035602	13996	14000	O	-1	-1	0

1958–1987	PMC3035602	14001	14010	O	-1	-1	0

Cohort	PMC3035602	14011	14017	O	-1	-1	0
study	PMC3035602	14018	14023	O	-1	-1	0

85	PMC3035602	14024	14026	O	-1	-1	0
births	PMC3035602	14027	14033	O	-1	-1	0
by	PMC3035602	14034	14036	O	-1	-1	0

Canada	PMC3035602	14037	14043	B-Location	-1	-1	0
Comparison	PMC3035602	14044	14054	O	-1	-1	0
:	PMC3035602	14054	14055	O	-1	-1	0

118	PMC3035602	14056	14059	O	-1	-1	0
women	PMC3035602	14060	14065	O	-1	-1	0
who	PMC3035602	14066	14069	O	-1	-1	0
1992	PMC3035602	14070	14074	O	-1	-1	0
Births	PMC3035602	14075	14081	O	-1	-1	0
of	PMC3035602	14082	14084	O	-1	-1	0
age	PMC3035602	14085	14088	O	-1	-1	0
-	PMC3035602	14088	14089	O	-1	-1	0
matched	PMC3035602	14089	14096	O	-1	-1	0
were	PMC3035602	14097	14101	O	-1	-1	0
pregnant	PMC3035602	14102	14110	O	-1	-1	0

no	PMC3035602	14111	14113	O	-1	-1	0
women	PMC3035602	14114	14119	O	-1	-1	0
exposed	PMC3035602	14120	14127	O	-1	-1	0
to	PMC3035602	14128	14130	O	-1	-1	0

earlier	PMC3035602	14131	14138	O	-1	-1	0
than	PMC3035602	14139	14143	O	-1	-1	0
9	PMC3035602	14144	14145	O	-1	-1	0
months	PMC3035602	14146	14152	O	-1	-1	0

nonteratogenic	PMC3035602	14153	14167	O	-1	-1	0
drugs	PMC3035602	14168	14173	O	-1	-1	0

before	PMC3035602	14174	14180	O	-1	-1	0
and	PMC3035602	14181	14184	O	-1	-1	0
no	PMC3035602	14185	14187	O	-1	-1	0
later	PMC3035602	14188	14193	O	-1	-1	0
in	PMC3035602	14194	14196	O	-1	-1	0
pregnancy	PMC3035602	14197	14206	O	-1	-1	0
than	PMC3035602	14207	14211	O	-1	-1	0
3	PMC3035602	14212	14213	O	-1	-1	0
months	PMC3035602	14214	14220	O	-1	-1	0
after	PMC3035602	14221	14226	O	-1	-1	0
their	PMC3035602	14227	14232	O	-1	-1	0
first	PMC3035602	14233	14238	O	-1	-1	0
treatment	PMC3035602	14239	14248	O	-1	-1	0
Smith	PMC3035602	14249	14254	O	-1	-1	0
et	PMC3035602	14255	14257	O	-1	-1	0
al18	PMC3035602	14258	14262	O	-1	-1	0

1992–1997	PMC3035602	14263	14272	O	-1	-1	0

Cohort	PMC3035602	14273	14279	O	-1	-1	0
study	PMC3035602	14280	14285	O	-1	-1	0

Births	PMC3035602	14286	14292	O	-1	-1	0
by	PMC3035602	14293	14295	O	-1	-1	0
423	PMC3035602	14296	14299	O	-1	-1	0
women	PMC3035602	14300	14305	O	-1	-1	0

USA	PMC3035602	14306	14309	B-Location	-1	-1	0
Comparison	PMC3035602	14310	14320	O	-1	-1	0
:	PMC3035602	14320	14321	O	-1	-1	0
who	PMC3035602	14322	14325	O	-1	-1	0
were	PMC3035602	14326	14330	O	-1	-1	0
diagnosed	PMC3035602	14331	14340	O	-1	-1	0

2001	PMC3035602	14341	14345	O	-1	-1	0

Comparison	PMC3035602	14346	14356	O	-1	-1	0
group	PMC3035602	14357	14362	O	-1	-1	0
from	PMC3035602	14363	14367	O	-1	-1	0
9	PMC3035602	14368	14369	O	-1	-1	0
months	PMC3035602	14370	14376	O	-1	-1	0
not	PMC3035602	14377	14380	O	-1	-1	0
specified	PMC3035602	14381	14390	O	-1	-1	0
preceding	PMC3035602	14391	14400	O	-1	-1	0
delivery	PMC3035602	14401	14409	O	-1	-1	0
until	PMC3035602	14410	14415	O	-1	-1	0
12	PMC3035602	14416	14418	O	-1	-1	0
months	PMC3035602	14419	14425	O	-1	-1	0
after	PMC3035602	14426	14431	O	-1	-1	0
delivery	PMC3035602	14432	14440	O	-1	-1	0

Langagergaard	PMC3035602	14441	14454	O	-1	-1	0

1943–2002	PMC3035602	14455	14464	O	-1	-1	0

Cohort	PMC3035602	14465	14471	O	-1	-1	0
study	PMC3035602	14472	14477	O	-1	-1	0

37	PMC3035602	14478	14480	O	-1	-1	0
births	PMC3035602	14481	14487	O	-1	-1	0
of	PMC3035602	14488	14490	O	-1	-1	0
women	PMC3035602	14491	14496	O	-1	-1	0

et	PMC3035602	14497	14499	O	-1	-1	0

al23	PMC3035602	14500	14504	O	-1	-1	0

Comparison	PMC3035602	14505	14515	O	-1	-1	0
:	PMC3035602	14515	14516	O	-1	-1	0
diagnosed	PMC3035602	14517	14526	O	-1	-1	0
during	PMC3035602	14527	14533	O	-1	-1	0
Denmark	PMC3035602	14534	14541	B-Location	-1	-1	0

Births	PMC3035602	14542	14548	O	-1	-1	0
by	PMC3035602	14549	14551	O	-1	-1	0
cancer	PMC3035602	14552	14558	O	-1	-1	0
free	PMC3035602	14559	14563	O	-1	-1	0
pregnancy	PMC3035602	14564	14573	O	-1	-1	0
and	PMC3035602	14574	14577	O	-1	-1	0

2006	PMC3035602	14578	14582	O	-1	-1	0

women	PMC3035602	14583	14588	O	-1	-1	0
matched	PMC3035602	14589	14596	O	-1	-1	0
by	PMC3035602	14597	14599	O	-1	-1	0
442	PMC3035602	14600	14603	O	-1	-1	0
births	PMC3035602	14604	14610	O	-1	-1	0
of	PMC3035602	14611	14613	O	-1	-1	0
time	PMC3035602	14614	14618	O	-1	-1	0
of	PMC3035602	14619	14621	O	-1	-1	0
birth	PMC3035602	14622	14627	O	-1	-1	0
and	PMC3035602	14628	14631	O	-1	-1	0
by	PMC3035602	14632	14634	O	-1	-1	0
women	PMC3035602	14635	14640	O	-1	-1	0
diagnosed	PMC3035602	14641	14650	O	-1	-1	0
county	PMC3035602	14651	14657	O	-1	-1	0
of	PMC3035602	14658	14660	O	-1	-1	0
mother	PMC3035602	14661	14667	O	-1	-1	0

’s	PMC3035602	14667	14669	O	-1	-1	0

within	PMC3035602	14670	14676	O	-1	-1	0
2	PMC3035602	14677	14678	O	-1	-1	0
years	PMC3035602	14679	14684	O	-1	-1	0
after	PMC3035602	14685	14690	O	-1	-1	0
residence	PMC3035602	14691	14700	O	-1	-1	0
delivery	PMC3035602	14701	14709	O	-1	-1	0


	PMC3035602	14709	14711	O	-1	-1	0

Dalberg	PMC3035602	14711	14718	O	-1	-1	0

et	PMC3035602	14719	14721	O	-1	-1	0

al24	PMC3035602	14722	14726	O	-1	-1	0

Sweden	PMC3035602	14727	14733	B-Location	-1	-1	0
2006	PMC3035602	14734	14738	O	-1	-1	0


	PMC3035602	14738	14740	O	-1	-1	0

Breast	PMC3035602	14740	14746	O	-1	-1	0
cancer	PMC3035602	14747	14753	O	-1	-1	0
diagnosed	PMC3035602	14754	14763	O	-1	-1	0
before	PMC3035602	14764	14770	O	-1	-1	0
pregnancy	PMC3035602	14771	14780	O	-1	-1	0

Langagergaard	PMC3035602	14781	14794	O	-1	-1	0
et	PMC3035602	14795	14797	O	-1	-1	0

al23	PMC3035602	14798	14802	O	-1	-1	0

1943–2002	PMC3035602	14803	14812	O	-1	-1	0

Cohort	PMC3035602	14813	14819	O	-1	-1	0
study	PMC3035602	14820	14825	O	-1	-1	0

Denmark	PMC3035602	14826	14833	B-Location	-1	-1	0

Comparison	PMC3035602	14834	14844	O	-1	-1	0
:	PMC3035602	14844	14845	O	-1	-1	0
2006	PMC3035602	14846	14850	O	-1	-1	0

Births	PMC3035602	14851	14857	O	-1	-1	0
by	PMC3035602	14858	14860	O	-1	-1	0
cancer	PMC3035602	14861	14867	O	-1	-1	0
free	PMC3035602	14868	14872	O	-1	-1	0

women	PMC3035602	14873	14878	O	-1	-1	0
matched	PMC3035602	14879	14886	O	-1	-1	0
by	PMC3035602	14887	14889	O	-1	-1	0
time	PMC3035602	14890	14894	O	-1	-1	0
of	PMC3035602	14895	14897	O	-1	-1	0
birth	PMC3035602	14898	14903	O	-1	-1	0
and	PMC3035602	14904	14907	O	-1	-1	0
by	PMC3035602	14908	14910	O	-1	-1	0
county	PMC3035602	14911	14917	O	-1	-1	0
of	PMC3035602	14918	14920	O	-1	-1	0
mother	PMC3035602	14921	14927	O	-1	-1	0

’s	PMC3035602	14927	14929	O	-1	-1	0
residence	PMC3035602	14930	14939	O	-1	-1	0


	PMC3035602	14939	14941	O	-1	-1	0

Author	PMC3035602	14941	14947	O	-1	-1	0

Country	PMC3035602	14948	14955	O	-1	-1	0

Year	PMC3035602	14956	14960	O	-1	-1	0


	PMC3035602	14960	14962	O	-1	-1	0
Table	PMC3035602	14962	14967	O	-1	-1	0

1	PMC3035602	14968	14969	O	-1	-1	0
Studies	PMC3035602	14970	14977	O	-1	-1	0
of	PMC3035602	14978	14980	O	-1	-1	0
birth	PMC3035602	14981	14986	O	-1	-1	0
outcome	PMC3035602	14987	14994	O	-1	-1	0
in	PMC3035602	14995	14997	O	-1	-1	0
women	PMC3035602	14998	15003	O	-1	-1	0
with	PMC3035602	15004	15008	O	-1	-1	0
breast	PMC3035602	15009	15015	O	-1	-1	0
cancer	PMC3035602	15016	15022	O	-1	-1	0


	PMC3035602	15022	15024	O	-1	-1	0

Yes	PMC3035602	15024	15027	O	-1	-1	0
,	PMC3035602	15027	15028	O	-1	-1	0
maternal	PMC3035602	15029	15037	O	-1	-1	0
age	PMC3035602	15038	15041	O	-1	-1	0
,	PMC3035602	15041	15042	O	-1	-1	0
parity	PMC3035602	15043	15049	O	-1	-1	0
,	PMC3035602	15049	15050	O	-1	-1	0
and	PMC3035602	15051	15054	O	-1	-1	0
calendar	PMC3035602	15055	15063	O	-1	-1	0
period	PMC3035602	15064	15070	O	-1	-1	0
of	PMC3035602	15071	15073	O	-1	-1	0
birth	PMC3035602	15074	15079	O	-1	-1	0
PORs	PMC3035602	15080	15084	O	-1	-1	0
for	PMC3035602	15085	15088	O	-1	-1	0
CAs	PMC3035602	15089	15092	O	-1	-1	0
and	PMC3035602	15093	15096	O	-1	-1	0
mean	PMC3035602	15097	15101	O	-1	-1	0

BW	PMC3035602	15102	15104	O	-1	-1	0
were	PMC3035602	15105	15109	O	-1	-1	0
also	PMC3035602	15110	15114	O	-1	-1	0
adjusted	PMC3035602	15115	15123	O	-1	-1	0
for	PMC3035602	15124	15127	O	-1	-1	0
gestational	PMC3035602	15128	15139	O	-1	-1	0
age	PMC3035602	15140	15143	O	-1	-1	0


	PMC3035602	15143	15145	O	-1	-1	0

Yes	PMC3035602	15145	15148	O	-1	-1	0
,	PMC3035602	15148	15149	O	-1	-1	0
maternal	PMC3035602	15150	15158	O	-1	-1	0
age	PMC3035602	15159	15162	O	-1	-1	0
(	PMC3035602	15163	15164	O	-1	-1	0
by	PMC3035602	15164	15166	O	-1	-1	0
matching	PMC3035602	15167	15175	O	-1	-1	0
)	PMC3035602	15175	15176	O	-1	-1	0
and	PMC3035602	15177	15180	O	-1	-1	0
mean	PMC3035602	15181	15185	O	-1	-1	0
BW	PMC3035602	15186	15188	O	-1	-1	0
was	PMC3035602	15189	15192	O	-1	-1	0
adjusted	PMC3035602	15193	15201	O	-1	-1	0
for	PMC3035602	15202	15205	O	-1	-1	0
GA	PMC3035602	15206	15208	O	-1	-1	0

Yes	PMC3035602	15209	15212	O	-1	-1	0
,	PMC3035602	15212	15213	O	-1	-1	0
maternal	PMC3035602	15214	15222	O	-1	-1	0
age	PMC3035602	15223	15226	O	-1	-1	0


	PMC3035602	15226	15228	O	-1	-1	0

Yes	PMC3035602	15228	15231	O	-1	-1	0
,	PMC3035602	15231	15232	O	-1	-1	0
maternal	PMC3035602	15233	15241	O	-1	-1	0
age	PMC3035602	15242	15245	O	-1	-1	0
,	PMC3035602	15245	15246	O	-1	-1	0
parity	PMC3035602	15247	15253	O	-1	-1	0
,	PMC3035602	15253	15254	O	-1	-1	0
and	PMC3035602	15255	15258	O	-1	-1	0
year	PMC3035602	15259	15263	O	-1	-1	0
of	PMC3035602	15264	15266	O	-1	-1	0
delivery	PMC3035602	15267	15275	O	-1	-1	0


	PMC3035602	15275	15277	O	-1	-1	0

Yes	PMC3035602	15277	15280	O	-1	-1	0
,	PMC3035602	15280	15281	O	-1	-1	0
maternal	PMC3035602	15282	15290	O	-1	-1	0
age	PMC3035602	15291	15294	O	-1	-1	0
,	PMC3035602	15294	15295	O	-1	-1	0
parity	PMC3035602	15296	15302	O	-1	-1	0
,	PMC3035602	15302	15303	O	-1	-1	0
and	PMC3035602	15304	15307	O	-1	-1	0
calendar	PMC3035602	15308	15316	O	-1	-1	0
period	PMC3035602	15317	15323	O	-1	-1	0
of	PMC3035602	15324	15326	O	-1	-1	0
birth	PMC3035602	15327	15332	O	-1	-1	0
.	PMC3035602	15332	15333	O	-1	-1	0

PORs	PMC3035602	15334	15338	O	-1	-1	0
for	PMC3035602	15339	15342	O	-1	-1	0
CAs	PMC3035602	15343	15346	O	-1	-1	0
and	PMC3035602	15347	15350	O	-1	-1	0
mean	PMC3035602	15351	15355	O	-1	-1	0

BW	PMC3035602	15356	15358	O	-1	-1	0
were	PMC3035602	15359	15363	O	-1	-1	0
also	PMC3035602	15364	15368	O	-1	-1	0
adjusted	PMC3035602	15369	15377	O	-1	-1	0
for	PMC3035602	15378	15381	O	-1	-1	0
gestational	PMC3035602	15382	15393	O	-1	-1	0
age	PMC3035602	15394	15397	O	-1	-1	0


	PMC3035602	15397	15399	O	-1	-1	0

Adjustment	PMC3035602	15399	15409	O	-1	-1	0


	PMC3035602	15409	15411	O	-1	-1	0
POR	PMC3035602	15411	15414	O	-1	-1	0
for	PMC3035602	15415	15418	O	-1	-1	0
preterm	PMC3035602	15419	15426	O	-1	-1	0
birth	PMC3035602	15427	15432	O	-1	-1	0
,	PMC3035602	15432	15433	O	-1	-1	0

LBW	PMC3035602	15434	15437	O	-1	-1	0
at	PMC3035602	15438	15440	O	-1	-1	0
term	PMC3035602	15441	15445	O	-1	-1	0
,	PMC3035602	15445	15446	O	-1	-1	0
stillbirth	PMC3035602	15447	15457	O	-1	-1	0
,	PMC3035602	15457	15458	O	-1	-1	0
and	PMC3035602	15459	15462	O	-1	-1	0
CAs	PMC3035602	15463	15466	O	-1	-1	0


	PMC3035602	15466	15468	O	-1	-1	0

No	PMC3035602	15468	15470	O	-1	-1	0

OR	PMC3035602	15471	15473	O	-1	-1	0
for	PMC3035602	15474	15477	O	-1	-1	0
preterm	PMC3035602	15478	15485	O	-1	-1	0
birth	PMC3035602	15486	15491	O	-1	-1	0

and	PMC3035602	15492	15495	O	-1	-1	0
very	PMC3035602	15496	15500	O	-1	-1	0
LBW	PMC3035602	15501	15504	O	-1	-1	0


	PMC3035602	15504	15506	O	-1	-1	0

OR	PMC3035602	15506	15508	O	-1	-1	0
for	PMC3035602	15509	15512	O	-1	-1	0
preterm	PMC3035602	15513	15520	O	-1	-1	0

birth	PMC3035602	15521	15526	O	-1	-1	0

(	PMC3035602	15527	15528	O	-1	-1	0
,	PMC3035602	15528	15529	O	-1	-1	0
32	PMC3035602	15529	15531	O	-1	-1	0
wk	PMC3035602	15532	15534	O	-1	-1	0
and	PMC3035602	15535	15538	O	-1	-1	0
32–36	PMC3035602	15539	15544	O	-1	-1	0
wk	PMC3035602	15545	15547	O	-1	-1	0
)	PMC3035602	15547	15548	O	-1	-1	0
,	PMC3035602	15548	15549	O	-1	-1	0

stillbirth	PMC3035602	15550	15560	O	-1	-1	0
,	PMC3035602	15560	15561	O	-1	-1	0

LBW	PMC3035602	15562	15565	O	-1	-1	0
(	PMC3035602	15566	15567	O	-1	-1	0
,	PMC3035602	15567	15568	O	-1	-1	0

1500	PMC3035602	15568	15572	O	-1	-1	0
g	PMC3035602	15573	15574	O	-1	-1	0
and	PMC3035602	15575	15578	O	-1	-1	0
1500–2499	PMC3035602	15579	15588	O	-1	-1	0
g	PMC3035602	15589	15590	O	-1	-1	0
)	PMC3035602	15590	15591	O	-1	-1	0

CAs	PMC3035602	15592	15595	O	-1	-1	0
,	PMC3035602	15595	15596	O	-1	-1	0
and	PMC3035602	15597	15600	O	-1	-1	0
SGA	PMC3035602	15601	15604	O	-1	-1	0


	PMC3035602	15604	15606	O	-1	-1	0
POR	PMC3035602	15606	15609	O	-1	-1	0
for	PMC3035602	15610	15613	O	-1	-1	0
preterm	PMC3035602	15614	15621	O	-1	-1	0
birth	PMC3035602	15622	15627	O	-1	-1	0
,	PMC3035602	15627	15628	O	-1	-1	0

LBW	PMC3035602	15629	15632	O	-1	-1	0
at	PMC3035602	15633	15635	O	-1	-1	0
term	PMC3035602	15636	15640	O	-1	-1	0
,	PMC3035602	15640	15641	O	-1	-1	0

stillbirth	PMC3035602	15642	15652	O	-1	-1	0
,	PMC3035602	15652	15653	O	-1	-1	0
and	PMC3035602	15654	15657	O	-1	-1	0
CAs	PMC3035602	15658	15661	O	-1	-1	0


	PMC3035602	15661	15663	O	-1	-1	0

Relative	PMC3035602	15663	15671	O	-1	-1	0
effect	PMC3035602	15672	15678	O	-1	-1	0

estimates	PMC3035602	15679	15688	O	-1	-1	0


	PMC3035602	15688	15690	O	-1	-1	0

Women	PMC3035602	15690	15695	O	-1	-1	0
diagnosed	PMC3035602	15696	15705	O	-1	-1	0
during	PMC3035602	15706	15712	O	-1	-1	0
pregnancy	PMC3035602	15713	15722	O	-1	-1	0
:	PMC3035602	15722	15723	O	-1	-1	0

PORpreterm	PMC3035602	15724	15734	O	-1	-1	0
birth	PMC3035602	15735	15740	O	-1	-1	0
=	PMC3035602	15741	15742	O	-1	-1	0
8.1	PMC3035602	15743	15746	O	-1	-1	0

(	PMC3035602	15747	15748	O	-1	-1	0
95	PMC3035602	15748	15750	O	-1	-1	0
%	PMC3035602	15750	15751	O	-1	-1	0
CI	PMC3035602	15752	15754	O	-1	-1	0
:	PMC3035602	15754	15755	O	-1	-1	0
3.8–1.7	PMC3035602	15756	15763	O	-1	-1	0
)	PMC3035602	15763	15764	O	-1	-1	0
(	PMC3035602	15765	15766	O	-1	-1	0
10	PMC3035602	15766	15768	O	-1	-1	0
of	PMC3035602	15769	15771	O	-1	-1	0
12	PMC3035602	15772	15774	O	-1	-1	0
preterm	PMC3035602	15775	15782	O	-1	-1	0
deliveries	PMC3035602	15783	15793	O	-1	-1	0
were	PMC3035602	15794	15798	O	-1	-1	0
induced	PMC3035602	15799	15806	O	-1	-1	0
)	PMC3035602	15806	15807	O	-1	-1	0

PORLBW	PMC3035602	15808	15814	O	-1	-1	0
at	PMC3035602	15815	15817	O	-1	-1	0
term	PMC3035602	15818	15822	O	-1	-1	0
=	PMC3035602	15823	15824	O	-1	-1	0

5.3	PMC3035602	15825	15828	O	-1	-1	0
(	PMC3035602	15829	15830	O	-1	-1	0
95	PMC3035602	15830	15832	O	-1	-1	0
%	PMC3035602	15832	15833	O	-1	-1	0
CI	PMC3035602	15834	15836	O	-1	-1	0
:	PMC3035602	15836	15837	O	-1	-1	0
0.6–5.1	PMC3035602	15838	15845	O	-1	-1	0
)	PMC3035602	15845	15846	O	-1	-1	0

PORCAs	PMC3035602	15847	15853	O	-1	-1	0
=	PMC3035602	15854	15855	O	-1	-1	0
0.5	PMC3035602	15856	15859	O	-1	-1	0

(	PMC3035602	15860	15861	O	-1	-1	0
95	PMC3035602	15861	15863	O	-1	-1	0
%	PMC3035602	15863	15864	O	-1	-1	0
CI	PMC3035602	15865	15867	O	-1	-1	0
:	PMC3035602	15867	15868	O	-1	-1	0
0.1–3.6	PMC3035602	15869	15876	O	-1	-1	0
)	PMC3035602	15876	15877	O	-1	-1	0

Stillbirths	PMC3035602	15878	15889	O	-1	-1	0
:	PMC3035602	15889	15890	O	-1	-1	0
none	PMC3035602	15891	15895	O	-1	-1	0

Mean	PMC3035602	15896	15900	O	-1	-1	0
BW	PMC3035602	15901	15903	O	-1	-1	0
 	PMC3035602	15903	15904	O	-1	-1	0
=	PMC3035602	15904	15905	O	-1	-1	0
2948	PMC3035602	15906	15910	O	-1	-1	0
g	PMC3035602	15911	15912	O	-1	-1	0
vs	PMC3035602	15913	15915	O	-1	-1	0
3472	PMC3035602	15916	15920	O	-1	-1	0
g	PMC3035602	15921	15922	O	-1	-1	0
in	PMC3035602	15923	15925	O	-1	-1	0
controls	PMC3035602	15926	15934	O	-1	-1	0
.	PMC3035602	15934	15935	O	-1	-1	0

Proportion	PMC3035602	15936	15946	O	-1	-1	0
of	PMC3035602	15947	15949	O	-1	-1	0
male	PMC3035602	15950	15954	O	-1	-1	0
newborns	PMC3035602	15955	15963	O	-1	-1	0
49	PMC3035602	15964	15966	O	-1	-1	0
%	PMC3035602	15966	15967	O	-1	-1	0
vs	PMC3035602	15968	15970	O	-1	-1	0
52	PMC3035602	15971	15973	O	-1	-1	0
%	PMC3035602	15973	15974	O	-1	-1	0
in	PMC3035602	15975	15977	O	-1	-1	0
controls	PMC3035602	15978	15986	O	-1	-1	0
,	PMC3035602	15986	15987	O	-1	-1	0
difference	PMC3035602	15988	15998	O	-1	-1	0
=	PMC3035602	15999	16000	O	-1	-1	0
–	PMC3035602	16001	16002	O	-1	-1	0
3.4	PMC3035602	16002	16005	O	-1	-1	0
%	PMC3035602	16005	16006	O	-1	-1	0
(	PMC3035602	16007	16008	O	-1	-1	0
95	PMC3035602	16008	16010	O	-1	-1	0
%	PMC3035602	16010	16011	O	-1	-1	0
CI	PMC3035602	16012	16014	O	-1	-1	0
:	PMC3035602	16014	16015	O	-1	-1	0
–	PMC3035602	16016	16017	O	-1	-1	0
20	PMC3035602	16017	16019	O	-1	-1	0
;	PMC3035602	16019	16020	O	-1	-1	0
13	PMC3035602	16021	16023	O	-1	-1	0
)	PMC3035602	16023	16024	O	-1	-1	0
.	PMC3035602	16024	16025	O	-1	-1	0


	PMC3035602	16025	16027	O	-1	-1	0

Lower	PMC3035602	16027	16032	O	-1	-1	0
mean	PMC3035602	16033	16037	O	-1	-1	0
BW	PMC3035602	16038	16040	O	-1	-1	0
(	PMC3035602	16041	16042	O	-1	-1	0
P	PMC3035602	16042	16043	O	-1	-1	0
=	PMC3035602	16044	16045	O	-1	-1	0
0.02	PMC3035602	16046	16050	O	-1	-1	0
)	PMC3035602	16050	16051	O	-1	-1	0

Shorter	PMC3035602	16052	16059	O	-1	-1	0
mean	PMC3035602	16060	16064	O	-1	-1	0
GA	PMC3035602	16065	16067	O	-1	-1	0
(	PMC3035602	16068	16069	O	-1	-1	0
P	PMC3035602	16069	16070	O	-1	-1	0
=	PMC3035602	16071	16072	O	-1	-1	0
0.01	PMC3035602	16073	16077	O	-1	-1	0
)	PMC3035602	16077	16078	O	-1	-1	0

Higher	PMC3035602	16079	16085	O	-1	-1	0
proportion	PMC3035602	16086	16096	O	-1	-1	0
of	PMC3035602	16097	16099	O	-1	-1	0
preterm	PMC3035602	16100	16107	O	-1	-1	0
births	PMC3035602	16108	16114	O	-1	-1	0

(	PMC3035602	16115	16116	O	-1	-1	0
P	PMC3035602	16116	16117	O	-1	-1	0
=	PMC3035602	16118	16119	O	-1	-1	0
0.003	PMC3035602	16120	16125	O	-1	-1	0
)	PMC3035602	16125	16126	O	-1	-1	0

Mean	PMC3035602	16127	16131	O	-1	-1	0
BW	PMC3035602	16132	16134	O	-1	-1	0
 	PMC3035602	16134	16135	O	-1	-1	0
=	PMC3035602	16135	16136	O	-1	-1	0
3010	PMC3035602	16137	16141	O	-1	-1	0
g	PMC3035602	16142	16143	O	-1	-1	0
vs	PMC3035602	16144	16146	O	-1	-1	0
3451	PMC3035602	16147	16151	O	-1	-1	0
g	PMC3035602	16152	16153	O	-1	-1	0
in	PMC3035602	16154	16156	O	-1	-1	0
controls	PMC3035602	16157	16165	O	-1	-1	0

Mean	PMC3035602	16166	16170	O	-1	-1	0
GA	PMC3035602	16171	16173	O	-1	-1	0
=	PMC3035602	16174	16175	O	-1	-1	0
38.3	PMC3035602	16176	16180	O	-1	-1	0
wk	PMC3035602	16181	16183	O	-1	-1	0
vs	PMC3035602	16184	16186	O	-1	-1	0
39.4	PMC3035602	16187	16191	O	-1	-1	0
wk	PMC3035602	16192	16194	O	-1	-1	0
in	PMC3035602	16195	16197	O	-1	-1	0
controls	PMC3035602	16198	16206	O	-1	-1	0

Preterm	PMC3035602	16207	16214	O	-1	-1	0
births	PMC3035602	16215	16221	O	-1	-1	0
=	PMC3035602	16222	16223	O	-1	-1	0
26.7	PMC3035602	16224	16228	O	-1	-1	0
%	PMC3035602	16228	16229	O	-1	-1	0
Stillbirths	PMC3035602	16230	16241	O	-1	-1	0

=	PMC3035602	16242	16243	O	-1	-1	0
2.4	PMC3035602	16244	16247	O	-1	-1	0
%	PMC3035602	16247	16248	O	-1	-1	0

CAs	PMC3035602	16249	16252	O	-1	-1	0
=	PMC3035602	16253	16254	O	-1	-1	0
none	PMC3035602	16255	16259	O	-1	-1	0

ORvery	PMC3035602	16260	16266	O	-1	-1	0
LBW	PMC3035602	16267	16270	O	-1	-1	0
=	PMC3035602	16271	16272	O	-1	-1	0
2.0	PMC3035602	16273	16276	O	-1	-1	0

(	PMC3035602	16277	16278	O	-1	-1	0
95	PMC3035602	16278	16280	O	-1	-1	0
%	PMC3035602	16280	16281	O	-1	-1	0
CI	PMC3035602	16282	16284	O	-1	-1	0
:	PMC3035602	16284	16285	O	-1	-1	0
1.0–4.1	PMC3035602	16286	16293	O	-1	-1	0
)	PMC3035602	16293	16294	O	-1	-1	0

ORpreterm	PMC3035602	16295	16304	O	-1	-1	0

birth	PMC3035602	16305	16310	O	-1	-1	0
=	PMC3035602	16311	16312	O	-1	-1	0
2.2	PMC3035602	16313	16316	O	-1	-1	0
(	PMC3035602	16317	16318	O	-1	-1	0
95	PMC3035602	16318	16320	O	-1	-1	0
%	PMC3035602	16320	16321	O	-1	-1	0
CI	PMC3035602	16322	16324	O	-1	-1	0
:	PMC3035602	16324	16325	O	-1	-1	0

1.7–2.8	PMC3035602	16326	16333	O	-1	-1	0
)	PMC3035602	16333	16334	O	-1	-1	0


	PMC3035602	16334	16336	O	-1	-1	0
PORpreterm	PMC3035602	16336	16346	O	-1	-1	0
birth	PMC3035602	16347	16352	O	-1	-1	0
=	PMC3035602	16353	16354	O	-1	-1	0
1.3	PMC3035602	16355	16358	O	-1	-1	0

(	PMC3035602	16359	16360	O	-1	-1	0
95	PMC3035602	16360	16362	O	-1	-1	0
%	PMC3035602	16362	16363	O	-1	-1	0
CI	PMC3035602	16364	16366	O	-1	-1	0
:	PMC3035602	16366	16367	O	-1	-1	0
0.7–2.2	PMC3035602	16368	16375	O	-1	-1	0
)	PMC3035602	16375	16376	O	-1	-1	0
PORLBW	PMC3035602	16377	16383	O	-1	-1	0
at	PMC3035602	16384	16386	O	-1	-1	0
term	PMC3035602	16387	16391	O	-1	-1	0
=	PMC3035602	16392	16393	O	-1	-1	0
1.2	PMC3035602	16394	16397	O	-1	-1	0

(	PMC3035602	16398	16399	O	-1	-1	0
95	PMC3035602	16399	16401	O	-1	-1	0
%	PMC3035602	16401	16402	O	-1	-1	0
CI	PMC3035602	16403	16405	O	-1	-1	0
:	PMC3035602	16405	16406	O	-1	-1	0
0.4–3.8	PMC3035602	16407	16414	O	-1	-1	0
)	PMC3035602	16414	16415	O	-1	-1	0
PORCAs	PMC3035602	16416	16422	O	-1	-1	0
=	PMC3035602	16423	16424	O	-1	-1	0
0.9	PMC3035602	16425	16428	O	-1	-1	0

(	PMC3035602	16429	16430	O	-1	-1	0
95	PMC3035602	16430	16432	O	-1	-1	0
%	PMC3035602	16432	16433	O	-1	-1	0
CI	PMC3035602	16434	16436	O	-1	-1	0
:	PMC3035602	16436	16437	O	-1	-1	0
0.4–1.9	PMC3035602	16438	16445	O	-1	-1	0
)	PMC3035602	16445	16446	O	-1	-1	0

Stillbirths	PMC3035602	16447	16458	O	-1	-1	0
:	PMC3035602	16458	16459	O	-1	-1	0
none	PMC3035602	16460	16464	O	-1	-1	0

Mean	PMC3035602	16465	16469	O	-1	-1	0
BW	PMC3035602	16470	16472	O	-1	-1	0
 	PMC3035602	16472	16473	O	-1	-1	0
=	PMC3035602	16473	16474	O	-1	-1	0
3411	PMC3035602	16475	16479	O	-1	-1	0
g	PMC3035602	16480	16481	O	-1	-1	0
vs	PMC3035602	16482	16484	O	-1	-1	0
3474	PMC3035602	16485	16489	O	-1	-1	0
g	PMC3035602	16490	16491	O	-1	-1	0
in	PMC3035602	16492	16494	O	-1	-1	0
controls	PMC3035602	16495	16503	O	-1	-1	0
.	PMC3035602	16503	16504	O	-1	-1	0

Proportion	PMC3035602	16505	16515	O	-1	-1	0
of	PMC3035602	16516	16518	O	-1	-1	0
male	PMC3035602	16519	16523	O	-1	-1	0
newborns	PMC3035602	16524	16532	O	-1	-1	0
=	PMC3035602	16533	16534	O	-1	-1	0

50	PMC3035602	16535	16537	O	-1	-1	0
%	PMC3035602	16537	16538	O	-1	-1	0
vs	PMC3035602	16539	16541	O	-1	-1	0
52	PMC3035602	16542	16544	O	-1	-1	0
%	PMC3035602	16544	16545	O	-1	-1	0
in	PMC3035602	16546	16548	O	-1	-1	0
controls	PMC3035602	16549	16557	O	-1	-1	0
,	PMC3035602	16557	16558	O	-1	-1	0
difference	PMC3035602	16559	16569	O	-1	-1	0
=	PMC3035602	16570	16571	O	-1	-1	0
–	PMC3035602	16572	16573	O	-1	-1	0
2.2	PMC3035602	16573	16576	O	-1	-1	0
%	PMC3035602	16576	16577	O	-1	-1	0
(	PMC3035602	16578	16579	O	-1	-1	0
95	PMC3035602	16579	16581	O	-1	-1	0
%	PMC3035602	16581	16582	O	-1	-1	0
CI	PMC3035602	16583	16585	O	-1	-1	0
:	PMC3035602	16585	16586	O	-1	-1	0
–	PMC3035602	16587	16588	O	-1	-1	0
8.9	PMC3035602	16588	16591	O	-1	-1	0
;	PMC3035602	16591	16592	O	-1	-1	0
4.5	PMC3035602	16593	16596	O	-1	-1	0
)	PMC3035602	16596	16597	O	-1	-1	0

OR,32	PMC3035602	16598	16603	O	-1	-1	0
wk	PMC3035602	16604	16606	O	-1	-1	0
=	PMC3035602	16607	16608	O	-1	-1	0
3.2	PMC3035602	16609	16612	O	-1	-1	0

(	PMC3035602	16613	16614	O	-1	-1	0
95	PMC3035602	16614	16616	O	-1	-1	0
%	PMC3035602	16616	16617	O	-1	-1	0
CI	PMC3035602	16618	16620	O	-1	-1	0
:	PMC3035602	16620	16621	O	-1	-1	0
1.7–6.0	PMC3035602	16622	16629	O	-1	-1	0
)	PMC3035602	16629	16630	O	-1	-1	0

OR32–36	PMC3035602	16631	16638	O	-1	-1	0
wk	PMC3035602	16639	16641	O	-1	-1	0
=	PMC3035602	16642	16643	O	-1	-1	0

1.5	PMC3035602	16644	16647	O	-1	-1	0

(	PMC3035602	16648	16649	O	-1	-1	0
95	PMC3035602	16649	16651	O	-1	-1	0
%	PMC3035602	16651	16652	O	-1	-1	0
CI	PMC3035602	16653	16655	O	-1	-1	0
:	PMC3035602	16655	16656	O	-1	-1	0
1.0–2.3	PMC3035602	16657	16664	O	-1	-1	0
)	PMC3035602	16664	16665	O	-1	-1	0

ORstillbirth	PMC3035602	16666	16678	O	-1	-1	0
=	PMC3035602	16679	16680	O	-1	-1	0
1.2	PMC3035602	16681	16684	O	-1	-1	0

(	PMC3035602	16685	16686	O	-1	-1	0
95	PMC3035602	16686	16688	O	-1	-1	0
%	PMC3035602	16688	16689	O	-1	-1	0
CI	PMC3035602	16690	16692	O	-1	-1	0
:	PMC3035602	16692	16693	O	-1	-1	0
0.3–4.7	PMC3035602	16694	16701	O	-1	-1	0
)	PMC3035602	16701	16702	O	-1	-1	0

OR,1,500	PMC3035602	16703	16711	O	-1	-1	0
g	PMC3035602	16712	16713	O	-1	-1	0

=	PMC3035602	16714	16715	O	-1	-1	0
2.9	PMC3035602	16716	16719	O	-1	-1	0

(	PMC3035602	16720	16721	O	-1	-1	0
95	PMC3035602	16721	16723	O	-1	-1	0
%	PMC3035602	16723	16724	O	-1	-1	0
CI	PMC3035602	16725	16727	O	-1	-1	0
:	PMC3035602	16727	16728	O	-1	-1	0
1.4–5.8	PMC3035602	16729	16736	O	-1	-1	0
)	PMC3035602	16736	16737	O	-1	-1	0
OR1,500	PMC3035602	16738	16745	O	-1	-1	0
g-2,499	PMC3035602	16746	16753	O	-1	-1	0

g	PMC3035602	16754	16755	O	-1	-1	0
=	PMC3035602	16756	16757	O	-1	-1	0
1.0	PMC3035602	16758	16761	O	-1	-1	0

(	PMC3035602	16762	16763	O	-1	-1	0
95	PMC3035602	16763	16765	O	-1	-1	0
%	PMC3035602	16765	16766	O	-1	-1	0
CI	PMC3035602	16767	16769	O	-1	-1	0
:	PMC3035602	16769	16770	O	-1	-1	0
0.6–1.8	PMC3035602	16771	16778	O	-1	-1	0
)	PMC3035602	16778	16779	O	-1	-1	0

ORCAs	PMC3035602	16780	16785	O	-1	-1	0
=	PMC3035602	16786	16787	O	-1	-1	0
1.7	PMC3035602	16788	16791	O	-1	-1	0

(	PMC3035602	16792	16793	O	-1	-1	0
95	PMC3035602	16793	16795	O	-1	-1	0
%	PMC3035602	16795	16796	O	-1	-1	0
CI	PMC3035602	16797	16799	O	-1	-1	0
:	PMC3035602	16799	16800	O	-1	-1	0
1.1–2.5	PMC3035602	16801	16808	O	-1	-1	0
)	PMC3035602	16808	16809	O	-1	-1	0

ORSGA	PMC3035602	16810	16815	O	-1	-1	0
=	PMC3035602	16816	16817	O	-1	-1	0

1.2	PMC3035602	16818	16821	O	-1	-1	0

(	PMC3035602	16822	16823	O	-1	-1	0
95	PMC3035602	16823	16825	O	-1	-1	0
%	PMC3035602	16825	16826	O	-1	-1	0
CI	PMC3035602	16827	16829	O	-1	-1	0
:	PMC3035602	16829	16830	O	-1	-1	0
0.9–1.4	PMC3035602	16831	16838	O	-1	-1	0
)	PMC3035602	16838	16839	O	-1	-1	0


	PMC3035602	16839	16841	O	-1	-1	0
Results	PMC3035602	16841	16848	O	-1	-1	0
for	PMC3035602	16849	16852	O	-1	-1	0
birth	PMC3035602	16853	16858	O	-1	-1	0
outcome	PMC3035602	16859	16866	O	-1	-1	0


	PMC3035602	16866	16868	O	-1	-1	0

Langagergaard	PMC3035602	16868	16881	O	-1	-1	0

Dovepress	PMC3035602	16882	16891	O	-1	-1	0


	PMC3035602	16891	16893	O	-1	-1	0

Clinical	PMC3035602	16893	16901	O	-1	-1	0
Epidemiology	PMC3035602	16902	16914	O	-1	-1	0
2011:3	PMC3035602	16915	16921	O	-1	-1	0


	PMC3035602	16921	16923	O	-1	-1	0

Clinical	PMC3035602	16923	16931	O	-1	-1	0
Epidemiology	PMC3035602	16932	16944	O	-1	-1	0
2011:3	PMC3035602	16945	16951	O	-1	-1	0


	PMC3035602	16951	16953	O	-1	-1	0

Birth	PMC3035602	16953	16958	O	-1	-1	0
outcome	PMC3035602	16959	16966	O	-1	-1	0
in	PMC3035602	16967	16969	O	-1	-1	0
women	PMC3035602	16970	16975	O	-1	-1	0
with	PMC3035602	16976	16980	O	-1	-1	0
cancer	PMC3035602	16981	16987	O	-1	-1	0


	PMC3035602	16987	16989	O	-1	-1	0
Abbreviations	PMC3035602	16989	17002	O	-1	-1	0
:	PMC3035602	17002	17003	O	-1	-1	0

BW	PMC3035602	17004	17006	O	-1	-1	0
,	PMC3035602	17006	17007	O	-1	-1	0
birth	PMC3035602	17008	17013	O	-1	-1	0
weight	PMC3035602	17014	17020	O	-1	-1	0
;	PMC3035602	17020	17021	O	-1	-1	0
CAs	PMC3035602	17022	17025	O	-1	-1	0
,	PMC3035602	17025	17026	O	-1	-1	0
congenital	PMC3035602	17027	17037	O	-1	-1	0
abnormalities	PMC3035602	17038	17051	O	-1	-1	0
;	PMC3035602	17051	17052	O	-1	-1	0
CI	PMC3035602	17053	17055	O	-1	-1	0
,	PMC3035602	17055	17056	O	-1	-1	0
confidence	PMC3035602	17057	17067	O	-1	-1	0
interval	PMC3035602	17068	17076	O	-1	-1	0
;	PMC3035602	17076	17077	O	-1	-1	0
GA	PMC3035602	17078	17080	O	-1	-1	0
,	PMC3035602	17080	17081	O	-1	-1	0
gestational	PMC3035602	17082	17093	O	-1	-1	0
age	PMC3035602	17094	17097	O	-1	-1	0
;	PMC3035602	17097	17098	O	-1	-1	0
LBW	PMC3035602	17099	17102	O	-1	-1	0
,	PMC3035602	17102	17103	O	-1	-1	0
low	PMC3035602	17104	17107	O	-1	-1	0
birth	PMC3035602	17108	17113	O	-1	-1	0
weight	PMC3035602	17114	17120	O	-1	-1	0
;	PMC3035602	17120	17121	O	-1	-1	0
OR	PMC3035602	17122	17124	O	-1	-1	0
,	PMC3035602	17124	17125	O	-1	-1	0
odds	PMC3035602	17126	17130	O	-1	-1	0
ratio	PMC3035602	17131	17136	O	-1	-1	0
;	PMC3035602	17136	17137	O	-1	-1	0
POR	PMC3035602	17138	17141	O	-1	-1	0
,	PMC3035602	17141	17142	O	-1	-1	0
prevalence	PMC3035602	17143	17153	O	-1	-1	0
odds	PMC3035602	17154	17158	O	-1	-1	0
ratios	PMC3035602	17159	17165	O	-1	-1	0
;	PMC3035602	17165	17166	O	-1	-1	0
RR	PMC3035602	17167	17169	O	-1	-1	0
,	PMC3035602	17169	17170	O	-1	-1	0
relative	PMC3035602	17171	17179	O	-1	-1	0
risk	PMC3035602	17180	17184	O	-1	-1	0
;	PMC3035602	17184	17185	O	-1	-1	0
SGA	PMC3035602	17186	17189	O	-1	-1	0
,	PMC3035602	17189	17190	O	-1	-1	0
small	PMC3035602	17191	17196	O	-1	-1	0
for	PMC3035602	17197	17200	O	-1	-1	0
gestational	PMC3035602	17201	17212	O	-1	-1	0
age	PMC3035602	17213	17216	O	-1	-1	0
.	PMC3035602	17216	17217	O	-1	-1	0


	PMC3035602	17217	17219	O	-1	-1	0

Women	PMC3035602	17219	17224	O	-1	-1	0
diagnosed	PMC3035602	17225	17234	O	-1	-1	0
within	PMC3035602	17235	17241	O	-1	-1	0
2	PMC3035602	17242	17243	O	-1	-1	0
years	PMC3035602	17244	17249	O	-1	-1	0
after	PMC3035602	17250	17255	O	-1	-1	0
delivery	PMC3035602	17256	17264	O	-1	-1	0
:	PMC3035602	17264	17265	O	-1	-1	0

PORpreterm	PMC3035602	17266	17276	O	-1	-1	0
birth	PMC3035602	17277	17282	O	-1	-1	0
=	PMC3035602	17283	17284	O	-1	-1	0
1.4	PMC3035602	17285	17288	O	-1	-1	0

(	PMC3035602	17289	17290	O	-1	-1	0
95	PMC3035602	17290	17292	O	-1	-1	0
%	PMC3035602	17292	17293	O	-1	-1	0
CI	PMC3035602	17294	17296	O	-1	-1	0
:	PMC3035602	17296	17297	O	-1	-1	0
1.0–2.0	PMC3035602	17298	17305	O	-1	-1	0
)	PMC3035602	17305	17306	O	-1	-1	0
PORLBW	PMC3035602	17307	17313	O	-1	-1	0
at	PMC3035602	17314	17316	O	-1	-1	0
term	PMC3035602	17317	17321	O	-1	-1	0
=	PMC3035602	17322	17323	O	-1	-1	0
1.4	PMC3035602	17324	17327	O	-1	-1	0

(	PMC3035602	17328	17329	O	-1	-1	0
95	PMC3035602	17329	17331	O	-1	-1	0
%	PMC3035602	17331	17332	O	-1	-1	0
CI	PMC3035602	17333	17335	O	-1	-1	0
:	PMC3035602	17335	17336	O	-1	-1	0
0.7–2.8	PMC3035602	17337	17344	O	-1	-1	0
)	PMC3035602	17344	17345	O	-1	-1	0

PORCAs	PMC3035602	17346	17352	O	-1	-1	0
=	PMC3035602	17353	17354	O	-1	-1	0
1.1	PMC3035602	17355	17358	O	-1	-1	0

(	PMC3035602	17359	17360	O	-1	-1	0
95	PMC3035602	17360	17362	O	-1	-1	0
%	PMC3035602	17362	17363	O	-1	-1	0
CI	PMC3035602	17364	17366	O	-1	-1	0
:	PMC3035602	17366	17367	O	-1	-1	0
0.6–1.8	PMC3035602	17368	17375	O	-1	-1	0
)	PMC3035602	17375	17376	O	-1	-1	0

Stillbirths	PMC3035602	17377	17388	O	-1	-1	0
:	PMC3035602	17388	17389	O	-1	-1	0
none	PMC3035602	17390	17394	O	-1	-1	0

Mean	PMC3035602	17395	17399	O	-1	-1	0
BW	PMC3035602	17400	17402	O	-1	-1	0
 	PMC3035602	17402	17403	O	-1	-1	0
=	PMC3035602	17403	17404	O	-1	-1	0
3471	PMC3035602	17405	17409	O	-1	-1	0
g	PMC3035602	17410	17411	O	-1	-1	0
vs	PMC3035602	17412	17414	O	-1	-1	0
3466	PMC3035602	17415	17419	O	-1	-1	0
g	PMC3035602	17420	17421	O	-1	-1	0
in	PMC3035602	17422	17424	O	-1	-1	0
controls	PMC3035602	17425	17433	O	-1	-1	0
.	PMC3035602	17433	17434	O	-1	-1	0

Proportion	PMC3035602	17435	17445	O	-1	-1	0
of	PMC3035602	17446	17448	O	-1	-1	0
male	PMC3035602	17449	17453	O	-1	-1	0
newborns	PMC3035602	17454	17462	O	-1	-1	0
53	PMC3035602	17463	17465	O	-1	-1	0
%	PMC3035602	17465	17466	O	-1	-1	0
vs	PMC3035602	17467	17469	O	-1	-1	0
51	PMC3035602	17470	17472	O	-1	-1	0
%	PMC3035602	17472	17473	O	-1	-1	0
in	PMC3035602	17474	17476	O	-1	-1	0
controls	PMC3035602	17477	17485	O	-1	-1	0
,	PMC3035602	17485	17486	O	-1	-1	0
difference	PMC3035602	17487	17497	O	-1	-1	0
=	PMC3035602	17498	17499	O	-1	-1	0

2.5	PMC3035602	17500	17503	O	-1	-1	0
%	PMC3035602	17503	17504	O	-1	-1	0
(	PMC3035602	17505	17506	O	-1	-1	0
95	PMC3035602	17506	17508	O	-1	-1	0
%	PMC3035602	17508	17509	O	-1	-1	0
CI	PMC3035602	17510	17512	O	-1	-1	0
:	PMC3035602	17512	17513	O	-1	-1	0
–	PMC3035602	17514	17515	O	-1	-1	0
2.2	PMC3035602	17515	17518	O	-1	-1	0
;	PMC3035602	17518	17519	O	-1	-1	0
7.2	PMC3035602	17520	17523	O	-1	-1	0
)	PMC3035602	17523	17524	O	-1	-1	0


	PMC3035602	17524	17526	O	-1	-1	0

Dovepress	PMC3035602	17526	17535	O	-1	-1	0


	PMC3035602	17535	17537	O	-1	-1	0

age	PMC3035602	17537	17540	O	-1	-1	0
,	PMC3035602	17540	17541	O	-1	-1	0
there	PMC3035602	17542	17547	O	-1	-1	0
was	PMC3035602	17548	17551	O	-1	-1	0
a	PMC3035602	17552	17553	O	-1	-1	0
240	PMC3035602	17554	17557	O	-1	-1	0
g	PMC3035602	17558	17559	O	-1	-1	0
reduction	PMC3035602	17560	17569	O	-1	-1	0
(	PMC3035602	17570	17571	O	-1	-1	0
95	PMC3035602	17571	17573	O	-1	-1	0
%	PMC3035602	17573	17574	O	-1	-1	0
CI	PMC3035602	17575	17577	O	-1	-1	0
:	PMC3035602	17577	17578	O	-1	-1	0

-404	PMC3035602	17579	17583	O	-1	-1	0

;	PMC3035602	17583	17584	O	-1	-1	0
-76	PMC3035602	17585	17588	O	-1	-1	0
)	PMC3035602	17588	17589	O	-1	-1	0

in	PMC3035602	17590	17592	O	-1	-1	0
mean	PMC3035602	17593	17597	O	-1	-1	0
birth	PMC3035602	17598	17603	O	-1	-1	0
weight	PMC3035602	17604	17610	O	-1	-1	0
for	PMC3035602	17611	17614	O	-1	-1	0
newborns	PMC3035602	17615	17623	O	-1	-1	0
of	PMC3035602	17624	17626	O	-1	-1	0
women	PMC3035602	17627	17632	O	-1	-1	0
diagnosed	PMC3035602	17633	17642	O	-1	-1	0
with	PMC3035602	17643	17647	O	-1	-1	0
breast	PMC3035602	17648	17654	O	-1	-1	0
cancer	PMC3035602	17655	17661	O	-1	-1	0
during	PMC3035602	17662	17668	O	-1	-1	0
pregnancy	PMC3035602	17669	17678	O	-1	-1	0
.	PMC3035602	17678	17679	O	-1	-1	0

­Furthermore	PMC3035602	17680	17692	O	-1	-1	0

,	PMC3035602	17692	17693	O	-1	-1	0
the	PMC3035602	17694	17697	O	-1	-1	0
study	PMC3035602	17698	17703	O	-1	-1	0
showed	PMC3035602	17704	17710	O	-1	-1	0
a	PMC3035602	17711	17712	O	-1	-1	0
tendency	PMC3035602	17713	17721	O	-1	-1	0
towards	PMC3035602	17722	17729	O	-1	-1	0
an	PMC3035602	17730	17732	O	-1	-1	0
increased	PMC3035602	17733	17742	O	-1	-1	0
risk	PMC3035602	17743	17747	O	-1	-1	0
of	PMC3035602	17748	17750	O	-1	-1	0
preterm	PMC3035602	17751	17758	O	-1	-1	0
birth	PMC3035602	17759	17764	O	-1	-1	0
for	PMC3035602	17765	17768	O	-1	-1	0
442	PMC3035602	17769	17772	O	-1	-1	0
women	PMC3035602	17773	17778	O	-1	-1	0
diagnosed	PMC3035602	17779	17788	O	-1	-1	0
with	PMC3035602	17789	17793	O	-1	-1	0
breast	PMC3035602	17794	17800	O	-1	-1	0
cancer	PMC3035602	17801	17807	O	-1	-1	0
within	PMC3035602	17808	17814	O	-1	-1	0
2	PMC3035602	17815	17816	O	-1	-1	0
years	PMC3035602	17817	17822	O	-1	-1	0
after	PMC3035602	17823	17828	O	-1	-1	0
delivery.23	PMC3035602	17829	17840	O	-1	-1	0

The	PMC3035602	17841	17844	O	-1	-1	0
study	PMC3035602	17845	17850	O	-1	-1	0
found	PMC3035602	17851	17856	O	-1	-1	0
no	PMC3035602	17857	17859	O	-1	-1	0
increased	PMC3035602	17860	17869	O	-1	-1	0
risk	PMC3035602	17870	17874	O	-1	-1	0
of	PMC3035602	17875	17877	O	-1	-1	0
stillbirth	PMC3035602	17878	17888	O	-1	-1	0
or	PMC3035602	17889	17891	O	-1	-1	0
congenital	PMC3035602	17892	17902	O	-1	-1	0
abnormalities	PMC3035602	17903	17916	O	-1	-1	0
in	PMC3035602	17917	17919	O	-1	-1	0
women	PMC3035602	17920	17925	O	-1	-1	0
diagnosed	PMC3035602	17926	17935	O	-1	-1	0
with	PMC3035602	17936	17940	O	-1	-1	0
breast	PMC3035602	17941	17947	O	-1	-1	0
cancer	PMC3035602	17948	17954	O	-1	-1	0
during	PMC3035602	17955	17961	O	-1	-1	0
pregnancy	PMC3035602	17962	17971	O	-1	-1	0
or	PMC3035602	17972	17974	O	-1	-1	0
within	PMC3035602	17975	17981	O	-1	-1	0
2	PMC3035602	17982	17983	O	-1	-1	0
years	PMC3035602	17984	17989	O	-1	-1	0
of	PMC3035602	17990	17992	O	-1	-1	0
delivery	PMC3035602	17993	18001	O	-1	-1	0
.	PMC3035602	18001	18002	O	-1	-1	0

These	PMC3035602	18003	18008	O	-1	-1	0
findings	PMC3035602	18009	18017	O	-1	-1	0
corroborate	PMC3035602	18018	18029	O	-1	-1	0
the	PMC3035602	18030	18033	O	-1	-1	0
results	PMC3035602	18034	18041	O	-1	-1	0
of	PMC3035602	18042	18044	O	-1	-1	0
2	PMC3035602	18045	18046	O	-1	-1	0
earlier	PMC3035602	18047	18054	O	-1	-1	0
cohort	PMC3035602	18055	18061	O	-1	-1	0
studies	PMC3035602	18062	18069	O	-1	-1	0
of	PMC3035602	18070	18072	O	-1	-1	0
birth	PMC3035602	18073	18078	O	-1	-1	0
outcome	PMC3035602	18079	18086	O	-1	-1	0
in	PMC3035602	18087	18089	O	-1	-1	0
women	PMC3035602	18090	18095	O	-1	-1	0
with	PMC3035602	18096	18100	O	-1	-1	0
breast	PMC3035602	18101	18107	O	-1	-1	0
cancer	PMC3035602	18108	18114	O	-1	-1	0
­diagnosed	PMC3035602	18115	18125	O	-1	-1	0

during	PMC3035602	18126	18132	O	-1	-1	0
or	PMC3035602	18133	18135	O	-1	-1	0
shortly	PMC3035602	18136	18143	O	-1	-1	0
after	PMC3035602	18144	18149	O	-1	-1	0
pregnancy	PMC3035602	18150	18159	O	-1	-1	0
(	PMC3035602	18160	18161	O	-1	-1	0
Table	PMC3035602	18161	18166	O	-1	-1	0
1).18,25	PMC3035602	18167	18175	O	-1	-1	0

In	PMC3035602	18176	18178	O	-1	-1	0
these	PMC3035602	18179	18184	O	-1	-1	0
studies	PMC3035602	18185	18192	O	-1	-1	0
,	PMC3035602	18192	18193	O	-1	-1	0
however	PMC3035602	18194	18201	O	-1	-1	0
,	PMC3035602	18201	18202	O	-1	-1	0
the	PMC3035602	18203	18206	O	-1	-1	0
authors	PMC3035602	18207	18214	O	-1	-1	0
did	PMC3035602	18215	18218	O	-1	-1	0
not	PMC3035602	18219	18222	O	-1	-1	0
distinguish	PMC3035602	18223	18234	O	-1	-1	0
between	PMC3035602	18235	18242	O	-1	-1	0
birth	PMC3035602	18243	18248	O	-1	-1	0
outcome	PMC3035602	18249	18256	O	-1	-1	0
in	PMC3035602	18257	18259	O	-1	-1	0
women	PMC3035602	18260	18265	O	-1	-1	0
diagnosed	PMC3035602	18266	18275	O	-1	-1	0
with	PMC3035602	18276	18280	O	-1	-1	0
breast	PMC3035602	18281	18287	O	-1	-1	0
cancer	PMC3035602	18288	18294	O	-1	-1	0
during	PMC3035602	18295	18301	O	-1	-1	0
pregnancy	PMC3035602	18302	18311	O	-1	-1	0
and	PMC3035602	18312	18315	O	-1	-1	0

women	PMC3035602	18316	18321	O	-1	-1	0
diagnosed	PMC3035602	18322	18331	O	-1	-1	0
shortly	PMC3035602	18332	18339	O	-1	-1	0
after	PMC3035602	18340	18345	O	-1	-1	0
pregnancy	PMC3035602	18346	18355	O	-1	-1	0
.	PMC3035602	18355	18356	O	-1	-1	0

Smith	PMC3035602	18357	18362	O	-1	-1	0
et	PMC3035602	18363	18365	O	-1	-1	0
al	PMC3035602	18366	18368	O	-1	-1	0
identified	PMC3035602	18369	18379	O	-1	-1	0
423	PMC3035602	18380	18383	O	-1	-1	0
cases	PMC3035602	18384	18389	O	-1	-1	0
of	PMC3035602	18390	18392	O	-1	-1	0
breast	PMC3035602	18393	18399	O	-1	-1	0
cancer	PMC3035602	18400	18406	O	-1	-1	0
diagnosed	PMC3035602	18407	18416	O	-1	-1	0
from	PMC3035602	18417	18421	O	-1	-1	0
9	PMC3035602	18422	18423	O	-1	-1	0
months	PMC3035602	18424	18430	O	-1	-1	0
preceding	PMC3035602	18431	18440	O	-1	-1	0
delivery	PMC3035602	18441	18449	O	-1	-1	0
until	PMC3035602	18450	18455	O	-1	-1	0
12	PMC3035602	18456	18458	O	-1	-1	0
months	PMC3035602	18459	18465	O	-1	-1	0

after	PMC3035602	18466	18471	O	-1	-1	0
delivery	PMC3035602	18472	18480	O	-1	-1	0
over	PMC3035602	18481	18485	O	-1	-1	0
a	PMC3035602	18486	18487	O	-1	-1	0
period	PMC3035602	18488	18494	O	-1	-1	0
of	PMC3035602	18495	18497	O	-1	-1	0
6	PMC3035602	18498	18499	O	-1	-1	0
years	PMC3035602	18500	18505	O	-1	-1	0
in	PMC3035602	18506	18508	O	-1	-1	0
­California.18	PMC3035602	18509	18523	O	-1	-1	0

After	PMC3035602	18524	18529	O	-1	-1	0
adjusting	PMC3035602	18530	18539	O	-1	-1	0
the	PMC3035602	18540	18543	O	-1	-1	0
analyses	PMC3035602	18544	18552	O	-1	-1	0
for	PMC3035602	18553	18556	O	-1	-1	0
maternal	PMC3035602	18557	18565	O	-1	-1	0
age	PMC3035602	18566	18569	O	-1	-1	0
,	PMC3035602	18569	18570	O	-1	-1	0
the	PMC3035602	18571	18574	O	-1	-1	0
authors	PMC3035602	18575	18582	O	-1	-1	0
reported	PMC3035602	18583	18591	O	-1	-1	0

an	PMC3035602	18592	18594	O	-1	-1	0
OR	PMC3035602	18595	18597	O	-1	-1	0
of	PMC3035602	18598	18600	O	-1	-1	0
2.2	PMC3035602	18601	18604	O	-1	-1	0

(	PMC3035602	18605	18606	O	-1	-1	0
95	PMC3035602	18606	18608	O	-1	-1	0
%	PMC3035602	18608	18609	O	-1	-1	0
CI	PMC3035602	18610	18612	O	-1	-1	0
:	PMC3035602	18612	18613	O	-1	-1	0
1.7–2.8	PMC3035602	18614	18621	O	-1	-1	0
)	PMC3035602	18621	18622	O	-1	-1	0
for	PMC3035602	18623	18626	O	-1	-1	0
preterm	PMC3035602	18627	18634	O	-1	-1	0
birth	PMC3035602	18635	18640	O	-1	-1	0
,	PMC3035602	18640	18641	O	-1	-1	0
and	PMC3035602	18642	18645	O	-1	-1	0
an	PMC3035602	18646	18648	O	-1	-1	0
OR	PMC3035602	18649	18651	O	-1	-1	0
of	PMC3035602	18652	18654	O	-1	-1	0
2.0	PMC3035602	18655	18658	O	-1	-1	0
(	PMC3035602	18659	18660	O	-1	-1	0
95	PMC3035602	18660	18662	O	-1	-1	0
%	PMC3035602	18662	18663	O	-1	-1	0
CI	PMC3035602	18664	18666	O	-1	-1	0
:	PMC3035602	18666	18667	O	-1	-1	0
1.0–4.1	PMC3035602	18668	18675	O	-1	-1	0
)	PMC3035602	18675	18676	O	-1	-1	0
for	PMC3035602	18677	18680	O	-1	-1	0
very	PMC3035602	18681	18685	O	-1	-1	0
low	PMC3035602	18686	18689	O	-1	-1	0
birth	PMC3035602	18690	18695	O	-1	-1	0
weight	PMC3035602	18696	18702	O	-1	-1	0
.	PMC3035602	18702	18703	O	-1	-1	0

The	PMC3035602	18704	18707	O	-1	-1	0
study	PMC3035602	18708	18713	O	-1	-1	0
concluded	PMC3035602	18714	18723	O	-1	-1	0
that	PMC3035602	18724	18728	O	-1	-1	0
the	PMC3035602	18729	18732	O	-1	-1	0
data	PMC3035602	18733	18737	O	-1	-1	0
were	PMC3035602	18738	18742	O	-1	-1	0
consistent	PMC3035602	18743	18753	O	-1	-1	0
with	PMC3035602	18754	18758	O	-1	-1	0
an	PMC3035602	18759	18761	O	-1	-1	0
obstetric	PMC3035602	18762	18771	O	-1	-1	0
practice	PMC3035602	18772	18780	O	-1	-1	0
involving	PMC3035602	18781	18790	O	-1	-1	0
elective	PMC3035602	18791	18799	O	-1	-1	0
early	PMC3035602	18800	18805	O	-1	-1	0
delivery	PMC3035602	18806	18814	O	-1	-1	0
for	PMC3035602	18815	18818	O	-1	-1	0
cancer	PMC3035602	18819	18825	O	-1	-1	0
patients	PMC3035602	18826	18834	O	-1	-1	0
.	PMC3035602	18834	18835	O	-1	-1	0

Likewise	PMC3035602	18836	18844	O	-1	-1	0
,	PMC3035602	18844	18845	O	-1	-1	0
a	PMC3035602	18846	18847	O	-1	-1	0
historical	PMC3035602	18848	18858	O	-1	-1	0
cohort	PMC3035602	18859	18865	O	-1	-1	0
study	PMC3035602	18866	18871	O	-1	-1	0
of	PMC3035602	18872	18874	O	-1	-1	0
118	PMC3035602	18875	18878	O	-1	-1	0
women	PMC3035602	18879	18884	O	-1	-1	0
,	PMC3035602	18884	18885	O	-1	-1	0
who	PMC3035602	18886	18889	O	-1	-1	0
were	PMC3035602	18890	18894	O	-1	-1	0
pregnant	PMC3035602	18895	18903	O	-1	-1	0
within	PMC3035602	18904	18910	O	-1	-1	0
9	PMC3035602	18911	18912	O	-1	-1	0
months	PMC3035602	18913	18919	O	-1	-1	0
before	PMC3035602	18920	18926	O	-1	-1	0
or	PMC3035602	18927	18929	O	-1	-1	0
3	PMC3035602	18930	18931	O	-1	-1	0
months	PMC3035602	18932	18938	O	-1	-1	0
after	PMC3035602	18939	18944	O	-1	-1	0
their	PMC3035602	18945	18950	O	-1	-1	0
first	PMC3035602	18951	18956	O	-1	-1	0
treatment	PMC3035602	18957	18966	O	-1	-1	0
for	PMC3035602	18967	18970	O	-1	-1	0
breast	PMC3035602	18971	18977	O	-1	-1	0
cancer	PMC3035602	18978	18984	O	-1	-1	0
,	PMC3035602	18984	18985	O	-1	-1	0
reported	PMC3035602	18986	18994	O	-1	-1	0
a	PMC3035602	18995	18996	O	-1	-1	0
higher	PMC3035602	18997	19003	O	-1	-1	0
proportion	PMC3035602	19004	19014	O	-1	-1	0
of	PMC3035602	19015	19017	O	-1	-1	0
preterm	PMC3035602	19018	19025	O	-1	-1	0
births	PMC3035602	19026	19032	O	-1	-1	0
among	PMC3035602	19033	19038	O	-1	-1	0
offspring	PMC3035602	19039	19048	O	-1	-1	0
of	PMC3035602	19049	19051	O	-1	-1	0
women	PMC3035602	19052	19057	O	-1	-1	0
with	PMC3035602	19058	19062	O	-1	-1	0
breast	PMC3035602	19063	19069	O	-1	-1	0
cancer	PMC3035602	19070	19076	O	-1	-1	0
compared	PMC3035602	19077	19085	O	-1	-1	0
with	PMC3035602	19086	19090	O	-1	-1	0
controls	PMC3035602	19091	19099	O	-1	-1	0
,	PMC3035602	19099	19100	O	-1	-1	0
mainly	PMC3035602	19101	19107	O	-1	-1	0
because	PMC3035602	19108	19115	O	-1	-1	0
elective	PMC3035602	19116	19124	O	-1	-1	0
cesarean	PMC3035602	19125	19133	O	-1	-1	0
sections	PMC3035602	19134	19142	O	-1	-1	0
were	PMC3035602	19143	19147	O	-1	-1	0
done	PMC3035602	19148	19152	O	-1	-1	0
more	PMC3035602	19153	19157	O	-1	-1	0
often	PMC3035602	19158	19163	O	-1	-1	0
to	PMC3035602	19164	19166	O	-1	-1	0
allow	PMC3035602	19167	19172	O	-1	-1	0
earlier	PMC3035602	19173	19180	O	-1	-1	0
start	PMC3035602	19181	19186	O	-1	-1	0
to	PMC3035602	19187	19189	O	-1	-1	0
cancer	PMC3035602	19190	19196	O	-1	-1	0
therapy.25	PMC3035602	19197	19207	O	-1	-1	0

In	PMC3035602	19208	19210	O	-1	-1	0
that	PMC3035602	19211	19215	O	-1	-1	0
study	PMC3035602	19216	19221	O	-1	-1	0
,	PMC3035602	19221	19222	O	-1	-1	0
only	PMC3035602	19223	19227	O	-1	-1	0
2	PMC3035602	19228	19229	O	-1	-1	0
stillbirths	PMC3035602	19230	19241	O	-1	-1	0
and	PMC3035602	19242	19245	O	-1	-1	0
no	PMC3035602	19246	19248	O	-1	-1	0
congenital	PMC3035602	19249	19259	O	-1	-1	0
abnormalities	PMC3035602	19260	19273	O	-1	-1	0
were	PMC3035602	19274	19278	O	-1	-1	0
observed	PMC3035602	19279	19287	O	-1	-1	0
.	PMC3035602	19287	19288	O	-1	-1	0

The	PMC3035602	19289	19292	O	-1	-1	0
authors	PMC3035602	19293	19300	O	-1	-1	0
also	PMC3035602	19301	19305	O	-1	-1	0
reported	PMC3035602	19306	19314	O	-1	-1	0
a	PMC3035602	19315	19316	O	-1	-1	0
lower	PMC3035602	19317	19322	O	-1	-1	0
mean	PMC3035602	19323	19327	O	-1	-1	0
birth	PMC3035602	19328	19333	O	-1	-1	0
weight	PMC3035602	19334	19340	O	-1	-1	0
after	PMC3035602	19341	19346	O	-1	-1	0
adjustment	PMC3035602	19347	19357	O	-1	-1	0
for	PMC3035602	19358	19361	O	-1	-1	0
gestational	PMC3035602	19362	19373	O	-1	-1	0
age	PMC3035602	19374	19377	O	-1	-1	0
.	PMC3035602	19377	19378	O	-1	-1	0

Three	PMC3035602	19379	19384	O	-1	-1	0
case	PMC3035602	19385	19389	O	-1	-1	0
-	PMC3035602	19389	19390	O	-1	-1	0
series	PMC3035602	19390	19396	O	-1	-1	0
of	PMC3035602	19397	19399	O	-1	-1	0
24	PMC3035602	19400	19402	O	-1	-1	0
,	PMC3035602	19402	19403	O	-1	-1	0
28	PMC3035602	19404	19406	O	-1	-1	0
,	PMC3035602	19406	19407	O	-1	-1	0
and	PMC3035602	19408	19411	O	-1	-1	0
29	PMC3035602	19412	19414	O	-1	-1	0
pregnant	PMC3035602	19415	19423	O	-1	-1	0
breast	PMC3035602	19424	19430	O	-1	-1	0
cancer	PMC3035602	19431	19437	O	-1	-1	0
patients	PMC3035602	19438	19446	O	-1	-1	0
,	PMC3035602	19446	19447	O	-1	-1	0
respectively	PMC3035602	19448	19460	O	-1	-1	0
,	PMC3035602	19460	19461	O	-1	-1	0
have	PMC3035602	19462	19466	O	-1	-1	0
reported	PMC3035602	19467	19475	O	-1	-1	0
that	PMC3035602	19476	19480	O	-1	-1	0
­chemotherapeutic	PMC3035602	19481	19498	O	-1	-1	0
treatment	PMC3035602	19499	19508	O	-1	-1	0
in	PMC3035602	19509	19511	O	-1	-1	0
the	PMC3035602	19512	19515	O	-1	-1	0
second	PMC3035602	19516	19522	O	-1	-1	0
and	PMC3035602	19523	19526	O	-1	-1	0
third	PMC3035602	19527	19532	O	-1	-1	0
trimester	PMC3035602	19533	19542	O	-1	-1	0
caused	PMC3035602	19543	19549	O	-1	-1	0
no	PMC3035602	19550	19552	O	-1	-1	0
­congenital	PMC3035602	19553	19564	O	-1	-1	0
abnormalities	PMC3035602	19565	19578	O	-1	-1	0
or	PMC3035602	19579	19581	O	-1	-1	0
other	PMC3035602	19582	19587	O	-1	-1	0
complications	PMC3035602	19588	19601	O	-1	-1	0
,	PMC3035602	19601	19602	O	-1	-1	0
except	PMC3035602	19603	19609	O	-1	-1	0
for	PMC3035602	19610	19613	O	-1	-1	0
intrauterine	PMC3035602	19614	19626	O	-1	-1	0
growth	PMC3035602	19627	19633	O	-1	-1	0
retardation	PMC3035602	19634	19645	O	-1	-1	0
(	PMC3035602	19646	19647	O	-1	-1	0
IUGR	PMC3035602	19647	19651	O	-1	-1	0
)	PMC3035602	19651	19652	O	-1	-1	0
in	PMC3035602	19653	19655	O	-1	-1	0
1	PMC3035602	19656	19657	O	-1	-1	0
case.26–28	PMC3035602	19658	19668	O	-1	-1	0

Only	PMC3035602	19669	19673	O	-1	-1	0
1	PMC3035602	19674	19675	O	-1	-1	0
study	PMC3035602	19676	19681	O	-1	-1	0
examined	PMC3035602	19682	19690	O	-1	-1	0
the	PMC3035602	19691	19694	O	-1	-1	0
sex	PMC3035602	19695	19698	O	-1	-1	0
ratio	PMC3035602	19699	19704	O	-1	-1	0
among	PMC3035602	19705	19710	O	-1	-1	0
newborns	PMC3035602	19711	19719	O	-1	-1	0
and	PMC3035602	19720	19723	O	-1	-1	0
found	PMC3035602	19724	19729	O	-1	-1	0
no	PMC3035602	19730	19732	O	-1	-1	0
substantial	PMC3035602	19733	19744	O	-1	-1	0
differences	PMC3035602	19745	19756	O	-1	-1	0
in	PMC3035602	19757	19759	O	-1	-1	0
proportions	PMC3035602	19760	19771	O	-1	-1	0
of	PMC3035602	19772	19774	O	-1	-1	0
boys	PMC3035602	19775	19779	O	-1	-1	0
born	PMC3035602	19780	19784	O	-1	-1	0
to	PMC3035602	19785	19787	O	-1	-1	0
breast	PMC3035602	19788	19794	O	-1	-1	0
cancer	PMC3035602	19795	19801	O	-1	-1	0
patients	PMC3035602	19802	19810	O	-1	-1	0
compared	PMC3035602	19811	19819	O	-1	-1	0
with	PMC3035602	19820	19824	O	-1	-1	0
cancer	PMC3035602	19825	19831	O	-1	-1	0
-	PMC3035602	19831	19832	O	-1	-1	0
free	PMC3035602	19832	19836	O	-1	-1	0
mothers.23	PMC3035602	19837	19847	O	-1	-1	0

Thus	PMC3035602	19848	19852	O	-1	-1	0
,	PMC3035602	19852	19853	O	-1	-1	0
the	PMC3035602	19854	19857	O	-1	-1	0
findings	PMC3035602	19858	19866	O	-1	-1	0
did	PMC3035602	19867	19870	O	-1	-1	0
not	PMC3035602	19871	19874	O	-1	-1	0
corroborate	PMC3035602	19875	19886	O	-1	-1	0
a	PMC3035602	19887	19888	O	-1	-1	0
theory	PMC3035602	19889	19895	O	-1	-1	0
of	PMC3035602	19896	19898	O	-1	-1	0
psychological	PMC3035602	19899	19912	O	-1	-1	0
stress29	PMC3035602	19913	19921	O	-1	-1	0
(	PMC3035602	19922	19923	O	-1	-1	0
caused	PMC3035602	19923	19929	O	-1	-1	0
by	PMC3035602	19930	19932	O	-1	-1	0
a	PMC3035602	19933	19934	O	-1	-1	0
cancer	PMC3035602	19935	19941	O	-1	-1	0
diagnosis	PMC3035602	19942	19951	O	-1	-1	0
)	PMC3035602	19951	19952	O	-1	-1	0
or	PMC3035602	19953	19955	O	-1	-1	0
potential	PMC3035602	19956	19965	O	-1	-1	0
mutagenic	PMC3035602	19966	19975	O	-1	-1	0
exposure	PMC3035602	19976	19984	O	-1	-1	0
(	PMC3035602	19985	19986	O	-1	-1	0
from	PMC3035602	19986	19990	O	-1	-1	0
chemotherapy	PMC3035602	19991	20003	O	-1	-1	0
or	PMC3035602	20004	20006	O	-1	-1	0
radiation)30	PMC3035602	20007	20019	O	-1	-1	0
reducing	PMC3035602	20020	20028	O	-1	-1	0
the	PMC3035602	20029	20032	O	-1	-1	0
male	PMC3035602	20033	20037	O	-1	-1	0
proportion	PMC3035602	20038	20048	O	-1	-1	0
of	PMC3035602	20049	20051	O	-1	-1	0
newborns	PMC3035602	20052	20060	O	-1	-1	0
.	PMC3035602	20060	20061	O	-1	-1	0

These	PMC3035602	20062	20067	O	-1	-1	0
findings	PMC3035602	20068	20076	O	-1	-1	0
are	PMC3035602	20077	20080	O	-1	-1	0
in	PMC3035602	20081	20083	O	-1	-1	0
line	PMC3035602	20084	20088	O	-1	-1	0
with	PMC3035602	20089	20093	O	-1	-1	0
earlier	PMC3035602	20094	20101	O	-1	-1	0
studies	PMC3035602	20102	20109	O	-1	-1	0
that	PMC3035602	20110	20114	O	-1	-1	0
examined	PMC3035602	20115	20123	O	-1	-1	0
the	PMC3035602	20124	20127	O	-1	-1	0
sex	PMC3035602	20128	20131	O	-1	-1	0
ratio	PMC3035602	20132	20137	O	-1	-1	0
for	PMC3035602	20138	20141	O	-1	-1	0
newborns	PMC3035602	20142	20150	O	-1	-1	0
of	PMC3035602	20151	20153	O	-1	-1	0
childhood	PMC3035602	20154	20163	O	-1	-1	0
cancer	PMC3035602	20164	20170	O	-1	-1	0
survivors	PMC3035602	20171	20180	O	-1	-1	0
and	PMC3035602	20181	20184	O	-1	-1	0
found	PMC3035602	20185	20190	O	-1	-1	0

no	PMC3035602	20191	20193	O	-1	-1	0
significant	PMC3035602	20194	20205	O	-1	-1	0
alterations.31–33	PMC3035602	20206	20223	O	-1	-1	0


	PMC3035602	20223	20225	O	-1	-1	0
submit	PMC3035602	20225	20231	O	-1	-1	0
your	PMC3035602	20232	20236	O	-1	-1	0
manuscript	PMC3035602	20237	20247	O	-1	-1	0
|	PMC3035602	20248	20249	O	-1	-1	0

www.dovepress.com	PMC3035602	20250	20267	O	-1	-1	0


	PMC3035602	20267	20269	O	-1	-1	0

Dovepress	PMC3035602	20269	20278	O	-1	-1	0


	PMC3035602	20278	20280	O	-1	-1	0
11	PMC3035602	20280	20282	O	-1	-1	0


	PMC3035602	20282	20284	O	-1	-1	0

12	PMC3035602	20284	20286	O	-1	-1	0


	PMC3035602	20286	20288	O	-1	-1	0

Period	PMC3035602	20288	20294	O	-1	-1	0
of	PMC3035602	20295	20297	O	-1	-1	0
cancer	PMC3035602	20298	20304	O	-1	-1	0
diagnosis	PMC3035602	20305	20314	O	-1	-1	0


	PMC3035602	20314	20316	O	-1	-1	0
submit	PMC3035602	20316	20322	O	-1	-1	0
your	PMC3035602	20323	20327	O	-1	-1	0
manuscript	PMC3035602	20328	20338	O	-1	-1	0
|	PMC3035602	20339	20340	O	-1	-1	0

www.dovepress.com	PMC3035602	20341	20358	O	-1	-1	0


	PMC3035602	20358	20360	O	-1	-1	0

Dovepress	PMC3035602	20360	20369	O	-1	-1	0


	PMC3035602	20369	20371	O	-1	-1	0

Cohort	PMC3035602	20371	20377	O	-1	-1	0
study	PMC3035602	20378	20383	O	-1	-1	0

Comparison	PMC3035602	20384	20394	O	-1	-1	0
:	PMC3035602	20394	20395	O	-1	-1	0
births	PMC3035602	20396	20402	O	-1	-1	0
of	PMC3035602	20403	20405	O	-1	-1	0
cancer	PMC3035602	20406	20412	O	-1	-1	0
free	PMC3035602	20413	20417	O	-1	-1	0
women	PMC3035602	20418	20423	O	-1	-1	0
matched	PMC3035602	20424	20431	O	-1	-1	0
by	PMC3035602	20432	20434	O	-1	-1	0
time	PMC3035602	20435	20439	O	-1	-1	0
of	PMC3035602	20440	20442	O	-1	-1	0
birth	PMC3035602	20443	20448	O	-1	-1	0
and	PMC3035602	20449	20452	O	-1	-1	0
by	PMC3035602	20453	20455	O	-1	-1	0
county	PMC3035602	20456	20462	O	-1	-1	0
of	PMC3035602	20463	20465	O	-1	-1	0
mother	PMC3035602	20466	20472	O	-1	-1	0

’s	PMC3035602	20472	20474	O	-1	-1	0

residence	PMC3035602	20475	20484	O	-1	-1	0


	PMC3035602	20484	20486	O	-1	-1	0

Design	PMC3035602	20486	20492	O	-1	-1	0


	PMC3035602	20492	20494	O	-1	-1	0
Cohort	PMC3035602	20494	20500	O	-1	-1	0
study	PMC3035602	20501	20506	O	-1	-1	0

Comparison	PMC3035602	20507	20517	O	-1	-1	0
:	PMC3035602	20517	20518	O	-1	-1	0
births	PMC3035602	20519	20525	O	-1	-1	0
of	PMC3035602	20526	20528	O	-1	-1	0
cancer	PMC3035602	20529	20535	O	-1	-1	0
free	PMC3035602	20536	20540	O	-1	-1	0
women	PMC3035602	20541	20546	O	-1	-1	0
matched	PMC3035602	20547	20554	O	-1	-1	0
by	PMC3035602	20555	20557	O	-1	-1	0
time	PMC3035602	20558	20562	O	-1	-1	0
of	PMC3035602	20563	20565	O	-1	-1	0
birth	PMC3035602	20566	20571	O	-1	-1	0
and	PMC3035602	20572	20575	O	-1	-1	0
by	PMC3035602	20576	20578	O	-1	-1	0
county	PMC3035602	20579	20585	O	-1	-1	0
of	PMC3035602	20586	20588	O	-1	-1	0
mother	PMC3035602	20589	20595	O	-1	-1	0

’s	PMC3035602	20595	20597	O	-1	-1	0

residence	PMC3035602	20598	20607	O	-1	-1	0


	PMC3035602	20607	20609	O	-1	-1	0

1970–2002	PMC3035602	20609	20618	O	-1	-1	0


	PMC3035602	20618	20620	O	-1	-1	0

Langagergaard	PMC3035602	20620	20633	O	-1	-1	0

et	PMC3035602	20634	20636	O	-1	-1	0

al34	PMC3035602	20637	20641	O	-1	-1	0
Denmark	PMC3035602	20642	20649	B-Location	-1	-1	0

2007	PMC3035602	20650	20654	O	-1	-1	0


	PMC3035602	20654	20656	O	-1	-1	0

149	PMC3035602	20656	20659	O	-1	-1	0
births	PMC3035602	20660	20666	O	-1	-1	0
by	PMC3035602	20667	20669	O	-1	-1	0
women	PMC3035602	20670	20675	O	-1	-1	0
diagnosed	PMC3035602	20676	20685	O	-1	-1	0
during	PMC3035602	20686	20692	O	-1	-1	0
pregnancy	PMC3035602	20693	20702	O	-1	-1	0
and	PMC3035602	20703	20706	O	-1	-1	0
263	PMC3035602	20707	20710	O	-1	-1	0
births	PMC3035602	20711	20717	O	-1	-1	0
by	PMC3035602	20718	20720	O	-1	-1	0
women	PMC3035602	20721	20726	O	-1	-1	0
diagnosed	PMC3035602	20727	20736	O	-1	-1	0
within	PMC3035602	20737	20743	O	-1	-1	0
12	PMC3035602	20744	20746	O	-1	-1	0
months	PMC3035602	20747	20753	O	-1	-1	0
after	PMC3035602	20754	20759	O	-1	-1	0
delivery	PMC3035602	20760	20768	O	-1	-1	0

88	PMC3035602	20769	20771	O	-1	-1	0
births	PMC3035602	20772	20778	O	-1	-1	0
by	PMC3035602	20779	20781	O	-1	-1	0
women	PMC3035602	20782	20787	O	-1	-1	0
diagnosed	PMC3035602	20788	20797	O	-1	-1	0
during	PMC3035602	20798	20804	O	-1	-1	0
pregnancy	PMC3035602	20805	20814	O	-1	-1	0
and	PMC3035602	20815	20818	O	-1	-1	0
351	PMC3035602	20819	20822	O	-1	-1	0
births	PMC3035602	20823	20829	O	-1	-1	0
by	PMC3035602	20830	20832	O	-1	-1	0
women	PMC3035602	20833	20838	O	-1	-1	0
diagnosed	PMC3035602	20839	20848	O	-1	-1	0
within	PMC3035602	20849	20855	O	-1	-1	0
2	PMC3035602	20856	20857	O	-1	-1	0
years	PMC3035602	20858	20863	O	-1	-1	0
of	PMC3035602	20864	20866	O	-1	-1	0
delivery	PMC3035602	20867	20875	O	-1	-1	0


	PMC3035602	20875	20877	O	-1	-1	0

18	PMC3035602	20877	20879	O	-1	-1	0
births	PMC3035602	20880	20886	O	-1	-1	0
of	PMC3035602	20887	20889	O	-1	-1	0
women	PMC3035602	20890	20895	O	-1	-1	0
diagnosed	PMC3035602	20896	20905	O	-1	-1	0
during	PMC3035602	20906	20912	O	-1	-1	0
pregnancy	PMC3035602	20913	20922	O	-1	-1	0


	PMC3035602	20922	20924	O	-1	-1	0

620	PMC3035602	20924	20927	O	-1	-1	0
births	PMC3035602	20928	20934	O	-1	-1	0
by	PMC3035602	20935	20937	O	-1	-1	0
women	PMC3035602	20938	20943	O	-1	-1	0
with	PMC3035602	20944	20948	O	-1	-1	0
previous	PMC3035602	20949	20957	O	-1	-1	0
melanoma	PMC3035602	20958	20966	O	-1	-1	0


	PMC3035602	20966	20968	O	-1	-1	0

Number	PMC3035602	20968	20974	O	-1	-1	0


	PMC3035602	20974	20976	O	-1	-1	0

Yes	PMC3035602	20976	20979	O	-1	-1	0
,	PMC3035602	20979	20980	O	-1	-1	0
maternal	PMC3035602	20981	20989	O	-1	-1	0
age	PMC3035602	20990	20993	O	-1	-1	0
,	PMC3035602	20993	20994	O	-1	-1	0
parity	PMC3035602	20995	21001	O	-1	-1	0
,	PMC3035602	21001	21002	O	-1	-1	0
and	PMC3035602	21003	21006	O	-1	-1	0
calendar	PMC3035602	21007	21015	O	-1	-1	0
period	PMC3035602	21016	21022	O	-1	-1	0
of	PMC3035602	21023	21025	O	-1	-1	0
birth	PMC3035602	21026	21031	O	-1	-1	0
PORs	PMC3035602	21032	21036	O	-1	-1	0
for	PMC3035602	21037	21040	O	-1	-1	0
stillbirth	PMC3035602	21041	21051	O	-1	-1	0

and	PMC3035602	21052	21055	O	-1	-1	0
mean	PMC3035602	21056	21060	O	-1	-1	0
BW	PMC3035602	21061	21063	O	-1	-1	0
was	PMC3035602	21064	21067	O	-1	-1	0
also	PMC3035602	21068	21072	O	-1	-1	0
adjusted	PMC3035602	21073	21081	O	-1	-1	0
for	PMC3035602	21082	21085	O	-1	-1	0
gestational	PMC3035602	21086	21097	O	-1	-1	0
age	PMC3035602	21098	21101	O	-1	-1	0


	PMC3035602	21101	21103	O	-1	-1	0

Yes	PMC3035602	21103	21106	O	-1	-1	0
,	PMC3035602	21106	21107	O	-1	-1	0
maternal	PMC3035602	21108	21116	O	-1	-1	0
age	PMC3035602	21117	21120	O	-1	-1	0
and	PMC3035602	21121	21124	O	-1	-1	0
race	PMC3035602	21125	21129	O	-1	-1	0


	PMC3035602	21129	21131	O	-1	-1	0

Yes	PMC3035602	21131	21134	O	-1	-1	0
,	PMC3035602	21134	21135	O	-1	-1	0
maternal	PMC3035602	21136	21144	O	-1	-1	0
age	PMC3035602	21145	21148	O	-1	-1	0
(	PMC3035602	21149	21150	O	-1	-1	0
by	PMC3035602	21150	21152	O	-1	-1	0
matching	PMC3035602	21153	21161	O	-1	-1	0
)	PMC3035602	21161	21162	O	-1	-1	0


	PMC3035602	21162	21164	O	-1	-1	0

Yes	PMC3035602	21164	21167	O	-1	-1	0
,	PMC3035602	21167	21168	O	-1	-1	0
maternal	PMC3035602	21169	21177	O	-1	-1	0
age	PMC3035602	21178	21181	O	-1	-1	0
,	PMC3035602	21181	21182	O	-1	-1	0
parity	PMC3035602	21183	21189	O	-1	-1	0
,	PMC3035602	21189	21190	O	-1	-1	0
and	PMC3035602	21191	21194	O	-1	-1	0
calendar	PMC3035602	21195	21203	O	-1	-1	0
period	PMC3035602	21204	21210	O	-1	-1	0
of	PMC3035602	21211	21213	O	-1	-1	0
birth	PMC3035602	21214	21219	O	-1	-1	0

Mean	PMC3035602	21220	21224	O	-1	-1	0
BW	PMC3035602	21225	21227	O	-1	-1	0
was	PMC3035602	21228	21231	O	-1	-1	0
also	PMC3035602	21232	21236	O	-1	-1	0
adjusted	PMC3035602	21237	21245	O	-1	-1	0
for	PMC3035602	21246	21249	O	-1	-1	0
gestational	PMC3035602	21250	21261	O	-1	-1	0
age	PMC3035602	21262	21265	O	-1	-1	0


	PMC3035602	21265	21267	O	-1	-1	0

Adjustment	PMC3035602	21267	21277	O	-1	-1	0


	PMC3035602	21277	21279	O	-1	-1	0
POR	PMC3035602	21279	21282	O	-1	-1	0
for	PMC3035602	21283	21286	O	-1	-1	0
preterm	PMC3035602	21287	21294	O	-1	-1	0
birth	PMC3035602	21295	21300	O	-1	-1	0
,	PMC3035602	21300	21301	O	-1	-1	0
LBW	PMC3035602	21302	21305	O	-1	-1	0

at	PMC3035602	21306	21308	O	-1	-1	0
term	PMC3035602	21309	21313	O	-1	-1	0
,	PMC3035602	21313	21314	O	-1	-1	0
stillbirth	PMC3035602	21315	21325	O	-1	-1	0
,	PMC3035602	21325	21326	O	-1	-1	0
and	PMC3035602	21327	21330	O	-1	-1	0
CAs	PMC3035602	21331	21334	O	-1	-1	0


	PMC3035602	21334	21336	O	-1	-1	0

OR	PMC3035602	21336	21338	O	-1	-1	0
for	PMC3035602	21339	21342	O	-1	-1	0
preterm	PMC3035602	21343	21350	O	-1	-1	0
birth	PMC3035602	21351	21356	O	-1	-1	0

and	PMC3035602	21357	21360	O	-1	-1	0
LBW	PMC3035602	21361	21364	O	-1	-1	0


	PMC3035602	21364	21366	O	-1	-1	0

No	PMC3035602	21366	21368	O	-1	-1	0


	PMC3035602	21368	21370	O	-1	-1	0
POR	PMC3035602	21370	21373	O	-1	-1	0
for	PMC3035602	21374	21377	O	-1	-1	0
preterm	PMC3035602	21378	21385	O	-1	-1	0
birth	PMC3035602	21386	21391	O	-1	-1	0
,	PMC3035602	21391	21392	O	-1	-1	0

LBW	PMC3035602	21393	21396	O	-1	-1	0
at	PMC3035602	21397	21399	O	-1	-1	0
term	PMC3035602	21400	21404	O	-1	-1	0
,	PMC3035602	21404	21405	O	-1	-1	0
stillbirth	PMC3035602	21406	21416	O	-1	-1	0
,	PMC3035602	21416	21417	O	-1	-1	0
and	PMC3035602	21418	21421	O	-1	-1	0
CAs	PMC3035602	21422	21425	O	-1	-1	0


	PMC3035602	21425	21427	O	-1	-1	0

Relative	PMC3035602	21427	21435	O	-1	-1	0
effect	PMC3035602	21436	21442	O	-1	-1	0

estimates	PMC3035602	21443	21452	O	-1	-1	0


	PMC3035602	21452	21454	O	-1	-1	0

Lower	PMC3035602	21454	21459	O	-1	-1	0
mean	PMC3035602	21460	21464	O	-1	-1	0
birth	PMC3035602	21465	21470	O	-1	-1	0
weight	PMC3035602	21471	21477	O	-1	-1	0

(	PMC3035602	21478	21479	O	-1	-1	0
P	PMC3035602	21479	21480	O	-1	-1	0
=	PMC3035602	21481	21482	O	-1	-1	0
0.15	PMC3035602	21483	21487	O	-1	-1	0
)	PMC3035602	21487	21488	O	-1	-1	0

No	PMC3035602	21489	21491	O	-1	-1	0
difference	PMC3035602	21492	21502	O	-1	-1	0
in	PMC3035602	21503	21505	O	-1	-1	0
mean	PMC3035602	21506	21510	O	-1	-1	0
GA	PMC3035602	21511	21513	O	-1	-1	0
(	PMC3035602	21514	21515	O	-1	-1	0
P	PMC3035602	21515	21516	O	-1	-1	0
=	PMC3035602	21517	21518	O	-1	-1	0
0.53	PMC3035602	21519	21523	O	-1	-1	0
)	PMC3035602	21523	21524	O	-1	-1	0

Mean	PMC3035602	21525	21529	O	-1	-1	0
birth	PMC3035602	21530	21535	O	-1	-1	0
weight	PMC3035602	21536	21542	O	-1	-1	0
=	PMC3035602	21543	21544	O	-1	-1	0

3036	PMC3035602	21545	21549	O	-1	-1	0
g	PMC3035602	21550	21551	O	-1	-1	0
vs	PMC3035602	21552	21554	O	-1	-1	0
3392	PMC3035602	21555	21559	O	-1	-1	0
g	PMC3035602	21560	21561	O	-1	-1	0
in	PMC3035602	21562	21564	O	-1	-1	0
controls	PMC3035602	21565	21573	O	-1	-1	0

Mean	PMC3035602	21574	21578	O	-1	-1	0
GA	PMC3035602	21579	21581	O	-1	-1	0

=	PMC3035602	21582	21583	O	-1	-1	0
39.5	PMC3035602	21584	21588	O	-1	-1	0
wk	PMC3035602	21589	21591	O	-1	-1	0
vs	PMC3035602	21592	21594	O	-1	-1	0
40.1	PMC3035602	21595	21599	O	-1	-1	0
wk	PMC3035602	21600	21602	O	-1	-1	0
in	PMC3035602	21603	21605	O	-1	-1	0
controls	PMC3035602	21606	21614	O	-1	-1	0
Stillbirths	PMC3035602	21615	21626	O	-1	-1	0

=	PMC3035602	21627	21628	O	-1	-1	0
5.6	PMC3035602	21629	21632	O	-1	-1	0
%	PMC3035602	21632	21633	O	-1	-1	0

CAs	PMC3035602	21634	21637	O	-1	-1	0
=	PMC3035602	21638	21639	O	-1	-1	0

5.6	PMC3035602	21640	21643	O	-1	-1	0
%	PMC3035602	21643	21644	O	-1	-1	0

Women	PMC3035602	21645	21650	O	-1	-1	0
diagnosed	PMC3035602	21651	21660	O	-1	-1	0
during	PMC3035602	21661	21667	O	-1	-1	0
pregnancy	PMC3035602	21668	21677	O	-1	-1	0
:	PMC3035602	21677	21678	O	-1	-1	0

ORLBW	PMC3035602	21679	21684	O	-1	-1	0
=	PMC3035602	21685	21686	O	-1	-1	0
0.8	PMC3035602	21687	21690	O	-1	-1	0

(	PMC3035602	21691	21692	O	-1	-1	0
95	PMC3035602	21692	21694	O	-1	-1	0
%	PMC3035602	21694	21695	O	-1	-1	0
CI	PMC3035602	21696	21698	O	-1	-1	0
:	PMC3035602	21698	21699	O	-1	-1	0
0.3–1.8	PMC3035602	21700	21707	O	-1	-1	0
)	PMC3035602	21707	21708	O	-1	-1	0

ORpreterm	PMC3035602	21709	21718	O	-1	-1	0

birth	PMC3035602	21719	21724	O	-1	-1	0
=	PMC3035602	21725	21726	O	-1	-1	0
0.9	PMC3035602	21727	21730	O	-1	-1	0

(	PMC3035602	21731	21732	O	-1	-1	0
95	PMC3035602	21732	21734	O	-1	-1	0
%	PMC3035602	21734	21735	O	-1	-1	0
CI	PMC3035602	21736	21738	O	-1	-1	0
:	PMC3035602	21738	21739	O	-1	-1	0
0.5–1.6	PMC3035602	21740	21747	O	-1	-1	0
)	PMC3035602	21747	21748	O	-1	-1	0

Stillbirths	PMC3035602	21749	21760	O	-1	-1	0
:	PMC3035602	21760	21761	O	-1	-1	0
none	PMC3035602	21762	21766	O	-1	-1	0

Women	PMC3035602	21767	21772	O	-1	-1	0
diagnosed	PMC3035602	21773	21782	O	-1	-1	0
within	PMC3035602	21783	21789	O	-1	-1	0
12	PMC3035602	21790	21792	O	-1	-1	0
months	PMC3035602	21793	21799	O	-1	-1	0
after	PMC3035602	21800	21805	O	-1	-1	0
delivery	PMC3035602	21806	21814	O	-1	-1	0
:	PMC3035602	21814	21815	O	-1	-1	0

No	PMC3035602	21816	21818	O	-1	-1	0
increased	PMC3035602	21819	21828	O	-1	-1	0
risk	PMC3035602	21829	21833	O	-1	-1	0
of	PMC3035602	21834	21836	O	-1	-1	0
LBW	PMC3035602	21837	21840	O	-1	-1	0
and	PMC3035602	21841	21844	O	-1	-1	0
preterm	PMC3035602	21845	21852	O	-1	-1	0
birth	PMC3035602	21853	21858	O	-1	-1	0

Stillbirths	PMC3035602	21859	21870	O	-1	-1	0
:	PMC3035602	21870	21871	O	-1	-1	0
none	PMC3035602	21872	21876	O	-1	-1	0

Women	PMC3035602	21877	21882	O	-1	-1	0
diagnosed	PMC3035602	21883	21892	O	-1	-1	0
during	PMC3035602	21893	21899	O	-1	-1	0
pregnancy	PMC3035602	21900	21909	O	-1	-1	0
:	PMC3035602	21909	21910	O	-1	-1	0

PORpreterm	PMC3035602	21911	21921	O	-1	-1	0
birth	PMC3035602	21922	21927	O	-1	-1	0
=	PMC3035602	21928	21929	O	-1	-1	0

0.2	PMC3035602	21930	21933	O	-1	-1	0

(	PMC3035602	21934	21935	O	-1	-1	0
95	PMC3035602	21935	21937	O	-1	-1	0
%	PMC3035602	21937	21938	O	-1	-1	0
CI	PMC3035602	21939	21941	O	-1	-1	0
:	PMC3035602	21941	21942	O	-1	-1	0
0.03–1.5	PMC3035602	21943	21951	O	-1	-1	0
)	PMC3035602	21951	21952	O	-1	-1	0

PORLBW	PMC3035602	21953	21959	O	-1	-1	0
at	PMC3035602	21960	21962	O	-1	-1	0
term	PMC3035602	21963	21967	O	-1	-1	0
=	PMC3035602	21968	21969	O	-1	-1	0
0.6	PMC3035602	21970	21973	O	-1	-1	0

(	PMC3035602	21974	21975	O	-1	-1	0
95	PMC3035602	21975	21977	O	-1	-1	0
%	PMC3035602	21977	21978	O	-1	-1	0
CI	PMC3035602	21979	21981	O	-1	-1	0
:	PMC3035602	21981	21982	O	-1	-1	0
0.1–4.5	PMC3035602	21983	21990	O	-1	-1	0
)	PMC3035602	21990	21991	O	-1	-1	0
PORCAs	PMC3035602	21992	21998	O	-1	-1	0
=	PMC3035602	21999	22000	O	-1	-1	0
0.6	PMC3035602	22001	22004	O	-1	-1	0

(	PMC3035602	22005	22006	O	-1	-1	0
95	PMC3035602	22006	22008	O	-1	-1	0
%	PMC3035602	22008	22009	O	-1	-1	0
CI	PMC3035602	22010	22012	O	-1	-1	0
:	PMC3035602	22012	22013	O	-1	-1	0
0.2–2.7	PMC3035602	22014	22021	O	-1	-1	0
)	PMC3035602	22021	22022	O	-1	-1	0

Stillbirths	PMC3035602	22023	22034	O	-1	-1	0
:	PMC3035602	22034	22035	O	-1	-1	0
none	PMC3035602	22036	22040	O	-1	-1	0

Higher	PMC3035602	22041	22047	O	-1	-1	0
mean	PMC3035602	22048	22052	O	-1	-1	0
BW	PMC3035602	22053	22055	O	-1	-1	0
(	PMC3035602	22056	22057	O	-1	-1	0
difference	PMC3035602	22057	22067	O	-1	-1	0
=	PMC3035602	22068	22069	O	-1	-1	0
88	PMC3035602	22070	22072	O	-1	-1	0
g	PMC3035602	22073	22074	O	-1	-1	0
(	PMC3035602	22075	22076	O	-1	-1	0
95	PMC3035602	22076	22078	O	-1	-1	0
%	PMC3035602	22078	22079	O	-1	-1	0
CI	PMC3035602	22080	22082	O	-1	-1	0
:	PMC3035602	22082	22083	O	-1	-1	0
–	PMC3035602	22084	22085	O	-1	-1	0
18	PMC3035602	22085	22087	O	-1	-1	0
;	PMC3035602	22087	22088	O	-1	-1	0
194	PMC3035602	22089	22092	O	-1	-1	0
)	PMC3035602	22092	22093	O	-1	-1	0
.	PMC3035602	22093	22094	O	-1	-1	0

Proportion	PMC3035602	22095	22105	O	-1	-1	0
of	PMC3035602	22106	22108	O	-1	-1	0
male	PMC3035602	22109	22113	O	-1	-1	0
newborns	PMC3035602	22114	22122	O	-1	-1	0
=	PMC3035602	22123	22124	O	-1	-1	0
56.8	PMC3035602	22125	22129	O	-1	-1	0
%	PMC3035602	22129	22130	O	-1	-1	0
vs	PMC3035602	22131	22133	O	-1	-1	0
51.9	PMC3035602	22134	22138	O	-1	-1	0
%	PMC3035602	22138	22139	O	-1	-1	0
in	PMC3035602	22140	22142	O	-1	-1	0
controls	PMC3035602	22143	22151	O	-1	-1	0
,	PMC3035602	22151	22152	O	-1	-1	0
difference	PMC3035602	22153	22163	O	-1	-1	0
=	PMC3035602	22164	22165	O	-1	-1	0

4.9	PMC3035602	22166	22169	O	-1	-1	0
%	PMC3035602	22169	22170	O	-1	-1	0
(	PMC3035602	22171	22172	O	-1	-1	0
95	PMC3035602	22172	22174	O	-1	-1	0
%	PMC3035602	22174	22175	O	-1	-1	0
CI	PMC3035602	22176	22178	O	-1	-1	0
:	PMC3035602	22178	22179	O	-1	-1	0
–	PMC3035602	22180	22181	O	-1	-1	0
5.5	PMC3035602	22181	22184	O	-1	-1	0
;	PMC3035602	22184	22185	O	-1	-1	0
15	PMC3035602	22186	22188	O	-1	-1	0
)	PMC3035602	22188	22189	O	-1	-1	0

Women	PMC3035602	22190	22195	O	-1	-1	0
diagnosed	PMC3035602	22196	22205	O	-1	-1	0
within	PMC3035602	22206	22212	O	-1	-1	0
2	PMC3035602	22213	22214	O	-1	-1	0
years	PMC3035602	22215	22220	O	-1	-1	0
after	PMC3035602	22221	22226	O	-1	-1	0
delivery	PMC3035602	22227	22235	O	-1	-1	0
:	PMC3035602	22235	22236	O	-1	-1	0

PORpreterm	PMC3035602	22237	22247	O	-1	-1	0
birth	PMC3035602	22248	22253	O	-1	-1	0
=	PMC3035602	22254	22255	O	-1	-1	0
0.9	PMC3035602	22256	22259	O	-1	-1	0

(	PMC3035602	22260	22261	O	-1	-1	0
95	PMC3035602	22261	22263	O	-1	-1	0
%	PMC3035602	22263	22264	O	-1	-1	0
CI	PMC3035602	22265	22267	O	-1	-1	0
:	PMC3035602	22267	22268	O	-1	-1	0
0.5–1.5	PMC3035602	22269	22276	O	-1	-1	0
)	PMC3035602	22276	22277	O	-1	-1	0
PORLBW	PMC3035602	22278	22284	O	-1	-1	0
at	PMC3035602	22285	22287	O	-1	-1	0
term	PMC3035602	22288	22292	O	-1	-1	0
=	PMC3035602	22293	22294	O	-1	-1	0
0.9	PMC3035602	22295	22298	O	-1	-1	0

(	PMC3035602	22299	22300	O	-1	-1	0
95	PMC3035602	22300	22302	O	-1	-1	0
%	PMC3035602	22302	22303	O	-1	-1	0
CI	PMC3035602	22304	22306	O	-1	-1	0
:	PMC3035602	22306	22307	O	-1	-1	0
0.4–2.2	PMC3035602	22308	22315	O	-1	-1	0
)	PMC3035602	22315	22316	O	-1	-1	0

PORstillbirth	PMC3035602	22317	22330	O	-1	-1	0
=	PMC3035602	22331	22332	O	-1	-1	0
4.6	PMC3035602	22333	22336	O	-1	-1	0

(	PMC3035602	22337	22338	O	-1	-1	0
95	PMC3035602	22338	22340	O	-1	-1	0
%	PMC3035602	22340	22341	O	-1	-1	0
CI	PMC3035602	22342	22344	O	-1	-1	0
:	PMC3035602	22344	22345	O	-1	-1	0
1.7–12.3	PMC3035602	22346	22354	O	-1	-1	0
)	PMC3035602	22354	22355	O	-1	-1	0

PORCAs	PMC3035602	22356	22362	O	-1	-1	0
=	PMC3035602	22363	22364	O	-1	-1	0
1.1	PMC3035602	22365	22368	O	-1	-1	0

(	PMC3035602	22369	22370	O	-1	-1	0
95	PMC3035602	22370	22372	O	-1	-1	0
%	PMC3035602	22372	22373	O	-1	-1	0
CI	PMC3035602	22374	22376	O	-1	-1	0
:	PMC3035602	22376	22377	O	-1	-1	0
0.6–2.0	PMC3035602	22378	22385	O	-1	-1	0
)	PMC3035602	22385	22386	O	-1	-1	0

No	PMC3035602	22387	22389	O	-1	-1	0
difference	PMC3035602	22390	22400	O	-1	-1	0
in	PMC3035602	22401	22403	O	-1	-1	0
mean	PMC3035602	22404	22408	O	-1	-1	0
BW	PMC3035602	22409	22411	O	-1	-1	0
Proportion	PMC3035602	22412	22422	O	-1	-1	0
of	PMC3035602	22423	22425	O	-1	-1	0
male	PMC3035602	22426	22430	O	-1	-1	0
newborns	PMC3035602	22431	22439	O	-1	-1	0
=	PMC3035602	22440	22441	O	-1	-1	0

58.4	PMC3035602	22442	22446	O	-1	-1	0
%	PMC3035602	22446	22447	O	-1	-1	0
vs	PMC3035602	22448	22450	O	-1	-1	0
51.9	PMC3035602	22451	22455	O	-1	-1	0
%	PMC3035602	22455	22456	O	-1	-1	0
,	PMC3035602	22456	22457	O	-1	-1	0
difference	PMC3035602	22458	22468	O	-1	-1	0
=	PMC3035602	22469	22470	O	-1	-1	0
6.5	PMC3035602	22471	22474	O	-1	-1	0
%	PMC3035602	22474	22475	O	-1	-1	0
(	PMC3035602	22476	22477	O	-1	-1	0
95	PMC3035602	22477	22479	O	-1	-1	0
%	PMC3035602	22479	22480	O	-1	-1	0
CI	PMC3035602	22481	22483	O	-1	-1	0
:	PMC3035602	22483	22484	O	-1	-1	0
1.3	PMC3035602	22485	22488	O	-1	-1	0
;	PMC3035602	22488	22489	O	-1	-1	0
12	PMC3035602	22490	22492	O	-1	-1	0
)	PMC3035602	22492	22493	O	-1	-1	0


	PMC3035602	22493	22495	O	-1	-1	0

PORpreterm	PMC3035602	22495	22505	O	-1	-1	0
birth	PMC3035602	22506	22511	O	-1	-1	0
=	PMC3035602	22512	22513	O	-1	-1	0
1.1	PMC3035602	22514	22517	O	-1	-1	0

(	PMC3035602	22518	22519	O	-1	-1	0
95	PMC3035602	22519	22521	O	-1	-1	0
%	PMC3035602	22521	22522	O	-1	-1	0
CI	PMC3035602	22523	22525	O	-1	-1	0
:	PMC3035602	22525	22526	O	-1	-1	0
0.8–1.6	PMC3035602	22527	22534	O	-1	-1	0
)	PMC3035602	22534	22535	O	-1	-1	0

PORLBW	PMC3035602	22536	22542	O	-1	-1	0
at	PMC3035602	22543	22545	O	-1	-1	0
term	PMC3035602	22546	22550	O	-1	-1	0
=	PMC3035602	22551	22552	O	-1	-1	0
1.1	PMC3035602	22553	22556	O	-1	-1	0

(	PMC3035602	22557	22558	O	-1	-1	0
95	PMC3035602	22558	22560	O	-1	-1	0
%	PMC3035602	22560	22561	O	-1	-1	0
CI	PMC3035602	22562	22564	O	-1	-1	0
:	PMC3035602	22564	22565	O	-1	-1	0
0.6–2.0	PMC3035602	22566	22573	O	-1	-1	0
)	PMC3035602	22573	22574	O	-1	-1	0
PORCAs	PMC3035602	22575	22581	O	-1	-1	0
=	PMC3035602	22582	22583	O	-1	-1	0
1.2	PMC3035602	22584	22587	O	-1	-1	0

(	PMC3035602	22588	22589	O	-1	-1	0
95	PMC3035602	22589	22591	O	-1	-1	0
%	PMC3035602	22591	22592	O	-1	-1	0
CI	PMC3035602	22593	22595	O	-1	-1	0
:	PMC3035602	22595	22596	O	-1	-1	0
0.8–2.0	PMC3035602	22597	22604	O	-1	-1	0
)	PMC3035602	22604	22605	O	-1	-1	0

Stillbirths	PMC3035602	22606	22617	O	-1	-1	0
:	PMC3035602	22617	22618	O	-1	-1	0
none	PMC3035602	22619	22623	O	-1	-1	0

No	PMC3035602	22624	22626	O	-1	-1	0
difference	PMC3035602	22627	22637	O	-1	-1	0
in	PMC3035602	22638	22640	O	-1	-1	0
mean	PMC3035602	22641	22645	O	-1	-1	0
BW	PMC3035602	22646	22648	O	-1	-1	0
Proportion	PMC3035602	22649	22659	O	-1	-1	0
of	PMC3035602	22660	22662	O	-1	-1	0
male	PMC3035602	22663	22667	O	-1	-1	0
newborns	PMC3035602	22668	22676	O	-1	-1	0
=	PMC3035602	22677	22678	O	-1	-1	0

53.2	PMC3035602	22679	22683	O	-1	-1	0
%	PMC3035602	22683	22684	O	-1	-1	0
vs	PMC3035602	22685	22687	O	-1	-1	0
51.7	PMC3035602	22688	22692	O	-1	-1	0
%	PMC3035602	22692	22693	O	-1	-1	0
in	PMC3035602	22694	22696	O	-1	-1	0
controls	PMC3035602	22697	22705	O	-1	-1	0
,	PMC3035602	22705	22706	O	-1	-1	0
difference	PMC3035602	22707	22717	O	-1	-1	0
=	PMC3035602	22718	22719	O	-1	-1	0
1.5	PMC3035602	22720	22723	O	-1	-1	0
%	PMC3035602	22723	22724	O	-1	-1	0
(	PMC3035602	22725	22726	O	-1	-1	0
95	PMC3035602	22726	22728	O	-1	-1	0
%	PMC3035602	22728	22729	O	-1	-1	0
CI	PMC3035602	22730	22732	O	-1	-1	0
:	PMC3035602	22732	22733	O	-1	-1	0
–	PMC3035602	22734	22735	O	-1	-1	0
2.5	PMC3035602	22735	22738	O	-1	-1	0
;	PMC3035602	22738	22739	O	-1	-1	0
5.5	PMC3035602	22740	22743	O	-1	-1	0
)	PMC3035602	22743	22744	O	-1	-1	0


	PMC3035602	22744	22746	O	-1	-1	0
Results	PMC3035602	22746	22753	O	-1	-1	0
for	PMC3035602	22754	22757	O	-1	-1	0
birth	PMC3035602	22758	22763	O	-1	-1	0
outcome	PMC3035602	22764	22771	O	-1	-1	0


	PMC3035602	22771	22773	O	-1	-1	0

Abbreviations	PMC3035602	22773	22786	O	-1	-1	0
:	PMC3035602	22786	22787	O	-1	-1	0
BW	PMC3035602	22788	22790	O	-1	-1	0
,	PMC3035602	22790	22791	O	-1	-1	0
birth	PMC3035602	22792	22797	O	-1	-1	0
weight	PMC3035602	22798	22804	O	-1	-1	0
;	PMC3035602	22804	22805	O	-1	-1	0
CAs	PMC3035602	22806	22809	O	-1	-1	0
,	PMC3035602	22809	22810	O	-1	-1	0
congenital	PMC3035602	22811	22821	O	-1	-1	0
abnormalities	PMC3035602	22822	22835	O	-1	-1	0
;	PMC3035602	22835	22836	O	-1	-1	0
CI	PMC3035602	22837	22839	O	-1	-1	0
,	PMC3035602	22839	22840	O	-1	-1	0
confidence	PMC3035602	22841	22851	O	-1	-1	0
interval	PMC3035602	22852	22860	O	-1	-1	0
;	PMC3035602	22860	22861	O	-1	-1	0
CMM	PMC3035602	22862	22865	O	-1	-1	0
,	PMC3035602	22865	22866	O	-1	-1	0
cutaneous	PMC3035602	22867	22876	O	-1	-1	0
malignant	PMC3035602	22877	22886	O	-1	-1	0
melanoma	PMC3035602	22887	22895	O	-1	-1	0
;	PMC3035602	22895	22896	O	-1	-1	0
GA	PMC3035602	22897	22899	O	-1	-1	0
,	PMC3035602	22899	22900	O	-1	-1	0
gestational	PMC3035602	22901	22912	O	-1	-1	0
age	PMC3035602	22913	22916	O	-1	-1	0
;	PMC3035602	22916	22917	O	-1	-1	0
LBW	PMC3035602	22918	22921	O	-1	-1	0
,	PMC3035602	22921	22922	O	-1	-1	0
low	PMC3035602	22923	22926	O	-1	-1	0
birth	PMC3035602	22927	22932	O	-1	-1	0
weight	PMC3035602	22933	22939	O	-1	-1	0
;	PMC3035602	22939	22940	O	-1	-1	0
OR	PMC3035602	22941	22943	O	-1	-1	0
,	PMC3035602	22943	22944	O	-1	-1	0
odds	PMC3035602	22945	22949	O	-1	-1	0
ratio	PMC3035602	22950	22955	O	-1	-1	0
;	PMC3035602	22955	22956	O	-1	-1	0
POR	PMC3035602	22957	22960	O	-1	-1	0
,	PMC3035602	22960	22961	O	-1	-1	0
prevalence	PMC3035602	22962	22972	O	-1	-1	0
odds	PMC3035602	22973	22977	O	-1	-1	0
ratio	PMC3035602	22978	22983	O	-1	-1	0
;	PMC3035602	22983	22984	O	-1	-1	0
RR	PMC3035602	22985	22987	O	-1	-1	0
,	PMC3035602	22987	22988	O	-1	-1	0
relative	PMC3035602	22989	22997	O	-1	-1	0
risk	PMC3035602	22998	23002	O	-1	-1	0
;	PMC3035602	23002	23003	O	-1	-1	0
SGA	PMC3035602	23004	23007	O	-1	-1	0
,	PMC3035602	23007	23008	O	-1	-1	0
small	PMC3035602	23009	23014	O	-1	-1	0
for	PMC3035602	23015	23018	O	-1	-1	0
gestational	PMC3035602	23019	23030	O	-1	-1	0
age	PMC3035602	23031	23034	O	-1	-1	0
.	PMC3035602	23034	23035	O	-1	-1	0


	PMC3035602	23035	23037	O	-1	-1	0

Cohort	PMC3035602	23037	23043	O	-1	-1	0
study	PMC3035602	23044	23049	O	-1	-1	0

comparison	PMC3035602	23050	23060	O	-1	-1	0
:	PMC3035602	23060	23061	O	-1	-1	0
births	PMC3035602	23062	23068	O	-1	-1	0
by	PMC3035602	23069	23071	O	-1	-1	0
melanoma	PMC3035602	23072	23080	O	-1	-1	0

free	PMC3035602	23081	23085	O	-1	-1	0
women	PMC3035602	23086	23091	O	-1	-1	0


	PMC3035602	23091	23093	O	-1	-1	0

1991–1999	PMC3035602	23093	23102	O	-1	-1	0


	PMC3035602	23102	23104	O	-1	-1	0

O’Meara	PMC3035602	23104	23111	O	-1	-1	0
et	PMC3035602	23112	23114	O	-1	-1	0
al35	PMC3035602	23115	23119	O	-1	-1	0

USA	PMC3035602	23120	23123	B-Location	-1	-1	0

2005	PMC3035602	23124	23128	O	-1	-1	0


	PMC3035602	23128	23130	O	-1	-1	0

CMM	PMC3035602	23130	23133	O	-1	-1	0
diagnosed	PMC3035602	23134	23143	O	-1	-1	0
during	PMC3035602	23144	23150	O	-1	-1	0
or	PMC3035602	23151	23153	O	-1	-1	0
shortly	PMC3035602	23154	23161	O	-1	-1	0
after	PMC3035602	23162	23167	O	-1	-1	0
pregnancy	PMC3035602	23168	23177	O	-1	-1	0

Ravid	PMC3035602	23178	23183	O	-1	-1	0
et	PMC3035602	23184	23186	O	-1	-1	0
al36	PMC3035602	23187	23191	O	-1	-1	0
Not	PMC3035602	23192	23195	O	-1	-1	0
stated	PMC3035602	23196	23202	O	-1	-1	0
,	PMC3035602	23202	23203	O	-1	-1	0
but	PMC3035602	23204	23207	O	-1	-1	0

Cohort	PMC3035602	23208	23214	O	-1	-1	0
study	PMC3035602	23215	23220	O	-1	-1	0

Canada	PMC3035602	23221	23227	B-Location	-1	-1	0
over	PMC3035602	23228	23232	O	-1	-1	0
a	PMC3035602	23233	23234	O	-1	-1	0
period	PMC3035602	23235	23241	O	-1	-1	0

Comparison	PMC3035602	23242	23252	O	-1	-1	0
:	PMC3035602	23252	23253	O	-1	-1	0
births	PMC3035602	23254	23260	O	-1	-1	0
1996	PMC3035602	23261	23265	O	-1	-1	0
of	PMC3035602	23266	23268	O	-1	-1	0
30	PMC3035602	23269	23271	O	-1	-1	0
years	PMC3035602	23272	23277	O	-1	-1	0
by	PMC3035602	23278	23280	O	-1	-1	0
aged	PMC3035602	23281	23285	O	-1	-1	0
-	PMC3035602	23285	23286	O	-1	-1	0
matched	PMC3035602	23286	23293	O	-1	-1	0
women	PMC3035602	23294	23299	O	-1	-1	0


	PMC3035602	23299	23301	O	-1	-1	0

CMM	PMC3035602	23301	23304	O	-1	-1	0
diagnosed	PMC3035602	23305	23314	O	-1	-1	0
before	PMC3035602	23315	23321	O	-1	-1	0
pregnancy	PMC3035602	23322	23331	O	-1	-1	0

Langagergaard	PMC3035602	23332	23345	O	-1	-1	0

1970–2002	PMC3035602	23346	23355	O	-1	-1	0

et	PMC3035602	23356	23358	O	-1	-1	0

al34	PMC3035602	23359	23363	O	-1	-1	0
Denmark	PMC3035602	23364	23371	B-Location	-1	-1	0

2007	PMC3035602	23372	23376	O	-1	-1	0


	PMC3035602	23376	23378	O	-1	-1	0

Author	PMC3035602	23378	23384	O	-1	-1	0

Country	PMC3035602	23385	23392	O	-1	-1	0
year	PMC3035602	23393	23397	O	-1	-1	0


	PMC3035602	23397	23399	O	-1	-1	0

Table	PMC3035602	23399	23404	O	-1	-1	0
2	PMC3035602	23405	23406	O	-1	-1	0
Studies	PMC3035602	23407	23414	O	-1	-1	0
of	PMC3035602	23415	23417	O	-1	-1	0
birth	PMC3035602	23418	23423	O	-1	-1	0
outcome	PMC3035602	23424	23431	O	-1	-1	0
in	PMC3035602	23432	23434	O	-1	-1	0
women	PMC3035602	23435	23440	O	-1	-1	0
with	PMC3035602	23441	23445	O	-1	-1	0
cutaneous	PMC3035602	23446	23455	O	-1	-1	0
malignant	PMC3035602	23456	23465	O	-1	-1	0
melanoma	PMC3035602	23466	23474	O	-1	-1	0


	PMC3035602	23474	23476	O	-1	-1	0

Langagergaard	PMC3035602	23476	23489	O	-1	-1	0

Dovepress	PMC3035602	23490	23499	O	-1	-1	0


	PMC3035602	23499	23501	O	-1	-1	0

Clinical	PMC3035602	23501	23509	O	-1	-1	0
Epidemiology	PMC3035602	23510	23522	O	-1	-1	0
2011:3	PMC3035602	23523	23529	O	-1	-1	0


	PMC3035602	23529	23531	O	-1	-1	0

Clinical	PMC3035602	23531	23539	O	-1	-1	0
Epidemiology	PMC3035602	23540	23552	O	-1	-1	0
2011:3	PMC3035602	23553	23559	O	-1	-1	0

Cohort	PMC3035602	23560	23566	O	-1	-1	0
study	PMC3035602	23567	23572	O	-1	-1	0

Comparison	PMC3035602	23573	23583	O	-1	-1	0
:	PMC3035602	23583	23584	O	-1	-1	0

Births	PMC3035602	23585	23591	O	-1	-1	0
by	PMC3035602	23592	23594	O	-1	-1	0
cancer	PMC3035602	23595	23601	O	-1	-1	0
free	PMC3035602	23602	23606	O	-1	-1	0
women	PMC3035602	23607	23612	O	-1	-1	0
matched	PMC3035602	23613	23620	O	-1	-1	0
by	PMC3035602	23621	23623	O	-1	-1	0
time	PMC3035602	23624	23628	O	-1	-1	0
of	PMC3035602	23629	23631	O	-1	-1	0
birth	PMC3035602	23632	23637	O	-1	-1	0
and	PMC3035602	23638	23641	O	-1	-1	0
by	PMC3035602	23642	23644	O	-1	-1	0
county	PMC3035602	23645	23651	O	-1	-1	0
of	PMC3035602	23652	23654	O	-1	-1	0
mother	PMC3035602	23655	23661	O	-1	-1	0

’s	PMC3035602	23661	23663	O	-1	-1	0

residence	PMC3035602	23664	23673	O	-1	-1	0


	PMC3035602	23673	23675	O	-1	-1	0

1970–2002	PMC3035602	23675	23684	O	-1	-1	0


	PMC3035602	23684	23686	O	-1	-1	0

Hodgkin	PMC3035602	23686	23693	O	-1	-1	0
’s	PMC3035602	23693	23695	O	-1	-1	0
disease	PMC3035602	23696	23703	O	-1	-1	0
diagnosed	PMC3035602	23704	23713	O	-1	-1	0
during	PMC3035602	23714	23720	O	-1	-1	0
or	PMC3035602	23721	23723	O	-1	-1	0
shortly	PMC3035602	23724	23731	O	-1	-1	0
after	PMC3035602	23732	23737	O	-1	-1	0
pregnancy	PMC3035602	23738	23747	O	-1	-1	0

Lishner	PMC3035602	23748	23755	O	-1	-1	0
et	PMC3035602	23756	23758	O	-1	-1	0
al19	PMC3035602	23759	23763	O	-1	-1	0

1958–1984	PMC3035602	23764	23773	O	-1	-1	0

Cohort	PMC3035602	23774	23780	O	-1	-1	0
study	PMC3035602	23781	23786	O	-1	-1	0

Canada	PMC3035602	23787	23793	B-Location	-1	-1	0
Comparison	PMC3035602	23794	23804	O	-1	-1	0
:	PMC3035602	23804	23805	O	-1	-1	0
1992	PMC3035602	23806	23810	O	-1	-1	0

Births	PMC3035602	23811	23817	O	-1	-1	0
of	PMC3035602	23818	23820	O	-1	-1	0
age	PMC3035602	23821	23824	O	-1	-1	0
-	PMC3035602	23824	23825	O	-1	-1	0
matched	PMC3035602	23825	23832	O	-1	-1	0
women	PMC3035602	23833	23838	O	-1	-1	0
exposed	PMC3035602	23839	23846	O	-1	-1	0
to	PMC3035602	23847	23849	O	-1	-1	0
nonteratogenic	PMC3035602	23850	23864	O	-1	-1	0
drugs	PMC3035602	23865	23870	O	-1	-1	0
in	PMC3035602	23871	23873	O	-1	-1	0
pregnancy	PMC3035602	23874	23883	O	-1	-1	0


	PMC3035602	23883	23885	O	-1	-1	0

Langagergaard	PMC3035602	23885	23898	O	-1	-1	0
et	PMC3035602	23899	23901	O	-1	-1	0

al42	PMC3035602	23902	23906	O	-1	-1	0

Denmark	PMC3035602	23907	23914	B-Location	-1	-1	0

2008	PMC3035602	23915	23919	O	-1	-1	0


	PMC3035602	23919	23921	O	-1	-1	0

1970–1986	PMC3035602	23921	23930	O	-1	-1	0


	PMC3035602	23930	23932	O	-1	-1	0

Green	PMC3035602	23932	23937	O	-1	-1	0
et	PMC3035602	23938	23940	O	-1	-1	0

al41	PMC3035602	23941	23945	O	-1	-1	0

USA	PMC3035602	23946	23949	B-Location	-1	-1	0

2002	PMC3035602	23950	23954	O	-1	-1	0

Signorello	PMC3035602	23955	23965	O	-1	-1	0
et	PMC3035602	23966	23968	O	-1	-1	0
al40	PMC3035602	23969	23973	O	-1	-1	0

USA	PMC3035602	23974	23977	B-Location	-1	-1	0

2006	PMC3035602	23978	23982	O	-1	-1	0


	PMC3035602	23982	23984	O	-1	-1	0

1970–1986	PMC3035602	23984	23993	O	-1	-1	0


	PMC3035602	23993	23995	O	-1	-1	0

Cohort	PMC3035602	23995	24001	O	-1	-1	0
study	PMC3035602	24002	24007	O	-1	-1	0

Comparison	PMC3035602	24008	24018	O	-1	-1	0
:	PMC3035602	24018	24019	O	-1	-1	0
Birth	PMC3035602	24020	24025	O	-1	-1	0
outcome	PMC3035602	24026	24033	O	-1	-1	0
in	PMC3035602	24034	24036	O	-1	-1	0
siblings	PMC3035602	24037	24045	O	-1	-1	0

Cohort	PMC3035602	24046	24052	O	-1	-1	0
study	PMC3035602	24053	24058	O	-1	-1	0

Comparison	PMC3035602	24059	24069	O	-1	-1	0
:	PMC3035602	24069	24070	O	-1	-1	0
Birth	PMC3035602	24071	24076	O	-1	-1	0
outcome	PMC3035602	24077	24084	O	-1	-1	0
in	PMC3035602	24085	24087	O	-1	-1	0
siblings	PMC3035602	24088	24096	O	-1	-1	0


	PMC3035602	24096	24098	O	-1	-1	0

1970–1991	PMC3035602	24098	24107	O	-1	-1	0


	PMC3035602	24107	24109	O	-1	-1	0

Swerdlow	PMC3035602	24109	24117	O	-1	-1	0
et	PMC3035602	24118	24120	O	-1	-1	0

al38	PMC3035602	24121	24125	O	-1	-1	0
UK	PMC3035602	24126	24128	B-Location	-1	-1	0

1996	PMC3035602	24129	24133	O	-1	-1	0


	PMC3035602	24133	24135	O	-1	-1	0

40	PMC3035602	24135	24137	O	-1	-1	0
births	PMC3035602	24138	24144	O	-1	-1	0
by	PMC3035602	24145	24147	O	-1	-1	0
48	PMC3035602	24148	24150	O	-1	-1	0
women	PMC3035602	24151	24156	O	-1	-1	0
who	PMC3035602	24157	24160	O	-1	-1	0
were	PMC3035602	24161	24165	O	-1	-1	0
pregnant	PMC3035602	24166	24174	O	-1	-1	0

no	PMC3035602	24175	24177	O	-1	-1	0
earlier	PMC3035602	24178	24185	O	-1	-1	0
than	PMC3035602	24186	24190	O	-1	-1	0
9	PMC3035602	24191	24192	O	-1	-1	0
months	PMC3035602	24193	24199	O	-1	-1	0
before	PMC3035602	24200	24206	O	-1	-1	0
and	PMC3035602	24207	24210	O	-1	-1	0
no	PMC3035602	24211	24213	O	-1	-1	0
later	PMC3035602	24214	24219	O	-1	-1	0
than	PMC3035602	24220	24224	O	-1	-1	0
3	PMC3035602	24225	24226	O	-1	-1	0
months	PMC3035602	24227	24233	O	-1	-1	0
after	PMC3035602	24234	24239	O	-1	-1	0
their	PMC3035602	24240	24245	O	-1	-1	0
first	PMC3035602	24246	24251	O	-1	-1	0
treatment	PMC3035602	24252	24261	O	-1	-1	0


	PMC3035602	24261	24263	O	-1	-1	0
192	PMC3035602	24263	24266	O	-1	-1	0
births	PMC3035602	24267	24273	O	-1	-1	0
by	PMC3035602	24274	24276	O	-1	-1	0
women	PMC3035602	24277	24282	O	-1	-1	0
with	PMC3035602	24283	24287	O	-1	-1	0
previous	PMC3035602	24288	24296	O	-1	-1	0
Hodgkin	PMC3035602	24297	24304	O	-1	-1	0
’s	PMC3035602	24304	24306	O	-1	-1	0

disease	PMC3035602	24307	24314	O	-1	-1	0


	PMC3035602	24314	24316	O	-1	-1	0

729	PMC3035602	24316	24319	O	-1	-1	0
births	PMC3035602	24320	24326	O	-1	-1	0
by	PMC3035602	24327	24329	O	-1	-1	0
women	PMC3035602	24330	24335	O	-1	-1	0
with	PMC3035602	24336	24340	O	-1	-1	0
childhood	PMC3035602	24341	24350	O	-1	-1	0

Hodgkin	PMC3035602	24351	24358	O	-1	-1	0
’s	PMC3035602	24358	24360	O	-1	-1	0
disease	PMC3035602	24361	24368	O	-1	-1	0

337	PMC3035602	24369	24372	O	-1	-1	0
births	PMC3035602	24373	24379	O	-1	-1	0
by	PMC3035602	24380	24382	O	-1	-1	0
women	PMC3035602	24383	24388	O	-1	-1	0
with	PMC3035602	24389	24393	O	-1	-1	0
childhood	PMC3035602	24394	24403	O	-1	-1	0

Hodgkin	PMC3035602	24404	24411	O	-1	-1	0
’s	PMC3035602	24411	24413	O	-1	-1	0

disease	PMC3035602	24414	24421	O	-1	-1	0


	PMC3035602	24421	24423	O	-1	-1	0

49	PMC3035602	24423	24425	O	-1	-1	0
births	PMC3035602	24426	24432	O	-1	-1	0
by	PMC3035602	24433	24435	O	-1	-1	0
16	PMC3035602	24436	24438	O	-1	-1	0
women	PMC3035602	24439	24444	O	-1	-1	0
with	PMC3035602	24445	24449	O	-1	-1	0
previous	PMC3035602	24450	24458	O	-1	-1	0
Hodgkin	PMC3035602	24459	24466	O	-1	-1	0

’s	PMC3035602	24466	24468	O	-1	-1	0

disease	PMC3035602	24469	24476	O	-1	-1	0
and	PMC3035602	24477	24480	O	-1	-1	0
by	PMC3035602	24481	24483	O	-1	-1	0
wives	PMC3035602	24484	24489	O	-1	-1	0
of	PMC3035602	24490	24492	O	-1	-1	0
11	PMC3035602	24493	24495	O	-1	-1	0
men	PMC3035602	24496	24499	O	-1	-1	0
with	PMC3035602	24500	24504	O	-1	-1	0
a	PMC3035602	24505	24506	O	-1	-1	0
history	PMC3035602	24507	24514	O	-1	-1	0
of	PMC3035602	24515	24517	O	-1	-1	0
Hodgkin	PMC3035602	24518	24525	O	-1	-1	0

’s	PMC3035602	24525	24527	O	-1	-1	0
disease	PMC3035602	24528	24535	O	-1	-1	0


	PMC3035602	24535	24537	O	-1	-1	0
15	PMC3035602	24537	24539	O	-1	-1	0
births	PMC3035602	24540	24546	O	-1	-1	0
by	PMC3035602	24547	24549	O	-1	-1	0
women	PMC3035602	24550	24555	O	-1	-1	0
with	PMC3035602	24556	24560	O	-1	-1	0
previous	PMC3035602	24561	24569	O	-1	-1	0
Hodgkin	PMC3035602	24570	24577	O	-1	-1	0
’s	PMC3035602	24577	24579	O	-1	-1	0
disease	PMC3035602	24580	24587	O	-1	-1	0


	PMC3035602	24587	24589	O	-1	-1	0

Cohort	PMC3035602	24589	24595	O	-1	-1	0
study	PMC3035602	24596	24601	O	-1	-1	0

Comparison	PMC3035602	24602	24612	O	-1	-1	0
:	PMC3035602	24612	24613	O	-1	-1	0

Birth	PMC3035602	24614	24619	O	-1	-1	0
outcome	PMC3035602	24620	24627	O	-1	-1	0
in	PMC3035602	24628	24630	O	-1	-1	0
the	PMC3035602	24631	24634	O	-1	-1	0
general	PMC3035602	24635	24642	O	-1	-1	0
population	PMC3035602	24643	24653	O	-1	-1	0

Cohort	PMC3035602	24654	24660	O	-1	-1	0
study	PMC3035602	24661	24666	O	-1	-1	0

Comparison	PMC3035602	24667	24677	O	-1	-1	0
:	PMC3035602	24677	24678	O	-1	-1	0

Birth	PMC3035602	24679	24684	O	-1	-1	0
outcome	PMC3035602	24685	24692	O	-1	-1	0
in	PMC3035602	24693	24695	O	-1	-1	0
the	PMC3035602	24696	24699	O	-1	-1	0
general	PMC3035602	24700	24707	O	-1	-1	0
population	PMC3035602	24708	24718	O	-1	-1	0


	PMC3035602	24718	24720	O	-1	-1	0

1966–1986	PMC3035602	24720	24729	O	-1	-1	0


	PMC3035602	24729	24731	O	-1	-1	0

Number	PMC3035602	24731	24737	O	-1	-1	0


	PMC3035602	24737	24739	O	-1	-1	0

Janov	PMC3035602	24739	24744	O	-1	-1	0
et	PMC3035602	24745	24747	O	-1	-1	0

al37	PMC3035602	24748	24752	O	-1	-1	0
USA	PMC3035602	24753	24756	B-Location	-1	-1	0

1992	PMC3035602	24757	24761	O	-1	-1	0


	PMC3035602	24761	24763	O	-1	-1	0

Design	PMC3035602	24763	24769	O	-1	-1	0


	PMC3035602	24769	24771	O	-1	-1	0

52	PMC3035602	24771	24773	O	-1	-1	0
births	PMC3035602	24774	24780	O	-1	-1	0
by	PMC3035602	24781	24783	O	-1	-1	0
29	PMC3035602	24784	24786	O	-1	-1	0
women	PMC3035602	24787	24792	O	-1	-1	0
with	PMC3035602	24793	24797	O	-1	-1	0
a	PMC3035602	24798	24799	O	-1	-1	0
history	PMC3035602	24800	24807	O	-1	-1	0
of	PMC3035602	24808	24810	O	-1	-1	0
Hodgkin	PMC3035602	24811	24818	O	-1	-1	0
’s	PMC3035602	24818	24820	O	-1	-1	0

disease	PMC3035602	24821	24828	O	-1	-1	0


	PMC3035602	24828	24830	O	-1	-1	0

Period	PMC3035602	24830	24836	O	-1	-1	0
of	PMC3035602	24837	24839	O	-1	-1	0
cancer	PMC3035602	24840	24846	O	-1	-1	0

diagnosis	PMC3035602	24847	24856	O	-1	-1	0


	PMC3035602	24856	24858	O	-1	-1	0

Hodgkin	PMC3035602	24858	24865	O	-1	-1	0
’s	PMC3035602	24865	24867	O	-1	-1	0
disease	PMC3035602	24868	24875	O	-1	-1	0
diagnosed	PMC3035602	24876	24885	O	-1	-1	0
before	PMC3035602	24886	24892	O	-1	-1	0
pregnancy	PMC3035602	24893	24902	O	-1	-1	0
Holmes	PMC3035602	24903	24909	O	-1	-1	0
and	PMC3035602	24910	24913	O	-1	-1	0
1944–1975	PMC3035602	24914	24923	O	-1	-1	0

Cohort	PMC3035602	24924	24930	O	-1	-1	0
study	PMC3035602	24931	24936	O	-1	-1	0

Holmes39	PMC3035602	24937	24945	O	-1	-1	0
Comparison	PMC3035602	24946	24956	O	-1	-1	0
:	PMC3035602	24956	24957	O	-1	-1	0

USA	PMC3035602	24958	24961	B-Location	-1	-1	0

Birth	PMC3035602	24962	24967	O	-1	-1	0
outcome	PMC3035602	24968	24975	O	-1	-1	0

1978	PMC3035602	24976	24980	O	-1	-1	0
in	PMC3035602	24981	24983	O	-1	-1	0
siblings	PMC3035602	24984	24992	O	-1	-1	0


	PMC3035602	24992	24994	O	-1	-1	0

Author	PMC3035602	24994	25000	O	-1	-1	0

Country	PMC3035602	25001	25008	O	-1	-1	0

Year	PMC3035602	25009	25013	O	-1	-1	0


	PMC3035602	25013	25015	O	-1	-1	0
Table	PMC3035602	25015	25020	O	-1	-1	0
3	PMC3035602	25021	25022	O	-1	-1	0
Studies	PMC3035602	25023	25030	O	-1	-1	0
of	PMC3035602	25031	25033	O	-1	-1	0
birth	PMC3035602	25034	25039	O	-1	-1	0
outcome	PMC3035602	25040	25047	O	-1	-1	0
in	PMC3035602	25048	25050	O	-1	-1	0
women	PMC3035602	25051	25056	O	-1	-1	0
with	PMC3035602	25057	25061	O	-1	-1	0
Hodgkin	PMC3035602	25062	25069	O	-1	-1	0

’s	PMC3035602	25069	25071	O	-1	-1	0
disease	PMC3035602	25072	25079	O	-1	-1	0


	PMC3035602	25079	25081	O	-1	-1	0

Yes	PMC3035602	25081	25084	O	-1	-1	0
,	PMC3035602	25084	25085	O	-1	-1	0
maternal	PMC3035602	25086	25094	O	-1	-1	0
age	PMC3035602	25095	25098	O	-1	-1	0
(	PMC3035602	25099	25100	O	-1	-1	0
by	PMC3035602	25100	25102	O	-1	-1	0
matching	PMC3035602	25103	25111	O	-1	-1	0
)	PMC3035602	25111	25112	O	-1	-1	0


	PMC3035602	25112	25114	O	-1	-1	0

Yes	PMC3035602	25114	25117	O	-1	-1	0
,	PMC3035602	25117	25118	O	-1	-1	0
maternal	PMC3035602	25119	25127	O	-1	-1	0
age	PMC3035602	25128	25131	O	-1	-1	0
,	PMC3035602	25131	25132	O	-1	-1	0
parity	PMC3035602	25133	25139	O	-1	-1	0
,	PMC3035602	25139	25140	O	-1	-1	0
and	PMC3035602	25141	25144	O	-1	-1	0
calendar	PMC3035602	25145	25153	O	-1	-1	0
period	PMC3035602	25154	25160	O	-1	-1	0
of	PMC3035602	25161	25163	O	-1	-1	0
birth	PMC3035602	25164	25169	O	-1	-1	0

Mean	PMC3035602	25170	25174	O	-1	-1	0
BW	PMC3035602	25175	25177	O	-1	-1	0
was	PMC3035602	25178	25181	O	-1	-1	0
also	PMC3035602	25182	25186	O	-1	-1	0
adjusted	PMC3035602	25187	25195	O	-1	-1	0
for	PMC3035602	25196	25199	O	-1	-1	0
gestational	PMC3035602	25200	25211	O	-1	-1	0
age	PMC3035602	25212	25215	O	-1	-1	0


	PMC3035602	25215	25217	O	-1	-1	0

Yes	PMC3035602	25217	25220	O	-1	-1	0
,	PMC3035602	25220	25221	O	-1	-1	0
maternal	PMC3035602	25222	25230	O	-1	-1	0
age	PMC3035602	25231	25234	O	-1	-1	0
,	PMC3035602	25234	25235	O	-1	-1	0
smoking	PMC3035602	25236	25243	O	-1	-1	0
,	PMC3035602	25243	25244	O	-1	-1	0
alcohol	PMC3035602	25245	25252	O	-1	-1	0
use	PMC3035602	25253	25256	O	-1	-1	0
and	PMC3035602	25257	25260	O	-1	-1	0
education	PMC3035602	25261	25270	O	-1	-1	0

No	PMC3035602	25271	25273	O	-1	-1	0


	PMC3035602	25273	25275	O	-1	-1	0

No	PMC3035602	25275	25277	O	-1	-1	0


	PMC3035602	25277	25279	O	-1	-1	0

No	PMC3035602	25279	25281	O	-1	-1	0


	PMC3035602	25281	25283	O	-1	-1	0

No	PMC3035602	25283	25285	O	-1	-1	0


	PMC3035602	25285	25287	O	-1	-1	0

Adjustment	PMC3035602	25287	25297	O	-1	-1	0


	PMC3035602	25297	25299	O	-1	-1	0

No	PMC3035602	25299	25301	O	-1	-1	0


	PMC3035602	25301	25303	O	-1	-1	0
POR	PMC3035602	25303	25306	O	-1	-1	0
for	PMC3035602	25307	25310	O	-1	-1	0
preterm	PMC3035602	25311	25318	O	-1	-1	0

birth	PMC3035602	25319	25324	O	-1	-1	0
,	PMC3035602	25324	25325	O	-1	-1	0
LBW	PMC3035602	25326	25329	O	-1	-1	0
at	PMC3035602	25330	25332	O	-1	-1	0
term	PMC3035602	25333	25337	O	-1	-1	0
,	PMC3035602	25337	25338	O	-1	-1	0

stillbirth	PMC3035602	25339	25349	O	-1	-1	0
,	PMC3035602	25349	25350	O	-1	-1	0
and	PMC3035602	25351	25354	O	-1	-1	0
CAs	PMC3035602	25355	25358	O	-1	-1	0


	PMC3035602	25358	25360	O	-1	-1	0

No	PMC3035602	25360	25362	O	-1	-1	0


	PMC3035602	25362	25364	O	-1	-1	0

RR	PMC3035602	25364	25366	O	-1	-1	0
for	PMC3035602	25367	25370	O	-1	-1	0
stillbirth	PMC3035602	25371	25381	O	-1	-1	0


	PMC3035602	25381	25383	O	-1	-1	0

RR	PMC3035602	25383	25385	O	-1	-1	0
for	PMC3035602	25386	25389	O	-1	-1	0
preterm	PMC3035602	25390	25397	O	-1	-1	0
birth	PMC3035602	25398	25403	O	-1	-1	0
,	PMC3035602	25403	25404	O	-1	-1	0
LBW	PMC3035602	25405	25408	O	-1	-1	0
,	PMC3035602	25408	25409	O	-1	-1	0
and	PMC3035602	25410	25413	O	-1	-1	0
male	PMC3035602	25414	25418	O	-1	-1	0
sex	PMC3035602	25419	25422	O	-1	-1	0
in	PMC3035602	25423	25425	O	-1	-1	0
newborn	PMC3035602	25426	25433	O	-1	-1	0


	PMC3035602	25433	25435	O	-1	-1	0
RR	PMC3035602	25435	25437	O	-1	-1	0
for	PMC3035602	25438	25441	O	-1	-1	0
LBW	PMC3035602	25442	25445	O	-1	-1	0


	PMC3035602	25445	25447	O	-1	-1	0

No	PMC3035602	25447	25449	O	-1	-1	0


	PMC3035602	25449	25451	O	-1	-1	0

Relative	PMC3035602	25451	25459	O	-1	-1	0
effect	PMC3035602	25460	25466	O	-1	-1	0

estimates	PMC3035602	25467	25476	O	-1	-1	0


	PMC3035602	25476	25478	O	-1	-1	0
submit	PMC3035602	25478	25484	O	-1	-1	0
your	PMC3035602	25485	25489	O	-1	-1	0
manuscript	PMC3035602	25490	25500	O	-1	-1	0

|	PMC3035602	25501	25502	O	-1	-1	0

www.dovepress.com	PMC3035602	25503	25520	O	-1	-1	0


	PMC3035602	25520	25522	O	-1	-1	0

Dovepress	PMC3035602	25522	25531	O	-1	-1	0


	PMC3035602	25531	25533	O	-1	-1	0

(	PMC3035602	25533	25534	O	-1	-1	0
Continued	PMC3035602	25534	25543	O	-1	-1	0
)	PMC3035602	25543	25544	O	-1	-1	0


	PMC3035602	25544	25546	O	-1	-1	0

No	PMC3035602	25546	25548	O	-1	-1	0
difference	PMC3035602	25549	25559	O	-1	-1	0
in	PMC3035602	25560	25562	O	-1	-1	0
mean	PMC3035602	25563	25567	O	-1	-1	0
BW	PMC3035602	25568	25570	O	-1	-1	0
(	PMC3035602	25571	25572	O	-1	-1	0
P	PMC3035602	25572	25573	O	-1	-1	0
=	PMC3035602	25574	25575	O	-1	-1	0
0.7	PMC3035602	25576	25579	O	-1	-1	0
)	PMC3035602	25579	25580	O	-1	-1	0

,	PMC3035602	25580	25581	O	-1	-1	0
mean	PMC3035602	25582	25586	O	-1	-1	0
GA	PMC3035602	25587	25589	O	-1	-1	0

(	PMC3035602	25590	25591	O	-1	-1	0
P	PMC3035602	25591	25592	O	-1	-1	0
=	PMC3035602	25593	25594	O	-1	-1	0
0.3	PMC3035602	25595	25598	O	-1	-1	0
)	PMC3035602	25598	25599	O	-1	-1	0
,	PMC3035602	25599	25600	O	-1	-1	0
or	PMC3035602	25601	25603	O	-1	-1	0
stillbirths	PMC3035602	25604	25615	O	-1	-1	0
(	PMC3035602	25616	25617	O	-1	-1	0
P	PMC3035602	25617	25618	O	-1	-1	0
=	PMC3035602	25619	25620	O	-1	-1	0
0.08	PMC3035602	25621	25625	O	-1	-1	0
)	PMC3035602	25625	25626	O	-1	-1	0

Mean	PMC3035602	25627	25631	O	-1	-1	0
BW	PMC3035602	25632	25634	O	-1	-1	0
 	PMC3035602	25634	25635	O	-1	-1	0
=	PMC3035602	25635	25636	O	-1	-1	0
3325	PMC3035602	25637	25641	O	-1	-1	0
g	PMC3035602	25642	25643	O	-1	-1	0
vs	PMC3035602	25644	25646	O	-1	-1	0
3371	PMC3035602	25647	25651	O	-1	-1	0
g	PMC3035602	25652	25653	O	-1	-1	0
in	PMC3035602	25654	25656	O	-1	-1	0
controls	PMC3035602	25657	25665	O	-1	-1	0

Mean	PMC3035602	25666	25670	O	-1	-1	0
GA	PMC3035602	25671	25673	O	-1	-1	0
=	PMC3035602	25674	25675	O	-1	-1	0
39.7	PMC3035602	25676	25680	O	-1	-1	0
wk	PMC3035602	25681	25683	O	-1	-1	0
vs	PMC3035602	25684	25686	O	-1	-1	0
40.0	PMC3035602	25687	25691	O	-1	-1	0
in	PMC3035602	25692	25694	O	-1	-1	0
controls	PMC3035602	25695	25703	O	-1	-1	0

Preterm	PMC3035602	25704	25711	O	-1	-1	0
births	PMC3035602	25712	25718	O	-1	-1	0
=	PMC3035602	25719	25720	O	-1	-1	0

3.4	PMC3035602	25721	25724	O	-1	-1	0
%	PMC3035602	25724	25725	O	-1	-1	0

Stillbirths	PMC3035602	25726	25737	O	-1	-1	0
=	PMC3035602	25738	25739	O	-1	-1	0
5.0	PMC3035602	25740	25743	O	-1	-1	0
%	PMC3035602	25743	25744	O	-1	-1	0

CAs	PMC3035602	25745	25748	O	-1	-1	0
=	PMC3035602	25749	25750	O	-1	-1	0

3.2	PMC3035602	25751	25754	O	-1	-1	0
%	PMC3035602	25754	25755	O	-1	-1	0


	PMC3035602	25755	25757	O	-1	-1	0

PORpreterm	PMC3035602	25757	25767	O	-1	-1	0
birth	PMC3035602	25768	25773	O	-1	-1	0
=	PMC3035602	25774	25775	O	-1	-1	0
1.1	PMC3035602	25776	25779	O	-1	-1	0

(	PMC3035602	25780	25781	O	-1	-1	0
95	PMC3035602	25781	25783	O	-1	-1	0
%	PMC3035602	25783	25784	O	-1	-1	0
CI	PMC3035602	25785	25787	O	-1	-1	0
:	PMC3035602	25787	25788	O	-1	-1	0
0.6–2.0	PMC3035602	25789	25796	O	-1	-1	0
)	PMC3035602	25796	25797	O	-1	-1	0

PORLBW	PMC3035602	25798	25804	O	-1	-1	0
at	PMC3035602	25805	25807	O	-1	-1	0
term	PMC3035602	25808	25812	O	-1	-1	0
=	PMC3035602	25813	25814	O	-1	-1	0
0.6	PMC3035602	25815	25818	O	-1	-1	0

(	PMC3035602	25819	25820	O	-1	-1	0
95	PMC3035602	25820	25822	O	-1	-1	0
%	PMC3035602	25822	25823	O	-1	-1	0
CI	PMC3035602	25824	25826	O	-1	-1	0
:	PMC3035602	25826	25827	O	-1	-1	0
0.2–2.6	PMC3035602	25828	25835	O	-1	-1	0
)	PMC3035602	25835	25836	O	-1	-1	0

PORstillbirth	PMC3035602	25837	25850	O	-1	-1	0
=	PMC3035602	25851	25852	O	-1	-1	0
2.0	PMC3035602	25853	25856	O	-1	-1	0

(	PMC3035602	25857	25858	O	-1	-1	0
95	PMC3035602	25858	25860	O	-1	-1	0
%	PMC3035602	25860	25861	O	-1	-1	0
CI	PMC3035602	25862	25864	O	-1	-1	0
:	PMC3035602	25864	25865	O	-1	-1	0
0.3–15.4	PMC3035602	25866	25874	O	-1	-1	0
)	PMC3035602	25874	25875	O	-1	-1	0

PORCAs	PMC3035602	25876	25882	O	-1	-1	0
=	PMC3035602	25883	25884	O	-1	-1	0
1.7	PMC3035602	25885	25888	O	-1	-1	0
(	PMC3035602	25889	25890	O	-1	-1	0
95	PMC3035602	25890	25892	O	-1	-1	0
%	PMC3035602	25892	25893	O	-1	-1	0
CI	PMC3035602	25894	25896	O	-1	-1	0
:	PMC3035602	25896	25897	O	-1	-1	0
0.9–3.1	PMC3035602	25898	25905	O	-1	-1	0
)	PMC3035602	25905	25906	O	-1	-1	0

No	PMC3035602	25907	25909	O	-1	-1	0
difference	PMC3035602	25910	25920	O	-1	-1	0
in	PMC3035602	25921	25923	O	-1	-1	0
mean	PMC3035602	25924	25928	O	-1	-1	0
BW	PMC3035602	25929	25931	O	-1	-1	0
Proportion	PMC3035602	25932	25942	O	-1	-1	0
of	PMC3035602	25943	25945	O	-1	-1	0
male	PMC3035602	25946	25950	O	-1	-1	0
newborns	PMC3035602	25951	25959	O	-1	-1	0
=	PMC3035602	25960	25961	O	-1	-1	0

50	PMC3035602	25962	25964	O	-1	-1	0
%	PMC3035602	25964	25965	O	-1	-1	0
vs	PMC3035602	25966	25968	O	-1	-1	0
51.3	PMC3035602	25969	25973	O	-1	-1	0
%	PMC3035602	25973	25974	O	-1	-1	0
in	PMC3035602	25975	25977	O	-1	-1	0
controls	PMC3035602	25978	25986	O	-1	-1	0
,	PMC3035602	25986	25987	O	-1	-1	0
difference	PMC3035602	25988	25998	O	-1	-1	0
–	PMC3035602	25999	26000	O	-1	-1	0
1.3	PMC3035602	26000	26003	O	-1	-1	0
%	PMC3035602	26003	26004	O	-1	-1	0
(	PMC3035602	26005	26006	O	-1	-1	0
95	PMC3035602	26006	26008	O	-1	-1	0
%	PMC3035602	26008	26009	O	-1	-1	0
CI	PMC3035602	26010	26012	O	-1	-1	0
:	PMC3035602	26012	26013	O	-1	-1	0
–	PMC3035602	26014	26015	O	-1	-1	0
8.4	PMC3035602	26015	26018	O	-1	-1	0
;	PMC3035602	26018	26019	O	-1	-1	0
5.8	PMC3035602	26020	26023	O	-1	-1	0
)	PMC3035602	26023	26024	O	-1	-1	0


	PMC3035602	26024	26026	O	-1	-1	0

Proportionpreterm	PMC3035602	26026	26043	O	-1	-1	0
birth	PMC3035602	26044	26049	O	-1	-1	0
=	PMC3035602	26050	26051	O	-1	-1	0

19.2	PMC3035602	26052	26056	O	-1	-1	0
%	PMC3035602	26056	26057	O	-1	-1	0
vs	PMC3035602	26058	26060	O	-1	-1	0
12.5	PMC3035602	26061	26065	O	-1	-1	0
%	PMC3035602	26065	26066	O	-1	-1	0
in	PMC3035602	26067	26069	O	-1	-1	0
siblings	PMC3035602	26070	26078	O	-1	-1	0
ProportionLBW	PMC3035602	26079	26092	O	-1	-1	0

=	PMC3035602	26093	26094	O	-1	-1	0

5.9	PMC3035602	26095	26098	O	-1	-1	0
%	PMC3035602	26098	26099	O	-1	-1	0
vs	PMC3035602	26100	26102	O	-1	-1	0
4.2	PMC3035602	26103	26106	O	-1	-1	0
%	PMC3035602	26106	26107	O	-1	-1	0
in	PMC3035602	26108	26110	O	-1	-1	0
siblings	PMC3035602	26111	26119	O	-1	-1	0
ProportionSGA	PMC3035602	26120	26133	O	-1	-1	0

=	PMC3035602	26134	26135	O	-1	-1	0

9.0	PMC3035602	26136	26139	O	-1	-1	0
%	PMC3035602	26139	26140	O	-1	-1	0
vs	PMC3035602	26141	26143	O	-1	-1	0
9.2	PMC3035602	26144	26147	O	-1	-1	0
in	PMC3035602	26148	26150	O	-1	-1	0
siblings	PMC3035602	26151	26159	O	-1	-1	0


	PMC3035602	26159	26161	O	-1	-1	0
RRpreterm	PMC3035602	26161	26170	O	-1	-1	0
=	PMC3035602	26171	26172	O	-1	-1	0
0.88	PMC3035602	26173	26177	O	-1	-1	0
(	PMC3035602	26178	26179	O	-1	-1	0
95	PMC3035602	26179	26181	O	-1	-1	0
%	PMC3035602	26181	26182	O	-1	-1	0
CI	PMC3035602	26183	26185	O	-1	-1	0
:	PMC3035602	26185	26186	O	-1	-1	0
0.32–2.46	PMC3035602	26187	26196	O	-1	-1	0
)	PMC3035602	26196	26197	O	-1	-1	0

RRLBW	PMC3035602	26198	26203	O	-1	-1	0
=	PMC3035602	26204	26205	O	-1	-1	0
1.58	PMC3035602	26206	26210	O	-1	-1	0

(	PMC3035602	26211	26212	O	-1	-1	0
95	PMC3035602	26212	26214	O	-1	-1	0
%	PMC3035602	26214	26215	O	-1	-1	0
CI	PMC3035602	26216	26218	O	-1	-1	0
:	PMC3035602	26218	26219	O	-1	-1	0
0.52–4.26	PMC3035602	26220	26229	O	-1	-1	0
)	PMC3035602	26229	26230	O	-1	-1	0

RRmale	PMC3035602	26231	26237	O	-1	-1	0
sex	PMC3035602	26238	26241	O	-1	-1	0
=	PMC3035602	26242	26243	O	-1	-1	0

0.91	PMC3035602	26244	26248	O	-1	-1	0

(	PMC3035602	26249	26250	O	-1	-1	0
95	PMC3035602	26250	26252	O	-1	-1	0
%	PMC3035602	26252	26253	O	-1	-1	0
CI	PMC3035602	26254	26256	O	-1	-1	0
:	PMC3035602	26256	26257	O	-1	-1	0
0.52–1.59	PMC3035602	26258	26267	O	-1	-1	0
)	PMC3035602	26267	26268	O	-1	-1	0

Stillbirths	PMC3035602	26269	26280	O	-1	-1	0
:	PMC3035602	26280	26281	O	-1	-1	0
none	PMC3035602	26282	26286	O	-1	-1	0
Minor	PMC3035602	26287	26292	O	-1	-1	0
/	PMC3035602	26292	26293	O	-1	-1	0
major	PMC3035602	26293	26298	O	-1	-1	0
CAs	PMC3035602	26299	26302	O	-1	-1	0
:	PMC3035602	26302	26303	O	-1	-1	0
not	PMC3035602	26304	26307	O	-1	-1	0
different	PMC3035602	26308	26317	O	-1	-1	0
from	PMC3035602	26318	26322	O	-1	-1	0
general	PMC3035602	26323	26330	O	-1	-1	0
population	PMC3035602	26331	26341	O	-1	-1	0

RRstillbirth	PMC3035602	26342	26354	O	-1	-1	0
=	PMC3035602	26355	26356	O	-1	-1	0
1.6	PMC3035602	26357	26360	O	-1	-1	0

(	PMC3035602	26361	26362	O	-1	-1	0
95	PMC3035602	26362	26364	O	-1	-1	0
%	PMC3035602	26364	26365	O	-1	-1	0
CI	PMC3035602	26366	26368	O	-1	-1	0
:	PMC3035602	26368	26369	O	-1	-1	0
0.64–4.03	PMC3035602	26370	26379	O	-1	-1	0
)	PMC3035602	26379	26380	O	-1	-1	0


	PMC3035602	26380	26382	O	-1	-1	0

No	PMC3035602	26382	26384	O	-1	-1	0
overall	PMC3035602	26385	26392	O	-1	-1	0
increase	PMC3035602	26393	26401	O	-1	-1	0
in	PMC3035602	26402	26404	O	-1	-1	0
risk	PMC3035602	26405	26409	O	-1	-1	0
of	PMC3035602	26410	26412	O	-1	-1	0
abnormal	PMC3035602	26413	26421	O	-1	-1	0
birth	PMC3035602	26422	26427	O	-1	-1	0
outcome	PMC3035602	26428	26435	O	-1	-1	0
(	PMC3035602	26436	26437	O	-1	-1	0
stillbirth	PMC3035602	26437	26447	O	-1	-1	0
and	PMC3035602	26448	26451	O	-1	-1	0
CA	PMC3035602	26452	26454	O	-1	-1	0
combined	PMC3035602	26455	26463	O	-1	-1	0
)	PMC3035602	26463	26464	O	-1	-1	0

(	PMC3035602	26465	26466	O	-1	-1	0
P	PMC3035602	26466	26467	O	-1	-1	0
=	PMC3035602	26468	26469	O	-1	-1	0
1.00	PMC3035602	26470	26474	O	-1	-1	0
)	PMC3035602	26474	26475	O	-1	-1	0

No	PMC3035602	26476	26478	O	-1	-1	0
increased	PMC3035602	26479	26488	O	-1	-1	0
risk	PMC3035602	26489	26493	O	-1	-1	0
associated	PMC3035602	26494	26504	O	-1	-1	0
with	PMC3035602	26505	26509	O	-1	-1	0
radiotherapy	PMC3035602	26510	26522	O	-1	-1	0
alone	PMC3035602	26523	26528	O	-1	-1	0
(	PMC3035602	26529	26530	O	-1	-1	0
P	PMC3035602	26530	26531	O	-1	-1	0
=	PMC3035602	26532	26533	O	-1	-1	0
0.25	PMC3035602	26534	26538	O	-1	-1	0
)	PMC3035602	26538	26539	O	-1	-1	0

Increased	PMC3035602	26540	26549	O	-1	-1	0
risk	PMC3035602	26550	26554	O	-1	-1	0
of	PMC3035602	26555	26557	O	-1	-1	0
abnormal	PMC3035602	26558	26566	O	-1	-1	0
birth	PMC3035602	26567	26572	O	-1	-1	0
outcome	PMC3035602	26573	26580	O	-1	-1	0
associated	PMC3035602	26581	26591	O	-1	-1	0
with	PMC3035602	26592	26596	O	-1	-1	0
radiotherapy	PMC3035602	26597	26609	O	-1	-1	0
and	PMC3035602	26610	26613	O	-1	-1	0
chemotherapy	PMC3035602	26614	26626	O	-1	-1	0

combined	PMC3035602	26627	26635	O	-1	-1	0
(	PMC3035602	26636	26637	O	-1	-1	0
P	PMC3035602	26637	26638	O	-1	-1	0
=	PMC3035602	26639	26640	O	-1	-1	0
0.047	PMC3035602	26641	26646	O	-1	-1	0
)	PMC3035602	26646	26647	O	-1	-1	0

RRLBW	PMC3035602	26648	26653	O	-1	-1	0
=	PMC3035602	26654	26655	O	-1	-1	0

2.5	PMC3035602	26656	26659	O	-1	-1	0

(	PMC3035602	26660	26661	O	-1	-1	0
95	PMC3035602	26661	26663	O	-1	-1	0
%	PMC3035602	26663	26664	O	-1	-1	0
CI	PMC3035602	26665	26667	O	-1	-1	0
:	PMC3035602	26667	26668	O	-1	-1	0
0.3–9.0	PMC3035602	26669	26676	O	-1	-1	0
)	PMC3035602	26676	26677	O	-1	-1	0
CAs	PMC3035602	26678	26681	O	-1	-1	0
:	PMC3035602	26681	26682	O	-1	-1	0
none	PMC3035602	26683	26687	O	-1	-1	0


	PMC3035602	26687	26689	O	-1	-1	0
Results	PMC3035602	26689	26696	O	-1	-1	0
for	PMC3035602	26697	26700	O	-1	-1	0
birth	PMC3035602	26701	26706	O	-1	-1	0
outcome	PMC3035602	26707	26714	O	-1	-1	0


	PMC3035602	26714	26716	O	-1	-1	0

Dovepress	PMC3035602	26716	26725	O	-1	-1	0

Birth	PMC3035602	26726	26731	O	-1	-1	0
outcome	PMC3035602	26732	26739	O	-1	-1	0
in	PMC3035602	26740	26742	O	-1	-1	0
women	PMC3035602	26743	26748	O	-1	-1	0
with	PMC3035602	26749	26753	O	-1	-1	0
cancer	PMC3035602	26754	26760	O	-1	-1	0


	PMC3035602	26760	26762	O	-1	-1	0

13	PMC3035602	26762	26764	O	-1	-1	0


	PMC3035602	26764	26766	O	-1	-1	0

14	PMC3035602	26766	26768	O	-1	-1	0


	PMC3035602	26768	26770	O	-1	-1	0

submit	PMC3035602	26770	26776	O	-1	-1	0
your	PMC3035602	26777	26781	O	-1	-1	0
manuscript	PMC3035602	26782	26792	O	-1	-1	0

|	PMC3035602	26793	26794	O	-1	-1	0

www.dovepress.com	PMC3035602	26795	26812	O	-1	-1	0


	PMC3035602	26812	26814	O	-1	-1	0

Dovepress	PMC3035602	26814	26823	O	-1	-1	0


	PMC3035602	26823	26825	O	-1	-1	0

1966–1986	PMC3035602	26825	26834	O	-1	-1	0


	PMC3035602	26834	26836	O	-1	-1	0

1992–1997	PMC3035602	26836	26845	O	-1	-1	0


	PMC3035602	26845	26847	O	-1	-1	0

1970–2002	PMC3035602	26847	26856	O	-1	-1	0


	PMC3035602	26856	26858	O	-1	-1	0

Janov	PMC3035602	26858	26863	O	-1	-1	0
et	PMC3035602	26864	26866	O	-1	-1	0

al37	PMC3035602	26867	26871	O	-1	-1	0
USA	PMC3035602	26872	26875	B-Location	-1	-1	0

1992	PMC3035602	26876	26880	O	-1	-1	0


	PMC3035602	26880	26882	O	-1	-1	0

Smith	PMC3035602	26882	26887	O	-1	-1	0

et	PMC3035602	26888	26890	O	-1	-1	0
al18	PMC3035602	26891	26895	O	-1	-1	0

USA	PMC3035602	26896	26899	B-Location	-1	-1	0

2001	PMC3035602	26900	26904	O	-1	-1	0


	PMC3035602	26904	26906	O	-1	-1	0

Langagergaard	PMC3035602	26906	26919	O	-1	-1	0
et	PMC3035602	26920	26922	O	-1	-1	0

al42	PMC3035602	26923	26927	O	-1	-1	0

Denmark	PMC3035602	26928	26935	B-Location	-1	-1	0

2008	PMC3035602	26936	26940	O	-1	-1	0


	PMC3035602	26940	26942	O	-1	-1	0

Cohort	PMC3035602	26942	26948	O	-1	-1	0
study	PMC3035602	26949	26954	O	-1	-1	0

Comparison	PMC3035602	26955	26965	O	-1	-1	0
:	PMC3035602	26965	26966	O	-1	-1	0

Birth	PMC3035602	26967	26972	O	-1	-1	0
outcome	PMC3035602	26973	26980	O	-1	-1	0
in	PMC3035602	26981	26983	O	-1	-1	0
the	PMC3035602	26984	26987	O	-1	-1	0
general	PMC3035602	26988	26995	O	-1	-1	0
population	PMC3035602	26996	27006	O	-1	-1	0

Cohort	PMC3035602	27007	27013	O	-1	-1	0
study	PMC3035602	27014	27019	O	-1	-1	0

Comparison	PMC3035602	27020	27030	O	-1	-1	0
:	PMC3035602	27030	27031	O	-1	-1	0
Comparison	PMC3035602	27032	27042	O	-1	-1	0
group	PMC3035602	27043	27048	O	-1	-1	0

not	PMC3035602	27049	27052	O	-1	-1	0
specified	PMC3035602	27053	27062	O	-1	-1	0

Cohort	PMC3035602	27063	27069	O	-1	-1	0
study	PMC3035602	27070	27075	O	-1	-1	0

Comparison	PMC3035602	27076	27086	O	-1	-1	0
:	PMC3035602	27086	27087	O	-1	-1	0
Births	PMC3035602	27088	27094	O	-1	-1	0
of	PMC3035602	27095	27097	O	-1	-1	0
cancer	PMC3035602	27098	27104	O	-1	-1	0
free	PMC3035602	27105	27109	O	-1	-1	0

women	PMC3035602	27110	27115	O	-1	-1	0
matched	PMC3035602	27116	27123	O	-1	-1	0
by	PMC3035602	27124	27126	O	-1	-1	0
time	PMC3035602	27127	27131	O	-1	-1	0
of	PMC3035602	27132	27134	O	-1	-1	0
birth	PMC3035602	27135	27140	O	-1	-1	0
and	PMC3035602	27141	27144	O	-1	-1	0
county	PMC3035602	27145	27151	O	-1	-1	0
of	PMC3035602	27152	27154	O	-1	-1	0
mother	PMC3035602	27155	27161	O	-1	-1	0

’s	PMC3035602	27161	27163	O	-1	-1	0
residence	PMC3035602	27164	27173	O	-1	-1	0


	PMC3035602	27173	27175	O	-1	-1	0

Design	PMC3035602	27175	27181	O	-1	-1	0


	PMC3035602	27181	27183	O	-1	-1	0

10	PMC3035602	27183	27185	O	-1	-1	0
births	PMC3035602	27186	27192	O	-1	-1	0
by	PMC3035602	27193	27195	O	-1	-1	0
women	PMC3035602	27196	27201	O	-1	-1	0
who	PMC3035602	27202	27205	O	-1	-1	0
were	PMC3035602	27206	27210	O	-1	-1	0
pregnant	PMC3035602	27211	27219	O	-1	-1	0
from	PMC3035602	27220	27224	O	-1	-1	0
12	PMC3035602	27225	27227	O	-1	-1	0
months	PMC3035602	27228	27234	O	-1	-1	0
before	PMC3035602	27235	27241	O	-1	-1	0
diagnosis	PMC3035602	27242	27251	O	-1	-1	0
until	PMC3035602	27252	27257	O	-1	-1	0
end	PMC3035602	27258	27261	O	-1	-1	0
of	PMC3035602	27262	27264	O	-1	-1	0
treatment	PMC3035602	27265	27274	O	-1	-1	0

Births	PMC3035602	27275	27281	O	-1	-1	0
by	PMC3035602	27282	27284	O	-1	-1	0
172	PMC3035602	27285	27288	O	-1	-1	0
women	PMC3035602	27289	27294	O	-1	-1	0
who	PMC3035602	27295	27298	O	-1	-1	0
were	PMC3035602	27299	27303	O	-1	-1	0
diagnosed	PMC3035602	27304	27313	O	-1	-1	0
from	PMC3035602	27314	27318	O	-1	-1	0
9	PMC3035602	27319	27320	O	-1	-1	0
months	PMC3035602	27321	27327	O	-1	-1	0
before	PMC3035602	27328	27334	O	-1	-1	0
until	PMC3035602	27335	27340	O	-1	-1	0
12	PMC3035602	27341	27343	O	-1	-1	0
months	PMC3035602	27344	27350	O	-1	-1	0
after	PMC3035602	27351	27356	O	-1	-1	0
delivery	PMC3035602	27357	27365	O	-1	-1	0

15	PMC3035602	27366	27368	O	-1	-1	0
births	PMC3035602	27369	27375	O	-1	-1	0
by	PMC3035602	27376	27378	O	-1	-1	0
women	PMC3035602	27379	27384	O	-1	-1	0
diagnosed	PMC3035602	27385	27394	O	-1	-1	0
during	PMC3035602	27395	27401	O	-1	-1	0
pregnancy	PMC3035602	27402	27411	O	-1	-1	0
and	PMC3035602	27412	27415	O	-1	-1	0
85	PMC3035602	27416	27418	O	-1	-1	0
births	PMC3035602	27419	27425	O	-1	-1	0
by	PMC3035602	27426	27428	O	-1	-1	0
women	PMC3035602	27429	27434	O	-1	-1	0
diagnosed	PMC3035602	27435	27444	O	-1	-1	0
within	PMC3035602	27445	27451	O	-1	-1	0
2	PMC3035602	27452	27453	O	-1	-1	0
years	PMC3035602	27454	27459	O	-1	-1	0
after	PMC3035602	27460	27465	O	-1	-1	0
delivery	PMC3035602	27466	27474	O	-1	-1	0


	PMC3035602	27474	27476	O	-1	-1	0

Number	PMC3035602	27476	27482	O	-1	-1	0


	PMC3035602	27482	27484	O	-1	-1	0

Yes	PMC3035602	27484	27487	O	-1	-1	0
,	PMC3035602	27487	27488	O	-1	-1	0
maternal	PMC3035602	27489	27497	O	-1	-1	0
age	PMC3035602	27498	27501	O	-1	-1	0
,	PMC3035602	27501	27502	O	-1	-1	0
parity	PMC3035602	27503	27509	O	-1	-1	0
,	PMC3035602	27509	27510	O	-1	-1	0
and	PMC3035602	27511	27514	O	-1	-1	0
calendar	PMC3035602	27515	27523	O	-1	-1	0
period	PMC3035602	27524	27530	O	-1	-1	0
of	PMC3035602	27531	27533	O	-1	-1	0
birth	PMC3035602	27534	27539	O	-1	-1	0
.	PMC3035602	27539	27540	O	-1	-1	0

Mean	PMC3035602	27541	27545	O	-1	-1	0
BW	PMC3035602	27546	27548	O	-1	-1	0
was	PMC3035602	27549	27552	O	-1	-1	0
also	PMC3035602	27553	27557	O	-1	-1	0
adjusted	PMC3035602	27558	27566	O	-1	-1	0
for	PMC3035602	27567	27570	O	-1	-1	0
gestational	PMC3035602	27571	27582	O	-1	-1	0
age	PMC3035602	27583	27586	O	-1	-1	0


	PMC3035602	27586	27588	O	-1	-1	0

Yes	PMC3035602	27588	27591	O	-1	-1	0
,	PMC3035602	27591	27592	O	-1	-1	0
maternal	PMC3035602	27593	27601	O	-1	-1	0
age	PMC3035602	27602	27605	O	-1	-1	0


	PMC3035602	27605	27607	O	-1	-1	0

No	PMC3035602	27607	27609	O	-1	-1	0


	PMC3035602	27609	27611	O	-1	-1	0

Adjustment	PMC3035602	27611	27621	O	-1	-1	0


	PMC3035602	27621	27623	O	-1	-1	0
POR	PMC3035602	27623	27626	O	-1	-1	0
for	PMC3035602	27627	27630	O	-1	-1	0
preterm	PMC3035602	27631	27638	O	-1	-1	0

birth	PMC3035602	27639	27644	O	-1	-1	0
and	PMC3035602	27645	27648	O	-1	-1	0
CAs	PMC3035602	27649	27652	O	-1	-1	0


	PMC3035602	27652	27654	O	-1	-1	0

OR	PMC3035602	27654	27656	O	-1	-1	0
for	PMC3035602	27657	27660	O	-1	-1	0
prematurity	PMC3035602	27661	27672	O	-1	-1	0
and	PMC3035602	27673	27676	O	-1	-1	0
very	PMC3035602	27677	27681	O	-1	-1	0
LBW	PMC3035602	27682	27685	O	-1	-1	0


	PMC3035602	27685	27687	O	-1	-1	0

RR	PMC3035602	27687	27689	O	-1	-1	0
for	PMC3035602	27690	27693	O	-1	-1	0
LBW	PMC3035602	27694	27697	O	-1	-1	0


	PMC3035602	27697	27699	O	-1	-1	0

Relative	PMC3035602	27699	27707	O	-1	-1	0
effect	PMC3035602	27708	27714	O	-1	-1	0

estimates	PMC3035602	27715	27724	O	-1	-1	0


	PMC3035602	27724	27726	O	-1	-1	0

Women	PMC3035602	27726	27731	O	-1	-1	0
diagnosed	PMC3035602	27732	27741	O	-1	-1	0
during	PMC3035602	27742	27748	O	-1	-1	0
pregnancy	PMC3035602	27749	27758	O	-1	-1	0
:	PMC3035602	27758	27759	O	-1	-1	0

PORpreterm	PMC3035602	27760	27770	O	-1	-1	0
birth	PMC3035602	27771	27776	O	-1	-1	0
=	PMC3035602	27777	27778	O	-1	-1	0
26.6	PMC3035602	27779	27783	O	-1	-1	0
(	PMC3035602	27784	27785	O	-1	-1	0
95	PMC3035602	27785	27787	O	-1	-1	0
%	PMC3035602	27787	27788	O	-1	-1	0
CI	PMC3035602	27789	27791	O	-1	-1	0
:	PMC3035602	27791	27792	O	-1	-1	0
8.5–83.0	PMC3035602	27793	27801	O	-1	-1	0
)	PMC3035602	27801	27802	O	-1	-1	0

(	PMC3035602	27803	27804	O	-1	-1	0
5	PMC3035602	27804	27805	O	-1	-1	0
of	PMC3035602	27806	27808	O	-1	-1	0
8	PMC3035602	27809	27810	O	-1	-1	0
preterm	PMC3035602	27811	27818	O	-1	-1	0
deliveries	PMC3035602	27819	27829	O	-1	-1	0
were	PMC3035602	27830	27834	O	-1	-1	0
induced	PMC3035602	27835	27842	O	-1	-1	0
)	PMC3035602	27842	27843	O	-1	-1	0

PORCAs	PMC3035602	27844	27850	O	-1	-1	0
=	PMC3035602	27851	27852	O	-1	-1	0
2.7	PMC3035602	27853	27856	O	-1	-1	0

(	PMC3035602	27857	27858	O	-1	-1	0
95	PMC3035602	27858	27860	O	-1	-1	0
%	PMC3035602	27860	27861	O	-1	-1	0
CI	PMC3035602	27862	27864	O	-1	-1	0
:	PMC3035602	27864	27865	O	-1	-1	0
0.3–22.8	PMC3035602	27866	27874	O	-1	-1	0
)	PMC3035602	27874	27875	O	-1	-1	0

LBW	PMC3035602	27876	27879	O	-1	-1	0
at	PMC3035602	27880	27882	O	-1	-1	0
term	PMC3035602	27883	27887	O	-1	-1	0
:	PMC3035602	27887	27888	O	-1	-1	0
none	PMC3035602	27889	27893	O	-1	-1	0
Stillbirths	PMC3035602	27894	27905	O	-1	-1	0
:	PMC3035602	27905	27906	O	-1	-1	0
none	PMC3035602	27907	27911	O	-1	-1	0

No	PMC3035602	27912	27914	O	-1	-1	0
difference	PMC3035602	27915	27925	O	-1	-1	0
in	PMC3035602	27926	27928	O	-1	-1	0
mean	PMC3035602	27929	27933	O	-1	-1	0
BW	PMC3035602	27934	27936	O	-1	-1	0
Proportion	PMC3035602	27937	27947	O	-1	-1	0
of	PMC3035602	27948	27950	O	-1	-1	0
male	PMC3035602	27951	27955	O	-1	-1	0
newborns	PMC3035602	27956	27964	O	-1	-1	0
=	PMC3035602	27965	27966	O	-1	-1	0

73.3	PMC3035602	27967	27971	O	-1	-1	0
%	PMC3035602	27971	27972	O	-1	-1	0
vs	PMC3035602	27973	27975	O	-1	-1	0
50.1	PMC3035602	27976	27980	O	-1	-1	0
%	PMC3035602	27980	27981	O	-1	-1	0
in	PMC3035602	27982	27984	O	-1	-1	0
controls	PMC3035602	27985	27993	O	-1	-1	0
,	PMC3035602	27993	27994	O	-1	-1	0
difference	PMC3035602	27995	28005	O	-1	-1	0
=	PMC3035602	28006	28007	O	-1	-1	0

23.2	PMC3035602	28008	28012	O	-1	-1	0
%	PMC3035602	28012	28013	O	-1	-1	0

(	PMC3035602	28014	28015	O	-1	-1	0
95	PMC3035602	28015	28017	O	-1	-1	0
%	PMC3035602	28017	28018	O	-1	-1	0
CI	PMC3035602	28019	28021	O	-1	-1	0
:	PMC3035602	28021	28022	O	-1	-1	0
5.1–45.6	PMC3035602	28023	28031	O	-1	-1	0
)	PMC3035602	28031	28032	O	-1	-1	0

Women	PMC3035602	28033	28038	O	-1	-1	0
diagnosed	PMC3035602	28039	28048	O	-1	-1	0
within	PMC3035602	28049	28055	O	-1	-1	0
2	PMC3035602	28056	28057	O	-1	-1	0
years	PMC3035602	28058	28063	O	-1	-1	0
after	PMC3035602	28064	28069	O	-1	-1	0
delivery	PMC3035602	28070	28078	O	-1	-1	0
:	PMC3035602	28078	28079	O	-1	-1	0

PORpreterm	PMC3035602	28080	28090	O	-1	-1	0
birth	PMC3035602	28091	28096	O	-1	-1	0
=	PMC3035602	28097	28098	O	-1	-1	0

1.2	PMC3035602	28099	28102	O	-1	-1	0

(	PMC3035602	28103	28104	O	-1	-1	0
95	PMC3035602	28104	28106	O	-1	-1	0
%	PMC3035602	28106	28107	O	-1	-1	0
CI	PMC3035602	28108	28110	O	-1	-1	0
:	PMC3035602	28110	28111	O	-1	-1	0
0.5–2.9	PMC3035602	28112	28119	O	-1	-1	0
)	PMC3035602	28119	28120	O	-1	-1	0

PORCAs	PMC3035602	28121	28127	O	-1	-1	0
=	PMC3035602	28128	28129	O	-1	-1	0
1.6	PMC3035602	28130	28133	O	-1	-1	0

(	PMC3035602	28134	28135	O	-1	-1	0
95	PMC3035602	28135	28137	O	-1	-1	0
%	PMC3035602	28137	28138	O	-1	-1	0
CI	PMC3035602	28139	28141	O	-1	-1	0
:	PMC3035602	28141	28142	O	-1	-1	0
0.6–4.5	PMC3035602	28143	28150	O	-1	-1	0
)	PMC3035602	28150	28151	O	-1	-1	0

LBW	PMC3035602	28152	28155	O	-1	-1	0
at	PMC3035602	28156	28158	O	-1	-1	0
term	PMC3035602	28159	28163	O	-1	-1	0
:	PMC3035602	28163	28164	O	-1	-1	0
none	PMC3035602	28165	28169	O	-1	-1	0
Stillbirths	PMC3035602	28170	28181	O	-1	-1	0
:	PMC3035602	28181	28182	O	-1	-1	0
none	PMC3035602	28183	28187	O	-1	-1	0

No	PMC3035602	28188	28190	O	-1	-1	0
difference	PMC3035602	28191	28201	O	-1	-1	0
in	PMC3035602	28202	28204	O	-1	-1	0
mean	PMC3035602	28205	28209	O	-1	-1	0
BW	PMC3035602	28210	28212	O	-1	-1	0
Proportion	PMC3035602	28213	28223	O	-1	-1	0
of	PMC3035602	28224	28226	O	-1	-1	0
male	PMC3035602	28227	28231	O	-1	-1	0
newborns	PMC3035602	28232	28240	O	-1	-1	0
=	PMC3035602	28241	28242	O	-1	-1	0

61.2	PMC3035602	28243	28247	O	-1	-1	0
%	PMC3035602	28247	28248	O	-1	-1	0
vs	PMC3035602	28249	28251	O	-1	-1	0
51.4	PMC3035602	28252	28256	O	-1	-1	0
%	PMC3035602	28256	28257	O	-1	-1	0
,	PMC3035602	28257	28258	O	-1	-1	0
difference	PMC3035602	28259	28269	O	-1	-1	0

=	PMC3035602	28270	28271	O	-1	-1	0
9.8	PMC3035602	28272	28275	O	-1	-1	0
%	PMC3035602	28275	28276	O	-1	-1	0
(	PMC3035602	28277	28278	O	-1	-1	0
95	PMC3035602	28278	28280	O	-1	-1	0
%	PMC3035602	28280	28281	O	-1	-1	0
CI	PMC3035602	28282	28284	O	-1	-1	0
:	PMC3035602	28284	28285	O	-1	-1	0
–	PMC3035602	28286	28287	O	-1	-1	0
0.7	PMC3035602	28287	28290	O	-1	-1	0
;	PMC3035602	28290	28291	O	-1	-1	0
20.3	PMC3035602	28292	28296	O	-1	-1	0
)	PMC3035602	28296	28297	O	-1	-1	0


	PMC3035602	28297	28299	O	-1	-1	0
3	PMC3035602	28299	28300	O	-1	-1	0
premature	PMC3035602	28301	28310	O	-1	-1	0
children	PMC3035602	28311	28319	O	-1	-1	0
with	PMC3035602	28320	28324	O	-1	-1	0
LBW	PMC3035602	28325	28328	O	-1	-1	0
(	PMC3035602	28329	28330	O	-1	-1	0
1	PMC3035602	28330	28331	O	-1	-1	0
induced	PMC3035602	28332	28339	O	-1	-1	0
preterm	PMC3035602	28340	28347	O	-1	-1	0
delivery	PMC3035602	28348	28356	O	-1	-1	0
)	PMC3035602	28356	28357	O	-1	-1	0
RRLBW	PMC3035602	28358	28363	O	-1	-1	0
=	PMC3035602	28364	28365	O	-1	-1	0

5.6	PMC3035602	28366	28369	O	-1	-1	0

(	PMC3035602	28370	28371	O	-1	-1	0
95	PMC3035602	28371	28373	O	-1	-1	0
%	PMC3035602	28373	28374	O	-1	-1	0
CI	PMC3035602	28375	28377	O	-1	-1	0
:	PMC3035602	28377	28378	O	-1	-1	0
1.2–17.5	PMC3035602	28379	28387	O	-1	-1	0
)	PMC3035602	28387	28388	O	-1	-1	0
CAs	PMC3035602	28389	28392	O	-1	-1	0
:	PMC3035602	28392	28393	O	-1	-1	0
none	PMC3035602	28394	28398	O	-1	-1	0

ORvery	PMC3035602	28399	28405	O	-1	-1	0
LBW	PMC3035602	28406	28409	O	-1	-1	0
=	PMC3035602	28410	28411	O	-1	-1	0
3.6	PMC3035602	28412	28415	O	-1	-1	0

(	PMC3035602	28416	28417	O	-1	-1	0
95	PMC3035602	28417	28419	O	-1	-1	0
%	PMC3035602	28419	28420	O	-1	-1	0
CI	PMC3035602	28421	28423	O	-1	-1	0
:	PMC3035602	28423	28424	O	-1	-1	0
1.5–8.9	PMC3035602	28425	28432	O	-1	-1	0
)	PMC3035602	28432	28433	O	-1	-1	0

ORprematurity	PMC3035602	28434	28447	O	-1	-1	0
=	PMC3035602	28448	28449	O	-1	-1	0
2.4	PMC3035602	28450	28453	O	-1	-1	0

(	PMC3035602	28454	28455	O	-1	-1	0
95	PMC3035602	28455	28457	O	-1	-1	0
%	PMC3035602	28457	28458	O	-1	-1	0
CI	PMC3035602	28459	28461	O	-1	-1	0
:	PMC3035602	28461	28462	O	-1	-1	0
1.6–3.5	PMC3035602	28463	28470	O	-1	-1	0
)	PMC3035602	28470	28471	O	-1	-1	0


	PMC3035602	28471	28473	O	-1	-1	0
Results	PMC3035602	28473	28480	O	-1	-1	0
for	PMC3035602	28481	28484	O	-1	-1	0
birth	PMC3035602	28485	28490	O	-1	-1	0
outcome	PMC3035602	28491	28498	O	-1	-1	0


	PMC3035602	28498	28500	O	-1	-1	0

Abbreviations	PMC3035602	28500	28513	O	-1	-1	0
:	PMC3035602	28513	28514	O	-1	-1	0
BW	PMC3035602	28515	28517	O	-1	-1	0
,	PMC3035602	28517	28518	O	-1	-1	0
birth	PMC3035602	28519	28524	O	-1	-1	0
weight	PMC3035602	28525	28531	O	-1	-1	0
;	PMC3035602	28531	28532	O	-1	-1	0
CAs	PMC3035602	28533	28536	O	-1	-1	0
,	PMC3035602	28536	28537	O	-1	-1	0
congenital	PMC3035602	28538	28548	O	-1	-1	0
abnormalities	PMC3035602	28549	28562	O	-1	-1	0
;	PMC3035602	28562	28563	O	-1	-1	0
CI	PMC3035602	28564	28566	O	-1	-1	0
,	PMC3035602	28566	28567	O	-1	-1	0
confidence	PMC3035602	28568	28578	O	-1	-1	0
interval	PMC3035602	28579	28587	O	-1	-1	0
;	PMC3035602	28587	28588	O	-1	-1	0
GA	PMC3035602	28589	28591	O	-1	-1	0
,	PMC3035602	28591	28592	O	-1	-1	0
gestational	PMC3035602	28593	28604	O	-1	-1	0
age	PMC3035602	28605	28608	O	-1	-1	0
;	PMC3035602	28608	28609	O	-1	-1	0
LBW	PMC3035602	28610	28613	O	-1	-1	0
,	PMC3035602	28613	28614	O	-1	-1	0
low	PMC3035602	28615	28618	O	-1	-1	0
birth	PMC3035602	28619	28624	O	-1	-1	0
weight	PMC3035602	28625	28631	O	-1	-1	0
;	PMC3035602	28631	28632	O	-1	-1	0
OR	PMC3035602	28633	28635	O	-1	-1	0
,	PMC3035602	28635	28636	O	-1	-1	0
odds	PMC3035602	28637	28641	O	-1	-1	0
ratio	PMC3035602	28642	28647	O	-1	-1	0
;	PMC3035602	28647	28648	O	-1	-1	0
POR	PMC3035602	28649	28652	O	-1	-1	0
,	PMC3035602	28652	28653	O	-1	-1	0
prevalence	PMC3035602	28654	28664	O	-1	-1	0
odds	PMC3035602	28665	28669	O	-1	-1	0
ratios	PMC3035602	28670	28676	O	-1	-1	0
;	PMC3035602	28676	28677	O	-1	-1	0
RR	PMC3035602	28678	28680	O	-1	-1	0
,	PMC3035602	28680	28681	O	-1	-1	0
relative	PMC3035602	28682	28690	O	-1	-1	0
risk	PMC3035602	28691	28695	O	-1	-1	0
.	PMC3035602	28695	28696	O	-1	-1	0


	PMC3035602	28696	28698	O	-1	-1	0

Period	PMC3035602	28698	28704	O	-1	-1	0
of	PMC3035602	28705	28707	O	-1	-1	0
cancer	PMC3035602	28708	28714	O	-1	-1	0
diagnosis	PMC3035602	28715	28724	O	-1	-1	0


	PMC3035602	28724	28726	O	-1	-1	0

Author	PMC3035602	28726	28732	O	-1	-1	0

Country	PMC3035602	28733	28740	O	-1	-1	0

Year	PMC3035602	28741	28745	O	-1	-1	0


	PMC3035602	28745	28747	O	-1	-1	0

Table	PMC3035602	28747	28752	O	-1	-1	0
3	PMC3035602	28753	28754	O	-1	-1	0
(	PMC3035602	28755	28756	O	-1	-1	0
Continued	PMC3035602	28756	28765	O	-1	-1	0
)	PMC3035602	28765	28766	O	-1	-1	0


	PMC3035602	28766	28768	O	-1	-1	0

Langagergaard	PMC3035602	28768	28781	O	-1	-1	0

Dovepress	PMC3035602	28782	28791	O	-1	-1	0


	PMC3035602	28791	28793	O	-1	-1	0

Clinical	PMC3035602	28793	28801	O	-1	-1	0
Epidemiology	PMC3035602	28802	28814	O	-1	-1	0
2011:3	PMC3035602	28815	28821	O	-1	-1	0


	PMC3035602	28821	28823	O	-1	-1	0

Dovepress	PMC3035602	28823	28832	O	-1	-1	0


	PMC3035602	28832	28834	O	-1	-1	0

In	PMC3035602	28834	28836	O	-1	-1	0
conclusion	PMC3035602	28837	28847	O	-1	-1	0
,	PMC3035602	28847	28848	O	-1	-1	0
the	PMC3035602	28849	28852	O	-1	-1	0
overall	PMC3035602	28853	28860	O	-1	-1	0
results	PMC3035602	28861	28868	O	-1	-1	0
regarding	PMC3035602	28869	28878	O	-1	-1	0
the	PMC3035602	28879	28882	O	-1	-1	0
birth	PMC3035602	28883	28888	O	-1	-1	0
outcome	PMC3035602	28889	28896	O	-1	-1	0
among	PMC3035602	28897	28902	O	-1	-1	0
women	PMC3035602	28903	28908	O	-1	-1	0
with	PMC3035602	28909	28913	O	-1	-1	0
breast	PMC3035602	28914	28920	O	-1	-1	0
cancer	PMC3035602	28921	28927	O	-1	-1	0
are	PMC3035602	28928	28931	O	-1	-1	0
reassuring	PMC3035602	28932	28942	O	-1	-1	0
.	PMC3035602	28942	28943	O	-1	-1	0

However	PMC3035602	28944	28951	O	-1	-1	0
,	PMC3035602	28951	28952	O	-1	-1	0
additional	PMC3035602	28953	28963	O	-1	-1	0
studies	PMC3035602	28964	28971	O	-1	-1	0
of	PMC3035602	28972	28974	O	-1	-1	0
birth	PMC3035602	28975	28980	O	-1	-1	0
outcome	PMC3035602	28981	28988	O	-1	-1	0
in	PMC3035602	28989	28991	O	-1	-1	0
women	PMC3035602	28992	28997	O	-1	-1	0
who	PMC3035602	28998	29001	O	-1	-1	0
were	PMC3035602	29002	29006	O	-1	-1	0
diagnosed	PMC3035602	29007	29016	O	-1	-1	0
with	PMC3035602	29017	29021	O	-1	-1	0
breast	PMC3035602	29022	29028	O	-1	-1	0
cancer	PMC3035602	29029	29035	O	-1	-1	0
before	PMC3035602	29036	29042	O	-1	-1	0
pregnancy	PMC3035602	29043	29052	O	-1	-1	0
are	PMC3035602	29053	29056	O	-1	-1	0
needed	PMC3035602	29057	29063	O	-1	-1	0
to	PMC3035602	29064	29066	O	-1	-1	0
resolve	PMC3035602	29067	29074	O	-1	-1	0
the	PMC3035602	29075	29078	O	-1	-1	0
discrepancy	PMC3035602	29079	29090	O	-1	-1	0
between	PMC3035602	29091	29098	O	-1	-1	0
the	PMC3035602	29099	29102	O	-1	-1	0
findings	PMC3035602	29103	29111	O	-1	-1	0
of	PMC3035602	29112	29114	O	-1	-1	0
the	PMC3035602	29115	29118	O	-1	-1	0
Danish23	PMC3035602	29119	29127	O	-1	-1	0
and	PMC3035602	29128	29131	O	-1	-1	0
the	PMC3035602	29132	29135	O	-1	-1	0
Swedish24	PMC3035602	29136	29145	O	-1	-1	0
study	PMC3035602	29146	29151	O	-1	-1	0
.	PMC3035602	29151	29152	O	-1	-1	0


	PMC3035602	29152	29154	O	-1	-1	0

Birth	PMC3035602	29154	29159	O	-1	-1	0
outcome	PMC3035602	29160	29167	O	-1	-1	0
in	PMC3035602	29168	29170	O	-1	-1	0
women	PMC3035602	29171	29176	O	-1	-1	0
with	PMC3035602	29177	29181	O	-1	-1	0
cutaneous	PMC3035602	29182	29191	O	-1	-1	0
malignant	PMC3035602	29192	29201	O	-1	-1	0
melanoma	PMC3035602	29202	29210	O	-1	-1	0

A	PMC3035602	29211	29212	O	-1	-1	0
nationwide	PMC3035602	29213	29223	O	-1	-1	0
cohort	PMC3035602	29224	29230	O	-1	-1	0
study	PMC3035602	29231	29236	O	-1	-1	0
from	PMC3035602	29237	29241	O	-1	-1	0
Denmark	PMC3035602	29242	29249	B-Location	-1	-1	0
(	PMC3035602	29250	29251	O	-1	-1	0
Table	PMC3035602	29251	29256	O	-1	-1	0
2	PMC3035602	29257	29258	O	-1	-1	0
)	PMC3035602	29258	29259	O	-1	-1	0
found	PMC3035602	29260	29265	O	-1	-1	0
no	PMC3035602	29266	29268	O	-1	-1	0
excess	PMC3035602	29269	29275	O	-1	-1	0
risk	PMC3035602	29276	29280	O	-1	-1	0
with	PMC3035602	29281	29285	O	-1	-1	0
respect	PMC3035602	29286	29293	O	-1	-1	0
to	PMC3035602	29294	29296	O	-1	-1	0
preterm	PMC3035602	29297	29304	O	-1	-1	0
birth	PMC3035602	29305	29310	O	-1	-1	0
,	PMC3035602	29310	29311	O	-1	-1	0
LBW	PMC3035602	29312	29315	O	-1	-1	0
at	PMC3035602	29316	29318	O	-1	-1	0
term	PMC3035602	29319	29323	O	-1	-1	0
,	PMC3035602	29323	29324	O	-1	-1	0
stillbirth	PMC3035602	29325	29335	O	-1	-1	0
,	PMC3035602	29335	29336	O	-1	-1	0
and	PMC3035602	29337	29340	O	-1	-1	0
congenital	PMC3035602	29341	29351	O	-1	-1	0
abnormalities	PMC3035602	29352	29365	O	-1	-1	0
among	PMC3035602	29366	29371	O	-1	-1	0
620	PMC3035602	29372	29375	O	-1	-1	0
newborns	PMC3035602	29376	29384	O	-1	-1	0
of	PMC3035602	29385	29387	O	-1	-1	0
women	PMC3035602	29388	29393	O	-1	-1	0
who	PMC3035602	29394	29397	O	-1	-1	0
were	PMC3035602	29398	29402	O	-1	-1	0
diagnosed	PMC3035602	29403	29412	O	-1	-1	0
with	PMC3035602	29413	29417	O	-1	-1	0
melanoma	PMC3035602	29418	29426	O	-1	-1	0
before	PMC3035602	29427	29433	O	-1	-1	0
pregnancy	PMC3035602	29434	29443	O	-1	-1	0
or	PMC3035602	29444	29446	O	-1	-1	0
88	PMC3035602	29447	29449	O	-1	-1	0
newborns	PMC3035602	29450	29458	O	-1	-1	0
of	PMC3035602	29459	29461	O	-1	-1	0
women	PMC3035602	29462	29467	O	-1	-1	0
who	PMC3035602	29468	29471	O	-1	-1	0
were	PMC3035602	29472	29476	O	-1	-1	0
diagnosed	PMC3035602	29477	29486	O	-1	-1	0
during	PMC3035602	29487	29493	O	-1	-1	0
pregnancy	PMC3035602	29494	29503	O	-1	-1	0
,	PMC3035602	29503	29504	O	-1	-1	0
compared	PMC3035602	29505	29513	O	-1	-1	0
with	PMC3035602	29514	29518	O	-1	-1	0
,	PMC3035602	29518	29519	O	-1	-1	0
respectively	PMC3035602	29520	29532	O	-1	-1	0
,	PMC3035602	29532	29533	O	-1	-1	0
29,788	PMC3035602	29534	29540	O	-1	-1	0
and	PMC3035602	29541	29544	O	-1	-1	0
4180	PMC3035602	29545	29549	O	-1	-1	0
newborns	PMC3035602	29550	29558	O	-1	-1	0
of	PMC3035602	29559	29561	O	-1	-1	0
cancer	PMC3035602	29562	29568	O	-1	-1	0
free	PMC3035602	29569	29573	O	-1	-1	0

women.34	PMC3035602	29574	29582	O	-1	-1	0
Furthermore	PMC3035602	29583	29594	O	-1	-1	0
,	PMC3035602	29594	29595	O	-1	-1	0
there	PMC3035602	29596	29601	O	-1	-1	0
was	PMC3035602	29602	29605	O	-1	-1	0
no	PMC3035602	29606	29608	O	-1	-1	0
important	PMC3035602	29609	29618	O	-1	-1	0
difference	PMC3035602	29619	29629	O	-1	-1	0
in	PMC3035602	29630	29632	O	-1	-1	0
mean	PMC3035602	29633	29637	O	-1	-1	0
birth	PMC3035602	29638	29643	O	-1	-1	0
weight	PMC3035602	29644	29650	O	-1	-1	0
or	PMC3035602	29651	29653	O	-1	-1	0
male	PMC3035602	29654	29658	O	-1	-1	0
proportion	PMC3035602	29659	29669	O	-1	-1	0
of	PMC3035602	29670	29672	O	-1	-1	0
newborns	PMC3035602	29673	29681	O	-1	-1	0
between	PMC3035602	29682	29689	O	-1	-1	0
women	PMC3035602	29690	29695	O	-1	-1	0
with	PMC3035602	29696	29700	O	-1	-1	0
melanoma	PMC3035602	29701	29709	O	-1	-1	0
and	PMC3035602	29710	29713	O	-1	-1	0
comparison	PMC3035602	29714	29724	O	-1	-1	0
women	PMC3035602	29725	29730	O	-1	-1	0
.	PMC3035602	29730	29731	O	-1	-1	0

However	PMC3035602	29732	29739	O	-1	-1	0
,	PMC3035602	29739	29740	O	-1	-1	0
the	PMC3035602	29741	29744	O	-1	-1	0
study	PMC3035602	29745	29750	O	-1	-1	0
reported	PMC3035602	29751	29759	O	-1	-1	0
a	PMC3035602	29760	29761	O	-1	-1	0
prevalence	PMC3035602	29762	29772	O	-1	-1	0
odds	PMC3035602	29773	29777	O	-1	-1	0
ratio	PMC3035602	29778	29783	O	-1	-1	0
(	PMC3035602	29784	29785	O	-1	-1	0
POR	PMC3035602	29785	29788	O	-1	-1	0
)	PMC3035602	29788	29789	O	-1	-1	0
of	PMC3035602	29790	29792	O	-1	-1	0
4.6	PMC3035602	29793	29796	O	-1	-1	0
(	PMC3035602	29797	29798	O	-1	-1	0
95	PMC3035602	29798	29800	O	-1	-1	0
%	PMC3035602	29800	29801	O	-1	-1	0
CI	PMC3035602	29802	29804	O	-1	-1	0
:	PMC3035602	29804	29805	O	-1	-1	0
1.7–12.3	PMC3035602	29806	29814	O	-1	-1	0
)	PMC3035602	29814	29815	O	-1	-1	0
for	PMC3035602	29816	29819	O	-1	-1	0
stillbirth	PMC3035602	29820	29830	O	-1	-1	0
among	PMC3035602	29831	29836	O	-1	-1	0
351	PMC3035602	29837	29840	O	-1	-1	0
newborns	PMC3035602	29841	29849	O	-1	-1	0
of	PMC3035602	29850	29852	O	-1	-1	0
women	PMC3035602	29853	29858	O	-1	-1	0
,	PMC3035602	29858	29859	O	-1	-1	0
who	PMC3035602	29860	29863	O	-1	-1	0
were	PMC3035602	29864	29868	O	-1	-1	0
diagnosed	PMC3035602	29869	29878	O	-1	-1	0
with	PMC3035602	29879	29883	O	-1	-1	0
melanoma	PMC3035602	29884	29892	O	-1	-1	0
within	PMC3035602	29893	29899	O	-1	-1	0
2	PMC3035602	29900	29901	O	-1	-1	0
years	PMC3035602	29902	29907	O	-1	-1	0
after	PMC3035602	29908	29913	O	-1	-1	0
the	PMC3035602	29914	29917	O	-1	-1	0
time	PMC3035602	29918	29922	O	-1	-1	0
of	PMC3035602	29923	29925	O	-1	-1	0
delivery	PMC3035602	29926	29934	O	-1	-1	0
.	PMC3035602	29934	29935	O	-1	-1	0

This	PMC3035602	29936	29940	O	-1	-1	0
finding	PMC3035602	29941	29948	O	-1	-1	0
,	PMC3035602	29948	29949	O	-1	-1	0
which	PMC3035602	29950	29955	O	-1	-1	0
was	PMC3035602	29956	29959	O	-1	-1	0
unexpected	PMC3035602	29960	29970	O	-1	-1	0
,	PMC3035602	29970	29971	O	-1	-1	0
has	PMC3035602	29972	29975	O	-1	-1	0
not	PMC3035602	29976	29979	O	-1	-1	0
been	PMC3035602	29980	29984	O	-1	-1	0
shown	PMC3035602	29985	29990	O	-1	-1	0
by	PMC3035602	29991	29993	O	-1	-1	0
other	PMC3035602	29994	29999	O	-1	-1	0
studies	PMC3035602	30000	30007	O	-1	-1	0
,	PMC3035602	30007	30008	O	-1	-1	0
and	PMC3035602	30009	30012	O	-1	-1	0
may	PMC3035602	30013	30016	O	-1	-1	0
have	PMC3035602	30017	30021	O	-1	-1	0
been	PMC3035602	30022	30026	O	-1	-1	0
a	PMC3035602	30027	30028	O	-1	-1	0
chance	PMC3035602	30029	30035	O	-1	-1	0
finding	PMC3035602	30036	30043	O	-1	-1	0
.	PMC3035602	30043	30044	O	-1	-1	0

Two	PMC3035602	30045	30048	O	-1	-1	0
other	PMC3035602	30049	30054	O	-1	-1	0
cohort	PMC3035602	30055	30061	O	-1	-1	0
studies	PMC3035602	30062	30069	O	-1	-1	0
have	PMC3035602	30070	30074	O	-1	-1	0
examined	PMC3035602	30075	30083	O	-1	-1	0
birth	PMC3035602	30084	30089	O	-1	-1	0
outcome	PMC3035602	30090	30097	O	-1	-1	0
in	PMC3035602	30098	30100	O	-1	-1	0
offspring	PMC3035602	30101	30110	O	-1	-1	0
of	PMC3035602	30111	30113	O	-1	-1	0
women	PMC3035602	30114	30119	O	-1	-1	0
diagnosed	PMC3035602	30120	30129	O	-1	-1	0
with	PMC3035602	30130	30134	O	-1	-1	0
melanoma	PMC3035602	30135	30143	O	-1	-1	0
during	PMC3035602	30144	30150	O	-1	-1	0
or	PMC3035602	30151	30153	O	-1	-1	0
shortly	PMC3035602	30154	30161	O	-1	-1	0
after	PMC3035602	30162	30167	O	-1	-1	0
pregnancy	PMC3035602	30168	30177	O	-1	-1	0
(	PMC3035602	30178	30179	O	-1	-1	0
Table	PMC3035602	30179	30184	O	-1	-1	0
2).35,36	PMC3035602	30185	30193	O	-1	-1	0

In	PMC3035602	30194	30196	O	-1	-1	0
a	PMC3035602	30197	30198	O	-1	-1	0
hospital	PMC3035602	30199	30207	O	-1	-1	0
-	PMC3035602	30207	30208	O	-1	-1	0
based	PMC3035602	30208	30213	O	-1	-1	0
cohort	PMC3035602	30214	30220	O	-1	-1	0
study	PMC3035602	30221	30226	O	-1	-1	0
of	PMC3035602	30227	30229	O	-1	-1	0
18	PMC3035602	30230	30232	O	-1	-1	0
deliveries	PMC3035602	30233	30243	O	-1	-1	0
by	PMC3035602	30244	30246	O	-1	-1	0
women	PMC3035602	30247	30252	O	-1	-1	0
diagnosed	PMC3035602	30253	30262	O	-1	-1	0
with	PMC3035602	30263	30267	O	-1	-1	0
melanoma	PMC3035602	30268	30276	O	-1	-1	0
during	PMC3035602	30277	30283	O	-1	-1	0
pregnancy	PMC3035602	30284	30293	O	-1	-1	0
over	PMC3035602	30294	30298	O	-1	-1	0
a	PMC3035602	30299	30300	O	-1	-1	0
period	PMC3035602	30301	30307	O	-1	-1	0
of	PMC3035602	30308	30310	O	-1	-1	0
30	PMC3035602	30311	30313	O	-1	-1	0
years	PMC3035602	30314	30319	O	-1	-1	0
,	PMC3035602	30319	30320	O	-1	-1	0
there	PMC3035602	30321	30326	O	-1	-1	0
were	PMC3035602	30327	30331	O	-1	-1	0
17	PMC3035602	30332	30334	O	-1	-1	0
live	PMC3035602	30335	30339	O	-1	-1	0
births	PMC3035602	30340	30346	O	-1	-1	0
and	PMC3035602	30347	30350	O	-1	-1	0
1	PMC3035602	30351	30352	O	-1	-1	0
anencephalic	PMC3035602	30353	30365	O	-1	-1	0
stillbirth.36	PMC3035602	30366	30379	O	-1	-1	0

The	PMC3035602	30380	30383	O	-1	-1	0
newborns	PMC3035602	30384	30392	O	-1	-1	0
of	PMC3035602	30393	30395	O	-1	-1	0
women	PMC3035602	30396	30401	O	-1	-1	0
with	PMC3035602	30402	30406	O	-1	-1	0
melanoma	PMC3035602	30407	30415	O	-1	-1	0
had	PMC3035602	30416	30419	O	-1	-1	0
a	PMC3035602	30420	30421	O	-1	-1	0
lower	PMC3035602	30422	30427	O	-1	-1	0
mean	PMC3035602	30428	30432	O	-1	-1	0
birth	PMC3035602	30433	30438	O	-1	-1	0
weight	PMC3035602	30439	30445	O	-1	-1	0
than	PMC3035602	30446	30450	O	-1	-1	0
newborns	PMC3035602	30451	30459	O	-1	-1	0
of	PMC3035602	30460	30462	O	-1	-1	0
women	PMC3035602	30463	30468	O	-1	-1	0
without	PMC3035602	30469	30476	O	-1	-1	0
cancer	PMC3035602	30477	30483	O	-1	-1	0
,	PMC3035602	30483	30484	O	-1	-1	0
but	PMC3035602	30485	30488	O	-1	-1	0
there	PMC3035602	30489	30494	O	-1	-1	0
was	PMC3035602	30495	30498	O	-1	-1	0
no	PMC3035602	30499	30501	O	-1	-1	0
difference	PMC3035602	30502	30512	O	-1	-1	0
in	PMC3035602	30513	30515	O	-1	-1	0
mean	PMC3035602	30516	30520	O	-1	-1	0
gestational	PMC3035602	30521	30532	O	-1	-1	0
age	PMC3035602	30533	30536	O	-1	-1	0
.	PMC3035602	30536	30537	O	-1	-1	0

The	PMC3035602	30538	30541	O	-1	-1	0
authors	PMC3035602	30542	30549	O	-1	-1	0
suggested	PMC3035602	30550	30559	O	-1	-1	0
that	PMC3035602	30560	30564	O	-1	-1	0
the	PMC3035602	30565	30568	O	-1	-1	0
differences	PMC3035602	30569	30580	O	-1	-1	0
in	PMC3035602	30581	30583	O	-1	-1	0
birth	PMC3035602	30584	30589	O	-1	-1	0
weight	PMC3035602	30590	30596	O	-1	-1	0
were	PMC3035602	30597	30601	O	-1	-1	0
due	PMC3035602	30602	30605	O	-1	-1	0
to	PMC3035602	30606	30608	O	-1	-1	0
IUGR	PMC3035602	30609	30613	O	-1	-1	0
secondary	PMC3035602	30614	30623	O	-1	-1	0
to	PMC3035602	30624	30626	O	-1	-1	0
the	PMC3035602	30627	30630	O	-1	-1	0
melanoma	PMC3035602	30631	30639	O	-1	-1	0
,	PMC3035602	30639	30640	O	-1	-1	0
its	PMC3035602	30641	30644	O	-1	-1	0
therapies	PMC3035602	30645	30654	O	-1	-1	0
,	PMC3035602	30654	30655	O	-1	-1	0
or	PMC3035602	30656	30658	O	-1	-1	0
its	PMC3035602	30659	30662	O	-1	-1	0
complications	PMC3035602	30663	30676	O	-1	-1	0
.	PMC3035602	30676	30677	O	-1	-1	0

In	PMC3035602	30678	30680	O	-1	-1	0
that	PMC3035602	30681	30685	O	-1	-1	0
study	PMC3035602	30686	30691	O	-1	-1	0
,	PMC3035602	30691	30692	O	-1	-1	0
however	PMC3035602	30693	30700	O	-1	-1	0
,	PMC3035602	30700	30701	O	-1	-1	0
mean	PMC3035602	30702	30706	O	-1	-1	0
birth	PMC3035602	30707	30712	O	-1	-1	0
weights	PMC3035602	30713	30720	O	-1	-1	0
were	PMC3035602	30721	30725	O	-1	-1	0
based	PMC3035602	30726	30731	O	-1	-1	0
on	PMC3035602	30732	30734	O	-1	-1	0
only	PMC3035602	30735	30739	O	-1	-1	0
9	PMC3035602	30740	30741	O	-1	-1	0
melanoma	PMC3035602	30742	30750	O	-1	-1	0
-	PMC3035602	30750	30751	O	-1	-1	0
exposed	PMC3035602	30751	30758	O	-1	-1	0
newborns	PMC3035602	30759	30767	O	-1	-1	0
and	PMC3035602	30768	30771	O	-1	-1	0
9	PMC3035602	30772	30773	O	-1	-1	0
newborns	PMC3035602	30774	30782	O	-1	-1	0
of	PMC3035602	30783	30785	O	-1	-1	0
age	PMC3035602	30786	30789	O	-1	-1	0
-	PMC3035602	30789	30790	O	-1	-1	0
matched	PMC3035602	30790	30797	O	-1	-1	0
comparison	PMC3035602	30798	30808	O	-1	-1	0
mothers	PMC3035602	30809	30816	O	-1	-1	0
.	PMC3035602	30816	30817	O	-1	-1	0

In	PMC3035602	30818	30820	O	-1	-1	0
a	PMC3035602	30821	30822	O	-1	-1	0
population	PMC3035602	30823	30833	O	-1	-1	0
-	PMC3035602	30833	30834	O	-1	-1	0
based	PMC3035602	30834	30839	O	-1	-1	0
cohort	PMC3035602	30840	30846	O	-1	-1	0
study	PMC3035602	30847	30852	O	-1	-1	0
,	PMC3035602	30852	30853	O	-1	-1	0
O’Meara	PMC3035602	30854	30861	O	-1	-1	0
et	PMC3035602	30862	30864	O	-1	-1	0
al	PMC3035602	30865	30867	O	-1	-1	0
identified	PMC3035602	30868	30878	O	-1	-1	0
149	PMC3035602	30879	30882	O	-1	-1	0
women	PMC3035602	30883	30888	O	-1	-1	0
diagnosed	PMC3035602	30889	30898	O	-1	-1	0
with	PMC3035602	30899	30903	O	-1	-1	0
melanoma	PMC3035602	30904	30912	O	-1	-1	0
during	PMC3035602	30913	30919	O	-1	-1	0
pregnancy	PMC3035602	30920	30929	O	-1	-1	0
and	PMC3035602	30930	30933	O	-1	-1	0
263	PMC3035602	30934	30937	O	-1	-1	0
women	PMC3035602	30938	30943	O	-1	-1	0
diagnosed	PMC3035602	30944	30953	O	-1	-1	0
within	PMC3035602	30954	30960	O	-1	-1	0
12	PMC3035602	30961	30963	O	-1	-1	0
months	PMC3035602	30964	30970	O	-1	-1	0

after	PMC3035602	30971	30976	O	-1	-1	0
delivery	PMC3035602	30977	30985	O	-1	-1	0
over	PMC3035602	30986	30990	O	-1	-1	0
a	PMC3035602	30991	30992	O	-1	-1	0
period	PMC3035602	30993	30999	O	-1	-1	0
of	PMC3035602	31000	31002	O	-1	-1	0
9	PMC3035602	31003	31004	O	-1	-1	0
years	PMC3035602	31005	31010	O	-1	-1	0
in	PMC3035602	31011	31013	O	-1	-1	0
California.35	PMC3035602	31014	31027	B-Location	-1	-1	0

That	PMC3035602	31028	31032	O	-1	-1	0
study	PMC3035602	31033	31038	O	-1	-1	0
and	PMC3035602	31039	31042	O	-1	-1	0
the	PMC3035602	31043	31046	O	-1	-1	0
Danish	PMC3035602	31047	31053	O	-1	-1	0
study34	PMC3035602	31054	31061	O	-1	-1	0
were	PMC3035602	31062	31066	O	-1	-1	0
in	PMC3035602	31067	31069	O	-1	-1	0
agreement	PMC3035602	31070	31079	O	-1	-1	0
with	PMC3035602	31080	31084	O	-1	-1	0
respect	PMC3035602	31085	31092	O	-1	-1	0
to	PMC3035602	31093	31095	O	-1	-1	0
the	PMC3035602	31096	31099	O	-1	-1	0
findings	PMC3035602	31100	31108	O	-1	-1	0
of	PMC3035602	31109	31111	O	-1	-1	0
no	PMC3035602	31112	31114	O	-1	-1	0
increased	PMC3035602	31115	31124	O	-1	-1	0
risk	PMC3035602	31125	31129	O	-1	-1	0
of	PMC3035602	31130	31132	O	-1	-1	0
preterm	PMC3035602	31133	31140	O	-1	-1	0
birth	PMC3035602	31141	31146	O	-1	-1	0
or	PMC3035602	31147	31149	O	-1	-1	0
low	PMC3035602	31150	31153	O	-1	-1	0
birth	PMC3035602	31154	31159	O	-1	-1	0
weight	PMC3035602	31160	31166	O	-1	-1	0
among	PMC3035602	31167	31172	O	-1	-1	0
newborns	PMC3035602	31173	31181	O	-1	-1	0
of	PMC3035602	31182	31184	O	-1	-1	0
mothers	PMC3035602	31185	31192	O	-1	-1	0
with	PMC3035602	31193	31197	O	-1	-1	0
melanoma	PMC3035602	31198	31206	O	-1	-1	0
.	PMC3035602	31206	31207	O	-1	-1	0

For	PMC3035602	31208	31211	O	-1	-1	0
women	PMC3035602	31212	31217	O	-1	-1	0
diagnosed	PMC3035602	31218	31227	O	-1	-1	0
during	PMC3035602	31228	31234	O	-1	-1	0
pregnancy	PMC3035602	31235	31244	O	-1	-1	0
,	PMC3035602	31244	31245	O	-1	-1	0
O’Meara	PMC3035602	31246	31253	O	-1	-1	0
and	PMC3035602	31254	31257	O	-1	-1	0
colleagues	PMC3035602	31258	31268	O	-1	-1	0
reported	PMC3035602	31269	31277	O	-1	-1	0
an	PMC3035602	31278	31280	O	-1	-1	0
OR	PMC3035602	31281	31283	O	-1	-1	0
of	PMC3035602	31284	31286	O	-1	-1	0
0.9	PMC3035602	31287	31290	O	-1	-1	0

(	PMC3035602	31291	31292	O	-1	-1	0
95	PMC3035602	31292	31294	O	-1	-1	0
%	PMC3035602	31294	31295	O	-1	-1	0
CI	PMC3035602	31296	31298	O	-1	-1	0
:	PMC3035602	31298	31299	O	-1	-1	0
0.5–1.6	PMC3035602	31300	31307	O	-1	-1	0
)	PMC3035602	31307	31308	O	-1	-1	0
for	PMC3035602	31309	31312	O	-1	-1	0
preterm	PMC3035602	31313	31320	O	-1	-1	0
birth	PMC3035602	31321	31326	O	-1	-1	0
and	PMC3035602	31327	31330	O	-1	-1	0
an	PMC3035602	31331	31333	O	-1	-1	0
OR	PMC3035602	31334	31336	O	-1	-1	0
of	PMC3035602	31337	31339	O	-1	-1	0
0.8	PMC3035602	31340	31343	O	-1	-1	0
(	PMC3035602	31344	31345	O	-1	-1	0
95	PMC3035602	31345	31347	O	-1	-1	0
%	PMC3035602	31347	31348	O	-1	-1	0
CI	PMC3035602	31349	31351	O	-1	-1	0
:	PMC3035602	31351	31352	O	-1	-1	0
0.3–1.8	PMC3035602	31353	31360	O	-1	-1	0
)	PMC3035602	31360	31361	O	-1	-1	0
for	PMC3035602	31362	31365	O	-1	-1	0
LBW	PMC3035602	31366	31369	O	-1	-1	0
,	PMC3035602	31369	31370	O	-1	-1	0


	PMC3035602	31370	31372	O	-1	-1	0

Clinical	PMC3035602	31372	31380	O	-1	-1	0
Epidemiology	PMC3035602	31381	31393	O	-1	-1	0
2011:3	PMC3035602	31394	31400	O	-1	-1	0


	PMC3035602	31400	31402	O	-1	-1	0

Birth	PMC3035602	31402	31407	O	-1	-1	0
outcome	PMC3035602	31408	31415	O	-1	-1	0
in	PMC3035602	31416	31418	O	-1	-1	0
women	PMC3035602	31419	31424	O	-1	-1	0
with	PMC3035602	31425	31429	O	-1	-1	0
cancer	PMC3035602	31430	31436	O	-1	-1	0


	PMC3035602	31436	31438	O	-1	-1	0

adjusted	PMC3035602	31438	31446	O	-1	-1	0
for	PMC3035602	31447	31450	O	-1	-1	0
age	PMC3035602	31451	31454	O	-1	-1	0
and	PMC3035602	31455	31458	O	-1	-1	0
race	PMC3035602	31459	31463	O	-1	-1	0
.	PMC3035602	31463	31464	O	-1	-1	0

They	PMC3035602	31465	31469	O	-1	-1	0
found	PMC3035602	31470	31475	O	-1	-1	0
no	PMC3035602	31476	31478	O	-1	-1	0
fetal	PMC3035602	31479	31484	O	-1	-1	0
deaths	PMC3035602	31485	31491	O	-1	-1	0
in	PMC3035602	31492	31494	O	-1	-1	0
the	PMC3035602	31495	31498	O	-1	-1	0
exposed	PMC3035602	31499	31506	O	-1	-1	0
group	PMC3035602	31507	31512	O	-1	-1	0
and	PMC3035602	31513	31516	O	-1	-1	0
no	PMC3035602	31517	31519	O	-1	-1	0
increased	PMC3035602	31520	31529	O	-1	-1	0
risk	PMC3035602	31530	31534	O	-1	-1	0
of	PMC3035602	31535	31537	O	-1	-1	0
adverse	PMC3035602	31538	31545	O	-1	-1	0
birth	PMC3035602	31546	31551	O	-1	-1	0
outcome	PMC3035602	31552	31559	O	-1	-1	0
in	PMC3035602	31560	31562	O	-1	-1	0
women	PMC3035602	31563	31568	O	-1	-1	0
diagnosed	PMC3035602	31569	31578	O	-1	-1	0
with	PMC3035602	31579	31583	O	-1	-1	0
melanoma	PMC3035602	31584	31592	O	-1	-1	0
in	PMC3035602	31593	31595	O	-1	-1	0
the	PMC3035602	31596	31599	O	-1	-1	0
first	PMC3035602	31600	31605	O	-1	-1	0
post	PMC3035602	31606	31610	O	-1	-1	0
partum	PMC3035602	31611	31617	O	-1	-1	0
year	PMC3035602	31618	31622	O	-1	-1	0
.	PMC3035602	31622	31623	O	-1	-1	0

The	PMC3035602	31624	31627	O	-1	-1	0
study	PMC3035602	31628	31633	O	-1	-1	0
did	PMC3035602	31634	31637	O	-1	-1	0
not	PMC3035602	31638	31641	O	-1	-1	0
examine	PMC3035602	31642	31649	O	-1	-1	0
the	PMC3035602	31650	31653	O	-1	-1	0
risk	PMC3035602	31654	31658	O	-1	-1	0
of	PMC3035602	31659	31661	O	-1	-1	0
congenital	PMC3035602	31662	31672	O	-1	-1	0
abnormalities	PMC3035602	31673	31686	O	-1	-1	0
among	PMC3035602	31687	31692	O	-1	-1	0
newborns	PMC3035602	31693	31701	O	-1	-1	0
.	PMC3035602	31701	31702	O	-1	-1	0

The	PMC3035602	31703	31706	O	-1	-1	0
overall	PMC3035602	31707	31714	O	-1	-1	0
results	PMC3035602	31715	31722	O	-1	-1	0
from	PMC3035602	31723	31727	O	-1	-1	0
these	PMC3035602	31728	31733	O	-1	-1	0
studies	PMC3035602	31734	31741	O	-1	-1	0
show	PMC3035602	31742	31746	O	-1	-1	0
no	PMC3035602	31747	31749	O	-1	-1	0
substantially	PMC3035602	31750	31763	O	-1	-1	0
increased	PMC3035602	31764	31773	O	-1	-1	0
risk	PMC3035602	31774	31778	O	-1	-1	0
of	PMC3035602	31779	31781	O	-1	-1	0
adverse	PMC3035602	31782	31789	O	-1	-1	0
birth	PMC3035602	31790	31795	O	-1	-1	0
outcome	PMC3035602	31796	31803	O	-1	-1	0
for	PMC3035602	31804	31807	O	-1	-1	0
women	PMC3035602	31808	31813	O	-1	-1	0
with	PMC3035602	31814	31818	O	-1	-1	0
melanoma	PMC3035602	31819	31827	O	-1	-1	0
,	PMC3035602	31827	31828	O	-1	-1	0
with	PMC3035602	31829	31833	O	-1	-1	0
the	PMC3035602	31834	31837	O	-1	-1	0
possible	PMC3035602	31838	31846	O	-1	-1	0
exception	PMC3035602	31847	31856	O	-1	-1	0
of	PMC3035602	31857	31859	O	-1	-1	0
an	PMC3035602	31860	31862	O	-1	-1	0
increased	PMC3035602	31863	31872	O	-1	-1	0
risk	PMC3035602	31873	31877	O	-1	-1	0
of	PMC3035602	31878	31880	O	-1	-1	0
stillbirth	PMC3035602	31881	31891	O	-1	-1	0
for	PMC3035602	31892	31895	O	-1	-1	0
newborns	PMC3035602	31896	31904	O	-1	-1	0
of	PMC3035602	31905	31907	O	-1	-1	0
women	PMC3035602	31908	31913	O	-1	-1	0
diagnosed	PMC3035602	31914	31923	O	-1	-1	0
within	PMC3035602	31924	31930	O	-1	-1	0
2	PMC3035602	31931	31932	O	-1	-1	0
years	PMC3035602	31933	31938	O	-1	-1	0
of	PMC3035602	31939	31941	O	-1	-1	0
delivery	PMC3035602	31942	31950	O	-1	-1	0
.	PMC3035602	31950	31951	O	-1	-1	0


	PMC3035602	31951	31953	O	-1	-1	0

Birth	PMC3035602	31953	31958	O	-1	-1	0
outcome	PMC3035602	31959	31966	O	-1	-1	0
in	PMC3035602	31967	31969	O	-1	-1	0
women	PMC3035602	31970	31975	O	-1	-1	0
with	PMC3035602	31976	31980	O	-1	-1	0
Hodgkin	PMC3035602	31981	31988	O	-1	-1	0

’s	PMC3035602	31988	31990	O	-1	-1	0

disease	PMC3035602	31991	31998	O	-1	-1	0

More	PMC3035602	31999	32003	O	-1	-1	0
studies	PMC3035602	32004	32011	O	-1	-1	0
have	PMC3035602	32012	32016	O	-1	-1	0
examined	PMC3035602	32017	32025	O	-1	-1	0
birth	PMC3035602	32026	32031	O	-1	-1	0
outcome	PMC3035602	32032	32039	O	-1	-1	0
in	PMC3035602	32040	32042	O	-1	-1	0
women	PMC3035602	32043	32048	O	-1	-1	0
with	PMC3035602	32049	32053	O	-1	-1	0
previous	PMC3035602	32054	32062	O	-1	-1	0
Hodgkin	PMC3035602	32063	32070	O	-1	-1	0
’s	PMC3035602	32070	32072	O	-1	-1	0
disease	PMC3035602	32073	32080	O	-1	-1	0
.	PMC3035602	32080	32081	O	-1	-1	0

Janov	PMC3035602	32082	32087	O	-1	-1	0
et	PMC3035602	32088	32090	O	-1	-1	0
al	PMC3035602	32091	32093	O	-1	-1	0
did	PMC3035602	32094	32097	O	-1	-1	0
not	PMC3035602	32098	32101	O	-1	-1	0
find	PMC3035602	32102	32106	O	-1	-1	0
any	PMC3035602	32107	32110	O	-1	-1	0
substantial	PMC3035602	32111	32122	O	-1	-1	0
increased	PMC3035602	32123	32132	O	-1	-1	0
risk	PMC3035602	32133	32137	O	-1	-1	0
of	PMC3035602	32138	32140	O	-1	-1	0
LBW	PMC3035602	32141	32144	O	-1	-1	0
and	PMC3035602	32145	32148	O	-1	-1	0
no	PMC3035602	32149	32151	O	-1	-1	0
congenital	PMC3035602	32152	32162	O	-1	-1	0
abnormalities	PMC3035602	32163	32176	O	-1	-1	0
among	PMC3035602	32177	32182	O	-1	-1	0
newborns	PMC3035602	32183	32191	O	-1	-1	0
of	PMC3035602	32192	32194	O	-1	-1	0
15	PMC3035602	32195	32197	O	-1	-1	0
women	PMC3035602	32198	32203	O	-1	-1	0
with	PMC3035602	32204	32208	O	-1	-1	0
prepregnancy	PMC3035602	32209	32221	O	-1	-1	0
Hodgkin	PMC3035602	32222	32229	O	-1	-1	0
’s	PMC3035602	32229	32231	O	-1	-1	0

disease	PMC3035602	32232	32239	O	-1	-1	0
compared	PMC3035602	32240	32248	O	-1	-1	0
with	PMC3035602	32249	32253	O	-1	-1	0
the	PMC3035602	32254	32257	O	-1	-1	0
general	PMC3035602	32258	32265	O	-1	-1	0
population	PMC3035602	32266	32276	O	-1	-1	0
(	PMC3035602	32277	32278	O	-1	-1	0
Table	PMC3035602	32278	32283	O	-1	-1	0
3).37	PMC3035602	32284	32289	O	-1	-1	0

Likewise	PMC3035602	32290	32298	O	-1	-1	0
,	PMC3035602	32298	32299	O	-1	-1	0
Swerdlow	PMC3035602	32300	32308	O	-1	-1	0
et	PMC3035602	32309	32311	O	-1	-1	0
al	PMC3035602	32312	32314	O	-1	-1	0
reported	PMC3035602	32315	32323	O	-1	-1	0
no	PMC3035602	32324	32326	O	-1	-1	0
increased	PMC3035602	32327	32336	O	-1	-1	0
risk	PMC3035602	32337	32341	O	-1	-1	0
of	PMC3035602	32342	32344	O	-1	-1	0
preterm	PMC3035602	32345	32352	O	-1	-1	0
birth	PMC3035602	32353	32358	O	-1	-1	0
,	PMC3035602	32358	32359	O	-1	-1	0
LBW	PMC3035602	32360	32363	O	-1	-1	0
,	PMC3035602	32363	32364	O	-1	-1	0
stillbirth	PMC3035602	32365	32375	O	-1	-1	0
,	PMC3035602	32375	32376	O	-1	-1	0
or	PMC3035602	32377	32379	O	-1	-1	0
congenital	PMC3035602	32380	32390	O	-1	-1	0
abnormalities	PMC3035602	32391	32404	O	-1	-1	0
among	PMC3035602	32405	32410	O	-1	-1	0
49	PMC3035602	32411	32413	O	-1	-1	0
children	PMC3035602	32414	32422	O	-1	-1	0
of	PMC3035602	32423	32425	O	-1	-1	0
16	PMC3035602	32426	32428	O	-1	-1	0
women	PMC3035602	32429	32434	O	-1	-1	0
and	PMC3035602	32435	32438	O	-1	-1	0
11	PMC3035602	32439	32441	O	-1	-1	0
men	PMC3035602	32442	32445	O	-1	-1	0
who	PMC3035602	32446	32449	O	-1	-1	0
had	PMC3035602	32450	32453	O	-1	-1	0
previously	PMC3035602	32454	32464	O	-1	-1	0
been	PMC3035602	32465	32469	O	-1	-1	0
treated	PMC3035602	32470	32477	O	-1	-1	0
for	PMC3035602	32478	32481	O	-1	-1	0
Hodgkin	PMC3035602	32482	32489	O	-1	-1	0
’s	PMC3035602	32489	32491	O	-1	-1	0

disease	PMC3035602	32492	32499	O	-1	-1	0
compared	PMC3035602	32500	32508	O	-1	-1	0
with	PMC3035602	32509	32513	O	-1	-1	0
the	PMC3035602	32514	32517	O	-1	-1	0
general	PMC3035602	32518	32525	O	-1	-1	0
population	PMC3035602	32526	32536	O	-1	-1	0
(	PMC3035602	32537	32538	O	-1	-1	0
Table	PMC3035602	32538	32543	O	-1	-1	0
3).38	PMC3035602	32544	32549	O	-1	-1	0

Another	PMC3035602	32550	32557	O	-1	-1	0
study	PMC3035602	32558	32563	O	-1	-1	0
,	PMC3035602	32563	32564	O	-1	-1	0
which	PMC3035602	32565	32570	O	-1	-1	0
compared	PMC3035602	32571	32579	O	-1	-1	0
52	PMC3035602	32580	32582	O	-1	-1	0
births	PMC3035602	32583	32589	O	-1	-1	0
by	PMC3035602	32590	32592	O	-1	-1	0
29	PMC3035602	32593	32595	O	-1	-1	0
women	PMC3035602	32596	32601	O	-1	-1	0
previously	PMC3035602	32602	32612	O	-1	-1	0
treated	PMC3035602	32613	32620	O	-1	-1	0
for	PMC3035602	32621	32624	O	-1	-1	0
Hodgkin	PMC3035602	32625	32632	O	-1	-1	0
’s	PMC3035602	32632	32634	O	-1	-1	0
disease	PMC3035602	32635	32642	O	-1	-1	0
with	PMC3035602	32643	32647	O	-1	-1	0
births	PMC3035602	32648	32654	O	-1	-1	0
by	PMC3035602	32655	32657	O	-1	-1	0
the	PMC3035602	32658	32661	O	-1	-1	0
women	PMC3035602	32662	32667	O	-1	-1	0
’s	PMC3035602	32667	32669	O	-1	-1	0
siblings	PMC3035602	32670	32678	O	-1	-1	0
,	PMC3035602	32678	32679	O	-1	-1	0
found	PMC3035602	32680	32685	O	-1	-1	0
no	PMC3035602	32686	32688	O	-1	-1	0
overall	PMC3035602	32689	32696	O	-1	-1	0
increased	PMC3035602	32697	32706	O	-1	-1	0
risk	PMC3035602	32707	32711	O	-1	-1	0
of	PMC3035602	32712	32714	O	-1	-1	0
congenital	PMC3035602	32715	32725	O	-1	-1	0
abnormalities	PMC3035602	32726	32739	O	-1	-1	0
and	PMC3035602	32740	32743	O	-1	-1	0
stillbirths	PMC3035602	32744	32755	O	-1	-1	0
combined	PMC3035602	32756	32764	O	-1	-1	0
among	PMC3035602	32765	32770	O	-1	-1	0
children	PMC3035602	32771	32779	O	-1	-1	0
of	PMC3035602	32780	32782	O	-1	-1	0
Hodgkin	PMC3035602	32783	32790	O	-1	-1	0
’s	PMC3035602	32790	32792	O	-1	-1	0
­disease	PMC3035602	32793	32801	O	-1	-1	0
patients	PMC3035602	32802	32810	O	-1	-1	0
.	PMC3035602	32810	32811	O	-1	-1	0

The	PMC3035602	32812	32815	O	-1	-1	0
study	PMC3035602	32816	32821	O	-1	-1	0
also	PMC3035602	32822	32826	O	-1	-1	0
found	PMC3035602	32827	32832	O	-1	-1	0
no	PMC3035602	32833	32835	O	-1	-1	0
association	PMC3035602	32836	32847	O	-1	-1	0
of	PMC3035602	32848	32850	O	-1	-1	0
birth	PMC3035602	32851	32856	O	-1	-1	0
outcome	PMC3035602	32857	32864	O	-1	-1	0
with	PMC3035602	32865	32869	O	-1	-1	0
radiotherapy	PMC3035602	32870	32882	O	-1	-1	0

alone	PMC3035602	32883	32888	O	-1	-1	0
(	PMC3035602	32889	32890	O	-1	-1	0
supra-	PMC3035602	32890	32896	O	-1	-1	0
or	PMC3035602	32897	32899	O	-1	-1	0
infradiaphragmatic	PMC3035602	32900	32918	O	-1	-1	0
)	PMC3035602	32918	32919	O	-1	-1	0
,	PMC3035602	32919	32920	O	-1	-1	0
whereas	PMC3035602	32921	32928	O	-1	-1	0
women	PMC3035602	32929	32934	O	-1	-1	0
treated	PMC3035602	32935	32942	O	-1	-1	0
with	PMC3035602	32943	32947	O	-1	-1	0
both	PMC3035602	32948	32952	O	-1	-1	0
chemotherapy	PMC3035602	32953	32965	O	-1	-1	0
and	PMC3035602	32966	32969	O	-1	-1	0
radiation	PMC3035602	32970	32979	O	-1	-1	0
were	PMC3035602	32980	32984	O	-1	-1	0
more	PMC3035602	32985	32989	O	-1	-1	0
likely	PMC3035602	32990	32996	O	-1	-1	0
to	PMC3035602	32997	32999	O	-1	-1	0
give	PMC3035602	33000	33004	O	-1	-1	0
birth	PMC3035602	33005	33010	O	-1	-1	0
to	PMC3035602	33011	33013	O	-1	-1	0
an	PMC3035602	33014	33016	O	-1	-1	0
abnormal	PMC3035602	33017	33025	O	-1	-1	0
child	PMC3035602	33026	33031	O	-1	-1	0
(	PMC3035602	33032	33033	O	-1	-1	0
P	PMC3035602	33033	33034	O	-1	-1	0
=	PMC3035602	33035	33036	O	-1	-1	0
0.047	PMC3035602	33037	33042	O	-1	-1	0
)	PMC3035602	33042	33043	O	-1	-1	0

(	PMC3035602	33044	33045	O	-1	-1	0
Table	PMC3035602	33045	33050	O	-1	-1	0
3	PMC3035602	33051	33052	O	-1	-1	0
)	PMC3035602	33052	33053	O	-1	-1	0
.	PMC3035602	33053	33054	O	-1	-1	0

The	PMC3035602	33055	33058	O	-1	-1	0
3	PMC3035602	33059	33060	O	-1	-1	0
 	PMC3035602	33060	33061	O	-1	-1	0
­studies	PMC3035602	33061	33069	O	-1	-1	0
,	PMC3035602	33069	33070	O	-1	-1	0
however	PMC3035602	33071	33078	O	-1	-1	0
,	PMC3035602	33078	33079	O	-1	-1	0
were	PMC3035602	33080	33084	O	-1	-1	0
all	PMC3035602	33085	33088	O	-1	-1	0
based	PMC3035602	33089	33094	O	-1	-1	0
on	PMC3035602	33095	33097	O	-1	-1	0
small	PMC3035602	33098	33103	O	-1	-1	0
study	PMC3035602	33104	33109	O	-1	-1	0
populations	PMC3035602	33110	33121	O	-1	-1	0
and	PMC3035602	33122	33125	O	-1	-1	0
did	PMC3035602	33126	33129	O	-1	-1	0
not	PMC3035602	33130	33133	O	-1	-1	0
control	PMC3035602	33134	33141	O	-1	-1	0
for	PMC3035602	33142	33145	O	-1	-1	0
potential	PMC3035602	33146	33155	O	-1	-1	0
confounders	PMC3035602	33156	33167	O	-1	-1	0
.	PMC3035602	33167	33168	O	-1	-1	0

Recently	PMC3035602	33169	33177	O	-1	-1	0
,	PMC3035602	33177	33178	O	-1	-1	0
a	PMC3035602	33179	33180	O	-1	-1	0
large	PMC3035602	33181	33186	O	-1	-1	0
cohort	PMC3035602	33187	33193	O	-1	-1	0
study	PMC3035602	33194	33199	O	-1	-1	0
of	PMC3035602	33200	33202	O	-1	-1	0
female	PMC3035602	33203	33209	O	-1	-1	0
survivors	PMC3035602	33210	33219	O	-1	-1	0
of	PMC3035602	33220	33222	O	-1	-1	0
childhood	PMC3035602	33223	33232	O	-1	-1	0
cancer	PMC3035602	33233	33239	O	-1	-1	0
found	PMC3035602	33240	33245	O	-1	-1	0
that	PMC3035602	33246	33250	O	-1	-1	0
19.2	PMC3035602	33251	33255	O	-1	-1	0
%	PMC3035602	33255	33256	O	-1	-1	0
of	PMC3035602	33257	33259	O	-1	-1	0
337	PMC3035602	33260	33263	O	-1	-1	0
women	PMC3035602	33264	33269	O	-1	-1	0
with	PMC3035602	33270	33274	O	-1	-1	0
childhood	PMC3035602	33275	33284	O	-1	-1	0
Hodgkin	PMC3035602	33285	33292	O	-1	-1	0

’s	PMC3035602	33292	33294	O	-1	-1	0
disease	PMC3035602	33295	33302	O	-1	-1	0
had	PMC3035602	33303	33306	O	-1	-1	0
a	PMC3035602	33307	33308	O	-1	-1	0
preterm	PMC3035602	33309	33316	O	-1	-1	0
birth	PMC3035602	33317	33322	O	-1	-1	0
compared	PMC3035602	33323	33331	O	-1	-1	0
with	PMC3035602	33332	33336	O	-1	-1	0
12.6	PMC3035602	33337	33341	O	-1	-1	0
%	PMC3035602	33341	33342	O	-1	-1	0
among	PMC3035602	33343	33348	O	-1	-1	0
sibling	PMC3035602	33349	33356	O	-1	-1	0
controls	PMC3035602	33357	33365	O	-1	-1	0
(	PMC3035602	33366	33367	O	-1	-1	0
Table	PMC3035602	33367	33372	O	-1	-1	0
3).40	PMC3035602	33373	33378	O	-1	-1	0

Another	PMC3035602	33379	33386	O	-1	-1	0
study	PMC3035602	33387	33392	O	-1	-1	0
reported	PMC3035602	33393	33401	O	-1	-1	0
11	PMC3035602	33402	33404	O	-1	-1	0
stillbirths	PMC3035602	33405	33416	O	-1	-1	0
among	PMC3035602	33417	33422	O	-1	-1	0
729	PMC3035602	33423	33426	O	-1	-1	0
births	PMC3035602	33427	33433	O	-1	-1	0
of	PMC3035602	33434	33436	O	-1	-1	0
female	PMC3035602	33437	33443	O	-1	-1	0
survivors	PMC3035602	33444	33453	O	-1	-1	0
of	PMC3035602	33454	33456	O	-1	-1	0
childhood	PMC3035602	33457	33466	O	-1	-1	0
Hodgkin	PMC3035602	33467	33474	O	-1	-1	0
’s	PMC3035602	33474	33476	O	-1	-1	0
disease	PMC3035602	33477	33484	O	-1	-1	0
,	PMC3035602	33484	33485	O	-1	-1	0
corresponding	PMC3035602	33486	33499	O	-1	-1	0
to	PMC3035602	33500	33502	O	-1	-1	0
a	PMC3035602	33503	33504	O	-1	-1	0
relative	PMC3035602	33505	33513	O	-1	-1	0
risk	PMC3035602	33514	33518	O	-1	-1	0
of	PMC3035602	33519	33521	O	-1	-1	0
1.6	PMC3035602	33522	33525	O	-1	-1	0
(	PMC3035602	33526	33527	O	-1	-1	0
95	PMC3035602	33527	33529	O	-1	-1	0
%	PMC3035602	33529	33530	O	-1	-1	0
CI	PMC3035602	33531	33533	O	-1	-1	0
:	PMC3035602	33533	33534	O	-1	-1	0
0.64–4.03	PMC3035602	33535	33544	O	-1	-1	0
)	PMC3035602	33544	33545	O	-1	-1	0

(	PMC3035602	33546	33547	O	-1	-1	0
Table	PMC3035602	33547	33552	O	-1	-1	0
3).41	PMC3035602	33553	33558	O	-1	-1	0

In	PMC3035602	33559	33561	O	-1	-1	0
contrast	PMC3035602	33562	33570	O	-1	-1	0
,	PMC3035602	33570	33571	O	-1	-1	0
a	PMC3035602	33572	33573	O	-1	-1	0
recent	PMC3035602	33574	33580	O	-1	-1	0
Danish	PMC3035602	33581	33587	O	-1	-1	0
cohort	PMC3035602	33588	33594	O	-1	-1	0
study	PMC3035602	33595	33600	O	-1	-1	0
of	PMC3035602	33601	33603	O	-1	-1	0
birth	PMC3035602	33604	33609	O	-1	-1	0
outcome	PMC3035602	33610	33617	O	-1	-1	0
in	PMC3035602	33618	33620	O	-1	-1	0
women	PMC3035602	33621	33626	O	-1	-1	0
with	PMC3035602	33627	33631	O	-1	-1	0
previous	PMC3035602	33632	33640	O	-1	-1	0
Hodgkin	PMC3035602	33641	33648	O	-1	-1	0

’s	PMC3035602	33648	33650	O	-1	-1	0
disease	PMC3035602	33651	33658	O	-1	-1	0
found	PMC3035602	33659	33664	O	-1	-1	0
no	PMC3035602	33665	33667	O	-1	-1	0
increased	PMC3035602	33668	33677	O	-1	-1	0
risk	PMC3035602	33678	33682	O	-1	-1	0
of	PMC3035602	33683	33685	O	-1	-1	0
preterm	PMC3035602	33686	33693	O	-1	-1	0
birth	PMC3035602	33694	33699	O	-1	-1	0
and	PMC3035602	33700	33703	O	-1	-1	0
only	PMC3035602	33704	33708	O	-1	-1	0
1	PMC3035602	33709	33710	O	-1	-1	0
stillbirth	PMC3035602	33711	33721	O	-1	-1	0
among	PMC3035602	33722	33727	O	-1	-1	0
192	PMC3035602	33728	33731	O	-1	-1	0
women	PMC3035602	33732	33737	O	-1	-1	0
,	PMC3035602	33737	33738	O	-1	-1	0
of	PMC3035602	33739	33741	O	-1	-1	0

whom	PMC3035602	33742	33746	O	-1	-1	0
more	PMC3035602	33747	33751	O	-1	-1	0
than	PMC3035602	33752	33756	O	-1	-1	0
75	PMC3035602	33757	33759	O	-1	-1	0
%	PMC3035602	33759	33760	O	-1	-1	0
had	PMC3035602	33761	33764	O	-1	-1	0
been	PMC3035602	33765	33769	O	-1	-1	0
diagnosed	PMC3035602	33770	33779	O	-1	-1	0
with	PMC3035602	33780	33784	O	-1	-1	0
­Hodgkin	PMC3035602	33785	33793	O	-1	-1	0

’s	PMC3035602	33793	33795	O	-1	-1	0

disease	PMC3035602	33796	33803	O	-1	-1	0
in	PMC3035602	33804	33806	O	-1	-1	0
adulthood	PMC3035602	33807	33816	O	-1	-1	0
(	PMC3035602	33817	33818	O	-1	-1	0
$	PMC3035602	33818	33819	O	-1	-1	0
20	PMC3035602	33819	33821	O	-1	-1	0
years	PMC3035602	33822	33827	O	-1	-1	0
of	PMC3035602	33828	33830	O	-1	-1	0
age	PMC3035602	33831	33834	O	-1	-1	0
at	PMC3035602	33835	33837	O	-1	-1	0
diagnosis	PMC3035602	33838	33847	O	-1	-1	0
)	PMC3035602	33847	33848	O	-1	-1	0

(	PMC3035602	33849	33850	O	-1	-1	0
Table	PMC3035602	33850	33855	O	-1	-1	0
3).42	PMC3035602	33856	33861	O	-1	-1	0

The	PMC3035602	33862	33865	O	-1	-1	0
results	PMC3035602	33866	33873	O	-1	-1	0
from	PMC3035602	33874	33878	O	-1	-1	0
the	PMC3035602	33879	33882	O	-1	-1	0
Danish	PMC3035602	33883	33889	O	-1	-1	0
study	PMC3035602	33890	33895	O	-1	-1	0
,	PMC3035602	33895	33896	O	-1	-1	0
however	PMC3035602	33897	33904	O	-1	-1	0
,	PMC3035602	33904	33905	O	-1	-1	0
indicated	PMC3035602	33906	33915	O	-1	-1	0
a	PMC3035602	33916	33917	O	-1	-1	0
slightly	PMC3035602	33918	33926	O	-1	-1	0
increased	PMC3035602	33927	33936	O	-1	-1	0
risk	PMC3035602	33937	33941	O	-1	-1	0
of	PMC3035602	33942	33944	O	-1	-1	0
congenital	PMC3035602	33945	33955	O	-1	-1	0
abnormalities	PMC3035602	33956	33969	O	-1	-1	0
among	PMC3035602	33970	33975	O	-1	-1	0
newborns	PMC3035602	33976	33984	O	-1	-1	0
of	PMC3035602	33985	33987	O	-1	-1	0
women	PMC3035602	33988	33993	O	-1	-1	0
with	PMC3035602	33994	33998	O	-1	-1	0
previous	PMC3035602	33999	34007	O	-1	-1	0
Hodgkin	PMC3035602	34008	34015	O	-1	-1	0
’s	PMC3035602	34015	34017	O	-1	-1	0


	PMC3035602	34017	34019	O	-1	-1	0

submit	PMC3035602	34019	34025	O	-1	-1	0
your	PMC3035602	34026	34030	O	-1	-1	0
manuscript	PMC3035602	34031	34041	O	-1	-1	0

|	PMC3035602	34042	34043	O	-1	-1	0

www.dovepress.com	PMC3035602	34044	34061	O	-1	-1	0


	PMC3035602	34061	34063	O	-1	-1	0

Dovepress	PMC3035602	34063	34072	O	-1	-1	0


	PMC3035602	34072	34074	O	-1	-1	0
15	PMC3035602	34074	34076	O	-1	-1	0


	PMC3035602	34076	34078	O	-1	-1	0

Langagergaard	PMC3035602	34078	34091	O	-1	-1	0


	PMC3035602	34091	34093	O	-1	-1	0
disease	PMC3035602	34093	34100	O	-1	-1	0
(	PMC3035602	34101	34102	O	-1	-1	0
POR	PMC3035602	34102	34105	O	-1	-1	0
=	PMC3035602	34106	34107	O	-1	-1	0
1.7	PMC3035602	34108	34111	O	-1	-1	0
;	PMC3035602	34111	34112	O	-1	-1	0
95	PMC3035602	34113	34115	O	-1	-1	0
%	PMC3035602	34115	34116	O	-1	-1	0
CI	PMC3035602	34117	34119	O	-1	-1	0
:	PMC3035602	34119	34120	O	-1	-1	0
0.9–3.1	PMC3035602	34121	34128	O	-1	-1	0
)	PMC3035602	34128	34129	O	-1	-1	0
.	PMC3035602	34129	34130	O	-1	-1	0

Furthermore	PMC3035602	34131	34142	O	-1	-1	0
,	PMC3035602	34142	34143	O	-1	-1	0
it	PMC3035602	34144	34146	O	-1	-1	0
was	PMC3035602	34147	34150	O	-1	-1	0
reported	PMC3035602	34151	34159	O	-1	-1	0
,	PMC3035602	34159	34160	O	-1	-1	0
that	PMC3035602	34161	34165	O	-1	-1	0
the	PMC3035602	34166	34169	O	-1	-1	0
POR	PMC3035602	34170	34173	O	-1	-1	0
for	PMC3035602	34174	34177	O	-1	-1	0
congenital	PMC3035602	34178	34188	O	-1	-1	0
abnormalities	PMC3035602	34189	34202	O	-1	-1	0
increased	PMC3035602	34203	34212	O	-1	-1	0
with	PMC3035602	34213	34217	O	-1	-1	0
calendar	PMC3035602	34218	34226	O	-1	-1	0
time	PMC3035602	34227	34231	O	-1	-1	0
of	PMC3035602	34232	34234	O	-1	-1	0
Hodgkin	PMC3035602	34235	34242	O	-1	-1	0

’s	PMC3035602	34242	34244	O	-1	-1	0
disease	PMC3035602	34245	34252	O	-1	-1	0
diagnosis	PMC3035602	34253	34262	O	-1	-1	0
(	PMC3035602	34263	34264	O	-1	-1	0

ie	PMC3035602	34264	34266	O	-1	-1	0
,	PMC3035602	34266	34267	O	-1	-1	0
for	PMC3035602	34268	34271	O	-1	-1	0
1991–2000	PMC3035602	34272	34281	O	-1	-1	0
the	PMC3035602	34282	34285	O	-1	-1	0
POR	PMC3035602	34286	34289	O	-1	-1	0
was	PMC3035602	34290	34293	O	-1	-1	0
3.1	PMC3035602	34294	34297	O	-1	-1	0
(	PMC3035602	34298	34299	O	-1	-1	0
95	PMC3035602	34299	34301	O	-1	-1	0
%	PMC3035602	34301	34302	O	-1	-1	0
CI	PMC3035602	34303	34305	O	-1	-1	0
:	PMC3035602	34305	34306	O	-1	-1	0

1.4–6.9	PMC3035602	34307	34314	O	-1	-1	0
)	PMC3035602	34314	34315	O	-1	-1	0
compared	PMC3035602	34316	34324	O	-1	-1	0
with	PMC3035602	34325	34329	O	-1	-1	0
POR	PMC3035602	34330	34333	O	-1	-1	0
=	PMC3035602	34334	34335	O	-1	-1	0
1.0	PMC3035602	34336	34339	O	-1	-1	0

(	PMC3035602	34340	34341	O	-1	-1	0
reference	PMC3035602	34341	34350	O	-1	-1	0
)	PMC3035602	34350	34351	O	-1	-1	0
for	PMC3035602	34352	34355	O	-1	-1	0
1970–1980).42	PMC3035602	34356	34369	O	-1	-1	0

The	PMC3035602	34370	34373	O	-1	-1	0
Danish	PMC3035602	34374	34380	O	-1	-1	0
study	PMC3035602	34381	34386	O	-1	-1	0
also	PMC3035602	34387	34391	O	-1	-1	0
reported	PMC3035602	34392	34400	O	-1	-1	0
increased	PMC3035602	34401	34410	O	-1	-1	0
risk	PMC3035602	34411	34415	O	-1	-1	0
estimates	PMC3035602	34416	34425	O	-1	-1	0
for	PMC3035602	34426	34429	O	-1	-1	0
congenital	PMC3035602	34430	34440	O	-1	-1	0
abnormalities	PMC3035602	34441	34454	O	-1	-1	0
among	PMC3035602	34455	34460	O	-1	-1	0
newborns	PMC3035602	34461	34469	O	-1	-1	0
of	PMC3035602	34470	34472	O	-1	-1	0
women	PMC3035602	34473	34478	O	-1	-1	0
who	PMC3035602	34479	34482	O	-1	-1	0
were	PMC3035602	34483	34487	O	-1	-1	0
diagnosed	PMC3035602	34488	34497	O	-1	-1	0
with	PMC3035602	34498	34502	O	-1	-1	0
Hodgkin	PMC3035602	34503	34510	O	-1	-1	0
’s	PMC3035602	34510	34512	O	-1	-1	0
disease	PMC3035602	34513	34520	O	-1	-1	0
during	PMC3035602	34521	34527	O	-1	-1	0
or	PMC3035602	34528	34530	O	-1	-1	0
shortly	PMC3035602	34531	34538	O	-1	-1	0
after	PMC3035602	34539	34544	O	-1	-1	0
pregnancy	PMC3035602	34545	34554	O	-1	-1	0
,	PMC3035602	34554	34555	O	-1	-1	0
but	PMC3035602	34556	34559	O	-1	-1	0
these	PMC3035602	34560	34565	O	-1	-1	0
estimates	PMC3035602	34566	34575	O	-1	-1	0
were	PMC3035602	34576	34580	O	-1	-1	0
based	PMC3035602	34581	34586	O	-1	-1	0
on	PMC3035602	34587	34589	O	-1	-1	0
few	PMC3035602	34590	34593	O	-1	-1	0
outcomes	PMC3035602	34594	34602	O	-1	-1	0
and	PMC3035602	34603	34606	O	-1	-1	0
were	PMC3035602	34607	34611	O	-1	-1	0
therefore	PMC3035602	34612	34621	O	-1	-1	0
imprecise	PMC3035602	34622	34631	O	-1	-1	0
.	PMC3035602	34631	34632	O	-1	-1	0

However	PMC3035602	34633	34640	O	-1	-1	0
,	PMC3035602	34640	34641	O	-1	-1	0
it	PMC3035602	34642	34644	O	-1	-1	0
is	PMC3035602	34645	34647	O	-1	-1	0
important	PMC3035602	34648	34657	O	-1	-1	0
to	PMC3035602	34658	34660	O	-1	-1	0
emphasize	PMC3035602	34661	34670	O	-1	-1	0
that	PMC3035602	34671	34675	O	-1	-1	0
teratogens	PMC3035602	34676	34686	O	-1	-1	0
increase	PMC3035602	34687	34695	O	-1	-1	0
the	PMC3035602	34696	34699	O	-1	-1	0
rate	PMC3035602	34700	34704	O	-1	-1	0
of	PMC3035602	34705	34707	O	-1	-1	0
specific	PMC3035602	34708	34716	O	-1	-1	0
,	PMC3035602	34716	34717	O	-1	-1	0
rather	PMC3035602	34718	34724	O	-1	-1	0
than	PMC3035602	34725	34729	O	-1	-1	0
all	PMC3035602	34730	34733	O	-1	-1	0
abnormalities	PMC3035602	34734	34747	O	-1	-1	0
,	PMC3035602	34747	34748	O	-1	-1	0
and	PMC3035602	34749	34752	O	-1	-1	0
the	PMC3035602	34753	34756	O	-1	-1	0
study	PMC3035602	34757	34762	O	-1	-1	0
was	PMC3035602	34763	34766	O	-1	-1	0
unable	PMC3035602	34767	34773	O	-1	-1	0
to	PMC3035602	34774	34776	O	-1	-1	0
evaluate	PMC3035602	34777	34785	O	-1	-1	0
those	PMC3035602	34786	34791	O	-1	-1	0
.	PMC3035602	34791	34792	O	-1	-1	0

Two	PMC3035602	34793	34796	O	-1	-1	0
studies	PMC3035602	34797	34804	O	-1	-1	0
reported	PMC3035602	34805	34813	O	-1	-1	0
an	PMC3035602	34814	34816	O	-1	-1	0
increased	PMC3035602	34817	34826	O	-1	-1	0
risk	PMC3035602	34827	34831	O	-1	-1	0
of	PMC3035602	34832	34834	O	-1	-1	0
preterm	PMC3035602	34835	34842	O	-1	-1	0
birth	PMC3035602	34843	34848	O	-1	-1	0
for	PMC3035602	34849	34852	O	-1	-1	0
women	PMC3035602	34853	34858	O	-1	-1	0
diagnosed	PMC3035602	34859	34868	O	-1	-1	0
with	PMC3035602	34869	34873	O	-1	-1	0
Hodgkin	PMC3035602	34874	34881	O	-1	-1	0
’s	PMC3035602	34881	34883	O	-1	-1	0
disease	PMC3035602	34884	34891	O	-1	-1	0
during	PMC3035602	34892	34898	O	-1	-1	0
pregnancy	PMC3035602	34899	34908	O	-1	-1	0
,	PMC3035602	34908	34909	O	-1	-1	0
which	PMC3035602	34910	34915	O	-1	-1	0
reflected	PMC3035602	34916	34925	O	-1	-1	0
a	PMC3035602	34926	34927	O	-1	-1	0
higher	PMC3035602	34928	34934	O	-1	-1	0
rate	PMC3035602	34935	34939	O	-1	-1	0
of	PMC3035602	34940	34942	O	-1	-1	0
elective	PMC3035602	34943	34951	O	-1	-1	0
early	PMC3035602	34952	34957	O	-1	-1	0
delivery	PMC3035602	34958	34966	O	-1	-1	0
(	PMC3035602	34967	34968	O	-1	-1	0
Table	PMC3035602	34968	34973	O	-1	-1	0
3).18,42	PMC3035602	34974	34982	O	-1	-1	0

In	PMC3035602	34983	34985	O	-1	-1	0
contrast	PMC3035602	34986	34994	O	-1	-1	0
,	PMC3035602	34994	34995	O	-1	-1	0
a	PMC3035602	34996	34997	O	-1	-1	0
historical	PMC3035602	34998	35008	O	-1	-1	0
cohort	PMC3035602	35009	35015	O	-1	-1	0
study	PMC3035602	35016	35021	O	-1	-1	0
by	PMC3035602	35022	35024	O	-1	-1	0
Lishner	PMC3035602	35025	35032	O	-1	-1	0
et	PMC3035602	35033	35035	O	-1	-1	0
al	PMC3035602	35036	35038	O	-1	-1	0
which	PMC3035602	35039	35044	O	-1	-1	0
included	PMC3035602	35045	35053	O	-1	-1	0
40	PMC3035602	35054	35056	O	-1	-1	0
births	PMC3035602	35057	35063	O	-1	-1	0
by	PMC3035602	35064	35066	O	-1	-1	0
women	PMC3035602	35067	35072	O	-1	-1	0
who	PMC3035602	35073	35076	O	-1	-1	0
were	PMC3035602	35077	35081	O	-1	-1	0
pregnant	PMC3035602	35082	35090	O	-1	-1	0
between	PMC3035602	35091	35098	O	-1	-1	0
9	PMC3035602	35099	35100	O	-1	-1	0
months	PMC3035602	35101	35107	O	-1	-1	0
before	PMC3035602	35108	35114	O	-1	-1	0
and	PMC3035602	35115	35118	O	-1	-1	0
3	PMC3035602	35119	35120	O	-1	-1	0
months	PMC3035602	35121	35127	O	-1	-1	0
after	PMC3035602	35128	35133	O	-1	-1	0
their	PMC3035602	35134	35139	O	-1	-1	0
first	PMC3035602	35140	35145	O	-1	-1	0
treatment	PMC3035602	35146	35155	O	-1	-1	0
for	PMC3035602	35156	35159	O	-1	-1	0
Hodgkin	PMC3035602	35160	35167	O	-1	-1	0
’s	PMC3035602	35167	35169	O	-1	-1	0
disease	PMC3035602	35170	35177	O	-1	-1	0
,	PMC3035602	35177	35178	O	-1	-1	0
reported	PMC3035602	35179	35187	O	-1	-1	0
no	PMC3035602	35188	35190	O	-1	-1	0
increased	PMC3035602	35191	35200	O	-1	-1	0
risk	PMC3035602	35201	35205	O	-1	-1	0
of	PMC3035602	35206	35208	O	-1	-1	0
preterm	PMC3035602	35209	35216	O	-1	-1	0
birth	PMC3035602	35217	35222	O	-1	-1	0
or	PMC3035602	35223	35225	O	-1	-1	0
induced	PMC3035602	35226	35233	O	-1	-1	0
deliveries	PMC3035602	35234	35244	O	-1	-1	0
(	PMC3035602	35245	35246	O	-1	-1	0

Table	PMC3035602	35246	35251	O	-1	-1	0
3).19	PMC3035602	35252	35257	O	-1	-1	0

Furthermore	PMC3035602	35258	35269	O	-1	-1	0
,	PMC3035602	35269	35270	O	-1	-1	0
the	PMC3035602	35271	35274	O	-1	-1	0
study	PMC3035602	35275	35280	O	-1	-1	0
indicated	PMC3035602	35281	35290	O	-1	-1	0
no	PMC3035602	35291	35293	O	-1	-1	0
difference	PMC3035602	35294	35304	O	-1	-1	0
in	PMC3035602	35305	35307	O	-1	-1	0
mean	PMC3035602	35308	35312	O	-1	-1	0
birth	PMC3035602	35313	35318	O	-1	-1	0
weight	PMC3035602	35319	35325	O	-1	-1	0
compared	PMC3035602	35326	35334	O	-1	-1	0
with	PMC3035602	35335	35339	O	-1	-1	0
controls	PMC3035602	35340	35348	O	-1	-1	0
,	PMC3035602	35348	35349	O	-1	-1	0
while	PMC3035602	35350	35355	O	-1	-1	0
the	PMC3035602	35356	35359	O	-1	-1	0
proportion	PMC3035602	35360	35370	O	-1	-1	0
of	PMC3035602	35371	35373	O	-1	-1	0
stillbirths	PMC3035602	35374	35385	O	-1	-1	0
was	PMC3035602	35386	35389	O	-1	-1	0
not	PMC3035602	35390	35393	O	-1	-1	0
statistically	PMC3035602	35394	35407	O	-1	-1	0
different	PMC3035602	35408	35417	O	-1	-1	0
from	PMC3035602	35418	35422	O	-1	-1	0
that	PMC3035602	35423	35427	O	-1	-1	0
of	PMC3035602	35428	35430	O	-1	-1	0
the	PMC3035602	35431	35434	O	-1	-1	0
general	PMC3035602	35435	35442	O	-1	-1	0
population	PMC3035602	35443	35453	O	-1	-1	0
.	PMC3035602	35453	35454	O	-1	-1	0

The	PMC3035602	35455	35458	O	-1	-1	0
study	PMC3035602	35459	35464	O	-1	-1	0
reported	PMC3035602	35465	35473	O	-1	-1	0
1	PMC3035602	35474	35475	O	-1	-1	0
child	PMC3035602	35476	35481	O	-1	-1	0
with	PMC3035602	35482	35486	O	-1	-1	0
a	PMC3035602	35487	35488	O	-1	-1	0
congenital	PMC3035602	35489	35499	O	-1	-1	0
abnormality	PMC3035602	35500	35511	O	-1	-1	0
born	PMC3035602	35512	35516	O	-1	-1	0
to	PMC3035602	35517	35519	O	-1	-1	0
the	PMC3035602	35520	35523	O	-1	-1	0
only	PMC3035602	35524	35528	O	-1	-1	0
patient	PMC3035602	35529	35536	O	-1	-1	0
treated	PMC3035602	35537	35544	O	-1	-1	0
with	PMC3035602	35545	35549	O	-1	-1	0
chemotherapy	PMC3035602	35550	35562	O	-1	-1	0
in	PMC3035602	35563	35565	O	-1	-1	0
the	PMC3035602	35566	35569	O	-1	-1	0
first	PMC3035602	35570	35575	O	-1	-1	0
trimester	PMC3035602	35576	35585	O	-1	-1	0
.	PMC3035602	35585	35586	O	-1	-1	0

There	PMC3035602	35587	35592	O	-1	-1	0
was	PMC3035602	35593	35596	O	-1	-1	0
no	PMC3035602	35597	35599	O	-1	-1	0
evidence	PMC3035602	35600	35608	O	-1	-1	0
of	PMC3035602	35609	35611	O	-1	-1	0
any	PMC3035602	35612	35615	O	-1	-1	0
substantial	PMC3035602	35616	35627	O	-1	-1	0
decrease	PMC3035602	35628	35636	O	-1	-1	0
in	PMC3035602	35637	35639	O	-1	-1	0
the	PMC3035602	35640	35643	O	-1	-1	0
male	PMC3035602	35644	35648	O	-1	-1	0
proportion	PMC3035602	35649	35659	O	-1	-1	0
of	PMC3035602	35660	35662	O	-1	-1	0
newborns	PMC3035602	35663	35671	O	-1	-1	0
among	PMC3035602	35672	35677	O	-1	-1	0
women	PMC3035602	35678	35683	O	-1	-1	0
diagnosed	PMC3035602	35684	35693	O	-1	-1	0
with	PMC3035602	35694	35698	O	-1	-1	0
Hodgkin	PMC3035602	35699	35706	O	-1	-1	0

’s	PMC3035602	35706	35708	O	-1	-1	0
disease	PMC3035602	35709	35716	O	-1	-1	0
before	PMC3035602	35717	35723	O	-1	-1	0
pregnancy	PMC3035602	35724	35733	O	-1	-1	0
,	PMC3035602	35733	35734	O	-1	-1	0
indicating	PMC3035602	35735	35745	O	-1	-1	0
that	PMC3035602	35746	35750	O	-1	-1	0
earlier	PMC3035602	35751	35758	O	-1	-1	0
treatment	PMC3035602	35759	35768	O	-1	-1	0
for	PMC3035602	35769	35772	O	-1	-1	0
Hodgkin	PMC3035602	35773	35780	O	-1	-1	0

’s	PMC3035602	35780	35782	O	-1	-1	0

disease	PMC3035602	35783	35790	O	-1	-1	0
is	PMC3035602	35791	35793	O	-1	-1	0
not	PMC3035602	35794	35797	O	-1	-1	0
a	PMC3035602	35798	35799	O	-1	-1	0
risk	PMC3035602	35800	35804	O	-1	-1	0
factor	PMC3035602	35805	35811	O	-1	-1	0
for	PMC3035602	35812	35815	O	-1	-1	0
early	PMC3035602	35816	35821	O	-1	-1	0
male	PMC3035602	35822	35826	O	-1	-1	0
abortion.42	PMC3035602	35827	35838	O	-1	-1	0

For	PMC3035602	35839	35842	O	-1	-1	0
newborns	PMC3035602	35843	35851	O	-1	-1	0
of	PMC3035602	35852	35854	O	-1	-1	0
women	PMC3035602	35855	35860	O	-1	-1	0
diagnosed	PMC3035602	35861	35870	O	-1	-1	0
with	PMC3035602	35871	35875	O	-1	-1	0
Hodgkin	PMC3035602	35876	35883	O	-1	-1	0
’s	PMC3035602	35883	35885	O	-1	-1	0
disease	PMC3035602	35886	35893	O	-1	-1	0
during	PMC3035602	35894	35900	O	-1	-1	0
pregnancy	PMC3035602	35901	35910	O	-1	-1	0
,	PMC3035602	35910	35911	O	-1	-1	0
there	PMC3035602	35912	35917	O	-1	-1	0
was	PMC3035602	35918	35921	O	-1	-1	0
an	PMC3035602	35922	35924	O	-1	-1	0
increase	PMC3035602	35925	35933	O	-1	-1	0
in	PMC3035602	35934	35936	O	-1	-1	0
the	PMC3035602	35937	35940	O	-1	-1	0
male	PMC3035602	35941	35945	O	-1	-1	0
proportion	PMC3035602	35946	35956	O	-1	-1	0
,	PMC3035602	35956	35957	O	-1	-1	0
compared	PMC3035602	35958	35966	O	-1	-1	0
with	PMC3035602	35967	35971	O	-1	-1	0
newborns	PMC3035602	35972	35980	O	-1	-1	0
of	PMC3035602	35981	35983	O	-1	-1	0
comparison	PMC3035602	35984	35994	O	-1	-1	0
mothers	PMC3035602	35995	36002	O	-1	-1	0
,	PMC3035602	36002	36003	O	-1	-1	0
which	PMC3035602	36004	36009	O	-1	-1	0
was	PMC3035602	36010	36013	O	-1	-1	0
surprising	PMC3035602	36014	36024	O	-1	-1	0
and	PMC3035602	36025	36028	O	-1	-1	0
could	PMC3035602	36029	36034	O	-1	-1	0
have	PMC3035602	36035	36039	O	-1	-1	0
been	PMC3035602	36040	36044	O	-1	-1	0
a	PMC3035602	36045	36046	O	-1	-1	0
chance	PMC3035602	36047	36053	O	-1	-1	0

finding.42	PMC3035602	36054	36064	O	-1	-1	0

In	PMC3035602	36065	36067	O	-1	-1	0
conclusion	PMC3035602	36068	36078	O	-1	-1	0
,	PMC3035602	36078	36079	O	-1	-1	0
the	PMC3035602	36080	36083	O	-1	-1	0
overall	PMC3035602	36084	36091	O	-1	-1	0
results	PMC3035602	36092	36099	O	-1	-1	0
are	PMC3035602	36100	36103	O	-1	-1	0
reassuring	PMC3035602	36104	36114	O	-1	-1	0
regarding	PMC3035602	36115	36124	O	-1	-1	0
the	PMC3035602	36125	36128	O	-1	-1	0
risks	PMC3035602	36129	36134	O	-1	-1	0
of	PMC3035602	36135	36137	O	-1	-1	0
adverse	PMC3035602	36138	36145	O	-1	-1	0
birth	PMC3035602	36146	36151	O	-1	-1	0
outcome	PMC3035602	36152	36159	O	-1	-1	0
for	PMC3035602	36160	36163	O	-1	-1	0
women	PMC3035602	36164	36169	O	-1	-1	0
with	PMC3035602	36170	36174	O	-1	-1	0
Hodgkin	PMC3035602	36175	36182	O	-1	-1	0
’s	PMC3035602	36182	36184	O	-1	-1	0
disease	PMC3035602	36185	36192	O	-1	-1	0
,	PMC3035602	36192	36193	O	-1	-1	0
although	PMC3035602	36194	36202	O	-1	-1	0
the	PMC3035602	36203	36206	O	-1	-1	0
possibility	PMC3035602	36207	36218	O	-1	-1	0
of	PMC3035602	36219	36221	O	-1	-1	0
an	PMC3035602	36222	36224	O	-1	-1	0
increased	PMC3035602	36225	36234	O	-1	-1	0
risk	PMC3035602	36235	36239	O	-1	-1	0
of	PMC3035602	36240	36242	O	-1	-1	0
congenital	PMC3035602	36243	36253	O	-1	-1	0
abnormalities	PMC3035602	36254	36267	O	-1	-1	0
in	PMC3035602	36268	36270	O	-1	-1	0
newborns	PMC3035602	36271	36279	O	-1	-1	0
of	PMC3035602	36280	36282	O	-1	-1	0
women	PMC3035602	36283	36288	O	-1	-1	0
diagnosed	PMC3035602	36289	36298	O	-1	-1	0
with	PMC3035602	36299	36303	O	-1	-1	0
Hodgkin	PMC3035602	36304	36311	O	-1	-1	0
’s	PMC3035602	36311	36313	O	-1	-1	0
disease	PMC3035602	36314	36321	O	-1	-1	0
before	PMC3035602	36322	36328	O	-1	-1	0
pregnancy	PMC3035602	36329	36338	O	-1	-1	0
can	PMC3035602	36339	36342	O	-1	-1	0
not	PMC3035602	36342	36345	O	-1	-1	0
be	PMC3035602	36346	36348	O	-1	-1	0
ruled	PMC3035602	36349	36354	O	-1	-1	0
out	PMC3035602	36355	36358	O	-1	-1	0
.	PMC3035602	36358	36359	O	-1	-1	0


	PMC3035602	36359	36361	O	-1	-1	0

Discussion	PMC3035602	36361	36371	O	-1	-1	0

Possible	PMC3035602	36372	36380	O	-1	-1	0
adverse	PMC3035602	36381	36388	O	-1	-1	0
effects	PMC3035602	36389	36396	O	-1	-1	0
of	PMC3035602	36397	36399	O	-1	-1	0
cancer	PMC3035602	36400	36406	O	-1	-1	0
and	PMC3035602	36407	36410	O	-1	-1	0
cancer	PMC3035602	36411	36417	O	-1	-1	0
therapy	PMC3035602	36418	36425	O	-1	-1	0
on	PMC3035602	36426	36428	O	-1	-1	0

birth	PMC3035602	36429	36434	O	-1	-1	0
outcome	PMC3035602	36435	36442	O	-1	-1	0

When	PMC3035602	36443	36447	O	-1	-1	0
cancer	PMC3035602	36448	36454	O	-1	-1	0
is	PMC3035602	36455	36457	O	-1	-1	0
diagnosed	PMC3035602	36458	36467	O	-1	-1	0
in	PMC3035602	36468	36470	O	-1	-1	0
pregnancy	PMC3035602	36471	36480	O	-1	-1	0
,	PMC3035602	36480	36481	O	-1	-1	0
there	PMC3035602	36482	36487	O	-1	-1	0
is	PMC3035602	36488	36490	O	-1	-1	0
often	PMC3035602	36491	36496	O	-1	-1	0
a	PMC3035602	36497	36498	O	-1	-1	0
­conflict	PMC3035602	36499	36508	O	-1	-1	0
between	PMC3035602	36509	36516	O	-1	-1	0
optimal	PMC3035602	36517	36524	O	-1	-1	0
maternal	PMC3035602	36525	36533	O	-1	-1	0
therapy	PMC3035602	36534	36541	O	-1	-1	0
and	PMC3035602	36542	36545	O	-1	-1	0
fetal	PMC3035602	36546	36551	O	-1	-1	0


	PMC3035602	36551	36553	O	-1	-1	0
16	PMC3035602	36553	36555	O	-1	-1	0


	PMC3035602	36555	36557	O	-1	-1	0
submit	PMC3035602	36557	36563	O	-1	-1	0
your	PMC3035602	36564	36568	O	-1	-1	0
manuscript	PMC3035602	36569	36579	O	-1	-1	0
|	PMC3035602	36580	36581	O	-1	-1	0

www.dovepress.com	PMC3035602	36582	36599	O	-1	-1	0


	PMC3035602	36599	36601	O	-1	-1	0

Dovepress	PMC3035602	36601	36610	O	-1	-1	0


	PMC3035602	36610	36612	O	-1	-1	0

Dovepress	PMC3035602	36612	36621	O	-1	-1	0


	PMC3035602	36621	36623	O	-1	-1	0

­	PMC3035602	36623	36624	O	-1	-1	0

ell	PMC3035602	36625	36628	O	-1	-1	0
-	PMC3035602	36628	36629	O	-1	-1	0

being.5	PMC3035602	36629	36636	O	-1	-1	0

The	PMC3035602	36637	36640	O	-1	-1	0
benefit	PMC3035602	36641	36648	O	-1	-1	0
of	PMC3035602	36649	36651	O	-1	-1	0
the	PMC3035602	36652	36655	O	-1	-1	0
diagnostic	PMC3035602	36656	36666	O	-1	-1	0
work	PMC3035602	36667	36671	O	-1	-1	0
-	PMC3035602	36671	36672	O	-1	-1	0
up	PMC3035602	36672	36674	O	-1	-1	0
,	PMC3035602	36674	36675	O	-1	-1	0
surgery	PMC3035602	36676	36683	O	-1	-1	0
,	PMC3035602	36683	36684	O	-1	-1	0

w	PMC3035602	36685	36686	O	-1	-1	0

radiotherapy	PMC3035602	36687	36699	O	-1	-1	0
and	PMC3035602	36700	36703	O	-1	-1	0
chemotherapy	PMC3035602	36704	36716	O	-1	-1	0
must	PMC3035602	36717	36721	O	-1	-1	0
be	PMC3035602	36722	36724	O	-1	-1	0
weighed	PMC3035602	36725	36732	O	-1	-1	0
carefully	PMC3035602	36733	36742	O	-1	-1	0
against	PMC3035602	36743	36750	O	-1	-1	0
the	PMC3035602	36751	36754	O	-1	-1	0
risk	PMC3035602	36755	36759	O	-1	-1	0
to	PMC3035602	36760	36762	O	-1	-1	0
the	PMC3035602	36763	36766	O	-1	-1	0
fetus.12	PMC3035602	36767	36775	O	-1	-1	0
Under	PMC3035602	36776	36781	O	-1	-1	0
these	PMC3035602	36782	36787	O	-1	-1	0
circumstances	PMC3035602	36788	36801	O	-1	-1	0
,	PMC3035602	36801	36802	O	-1	-1	0
preterm	PMC3035602	36803	36810	O	-1	-1	0
labor	PMC3035602	36811	36816	O	-1	-1	0
is	PMC3035602	36817	36819	O	-1	-1	0
often	PMC3035602	36820	36825	O	-1	-1	0
induced	PMC3035602	36826	36833	O	-1	-1	0
as	PMC3035602	36834	36836	O	-1	-1	0
soon	PMC3035602	36837	36841	O	-1	-1	0
as	PMC3035602	36842	36844	O	-1	-1	0
the	PMC3035602	36845	36848	O	-1	-1	0
fetus	PMC3035602	36849	36854	O	-1	-1	0
becomes	PMC3035602	36855	36862	O	-1	-1	0
viable	PMC3035602	36863	36869	O	-1	-1	0
,	PMC3035602	36869	36870	O	-1	-1	0
in	PMC3035602	36871	36873	O	-1	-1	0
order	PMC3035602	36874	36879	O	-1	-1	0
to	PMC3035602	36880	36882	O	-1	-1	0
allow	PMC3035602	36883	36888	O	-1	-1	0
amplification	PMC3035602	36889	36902	O	-1	-1	0
of	PMC3035602	36903	36905	O	-1	-1	0
therapy.12	PMC3035602	36906	36916	O	-1	-1	0

The	PMC3035602	36917	36920	O	-1	-1	0
rationale	PMC3035602	36921	36930	O	-1	-1	0
for	PMC3035602	36931	36934	O	-1	-1	0
examining	PMC3035602	36935	36944	O	-1	-1	0
birth	PMC3035602	36945	36950	O	-1	-1	0
outcome	PMC3035602	36951	36958	O	-1	-1	0
in	PMC3035602	36959	36961	O	-1	-1	0
women	PMC3035602	36962	36967	O	-1	-1	0
diagnosed	PMC3035602	36968	36977	O	-1	-1	0
with	PMC3035602	36978	36982	O	-1	-1	0
cancer	PMC3035602	36983	36989	O	-1	-1	0
within	PMC3035602	36990	36996	O	-1	-1	0
a	PMC3035602	36997	36998	O	-1	-1	0
few	PMC3035602	36999	37002	O	-1	-1	0
years	PMC3035602	37003	37008	O	-1	-1	0
after	PMC3035602	37009	37014	O	-1	-1	0
delivery	PMC3035602	37015	37023	O	-1	-1	0
is	PMC3035602	37024	37026	O	-1	-1	0
that	PMC3035602	37027	37031	O	-1	-1	0
pregnancies	PMC3035602	37032	37043	O	-1	-1	0
starting	PMC3035602	37044	37052	O	-1	-1	0
before	PMC3035602	37053	37059	O	-1	-1	0
the	PMC3035602	37060	37063	O	-1	-1	0
diagnosis	PMC3035602	37064	37073	O	-1	-1	0
may	PMC3035602	37074	37077	O	-1	-1	0
be	PMC3035602	37078	37080	O	-1	-1	0
affected	PMC3035602	37081	37089	O	-1	-1	0
by	PMC3035602	37090	37092	O	-1	-1	0
the	PMC3035602	37093	37096	O	-1	-1	0
preclinical	PMC3035602	37097	37108	O	-1	-1	0
cancer	PMC3035602	37109	37115	O	-1	-1	0
.	PMC3035602	37115	37116	O	-1	-1	0

A	PMC3035602	37117	37118	O	-1	-1	0
Swedish	PMC3035602	37119	37126	O	-1	-1	0
study	PMC3035602	37127	37132	O	-1	-1	0
,	PMC3035602	37132	37133	O	-1	-1	0
which	PMC3035602	37134	37139	O	-1	-1	0
compared	PMC3035602	37140	37148	O	-1	-1	0
observed	PMC3035602	37149	37157	O	-1	-1	0
to	PMC3035602	37158	37160	O	-1	-1	0
expected	PMC3035602	37161	37169	O	-1	-1	0
rates	PMC3035602	37170	37175	O	-1	-1	0
of	PMC3035602	37176	37178	O	-1	-1	0
cancer	PMC3035602	37179	37185	O	-1	-1	0
during	PMC3035602	37186	37192	O	-1	-1	0
pregnancy	PMC3035602	37193	37202	O	-1	-1	0
and	PMC3035602	37203	37206	O	-1	-1	0
during	PMC3035602	37207	37213	O	-1	-1	0
the	PMC3035602	37214	37217	O	-1	-1	0
first	PMC3035602	37218	37223	O	-1	-1	0
year	PMC3035602	37224	37228	O	-1	-1	0
after	PMC3035602	37229	37234	O	-1	-1	0
delivery	PMC3035602	37235	37243	O	-1	-1	0
,	PMC3035602	37243	37244	O	-1	-1	0
suggested	PMC3035602	37245	37254	O	-1	-1	0
that	PMC3035602	37255	37259	O	-1	-1	0
diagnosis	PMC3035602	37260	37269	O	-1	-1	0
is	PMC3035602	37270	37272	O	-1	-1	0
often	PMC3035602	37273	37278	O	-1	-1	0
delayed	PMC3035602	37279	37286	O	-1	-1	0
to	PMC3035602	37287	37289	O	-1	-1	0
the	PMC3035602	37290	37293	O	-1	-1	0
postpartum	PMC3035602	37294	37304	O	-1	-1	0

period.43	PMC3035602	37305	37314	O	-1	-1	0

A	PMC3035602	37315	37316	O	-1	-1	0
possible	PMC3035602	37317	37325	O	-1	-1	0
explanation	PMC3035602	37326	37337	O	-1	-1	0
for	PMC3035602	37338	37341	O	-1	-1	0
this	PMC3035602	37342	37346	O	-1	-1	0
delay	PMC3035602	37347	37352	O	-1	-1	0
could	PMC3035602	37353	37358	O	-1	-1	0
be	PMC3035602	37359	37361	O	-1	-1	0
that	PMC3035602	37362	37366	O	-1	-1	0
unusual	PMC3035602	37367	37374	O	-1	-1	0
signs	PMC3035602	37375	37380	O	-1	-1	0
and	PMC3035602	37381	37384	O	-1	-1	0
symptoms	PMC3035602	37385	37393	O	-1	-1	0
may	PMC3035602	37394	37397	O	-1	-1	0
be	PMC3035602	37398	37400	O	-1	-1	0
ascribed	PMC3035602	37401	37409	O	-1	-1	0
to	PMC3035602	37410	37412	O	-1	-1	0
the	PMC3035602	37413	37416	O	-1	-1	0
pregnancy	PMC3035602	37417	37426	O	-1	-1	0
rather	PMC3035602	37427	37433	O	-1	-1	0
than	PMC3035602	37434	37438	O	-1	-1	0
the	PMC3035602	37439	37442	O	-1	-1	0
cancer	PMC3035602	37443	37449	O	-1	-1	0
.	PMC3035602	37449	37450	O	-1	-1	0

For	PMC3035602	37451	37454	O	-1	-1	0
women	PMC3035602	37455	37460	O	-1	-1	0
who	PMC3035602	37461	37464	O	-1	-1	0
retain	PMC3035602	37465	37471	O	-1	-1	0
or	PMC3035602	37472	37474	O	-1	-1	0
regain	PMC3035602	37475	37481	O	-1	-1	0
fertility	PMC3035602	37482	37491	O	-1	-1	0
after	PMC3035602	37492	37497	O	-1	-1	0
cancer	PMC3035602	37498	37504	O	-1	-1	0
treatment	PMC3035602	37505	37514	O	-1	-1	0
,	PMC3035602	37514	37515	O	-1	-1	0
an	PMC3035602	37516	37518	O	-1	-1	0
issue	PMC3035602	37519	37524	O	-1	-1	0
of	PMC3035602	37525	37527	O	-1	-1	0
great	PMC3035602	37528	37533	O	-1	-1	0
importance	PMC3035602	37534	37544	O	-1	-1	0
is	PMC3035602	37545	37547	O	-1	-1	0
their	PMC3035602	37548	37553	O	-1	-1	0
ability	PMC3035602	37554	37561	O	-1	-1	0
to	PMC3035602	37562	37564	O	-1	-1	0
carry	PMC3035602	37565	37570	O	-1	-1	0
a	PMC3035602	37571	37572	O	-1	-1	0
pregnancy	PMC3035602	37573	37582	O	-1	-1	0
to	PMC3035602	37583	37585	O	-1	-1	0
term	PMC3035602	37586	37590	O	-1	-1	0
and	PMC3035602	37591	37594	O	-1	-1	0
give	PMC3035602	37595	37599	O	-1	-1	0
birth	PMC3035602	37600	37605	O	-1	-1	0
to	PMC3035602	37606	37608	O	-1	-1	0
a	PMC3035602	37609	37610	O	-1	-1	0
normal	PMC3035602	37611	37617	O	-1	-1	0
child	PMC3035602	37618	37623	O	-1	-1	0
.	PMC3035602	37623	37624	O	-1	-1	0

Chemotherapy	PMC3035602	37625	37637	O	-1	-1	0
and	PMC3035602	37638	37641	O	-1	-1	0
radiotherapy	PMC3035602	37642	37654	O	-1	-1	0
may	PMC3035602	37655	37658	O	-1	-1	0
affect	PMC3035602	37659	37665	O	-1	-1	0
future	PMC3035602	37666	37672	O	-1	-1	0
pregnancies	PMC3035602	37673	37684	O	-1	-1	0
in	PMC3035602	37685	37687	O	-1	-1	0
cancer	PMC3035602	37688	37694	O	-1	-1	0
survivors	PMC3035602	37695	37704	O	-1	-1	0
by	PMC3035602	37705	37707	O	-1	-1	0
directly	PMC3035602	37708	37716	O	-1	-1	0
affecting	PMC3035602	37717	37726	O	-1	-1	0
the	PMC3035602	37727	37730	O	-1	-1	0
reproductive	PMC3035602	37731	37743	O	-1	-1	0
tract	PMC3035602	37744	37749	O	-1	-1	0
or	PMC3035602	37750	37752	O	-1	-1	0
by	PMC3035602	37753	37755	O	-1	-1	0
causing	PMC3035602	37756	37763	O	-1	-1	0
mutations	PMC3035602	37764	37773	O	-1	-1	0
in	PMC3035602	37774	37776	O	-1	-1	0
germ	PMC3035602	37777	37781	O	-1	-1	0
cells.30	PMC3035602	37782	37790	O	-1	-1	0

It	PMC3035602	37791	37793	O	-1	-1	0
is	PMC3035602	37794	37796	O	-1	-1	0
therefore	PMC3035602	37797	37806	O	-1	-1	0
important	PMC3035602	37807	37816	O	-1	-1	0
to	PMC3035602	37817	37819	O	-1	-1	0
establish	PMC3035602	37820	37829	O	-1	-1	0
the	PMC3035602	37830	37833	O	-1	-1	0
magnitude	PMC3035602	37834	37843	O	-1	-1	0
of	PMC3035602	37844	37846	O	-1	-1	0
an	PMC3035602	37847	37849	O	-1	-1	0
increased	PMC3035602	37850	37859	O	-1	-1	0
risk	PMC3035602	37860	37864	O	-1	-1	0
(	PMC3035602	37865	37866	O	-1	-1	0
if	PMC3035602	37866	37868	O	-1	-1	0
any	PMC3035602	37869	37872	O	-1	-1	0
)	PMC3035602	37872	37873	O	-1	-1	0
of	PMC3035602	37874	37876	O	-1	-1	0
adverse	PMC3035602	37877	37884	O	-1	-1	0
birth	PMC3035602	37885	37890	O	-1	-1	0
outcomes	PMC3035602	37891	37899	O	-1	-1	0
such	PMC3035602	37900	37904	O	-1	-1	0
as	PMC3035602	37905	37907	O	-1	-1	0
preterm	PMC3035602	37908	37915	O	-1	-1	0
birth	PMC3035602	37916	37921	O	-1	-1	0
,	PMC3035602	37921	37922	O	-1	-1	0
LBW	PMC3035602	37923	37926	O	-1	-1	0
(	PMC3035602	37927	37928	O	-1	-1	0
or	PMC3035602	37928	37930	O	-1	-1	0
LBW	PMC3035602	37931	37934	O	-1	-1	0
at	PMC3035602	37935	37937	O	-1	-1	0
term	PMC3035602	37938	37942	O	-1	-1	0
)	PMC3035602	37942	37943	O	-1	-1	0
,	PMC3035602	37943	37944	O	-1	-1	0
stillbirth	PMC3035602	37945	37955	O	-1	-1	0
,	PMC3035602	37955	37956	O	-1	-1	0
and	PMC3035602	37957	37960	O	-1	-1	0
congenital	PMC3035602	37961	37971	O	-1	-1	0
abnormalities	PMC3035602	37972	37985	O	-1	-1	0
.	PMC3035602	37985	37986	O	-1	-1	0


	PMC3035602	37986	37988	O	-1	-1	0

Possible	PMC3035602	37988	37996	O	-1	-1	0
adverse	PMC3035602	37997	38004	O	-1	-1	0
effects	PMC3035602	38005	38012	O	-1	-1	0
of	PMC3035602	38013	38015	O	-1	-1	0
the	PMC3035602	38016	38019	O	-1	-1	0
cancer	PMC3035602	38020	38026	O	-1	-1	0
itself	PMC3035602	38027	38033	O	-1	-1	0
on	PMC3035602	38034	38036	O	-1	-1	0
birth	PMC3035602	38037	38042	O	-1	-1	0
outcome	PMC3035602	38043	38050	O	-1	-1	0

Little	PMC3035602	38051	38057	O	-1	-1	0
is	PMC3035602	38058	38060	O	-1	-1	0
known	PMC3035602	38061	38066	O	-1	-1	0
about	PMC3035602	38067	38072	O	-1	-1	0
exact	PMC3035602	38073	38078	O	-1	-1	0
mechanisms	PMC3035602	38079	38089	O	-1	-1	0
whereby	PMC3035602	38090	38097	O	-1	-1	0
maternal	PMC3035602	38098	38106	O	-1	-1	0
cancer	PMC3035602	38107	38113	O	-1	-1	0
may	PMC3035602	38114	38117	O	-1	-1	0
pose	PMC3035602	38118	38122	O	-1	-1	0
risk	PMC3035602	38123	38127	O	-1	-1	0
to	PMC3035602	38128	38130	O	-1	-1	0
a	PMC3035602	38131	38132	O	-1	-1	0
developing	PMC3035602	38133	38143	O	-1	-1	0
fetus	PMC3035602	38144	38149	O	-1	-1	0
.	PMC3035602	38149	38150	O	-1	-1	0

In	PMC3035602	38151	38153	O	-1	-1	0
theory	PMC3035602	38154	38160	O	-1	-1	0
,	PMC3035602	38160	38161	O	-1	-1	0
several	PMC3035602	38162	38169	O	-1	-1	0
factors	PMC3035602	38170	38177	O	-1	-1	0
might	PMC3035602	38178	38183	O	-1	-1	0
influence	PMC3035602	38184	38193	O	-1	-1	0
the	PMC3035602	38194	38197	O	-1	-1	0
fetus	PMC3035602	38198	38203	O	-1	-1	0
if	PMC3035602	38204	38206	O	-1	-1	0
the	PMC3035602	38207	38210	O	-1	-1	0
mother	PMC3035602	38211	38217	O	-1	-1	0
has	PMC3035602	38218	38221	O	-1	-1	0
malignant	PMC3035602	38222	38231	O	-1	-1	0
disease	PMC3035602	38232	38239	O	-1	-1	0
:	PMC3035602	38239	38240	O	-1	-1	0

•	PMC3035602	38241	38242	O	-1	-1	0

It	PMC3035602	38243	38245	O	-1	-1	0
has	PMC3035602	38246	38249	O	-1	-1	0
been	PMC3035602	38250	38254	O	-1	-1	0
proposed	PMC3035602	38255	38263	O	-1	-1	0
that	PMC3035602	38264	38268	O	-1	-1	0
the	PMC3035602	38269	38272	O	-1	-1	0
cancer	PMC3035602	38273	38279	O	-1	-1	0
may	PMC3035602	38280	38283	O	-1	-1	0
alter	PMC3035602	38284	38289	O	-1	-1	0
metabolism	PMC3035602	38290	38300	O	-1	-1	0
and	PMC3035602	38301	38304	O	-1	-1	0
distribution	PMC3035602	38305	38317	O	-1	-1	0
of	PMC3035602	38318	38320	O	-1	-1	0
hormones	PMC3035602	38321	38329	O	-1	-1	0
and	PMC3035602	38330	38333	O	-1	-1	0
vitamins	PMC3035602	38334	38342	O	-1	-1	0
,	PMC3035602	38342	38343	O	-1	-1	0
some	PMC3035602	38344	38348	O	-1	-1	0
of	PMC3035602	38349	38351	O	-1	-1	0
which	PMC3035602	38352	38357	O	-1	-1	0
are	PMC3035602	38358	38361	O	-1	-1	0
determinants	PMC3035602	38362	38374	O	-1	-1	0
for	PMC3035602	38375	38378	O	-1	-1	0
certain	PMC3035602	38379	38386	O	-1	-1	0
congenital	PMC3035602	38387	38397	O	-1	-1	0
abnormalities.44	PMC3035602	38398	38414	O	-1	-1	0

•	PMC3035602	38415	38416	O	-1	-1	0
Cancer	PMC3035602	38417	38423	O	-1	-1	0
patients	PMC3035602	38424	38432	O	-1	-1	0
have	PMC3035602	38433	38437	O	-1	-1	0
an	PMC3035602	38438	38440	O	-1	-1	0
increased	PMC3035602	38441	38450	O	-1	-1	0
tendency	PMC3035602	38451	38459	O	-1	-1	0
to	PMC3035602	38460	38462	O	-1	-1	0
suffer	PMC3035602	38463	38469	O	-1	-1	0
from	PMC3035602	38470	38474	O	-1	-1	0
febrile	PMC3035602	38475	38482	O	-1	-1	0
illness,5	PMC3035602	38483	38492	O	-1	-1	0
and	PMC3035602	38493	38496	O	-1	-1	0
maternal	PMC3035602	38497	38505	O	-1	-1	0
fever	PMC3035602	38506	38511	O	-1	-1	0
in	PMC3035602	38512	38514	O	-1	-1	0
early	PMC3035602	38515	38520	O	-1	-1	0
pregnancy	PMC3035602	38521	38530	O	-1	-1	0
has	PMC3035602	38531	38534	O	-1	-1	0
been	PMC3035602	38535	38539	O	-1	-1	0
associated	PMC3035602	38540	38550	O	-1	-1	0
with	PMC3035602	38551	38555	O	-1	-1	0
stillbirth	PMC3035602	38556	38566	O	-1	-1	0
45	PMC3035602	38567	38569	O	-1	-1	0
and	PMC3035602	38570	38573	O	-1	-1	0
congenital	PMC3035602	38574	38584	O	-1	-1	0

abnormalities.45,46	PMC3035602	38585	38604	O	-1	-1	0

•	PMC3035602	38605	38606	O	-1	-1	0
Malnutrition	PMC3035602	38607	38619	O	-1	-1	0
is	PMC3035602	38620	38622	O	-1	-1	0
more	PMC3035602	38623	38627	O	-1	-1	0
frequent	PMC3035602	38628	38636	O	-1	-1	0
in	PMC3035602	38637	38639	O	-1	-1	0
the	PMC3035602	38640	38643	O	-1	-1	0
patients	PMC3035602	38644	38652	O	-1	-1	0
.	PMC3035602	38652	38653	O	-1	-1	0

Maternal	PMC3035602	38654	38662	O	-1	-1	0
undernutrition	PMC3035602	38663	38677	O	-1	-1	0
during	PMC3035602	38678	38684	O	-1	-1	0
pregnancy	PMC3035602	38685	38694	O	-1	-1	0
resulting	PMC3035602	38695	38704	O	-1	-1	0
in	PMC3035602	38705	38707	O	-1	-1	0
reduced	PMC3035602	38708	38715	O	-1	-1	0
transfer	PMC3035602	38716	38724	O	-1	-1	0
of	PMC3035602	38725	38727	O	-1	-1	0
nutrients	PMC3035602	38728	38737	O	-1	-1	0
to	PMC3035602	38738	38740	O	-1	-1	0
the	PMC3035602	38741	38744	O	-1	-1	0
fetus	PMC3035602	38745	38750	O	-1	-1	0
may	PMC3035602	38751	38754	O	-1	-1	0
cause	PMC3035602	38755	38760	O	-1	-1	0
fetal	PMC3035602	38761	38766	O	-1	-1	0
undernutrition	PMC3035602	38767	38781	O	-1	-1	0
and	PMC3035602	38782	38785	O	-1	-1	0
intrauterine	PMC3035602	38786	38798	O	-1	-1	0
growth	PMC3035602	38799	38805	O	-1	-1	0
retardation.47	PMC3035602	38806	38820	O	-1	-1	0

Impaired	PMC3035602	38821	38829	O	-1	-1	0
fetal	PMC3035602	38830	38835	O	-1	-1	0
growth	PMC3035602	38836	38842	O	-1	-1	0
is	PMC3035602	38843	38845	O	-1	-1	0
strongly	PMC3035602	38846	38854	O	-1	-1	0
associated	PMC3035602	38855	38865	O	-1	-1	0
with	PMC3035602	38866	38870	O	-1	-1	0
neonatal	PMC3035602	38871	38879	O	-1	-1	0
morbidity	PMC3035602	38880	38889	O	-1	-1	0
and	PMC3035602	38890	38893	O	-1	-1	0
mortality,48	PMC3035602	38894	38906	O	-1	-1	0
and	PMC3035602	38907	38910	O	-1	-1	0
may	PMC3035602	38911	38914	O	-1	-1	0
also	PMC3035602	38915	38919	O	-1	-1	0
be	PMC3035602	38920	38922	O	-1	-1	0
associated	PMC3035602	38923	38933	O	-1	-1	0
with	PMC3035602	38934	38938	O	-1	-1	0
diseases	PMC3035602	38939	38947	O	-1	-1	0
later	PMC3035602	38948	38953	O	-1	-1	0
in	PMC3035602	38954	38956	O	-1	-1	0
life.49	PMC3035602	38957	38964	O	-1	-1	0

•	PMC3035602	38965	38966	O	-1	-1	0

Psychological	PMC3035602	38967	38980	O	-1	-1	0
stress	PMC3035602	38981	38987	O	-1	-1	0
related	PMC3035602	38988	38995	O	-1	-1	0
to	PMC3035602	38996	38998	O	-1	-1	0
severe	PMC3035602	38999	39005	O	-1	-1	0
life	PMC3035602	39006	39010	O	-1	-1	0
events	PMC3035602	39011	39017	O	-1	-1	0
(	PMC3035602	39018	39019	O	-1	-1	0
eg	PMC3035602	39019	39021	O	-1	-1	0
,	PMC3035602	39021	39022	O	-1	-1	0
a	PMC3035602	39023	39024	O	-1	-1	0
cancer	PMC3035602	39025	39031	O	-1	-1	0
diagnosis	PMC3035602	39032	39041	O	-1	-1	0
)	PMC3035602	39041	39042	O	-1	-1	0
around	PMC3035602	39043	39049	O	-1	-1	0
the	PMC3035602	39050	39053	O	-1	-1	0
time	PMC3035602	39054	39058	O	-1	-1	0
of	PMC3035602	39059	39061	O	-1	-1	0
conception	PMC3035602	39062	39072	O	-1	-1	0
may	PMC3035602	39073	39076	O	-1	-1	0
reduce	PMC3035602	39077	39083	O	-1	-1	0
the	PMC3035602	39084	39087	O	-1	-1	0
male	PMC3035602	39088	39092	O	-1	-1	0
proportion	PMC3035602	39093	39103	O	-1	-1	0
of	PMC3035602	39104	39106	O	-1	-1	0
newborns	PMC3035602	39107	39115	O	-1	-1	0
through	PMC3035602	39116	39123	O	-1	-1	0
differential	PMC3035602	39124	39136	O	-1	-1	0
conception	PMC3035602	39137	39147	O	-1	-1	0
or	PMC3035602	39148	39150	O	-1	-1	0
differential	PMC3035602	39151	39163	O	-1	-1	0
abortion	PMC3035602	39164	39172	O	-1	-1	0
of	PMC3035602	39173	39175	O	-1	-1	0
male	PMC3035602	39176	39180	O	-1	-1	0
­embryos.29	PMC3035602	39181	39192	O	-1	-1	0


	PMC3035602	39192	39194	O	-1	-1	0

Clinical	PMC3035602	39194	39202	O	-1	-1	0
Epidemiology	PMC3035602	39203	39215	O	-1	-1	0
2011:3	PMC3035602	39216	39222	O	-1	-1	0


	PMC3035602	39222	39224	O	-1	-1	0

Dovepress	PMC3035602	39224	39233	O	-1	-1	0


	PMC3035602	39233	39235	O	-1	-1	0

Likewise	PMC3035602	39235	39243	O	-1	-1	0
,	PMC3035602	39243	39244	O	-1	-1	0
some	PMC3035602	39245	39249	O	-1	-1	0
studies	PMC3035602	39250	39257	O	-1	-1	0
have	PMC3035602	39258	39262	O	-1	-1	0
reported	PMC3035602	39263	39271	O	-1	-1	0
­associations	PMC3035602	39272	39285	O	-1	-1	0
of	PMC3035602	39286	39288	O	-1	-1	0
stress	PMC3035602	39289	39295	O	-1	-1	0
in	PMC3035602	39296	39298	O	-1	-1	0
pregnancy	PMC3035602	39299	39308	O	-1	-1	0
with	PMC3035602	39309	39313	O	-1	-1	0
preterm	PMC3035602	39314	39321	O	-1	-1	0
delivery,50,51	PMC3035602	39322	39336	O	-1	-1	0
and	PMC3035602	39337	39340	O	-1	-1	0
congenital	PMC3035602	39341	39351	O	-1	-1	0
abnormalities.52	PMC3035602	39352	39368	O	-1	-1	0


	PMC3035602	39368	39370	O	-1	-1	0

Possible	PMC3035602	39370	39378	O	-1	-1	0
adverse	PMC3035602	39379	39386	O	-1	-1	0
effects	PMC3035602	39387	39394	O	-1	-1	0
of	PMC3035602	39395	39397	O	-1	-1	0
specific	PMC3035602	39398	39406	O	-1	-1	0
cancer	PMC3035602	39407	39413	O	-1	-1	0
therapy	PMC3035602	39414	39421	O	-1	-1	0
on	PMC3035602	39422	39424	O	-1	-1	0
birth	PMC3035602	39425	39430	O	-1	-1	0
outcome	PMC3035602	39431	39438	O	-1	-1	0

Surgery	PMC3035602	39439	39446	O	-1	-1	0


	PMC3035602	39446	39448	O	-1	-1	0

Most	PMC3035602	39448	39452	O	-1	-1	0
surgical	PMC3035602	39453	39461	O	-1	-1	0
interventions	PMC3035602	39462	39475	O	-1	-1	0
can	PMC3035602	39476	39479	O	-1	-1	0
be	PMC3035602	39480	39482	O	-1	-1	0
safely	PMC3035602	39483	39489	O	-1	-1	0
undertaken	PMC3035602	39490	39500	O	-1	-1	0
with	PMC3035602	39501	39505	O	-1	-1	0
minimum	PMC3035602	39506	39513	O	-1	-1	0
risk	PMC3035602	39514	39518	O	-1	-1	0
during	PMC3035602	39519	39525	O	-1	-1	0
pregnancy	PMC3035602	39526	39535	O	-1	-1	0
,	PMC3035602	39535	39536	O	-1	-1	0
although	PMC3035602	39537	39545	O	-1	-1	0
there	PMC3035602	39546	39551	O	-1	-1	0
is	PMC3035602	39552	39554	O	-1	-1	0
almost	PMC3035602	39555	39561	O	-1	-1	0
always	PMC3035602	39562	39568	O	-1	-1	0
some	PMC3035602	39569	39573	O	-1	-1	0
element	PMC3035602	39574	39581	O	-1	-1	0
of	PMC3035602	39582	39584	O	-1	-1	0
maternal	PMC3035602	39585	39593	O	-1	-1	0
–	PMC3035602	39593	39594	O	-1	-1	0
fetal	PMC3035602	39594	39599	O	-1	-1	0
conflict.53	PMC3035602	39600	39611	O	-1	-1	0


	PMC3035602	39611	39613	O	-1	-1	0
Radiation	PMC3035602	39613	39622	O	-1	-1	0

Radiation	PMC3035602	39623	39632	O	-1	-1	0
is	PMC3035602	39633	39635	O	-1	-1	0
commonly	PMC3035602	39636	39644	O	-1	-1	0
used	PMC3035602	39645	39649	O	-1	-1	0
for	PMC3035602	39650	39653	O	-1	-1	0
cancer	PMC3035602	39654	39660	O	-1	-1	0
diagnosis	PMC3035602	39661	39670	O	-1	-1	0
and	PMC3035602	39671	39674	O	-1	-1	0
treatment	PMC3035602	39675	39684	O	-1	-1	0
.	PMC3035602	39684	39685	O	-1	-1	0

The	PMC3035602	39686	39689	O	-1	-1	0
fetus	PMC3035602	39690	39695	O	-1	-1	0
is	PMC3035602	39696	39698	O	-1	-1	0
sensitive	PMC3035602	39699	39708	O	-1	-1	0
to	PMC3035602	39709	39711	O	-1	-1	0
ionizing	PMC3035602	39712	39720	O	-1	-1	0
radiation	PMC3035602	39721	39730	O	-1	-1	0
,	PMC3035602	39730	39731	O	-1	-1	0
with	PMC3035602	39732	39736	O	-1	-1	0
the	PMC3035602	39737	39740	O	-1	-1	0
brain	PMC3035602	39741	39746	O	-1	-1	0
being	PMC3035602	39747	39752	O	-1	-1	0
the	PMC3035602	39753	39756	O	-1	-1	0
most	PMC3035602	39757	39761	O	-1	-1	0
sensitive	PMC3035602	39762	39771	O	-1	-1	0
organ.54	PMC3035602	39772	39780	O	-1	-1	0
During	PMC3035602	39781	39787	O	-1	-1	0
the	PMC3035602	39788	39791	O	-1	-1	0
periimplantation	PMC3035602	39792	39808	O	-1	-1	0
and	PMC3035602	39809	39812	O	-1	-1	0
immediate	PMC3035602	39813	39822	O	-1	-1	0
post	PMC3035602	39823	39827	O	-1	-1	0
-	PMC3035602	39827	39828	O	-1	-1	0
implantation	PMC3035602	39828	39840	O	-1	-1	0
periods	PMC3035602	39841	39848	O	-1	-1	0
,	PMC3035602	39848	39849	O	-1	-1	0
radiation	PMC3035602	39850	39859	O	-1	-1	0
has	PMC3035602	39860	39863	O	-1	-1	0
an	PMC3035602	39864	39866	O	-1	-1	0
all	PMC3035602	39867	39870	O	-1	-1	0
or	PMC3035602	39871	39873	O	-1	-1	0
nothing	PMC3035602	39874	39881	O	-1	-1	0
effect	PMC3035602	39882	39888	O	-1	-1	0
,	PMC3035602	39888	39889	O	-1	-1	0
resulting	PMC3035602	39890	39899	O	-1	-1	0
in	PMC3035602	39900	39902	O	-1	-1	0
either	PMC3035602	39903	39909	O	-1	-1	0
embryonic	PMC3035602	39910	39919	O	-1	-1	0
death	PMC3035602	39920	39925	O	-1	-1	0
or	PMC3035602	39926	39928	O	-1	-1	0
further	PMC3035602	39929	39936	O	-1	-1	0
normal	PMC3035602	39937	39943	O	-1	-1	0
development	PMC3035602	39944	39955	O	-1	-1	0
.	PMC3035602	39955	39956	O	-1	-1	0

Later	PMC3035602	39957	39962	O	-1	-1	0
in	PMC3035602	39963	39965	O	-1	-1	0
pregnancy	PMC3035602	39966	39975	O	-1	-1	0
,	PMC3035602	39975	39976	O	-1	-1	0
radiation	PMC3035602	39977	39986	O	-1	-1	0
may	PMC3035602	39987	39990	O	-1	-1	0
cause	PMC3035602	39991	39996	O	-1	-1	0
congenital	PMC3035602	39997	40007	O	-1	-1	0
abnormalities	PMC3035602	40008	40021	O	-1	-1	0
,	PMC3035602	40021	40022	O	-1	-1	0

IUGR	PMC3035602	40023	40027	O	-1	-1	0
,	PMC3035602	40027	40028	O	-1	-1	0
mental	PMC3035602	40029	40035	O	-1	-1	0
retardation	PMC3035602	40036	40047	O	-1	-1	0
,	PMC3035602	40047	40048	O	-1	-1	0
or	PMC3035602	40049	40051	O	-1	-1	0
childhood	PMC3035602	40052	40061	O	-1	-1	0
cancer.54	PMC3035602	40062	40071	O	-1	-1	0

As	PMC3035602	40072	40074	O	-1	-1	0
a	PMC3035602	40075	40076	O	-1	-1	0
result	PMC3035602	40077	40083	O	-1	-1	0
,	PMC3035602	40083	40084	O	-1	-1	0
the	PMC3035602	40085	40088	O	-1	-1	0
general	PMC3035602	40089	40096	O	-1	-1	0
recommendation	PMC3035602	40097	40111	O	-1	-1	0
is	PMC3035602	40112	40114	O	-1	-1	0
to	PMC3035602	40115	40117	O	-1	-1	0
postpone	PMC3035602	40118	40126	O	-1	-1	0
radiotherapy	PMC3035602	40127	40139	O	-1	-1	0
until	PMC3035602	40140	40145	O	-1	-1	0
after	PMC3035602	40146	40151	O	-1	-1	0
delivery.12	PMC3035602	40152	40163	O	-1	-1	0

At	PMC3035602	40164	40166	O	-1	-1	0
the	PMC3035602	40167	40170	O	-1	-1	0
same	PMC3035602	40171	40175	O	-1	-1	0
time	PMC3035602	40176	40180	O	-1	-1	0
,	PMC3035602	40180	40181	O	-1	-1	0
births	PMC3035602	40182	40188	O	-1	-1	0
of	PMC3035602	40189	40191	O	-1	-1	0
healthy	PMC3035602	40192	40199	O	-1	-1	0
children	PMC3035602	40200	40208	O	-1	-1	0
after	PMC3035602	40209	40214	O	-1	-1	0
radiotherapy	PMC3035602	40215	40227	O	-1	-1	0
of	PMC3035602	40228	40230	O	-1	-1	0
pregnant	PMC3035602	40231	40239	O	-1	-1	0
women	PMC3035602	40240	40245	O	-1	-1	0
for	PMC3035602	40246	40249	O	-1	-1	0
breast	PMC3035602	40250	40256	O	-1	-1	0
cancer	PMC3035602	40257	40263	O	-1	-1	0
and	PMC3035602	40264	40267	O	-1	-1	0
supradiaphragmatic	PMC3035602	40268	40286	O	-1	-1	0
Hodgkin	PMC3035602	40287	40294	O	-1	-1	0

’s	PMC3035602	40294	40296	O	-1	-1	0

disease	PMC3035602	40297	40304	O	-1	-1	0
have	PMC3035602	40305	40309	O	-1	-1	0
been	PMC3035602	40310	40314	O	-1	-1	0
reported	PMC3035602	40315	40323	O	-1	-1	0
(	PMC3035602	40324	40325	O	-1	-1	0
with	PMC3035602	40325	40329	O	-1	-1	0
appropriate	PMC3035602	40330	40341	O	-1	-1	0
shielding	PMC3035602	40342	40351	O	-1	-1	0
of	PMC3035602	40352	40354	O	-1	-1	0
the	PMC3035602	40355	40358	O	-1	-1	0
fetus).19,55–57	PMC3035602	40359	40374	O	-1	-1	0

In	PMC3035602	40375	40377	O	-1	-1	0
nonpregnant	PMC3035602	40378	40389	O	-1	-1	0
women	PMC3035602	40390	40395	O	-1	-1	0
of	PMC3035602	40396	40398	O	-1	-1	0
childbearing	PMC3035602	40399	40411	O	-1	-1	0
age	PMC3035602	40412	40415	O	-1	-1	0
,	PMC3035602	40415	40416	O	-1	-1	0
ionizing	PMC3035602	40417	40425	O	-1	-1	0
radiation	PMC3035602	40426	40435	O	-1	-1	0
may	PMC3035602	40436	40439	O	-1	-1	0
damage	PMC3035602	40440	40446	O	-1	-1	0
ovarian	PMC3035602	40447	40454	O	-1	-1	0
function	PMC3035602	40455	40463	O	-1	-1	0
,	PMC3035602	40463	40464	O	-1	-1	0
cause	PMC3035602	40465	40470	O	-1	-1	0
premature	PMC3035602	40471	40480	O	-1	-1	0
ovarian	PMC3035602	40481	40488	O	-1	-1	0
failure	PMC3035602	40489	40496	O	-1	-1	0
,	PMC3035602	40496	40497	O	-1	-1	0
or	PMC3035602	40498	40500	O	-1	-1	0
trigger	PMC3035602	40501	40508	O	-1	-1	0
germ	PMC3035602	40509	40513	O	-1	-1	0
cell	PMC3035602	40514	40518	O	-1	-1	0
mutations	PMC3035602	40519	40528	O	-1	-1	0
,	PMC3035602	40528	40529	O	-1	-1	0
which	PMC3035602	40530	40535	O	-1	-1	0
can	PMC3035602	40536	40539	O	-1	-1	0
lead	PMC3035602	40540	40544	O	-1	-1	0
to	PMC3035602	40545	40547	O	-1	-1	0
congenital	PMC3035602	40548	40558	O	-1	-1	0
abnormalities	PMC3035602	40559	40572	O	-1	-1	0
in	PMC3035602	40573	40575	O	-1	-1	0
future	PMC3035602	40576	40582	O	-1	-1	0
offspring.30	PMC3035602	40583	40595	O	-1	-1	0

Studies	PMC3035602	40596	40603	O	-1	-1	0
of	PMC3035602	40604	40606	O	-1	-1	0
women	PMC3035602	40607	40612	O	-1	-1	0
exposed	PMC3035602	40613	40620	O	-1	-1	0
to	PMC3035602	40621	40623	O	-1	-1	0
the	PMC3035602	40624	40627	O	-1	-1	0
atomic	PMC3035602	40628	40634	O	-1	-1	0
-	PMC3035602	40634	40635	O	-1	-1	0
bomb	PMC3035602	40635	40639	O	-1	-1	0
radiation	PMC3035602	40640	40649	O	-1	-1	0
and	PMC3035602	40650	40653	O	-1	-1	0
their	PMC3035602	40654	40659	O	-1	-1	0
subsequently	PMC3035602	40660	40672	O	-1	-1	0
conceived	PMC3035602	40673	40682	O	-1	-1	0
offspring	PMC3035602	40683	40692	O	-1	-1	0
have	PMC3035602	40693	40697	O	-1	-1	0
indicated	PMC3035602	40698	40707	O	-1	-1	0
a	PMC3035602	40708	40709	O	-1	-1	0
higher	PMC3035602	40710	40716	O	-1	-1	0
rate	PMC3035602	40717	40721	O	-1	-1	0
of	PMC3035602	40722	40724	O	-1	-1	0
spontaneous	PMC3035602	40725	40736	O	-1	-1	0
abortion	PMC3035602	40737	40745	O	-1	-1	0
,	PMC3035602	40745	40746	O	-1	-1	0
but	PMC3035602	40747	40750	O	-1	-1	0
showed	PMC3035602	40751	40757	O	-1	-1	0
no	PMC3035602	40758	40760	O	-1	-1	0
increase	PMC3035602	40761	40769	O	-1	-1	0
in	PMC3035602	40770	40772	O	-1	-1	0
the	PMC3035602	40773	40776	O	-1	-1	0
risk	PMC3035602	40777	40781	O	-1	-1	0
of	PMC3035602	40782	40784	O	-1	-1	0
major	PMC3035602	40785	40790	O	-1	-1	0
congenital	PMC3035602	40791	40801	O	-1	-1	0
abnormalities	PMC3035602	40802	40815	O	-1	-1	0
compared	PMC3035602	40816	40824	O	-1	-1	0
with	PMC3035602	40825	40829	O	-1	-1	0
the	PMC3035602	40830	40833	O	-1	-1	0
children	PMC3035602	40834	40842	O	-1	-1	0
of	PMC3035602	40843	40845	O	-1	-1	0
women	PMC3035602	40846	40851	O	-1	-1	0
from	PMC3035602	40852	40856	O	-1	-1	0
the	PMC3035602	40857	40860	O	-1	-1	0
general	PMC3035602	40861	40868	O	-1	-1	0
population.10	PMC3035602	40869	40882	O	-1	-1	0

These	PMC3035602	40883	40888	O	-1	-1	0
results	PMC3035602	40889	40896	O	-1	-1	0
corroborate	PMC3035602	40897	40908	O	-1	-1	0
studies	PMC3035602	40909	40916	O	-1	-1	0
of	PMC3035602	40917	40919	O	-1	-1	0
childhood	PMC3035602	40920	40929	O	-1	-1	0
cancer	PMC3035602	40930	40936	O	-1	-1	0
survivors	PMC3035602	40937	40946	O	-1	-1	0
reporting	PMC3035602	40947	40956	O	-1	-1	0
no	PMC3035602	40957	40959	O	-1	-1	0
increased	PMC3035602	40960	40969	O	-1	-1	0
risk	PMC3035602	40970	40974	O	-1	-1	0
of	PMC3035602	40975	40977	O	-1	-1	0
congenital	PMC3035602	40978	40988	O	-1	-1	0
abnormalities	PMC3035602	40989	41002	O	-1	-1	0
or	PMC3035602	41003	41005	O	-1	-1	0
genetic	PMC3035602	41006	41013	O	-1	-1	0
diseases	PMC3035602	41014	41022	O	-1	-1	0
in	PMC3035602	41023	41025	O	-1	-1	0
the	PMC3035602	41026	41029	O	-1	-1	0
offspring	PMC3035602	41030	41039	O	-1	-1	0
of	PMC3035602	41040	41042	O	-1	-1	0
women	PMC3035602	41043	41048	O	-1	-1	0
exposed	PMC3035602	41049	41056	O	-1	-1	0
to	PMC3035602	41057	41059	O	-1	-1	0

­pre	PMC3035602	41060	41064	O	-1	-1	0
-	PMC3035602	41064	41065	O	-1	-1	0
gestational	PMC3035602	41065	41076	O	-1	-1	0
radiotherapy.58–61	PMC3035602	41077	41095	O	-1	-1	0

It	PMC3035602	41096	41098	O	-1	-1	0
has	PMC3035602	41099	41102	O	-1	-1	0
also	PMC3035602	41103	41107	O	-1	-1	0
been	PMC3035602	41108	41112	O	-1	-1	0
postulated	PMC3035602	41113	41123	O	-1	-1	0
that	PMC3035602	41124	41128	O	-1	-1	0
maternal	PMC3035602	41129	41137	O	-1	-1	0
gonadal	PMC3035602	41138	41145	O	-1	-1	0
exposure	PMC3035602	41146	41154	O	-1	-1	0
to	PMC3035602	41155	41157	O	-1	-1	0
radiation	PMC3035602	41158	41167	O	-1	-1	0
would	PMC3035602	41168	41173	O	-1	-1	0
decrease	PMC3035602	41174	41182	O	-1	-1	0
the	PMC3035602	41183	41186	O	-1	-1	0
male	PMC3035602	41187	41191	O	-1	-1	0
proportion	PMC3035602	41192	41202	O	-1	-1	0
of	PMC3035602	41203	41205	O	-1	-1	0
newborns	PMC3035602	41206	41214	O	-1	-1	0
by	PMC3035602	41215	41217	O	-1	-1	0
inducing	PMC3035602	41218	41226	O	-1	-1	0
recessive	PMC3035602	41227	41236	O	-1	-1	0
sex	PMC3035602	41237	41240	O	-1	-1	0
-	PMC3035602	41240	41241	O	-1	-1	0
linked	PMC3035602	41241	41247	O	-1	-1	0
lethal	PMC3035602	41248	41254	O	-1	-1	0
mutations.62	PMC3035602	41255	41267	O	-1	-1	0
In	PMC3035602	41268	41270	O	-1	-1	0
­addition	PMC3035602	41271	41280	O	-1	-1	0
,	PMC3035602	41280	41281	O	-1	-1	0
women	PMC3035602	41282	41287	O	-1	-1	0
previously	PMC3035602	41288	41298	O	-1	-1	0
treated	PMC3035602	41299	41306	O	-1	-1	0
with	PMC3035602	41307	41311	O	-1	-1	0
high	PMC3035602	41312	41316	O	-1	-1	0
-	PMC3035602	41316	41317	O	-1	-1	0
dose	PMC3035602	41317	41321	O	-1	-1	0
abdominal	PMC3035602	41322	41331	O	-1	-1	0
radiotherapy	PMC3035602	41332	41344	O	-1	-1	0
have	PMC3035602	41345	41349	O	-1	-1	0
been	PMC3035602	41350	41354	O	-1	-1	0
found	PMC3035602	41355	41360	O	-1	-1	0
to	PMC3035602	41361	41363	O	-1	-1	0
have	PMC3035602	41364	41368	O	-1	-1	0
an	PMC3035602	41369	41371	O	-1	-1	0
increased	PMC3035602	41372	41381	O	-1	-1	0
risk	PMC3035602	41382	41386	O	-1	-1	0
of	PMC3035602	41387	41389	O	-1	-1	0
spontaneous	PMC3035602	41390	41401	O	-1	-1	0
abortions,41,63,64	PMC3035602	41402	41420	O	-1	-1	0
preterm	PMC3035602	41421	41428	O	-1	-1	0
deliveries,40	PMC3035602	41429	41442	O	-1	-1	0

and	PMC3035602	41443	41446	O	-1	-1	0
LBW	PMC3035602	41447	41450	O	-1	-1	0
infants58,59,63	PMC3035602	41451	41466	O	-1	-1	0
during	PMC3035602	41467	41473	O	-1	-1	0
subsequent	PMC3035602	41474	41484	O	-1	-1	0
pregnancies	PMC3035602	41485	41496	O	-1	-1	0
.	PMC3035602	41496	41497	O	-1	-1	0

These	PMC3035602	41497	41502	O	-1	-1	0
effects	PMC3035602	41503	41510	O	-1	-1	0
are	PMC3035602	41511	41514	O	-1	-1	0
most	PMC3035602	41515	41519	O	-1	-1	0
likely	PMC3035602	41520	41526	O	-1	-1	0
due	PMC3035602	41527	41530	O	-1	-1	0
to	PMC3035602	41531	41533	O	-1	-1	0
radiation	PMC3035602	41534	41543	O	-1	-1	0
-	PMC3035602	41543	41544	O	-1	-1	0
induced	PMC3035602	41544	41551	O	-1	-1	0
damage	PMC3035602	41552	41558	O	-1	-1	0
to	PMC3035602	41559	41561	O	-1	-1	0

the	PMC3035602	41562	41565	O	-1	-1	0
women	PMC3035602	41566	41571	O	-1	-1	0
’s	PMC3035602	41571	41573	O	-1	-1	0
abdominopelvic	PMC3035602	41574	41588	O	-1	-1	0
structures.10,59	PMC3035602	41589	41605	O	-1	-1	0


	PMC3035602	41605	41607	O	-1	-1	0

Clinical	PMC3035602	41607	41615	O	-1	-1	0
Epidemiology	PMC3035602	41616	41628	O	-1	-1	0
2011:3	PMC3035602	41629	41635	O	-1	-1	0


	PMC3035602	41635	41637	O	-1	-1	0

Birth	PMC3035602	41637	41642	O	-1	-1	0
outcome	PMC3035602	41643	41650	O	-1	-1	0
in	PMC3035602	41651	41653	O	-1	-1	0
women	PMC3035602	41654	41659	O	-1	-1	0
with	PMC3035602	41660	41664	O	-1	-1	0
cancer	PMC3035602	41665	41671	O	-1	-1	0


	PMC3035602	41671	41673	O	-1	-1	0

Traditional	PMC3035602	41673	41684	O	-1	-1	0
ways	PMC3035602	41685	41689	O	-1	-1	0
to	PMC3035602	41690	41692	O	-1	-1	0
protect	PMC3035602	41693	41700	O	-1	-1	0
the	PMC3035602	41701	41704	O	-1	-1	0
ovaries	PMC3035602	41705	41712	O	-1	-1	0
against	PMC3035602	41713	41720	O	-1	-1	0
the	PMC3035602	41721	41724	O	-1	-1	0
radiation	PMC3035602	41725	41734	O	-1	-1	0
damage	PMC3035602	41735	41741	O	-1	-1	0
are	PMC3035602	41742	41745	O	-1	-1	0
shielding	PMC3035602	41746	41755	O	-1	-1	0
of	PMC3035602	41756	41758	O	-1	-1	0
the	PMC3035602	41759	41762	O	-1	-1	0
ovaries	PMC3035602	41763	41770	O	-1	-1	0
and	PMC3035602	41771	41774	O	-1	-1	0
,	PMC3035602	41774	41775	O	-1	-1	0
in	PMC3035602	41776	41778	O	-1	-1	0
case	PMC3035602	41779	41783	O	-1	-1	0
of	PMC3035602	41784	41786	O	-1	-1	0
pelvic	PMC3035602	41787	41793	O	-1	-1	0
lymph	PMC3035602	41794	41799	O	-1	-1	0
node	PMC3035602	41800	41804	O	-1	-1	0
irradiation	PMC3035602	41805	41816	O	-1	-1	0
,	PMC3035602	41816	41817	O	-1	-1	0
repositioning	PMC3035602	41818	41831	O	-1	-1	0
of	PMC3035602	41832	41834	O	-1	-1	0
the	PMC3035602	41835	41838	O	-1	-1	0
ovaries	PMC3035602	41839	41846	O	-1	-1	0
out	PMC3035602	41847	41850	O	-1	-1	0
of	PMC3035602	41851	41853	O	-1	-1	0
the	PMC3035602	41854	41857	O	-1	-1	0
irradiation	PMC3035602	41858	41869	O	-1	-1	0
field	PMC3035602	41870	41875	O	-1	-1	0
(	PMC3035602	41876	41877	O	-1	-1	0
oopheropexy).65	PMC3035602	41877	41892	O	-1	-1	0

Today	PMC3035602	41893	41898	O	-1	-1	0
,	PMC3035602	41898	41899	O	-1	-1	0
many	PMC3035602	41900	41904	O	-1	-1	0
young	PMC3035602	41905	41910	O	-1	-1	0
patients	PMC3035602	41911	41919	O	-1	-1	0
needing	PMC3035602	41920	41927	O	-1	-1	0
radiotherapy	PMC3035602	41928	41940	O	-1	-1	0
(	PMC3035602	41941	41942	O	-1	-1	0
or	PMC3035602	41942	41944	O	-1	-1	0
chemotherapy	PMC3035602	41945	41957	O	-1	-1	0
)	PMC3035602	41957	41958	O	-1	-1	0

are	PMC3035602	41959	41962	O	-1	-1	0
offered	PMC3035602	41963	41970	O	-1	-1	0
the	PMC3035602	41971	41974	O	-1	-1	0
option	PMC3035602	41975	41981	O	-1	-1	0
of	PMC3035602	41982	41984	O	-1	-1	0
cryopreservation	PMC3035602	41985	42001	O	-1	-1	0
of	PMC3035602	42002	42004	O	-1	-1	0
their	PMC3035602	42005	42010	O	-1	-1	0
ovarian	PMC3035602	42011	42018	O	-1	-1	0
tissue	PMC3035602	42019	42025	O	-1	-1	0
,	PMC3035602	42025	42026	O	-1	-1	0
while	PMC3035602	42027	42032	O	-1	-1	0
recent	PMC3035602	42033	42039	O	-1	-1	0
studies	PMC3035602	42040	42047	O	-1	-1	0
of	PMC3035602	42048	42050	O	-1	-1	0
ovarian	PMC3035602	42051	42058	O	-1	-1	0
tissue	PMC3035602	42059	42065	O	-1	-1	0
autotransplantation	PMC3035602	42066	42085	O	-1	-1	0
offer	PMC3035602	42086	42091	O	-1	-1	0
promising	PMC3035602	42092	42101	O	-1	-1	0
results.66	PMC3035602	42102	42112	O	-1	-1	0


	PMC3035602	42112	42114	O	-1	-1	0

Chemotherapy	PMC3035602	42114	42126	O	-1	-1	0

A	PMC3035602	42127	42128	O	-1	-1	0
potential	PMC3035602	42129	42138	O	-1	-1	0
teratogenic	PMC3035602	42139	42150	O	-1	-1	0
effect	PMC3035602	42151	42157	O	-1	-1	0
of	PMC3035602	42158	42160	O	-1	-1	0
chemotherapy	PMC3035602	42161	42173	O	-1	-1	0
­during	PMC3035602	42174	42181	O	-1	-1	0
pregnancy	PMC3035602	42182	42191	O	-1	-1	0
depends	PMC3035602	42192	42199	O	-1	-1	0
on	PMC3035602	42200	42202	O	-1	-1	0
the	PMC3035602	42203	42206	O	-1	-1	0
agent	PMC3035602	42207	42212	O	-1	-1	0
used	PMC3035602	42213	42217	O	-1	-1	0
,	PMC3035602	42217	42218	O	-1	-1	0
the	PMC3035602	42219	42222	O	-1	-1	0
timing	PMC3035602	42223	42229	O	-1	-1	0
of	PMC3035602	42230	42232	O	-1	-1	0
­exposure	PMC3035602	42233	42242	O	-1	-1	0
,	PMC3035602	42242	42243	O	-1	-1	0
the	PMC3035602	42244	42247	O	-1	-1	0
dose	PMC3035602	42248	42252	O	-1	-1	0
,	PMC3035602	42252	42253	O	-1	-1	0
and	PMC3035602	42254	42257	O	-1	-1	0
the	PMC3035602	42258	42261	O	-1	-1	0
characteristics	PMC3035602	42262	42277	O	-1	-1	0
affecting	PMC3035602	42278	42287	O	-1	-1	0
placental	PMC3035602	42288	42297	O	-1	-1	0
transfer	PMC3035602	42298	42306	O	-1	-1	0
.	PMC3035602	42306	42307	O	-1	-1	0

Use	PMC3035602	42308	42311	O	-1	-1	0
of	PMC3035602	42312	42314	O	-1	-1	0
chemotherapy	PMC3035602	42315	42327	O	-1	-1	0
during	PMC3035602	42328	42334	O	-1	-1	0
the	PMC3035602	42335	42338	O	-1	-1	0
first	PMC3035602	42339	42344	O	-1	-1	0
trimester	PMC3035602	42345	42354	O	-1	-1	0
increases	PMC3035602	42355	42364	O	-1	-1	0

the	PMC3035602	42365	42368	O	-1	-1	0
risk	PMC3035602	42369	42373	O	-1	-1	0
of	PMC3035602	42374	42376	O	-1	-1	0
miscarriage	PMC3035602	42377	42388	O	-1	-1	0
and	PMC3035602	42389	42392	O	-1	-1	0
congenital	PMC3035602	42393	42403	O	-1	-1	0
abnormalities	PMC3035602	42404	42417	O	-1	-1	0
.	PMC3035602	42417	42418	O	-1	-1	0

26	PMC3035602	42419	42421	O	-1	-1	0

A	PMC3035602	42422	42423	O	-1	-1	0
review	PMC3035602	42424	42430	O	-1	-1	0
of	PMC3035602	42431	42433	O	-1	-1	0
139	PMC3035602	42434	42437	O	-1	-1	0
cases	PMC3035602	42438	42443	O	-1	-1	0
of	PMC3035602	42444	42446	O	-1	-1	0
first	PMC3035602	42447	42452	O	-1	-1	0
-	PMC3035602	42452	42453	O	-1	-1	0
trimester	PMC3035602	42453	42462	O	-1	-1	0
exposure	PMC3035602	42463	42471	O	-1	-1	0
to	PMC3035602	42472	42474	O	-1	-1	0
chemotherapy	PMC3035602	42475	42487	O	-1	-1	0
reported	PMC3035602	42488	42496	O	-1	-1	0
a	PMC3035602	42497	42498	O	-1	-1	0
total	PMC3035602	42499	42504	O	-1	-1	0
of	PMC3035602	42505	42507	O	-1	-1	0
24	PMC3035602	42508	42510	O	-1	-1	0
(	PMC3035602	42511	42512	O	-1	-1	0
17	PMC3035602	42512	42514	O	-1	-1	0
%	PMC3035602	42514	42515	O	-1	-1	0
)	PMC3035602	42515	42516	O	-1	-1	0
infants	PMC3035602	42517	42524	O	-1	-1	0
with	PMC3035602	42525	42529	O	-1	-1	0
congenital	PMC3035602	42530	42540	O	-1	-1	0
abnormalities	PMC3035602	42541	42554	O	-1	-1	0
after	PMC3035602	42555	42560	O	-1	-1	0
a	PMC3035602	42561	42562	O	-1	-1	0
single	PMC3035602	42563	42569	O	-1	-1	0
agent	PMC3035602	42570	42575	O	-1	-1	0
exposure	PMC3035602	42576	42584	O	-1	-1	0
,	PMC3035602	42584	42585	O	-1	-1	0
and	PMC3035602	42586	42589	O	-1	-1	0
a	PMC3035602	42590	42591	O	-1	-1	0
prevalence	PMC3035602	42592	42602	O	-1	-1	0
of	PMC3035602	42603	42605	O	-1	-1	0
25	PMC3035602	42606	42608	O	-1	-1	0
%	PMC3035602	42608	42609	O	-1	-1	0
after	PMC3035602	42610	42615	O	-1	-1	0
combination	PMC3035602	42616	42627	O	-1	-1	0
-	PMC3035602	42627	42628	O	-1	-1	0
agent	PMC3035602	42628	42633	O	-1	-1	0
exposure.67	PMC3035602	42634	42645	O	-1	-1	0

Chemotherapy	PMC3035602	42646	42658	O	-1	-1	0
during	PMC3035602	42659	42665	O	-1	-1	0
the	PMC3035602	42666	42669	O	-1	-1	0
second	PMC3035602	42670	42676	O	-1	-1	0
and	PMC3035602	42677	42680	O	-1	-1	0
third	PMC3035602	42681	42686	O	-1	-1	0
trimesters	PMC3035602	42687	42697	O	-1	-1	0
may	PMC3035602	42698	42701	O	-1	-1	0
increase	PMC3035602	42702	42710	O	-1	-1	0
the	PMC3035602	42711	42714	O	-1	-1	0
risk	PMC3035602	42715	42719	O	-1	-1	0
of	PMC3035602	42720	42722	O	-1	-1	0
preterm	PMC3035602	42723	42730	O	-1	-1	0
birth	PMC3035602	42731	42736	O	-1	-1	0
,	PMC3035602	42736	42737	O	-1	-1	0
IUGR	PMC3035602	42738	42742	O	-1	-1	0
,	PMC3035602	42742	42743	O	-1	-1	0
and	PMC3035602	42744	42747	O	-1	-1	0
stillbirth.12	PMC3035602	42748	42761	O	-1	-1	0

Furthermore	PMC3035602	42762	42773	O	-1	-1	0
,	PMC3035602	42773	42774	O	-1	-1	0
the	PMC3035602	42775	42778	O	-1	-1	0
central	PMC3035602	42779	42786	O	-1	-1	0
nervous	PMC3035602	42787	42794	O	-1	-1	0
system	PMC3035602	42795	42801	O	-1	-1	0
continues	PMC3035602	42802	42811	O	-1	-1	0
to	PMC3035602	42812	42814	O	-1	-1	0
develop	PMC3035602	42815	42822	O	-1	-1	0
after	PMC3035602	42823	42828	O	-1	-1	0
the	PMC3035602	42829	42832	O	-1	-1	0
first	PMC3035602	42833	42838	O	-1	-1	0
trimester	PMC3035602	42839	42848	O	-1	-1	0
,	PMC3035602	42848	42849	O	-1	-1	0
which	PMC3035602	42850	42855	O	-1	-1	0
makes	PMC3035602	42856	42861	O	-1	-1	0
it	PMC3035602	42862	42864	O	-1	-1	0
sensitive	PMC3035602	42865	42874	O	-1	-1	0
to	PMC3035602	42875	42877	O	-1	-1	0
insults	PMC3035602	42878	42885	O	-1	-1	0
during	PMC3035602	42886	42892	O	-1	-1	0
the	PMC3035602	42893	42896	O	-1	-1	0
entire	PMC3035602	42897	42903	O	-1	-1	0
pregnancy.12	PMC3035602	42904	42916	O	-1	-1	0
While	PMC3035602	42917	42922	O	-1	-1	0
exposure	PMC3035602	42923	42931	O	-1	-1	0
to	PMC3035602	42932	42934	O	-1	-1	0
chemotherapy	PMC3035602	42935	42947	O	-1	-1	0
after	PMC3035602	42948	42953	O	-1	-1	0
the	PMC3035602	42954	42957	O	-1	-1	0
first	PMC3035602	42958	42963	O	-1	-1	0
trimester	PMC3035602	42964	42973	O	-1	-1	0
does	PMC3035602	42974	42978	O	-1	-1	0
not	PMC3035602	42979	42982	O	-1	-1	0
cause	PMC3035602	42983	42988	O	-1	-1	0
macroscopic	PMC3035602	42989	43000	O	-1	-1	0
anatomical	PMC3035602	43001	43011	O	-1	-1	0
defects	PMC3035602	43012	43019	O	-1	-1	0
,	PMC3035602	43019	43020	O	-1	-1	0
it	PMC3035602	43021	43023	O	-1	-1	0
may	PMC3035602	43024	43027	O	-1	-1	0
have	PMC3035602	43028	43032	O	-1	-1	0
long	PMC3035602	43033	43037	O	-1	-1	0
-	PMC3035602	43037	43038	O	-1	-1	0
term	PMC3035602	43038	43042	O	-1	-1	0
subanatomical	PMC3035602	43043	43056	O	-1	-1	0
consequences	PMC3035602	43057	43069	O	-1	-1	0
,	PMC3035602	43069	43070	O	-1	-1	0
for	PMC3035602	43071	43074	O	-1	-1	0
example	PMC3035602	43075	43082	O	-1	-1	0
,	PMC3035602	43082	43083	O	-1	-1	0
by	PMC3035602	43084	43086	O	-1	-1	0
interfering	PMC3035602	43087	43098	O	-1	-1	0
with	PMC3035602	43099	43103	O	-1	-1	0
the	PMC3035602	43104	43107	O	-1	-1	0
neuronal	PMC3035602	43108	43116	O	-1	-1	0
proliferation	PMC3035602	43117	43130	O	-1	-1	0
and	PMC3035602	43131	43134	O	-1	-1	0
migration.12	PMC3035602	43135	43147	O	-1	-1	0

However	PMC3035602	43148	43155	O	-1	-1	0
,	PMC3035602	43155	43156	O	-1	-1	0
a	PMC3035602	43157	43158	O	-1	-1	0
study	PMC3035602	43159	43164	O	-1	-1	0
of	PMC3035602	43165	43167	O	-1	-1	0
late	PMC3035602	43168	43172	O	-1	-1	0
side	PMC3035602	43173	43177	O	-1	-1	0
effects	PMC3035602	43178	43185	O	-1	-1	0
among	PMC3035602	43186	43191	O	-1	-1	0
84	PMC3035602	43192	43194	O	-1	-1	0
children	PMC3035602	43195	43203	O	-1	-1	0
whose	PMC3035602	43204	43209	O	-1	-1	0
mothers	PMC3035602	43210	43217	O	-1	-1	0
received	PMC3035602	43218	43226	O	-1	-1	0
chemotherapy	PMC3035602	43227	43239	O	-1	-1	0
,	PMC3035602	43239	43240	O	-1	-1	0
during	PMC3035602	43241	43247	O	-1	-1	0
pregnancy	PMC3035602	43248	43257	O	-1	-1	0
,	PMC3035602	43257	43258	O	-1	-1	0
for	PMC3035602	43259	43262	O	-1	-1	0
hematological	PMC3035602	43263	43276	O	-1	-1	0
malignancies	PMC3035602	43277	43289	O	-1	-1	0
did	PMC3035602	43290	43293	O	-1	-1	0
not	PMC3035602	43294	43297	O	-1	-1	0
show	PMC3035602	43298	43302	O	-1	-1	0
impairments	PMC3035602	43303	43314	O	-1	-1	0
in	PMC3035602	43315	43317	O	-1	-1	0
learning	PMC3035602	43318	43326	O	-1	-1	0
behavior	PMC3035602	43327	43335	O	-1	-1	0
,	PMC3035602	43335	43336	O	-1	-1	0
or	PMC3035602	43337	43339	O	-1	-1	0
neurological	PMC3035602	43340	43352	O	-1	-1	0
abnormalities	PMC3035602	43353	43366	O	-1	-1	0
after	PMC3035602	43367	43372	O	-1	-1	0
a	PMC3035602	43373	43374	O	-1	-1	0
median	PMC3035602	43375	43381	O	-1	-1	0
follow	PMC3035602	43382	43388	O	-1	-1	0
-	PMC3035602	43388	43389	O	-1	-1	0
up	PMC3035602	43389	43391	O	-1	-1	0
of	PMC3035602	43392	43394	O	-1	-1	0
18	PMC3035602	43395	43397	O	-1	-1	0
years.68	PMC3035602	43398	43406	O	-1	-1	0

Given	PMC3035602	43407	43412	O	-1	-1	0
all	PMC3035602	43413	43416	O	-1	-1	0
the	PMC3035602	43417	43420	O	-1	-1	0
evidence	PMC3035602	43421	43429	O	-1	-1	0
,	PMC3035602	43429	43430	O	-1	-1	0
it	PMC3035602	43431	43433	O	-1	-1	0
is	PMC3035602	43434	43436	O	-1	-1	0
generally	PMC3035602	43437	43446	O	-1	-1	0
recommended	PMC3035602	43447	43458	O	-1	-1	0
that	PMC3035602	43459	43463	O	-1	-1	0
chemotherapy	PMC3035602	43464	43476	O	-1	-1	0
is	PMC3035602	43477	43479	O	-1	-1	0
delayed	PMC3035602	43480	43487	O	-1	-1	0
until	PMC3035602	43488	43493	O	-1	-1	0
after	PMC3035602	43494	43499	O	-1	-1	0
the	PMC3035602	43500	43503	O	-1	-1	0
first	PMC3035602	43504	43509	O	-1	-1	0
trimester.12	PMC3035602	43510	43522	O	-1	-1	0

In	PMC3035602	43523	43525	O	-1	-1	0
nonpregnant	PMC3035602	43526	43537	O	-1	-1	0
women	PMC3035602	43538	43543	O	-1	-1	0
of	PMC3035602	43544	43546	O	-1	-1	0
childbearing	PMC3035602	43547	43559	O	-1	-1	0
age	PMC3035602	43560	43563	O	-1	-1	0
,	PMC3035602	43563	43564	O	-1	-1	0
chemotherapy	PMC3035602	43565	43577	O	-1	-1	0
can	PMC3035602	43578	43581	O	-1	-1	0
adversely	PMC3035602	43582	43591	O	-1	-1	0
affect	PMC3035602	43592	43598	O	-1	-1	0
fertility.69	PMC3035602	43599	43611	O	-1	-1	0
Damage	PMC3035602	43612	43618	O	-1	-1	0
to	PMC3035602	43619	43621	O	-1	-1	0
the	PMC3035602	43622	43625	O	-1	-1	0
ovarian	PMC3035602	43626	43633	O	-1	-1	0
tissue	PMC3035602	43634	43640	O	-1	-1	0

depends	PMC3035602	43641	43648	O	-1	-1	0
on	PMC3035602	43649	43651	O	-1	-1	0
the	PMC3035602	43652	43655	O	-1	-1	0
agent	PMC3035602	43656	43661	O	-1	-1	0
used	PMC3035602	43662	43666	O	-1	-1	0
,	PMC3035602	43666	43667	O	-1	-1	0
the	PMC3035602	43668	43671	O	-1	-1	0
dose	PMC3035602	43672	43676	O	-1	-1	0
,	PMC3035602	43676	43677	O	-1	-1	0
and	PMC3035602	43678	43681	O	-1	-1	0
the	PMC3035602	43682	43685	O	-1	-1	0
age	PMC3035602	43686	43689	O	-1	-1	0
of	PMC3035602	43690	43692	O	-1	-1	0
the	PMC3035602	43693	43696	O	-1	-1	0
patient	PMC3035602	43697	43704	O	-1	-1	0
at	PMC3035602	43705	43707	O	-1	-1	0
treatment.70	PMC3035602	43708	43720	O	-1	-1	0

Furthermore	PMC3035602	43721	43732	O	-1	-1	0
,	PMC3035602	43732	43733	O	-1	-1	0
chemotherapy	PMC3035602	43734	43746	O	-1	-1	0
is	PMC3035602	43747	43749	O	-1	-1	0
potentially	PMC3035602	43750	43761	O	-1	-1	0
mutagenic10	PMC3035602	43762	43773	O	-1	-1	0
with	PMC3035602	43774	43778	O	-1	-1	0
animal	PMC3035602	43779	43785	O	-1	-1	0
studies	PMC3035602	43786	43793	O	-1	-1	0
showing	PMC3035602	43794	43801	O	-1	-1	0
that	PMC3035602	43802	43806	O	-1	-1	0
it	PMC3035602	43807	43809	O	-1	-1	0
can	PMC3035602	43810	43813	O	-1	-1	0
cause	PMC3035602	43814	43819	O	-1	-1	0
mutations	PMC3035602	43820	43829	O	-1	-1	0
in	PMC3035602	43830	43832	O	-1	-1	0
oocytes	PMC3035602	43833	43840	O	-1	-1	0
and	PMC3035602	43841	43844	O	-1	-1	0
increase	PMC3035602	43845	43853	O	-1	-1	0
the	PMC3035602	43854	43857	O	-1	-1	0
risk	PMC3035602	43858	43862	O	-1	-1	0
of	PMC3035602	43863	43865	O	-1	-1	0
fetal	PMC3035602	43866	43871	O	-1	-1	0
abnormalities.65	PMC3035602	43872	43888	O	-1	-1	0


	PMC3035602	43888	43890	O	-1	-1	0
Endocrine	PMC3035602	43890	43899	O	-1	-1	0
therapy	PMC3035602	43900	43907	O	-1	-1	0

The	PMC3035602	43908	43911	O	-1	-1	0
use	PMC3035602	43912	43915	O	-1	-1	0
of	PMC3035602	43916	43918	O	-1	-1	0
anti	PMC3035602	43919	43923	O	-1	-1	0
-	PMC3035602	43923	43924	O	-1	-1	0
estrogenic	PMC3035602	43924	43934	O	-1	-1	0
therapy	PMC3035602	43935	43942	O	-1	-1	0
,	PMC3035602	43942	43943	O	-1	-1	0
such	PMC3035602	43944	43948	O	-1	-1	0
as	PMC3035602	43949	43951	O	-1	-1	0
tamoxifen	PMC3035602	43952	43961	O	-1	-1	0
,	PMC3035602	43961	43962	O	-1	-1	0
in	PMC3035602	43963	43965	O	-1	-1	0
­pregnant	PMC3035602	43966	43975	O	-1	-1	0
breast	PMC3035602	43976	43982	O	-1	-1	0
cancer	PMC3035602	43983	43989	O	-1	-1	0
patients	PMC3035602	43990	43998	O	-1	-1	0
has	PMC3035602	43999	44002	O	-1	-1	0
been	PMC3035602	44003	44007	O	-1	-1	0
discouraged	PMC3035602	44008	44019	O	-1	-1	0
because	PMC3035602	44020	44027	O	-1	-1	0
of	PMC3035602	44028	44030	O	-1	-1	0
teratogenic	PMC3035602	44031	44042	O	-1	-1	0
effects	PMC3035602	44043	44050	O	-1	-1	0
seen	PMC3035602	44051	44055	O	-1	-1	0
in	PMC3035602	44056	44058	O	-1	-1	0
animal	PMC3035602	44059	44065	O	-1	-1	0
models.12	PMC3035602	44066	44075	O	-1	-1	0
Direct	PMC3035602	44076	44082	O	-1	-1	0
evidence	PMC3035602	44083	44091	O	-1	-1	0
for	PMC3035602	44092	44095	O	-1	-1	0
teratogenesis	PMC3035602	44096	44109	O	-1	-1	0
in	PMC3035602	44110	44112	O	-1	-1	0
humans	PMC3035602	44113	44119	O	-1	-1	0
is	PMC3035602	44120	44122	O	-1	-1	0
limited	PMC3035602	44123	44130	O	-1	-1	0
,	PMC3035602	44130	44131	O	-1	-1	0
with	PMC3035602	44132	44136	O	-1	-1	0
only	PMC3035602	44137	44141	O	-1	-1	0
isolated	PMC3035602	44142	44150	O	-1	-1	0
reports	PMC3035602	44151	44158	O	-1	-1	0
of	PMC3035602	44159	44161	O	-1	-1	0
rare	PMC3035602	44162	44166	O	-1	-1	0
forms	PMC3035602	44167	44172	O	-1	-1	0
of	PMC3035602	44173	44175	O	-1	-1	0
congenital	PMC3035602	44176	44186	O	-1	-1	0
abnormalities	PMC3035602	44187	44200	O	-1	-1	0
associated	PMC3035602	44201	44211	O	-1	-1	0
with	PMC3035602	44212	44216	O	-1	-1	0
tamoxifen	PMC3035602	44217	44226	O	-1	-1	0
use.71	PMC3035602	44227	44233	O	-1	-1	0


	PMC3035602	44233	44235	O	-1	-1	0
submit	PMC3035602	44235	44241	O	-1	-1	0
your	PMC3035602	44242	44246	O	-1	-1	0
manuscript	PMC3035602	44247	44257	O	-1	-1	0

|	PMC3035602	44258	44259	O	-1	-1	0

www.dovepress.com	PMC3035602	44260	44277	O	-1	-1	0


	PMC3035602	44277	44279	O	-1	-1	0

Dovepress	PMC3035602	44279	44288	O	-1	-1	0


	PMC3035602	44288	44290	O	-1	-1	0
17	PMC3035602	44290	44292	O	-1	-1	0


	PMC3035602	44292	44294	O	-1	-1	0

Langagergaard	PMC3035602	44294	44307	O	-1	-1	0


	PMC3035602	44307	44309	O	-1	-1	0
Conclusions	PMC3035602	44309	44320	O	-1	-1	0
and	PMC3035602	44321	44324	O	-1	-1	0
perspectives	PMC3035602	44325	44337	O	-1	-1	0

This	PMC3035602	44338	44342	O	-1	-1	0
review	PMC3035602	44343	44349	O	-1	-1	0
summarizes	PMC3035602	44350	44360	O	-1	-1	0
the	PMC3035602	44361	44364	O	-1	-1	0
existing	PMC3035602	44365	44373	O	-1	-1	0
epidemiologic	PMC3035602	44374	44387	O	-1	-1	0
evidence	PMC3035602	44388	44396	O	-1	-1	0
of	PMC3035602	44397	44399	O	-1	-1	0
the	PMC3035602	44400	44403	O	-1	-1	0
adverse	PMC3035602	44404	44411	O	-1	-1	0
effect	PMC3035602	44412	44418	O	-1	-1	0
of	PMC3035602	44419	44421	O	-1	-1	0
maternal	PMC3035602	44422	44430	O	-1	-1	0
breast	PMC3035602	44431	44437	O	-1	-1	0
cancer	PMC3035602	44438	44444	O	-1	-1	0
,	PMC3035602	44444	44445	O	-1	-1	0
melanoma	PMC3035602	44446	44454	O	-1	-1	0
,	PMC3035602	44454	44455	O	-1	-1	0
and	PMC3035602	44456	44459	O	-1	-1	0
Hodgkin	PMC3035602	44460	44467	O	-1	-1	0
’s	PMC3035602	44467	44469	O	-1	-1	0
disease	PMC3035602	44470	44477	O	-1	-1	0
on	PMC3035602	44478	44480	O	-1	-1	0
birth	PMC3035602	44481	44486	O	-1	-1	0
outcome	PMC3035602	44487	44494	O	-1	-1	0
.	PMC3035602	44494	44495	O	-1	-1	0

On	PMC3035602	44496	44498	O	-1	-1	0
the	PMC3035602	44499	44502	O	-1	-1	0
whole	PMC3035602	44503	44508	O	-1	-1	0
,	PMC3035602	44508	44509	O	-1	-1	0
existing	PMC3035602	44510	44518	O	-1	-1	0
studies	PMC3035602	44519	44526	O	-1	-1	0
offer	PMC3035602	44527	44532	O	-1	-1	0
reassuring	PMC3035602	44533	44543	O	-1	-1	0
results	PMC3035602	44544	44551	O	-1	-1	0
concerning	PMC3035602	44552	44562	O	-1	-1	0
the	PMC3035602	44563	44566	O	-1	-1	0
risks	PMC3035602	44567	44572	O	-1	-1	0
of	PMC3035602	44573	44575	O	-1	-1	0
adverse	PMC3035602	44576	44583	O	-1	-1	0
birth	PMC3035602	44584	44589	O	-1	-1	0
outcome	PMC3035602	44590	44597	O	-1	-1	0
for	PMC3035602	44598	44601	O	-1	-1	0
women	PMC3035602	44602	44607	O	-1	-1	0
diagnosed	PMC3035602	44608	44617	O	-1	-1	0
with	PMC3035602	44618	44622	O	-1	-1	0
breast	PMC3035602	44623	44629	O	-1	-1	0
cancer	PMC3035602	44630	44636	O	-1	-1	0
,	PMC3035602	44636	44637	O	-1	-1	0
melanoma	PMC3035602	44638	44646	O	-1	-1	0
,	PMC3035602	44646	44647	O	-1	-1	0
or	PMC3035602	44648	44650	O	-1	-1	0
Hodgkin	PMC3035602	44651	44658	O	-1	-1	0
’s	PMC3035602	44658	44660	O	-1	-1	0
disease	PMC3035602	44661	44668	O	-1	-1	0
before	PMC3035602	44669	44675	O	-1	-1	0
,	PMC3035602	44675	44676	O	-1	-1	0
during	PMC3035602	44677	44683	O	-1	-1	0
or	PMC3035602	44684	44686	O	-1	-1	0
shortly	PMC3035602	44687	44694	O	-1	-1	0
after	PMC3035602	44695	44700	O	-1	-1	0
pregnancy	PMC3035602	44701	44710	O	-1	-1	0
.	PMC3035602	44710	44711	O	-1	-1	0

However	PMC3035602	44712	44719	O	-1	-1	0
,	PMC3035602	44719	44720	O	-1	-1	0
a	PMC3035602	44721	44722	O	-1	-1	0
limitation	PMC3035602	44723	44733	O	-1	-1	0
of	PMC3035602	44734	44736	O	-1	-1	0
most	PMC3035602	44737	44741	O	-1	-1	0
studies	PMC3035602	44742	44749	O	-1	-1	0
was	PMC3035602	44750	44753	O	-1	-1	0
the	PMC3035602	44754	44757	O	-1	-1	0
imprecise	PMC3035602	44758	44767	O	-1	-1	0
risk	PMC3035602	44768	44772	O	-1	-1	0
estimates	PMC3035602	44773	44782	O	-1	-1	0
caused	PMC3035602	44783	44789	O	-1	-1	0
by	PMC3035602	44790	44792	O	-1	-1	0
the	PMC3035602	44793	44796	O	-1	-1	0
small	PMC3035602	44797	44802	O	-1	-1	0
number	PMC3035602	44803	44809	O	-1	-1	0
of	PMC3035602	44810	44812	O	-1	-1	0
adverse	PMC3035602	44813	44820	O	-1	-1	0
birth	PMC3035602	44821	44826	O	-1	-1	0
outcomes	PMC3035602	44827	44835	O	-1	-1	0
and	PMC3035602	44836	44839	O	-1	-1	0
the	PMC3035602	44840	44843	O	-1	-1	0
lack	PMC3035602	44844	44848	O	-1	-1	0
of	PMC3035602	44849	44851	O	-1	-1	0
results	PMC3035602	44852	44859	O	-1	-1	0
stratified	PMC3035602	44860	44870	O	-1	-1	0
by	PMC3035602	44871	44873	O	-1	-1	0
treatment	PMC3035602	44874	44883	O	-1	-1	0
.	PMC3035602	44883	44884	O	-1	-1	0

Since	PMC3035602	44885	44890	O	-1	-1	0
even	PMC3035602	44891	44895	O	-1	-1	0
countrywide	PMC3035602	44896	44907	O	-1	-1	0
data	PMC3035602	44908	44912	O	-1	-1	0
may	PMC3035602	44913	44916	O	-1	-1	0
be	PMC3035602	44917	44919	O	-1	-1	0
sparse	PMC3035602	44920	44926	O	-1	-1	0
,	PMC3035602	44926	44927	O	-1	-1	0
an	PMC3035602	44928	44930	O	-1	-1	0
international	PMC3035602	44931	44944	O	-1	-1	0
collaboration	PMC3035602	44945	44958	O	-1	-1	0
is	PMC3035602	44959	44961	O	-1	-1	0
required	PMC3035602	44962	44970	O	-1	-1	0
in	PMC3035602	44971	44973	O	-1	-1	0
order	PMC3035602	44974	44979	O	-1	-1	0
to	PMC3035602	44980	44982	O	-1	-1	0
assemble	PMC3035602	44983	44991	O	-1	-1	0
data	PMC3035602	44992	44996	O	-1	-1	0
on	PMC3035602	44997	44999	O	-1	-1	0
a	PMC3035602	45000	45001	O	-1	-1	0
sufficient	PMC3035602	45002	45012	O	-1	-1	0
number	PMC3035602	45013	45019	O	-1	-1	0
of	PMC3035602	45020	45022	O	-1	-1	0
births	PMC3035602	45023	45029	O	-1	-1	0
by	PMC3035602	45030	45032	O	-1	-1	0
women	PMC3035602	45033	45038	O	-1	-1	0
with	PMC3035602	45039	45043	O	-1	-1	0
cancer	PMC3035602	45044	45050	O	-1	-1	0
in	PMC3035602	45051	45053	O	-1	-1	0
order	PMC3035602	45054	45059	O	-1	-1	0
to	PMC3035602	45060	45062	O	-1	-1	0
obtain	PMC3035602	45063	45069	O	-1	-1	0
more	PMC3035602	45070	45074	O	-1	-1	0
precise	PMC3035602	45075	45082	O	-1	-1	0
risk	PMC3035602	45083	45087	O	-1	-1	0
estimates	PMC3035602	45088	45097	O	-1	-1	0
for	PMC3035602	45098	45101	O	-1	-1	0
adverse	PMC3035602	45102	45109	O	-1	-1	0
birth	PMC3035602	45110	45115	O	-1	-1	0
outcomes	PMC3035602	45116	45124	O	-1	-1	0
.	PMC3035602	45124	45125	O	-1	-1	0

Moreover	PMC3035602	45126	45134	O	-1	-1	0
,	PMC3035602	45134	45135	O	-1	-1	0
a	PMC3035602	45136	45137	O	-1	-1	0
larger	PMC3035602	45138	45144	O	-1	-1	0
number	PMC3035602	45145	45151	O	-1	-1	0
of	PMC3035602	45152	45154	O	-1	-1	0
birth	PMC3035602	45155	45160	O	-1	-1	0
outcomes	PMC3035602	45161	45169	O	-1	-1	0
would	PMC3035602	45170	45175	O	-1	-1	0
allow	PMC3035602	45176	45181	O	-1	-1	0
stratified	PMC3035602	45182	45192	O	-1	-1	0
analyses	PMC3035602	45193	45201	O	-1	-1	0
according	PMC3035602	45202	45211	O	-1	-1	0
to	PMC3035602	45212	45214	O	-1	-1	0
,	PMC3035602	45214	45215	O	-1	-1	0
for	PMC3035602	45216	45219	O	-1	-1	0
example	PMC3035602	45220	45227	O	-1	-1	0
,	PMC3035602	45227	45228	O	-1	-1	0
different	PMC3035602	45229	45238	O	-1	-1	0
treatment	PMC3035602	45239	45248	O	-1	-1	0
regimens	PMC3035602	45249	45257	O	-1	-1	0
,	PMC3035602	45257	45258	O	-1	-1	0
stages	PMC3035602	45259	45265	O	-1	-1	0
,	PMC3035602	45265	45266	O	-1	-1	0
and	PMC3035602	45267	45270	O	-1	-1	0
how	PMC3035602	45271	45274	O	-1	-1	0
close	PMC3035602	45275	45280	O	-1	-1	0
in	PMC3035602	45281	45283	O	-1	-1	0
time	PMC3035602	45284	45288	O	-1	-1	0

the	PMC3035602	45289	45292	O	-1	-1	0
cancer	PMC3035602	45293	45299	O	-1	-1	0
diagnosis	PMC3035602	45300	45309	O	-1	-1	0
was	PMC3035602	45310	45313	O	-1	-1	0
to	PMC3035602	45314	45316	O	-1	-1	0
pregnancy	PMC3035602	45317	45326	O	-1	-1	0
.	PMC3035602	45326	45327	O	-1	-1	0

Information	PMC3035602	45328	45339	O	-1	-1	0
on	PMC3035602	45340	45342	O	-1	-1	0
these	PMC3035602	45343	45348	O	-1	-1	0
clinical	PMC3035602	45349	45357	O	-1	-1	0
details	PMC3035602	45358	45365	O	-1	-1	0
could	PMC3035602	45366	45371	O	-1	-1	0
be	PMC3035602	45372	45374	O	-1	-1	0
obtained	PMC3035602	45375	45383	O	-1	-1	0
from	PMC3035602	45384	45388	O	-1	-1	0
hospital	PMC3035602	45389	45397	O	-1	-1	0
medical	PMC3035602	45398	45405	O	-1	-1	0
records	PMC3035602	45406	45413	O	-1	-1	0
and	PMC3035602	45414	45417	O	-1	-1	0
clinical	PMC3035602	45418	45426	O	-1	-1	0
databases	PMC3035602	45427	45436	O	-1	-1	0
.	PMC3035602	45436	45437	O	-1	-1	0

Very	PMC3035602	45438	45442	O	-1	-1	0
few	PMC3035602	45443	45446	O	-1	-1	0
studies	PMC3035602	45447	45454	O	-1	-1	0
document	PMC3035602	45455	45463	O	-1	-1	0
the	PMC3035602	45464	45467	O	-1	-1	0
long	PMC3035602	45468	45472	O	-1	-1	0
-	PMC3035602	45472	45473	O	-1	-1	0
term	PMC3035602	45473	45477	O	-1	-1	0
follow	PMC3035602	45478	45484	O	-1	-1	0
-	PMC3035602	45484	45485	O	-1	-1	0
up	PMC3035602	45485	45487	O	-1	-1	0
of	PMC3035602	45488	45490	O	-1	-1	0
children	PMC3035602	45491	45499	O	-1	-1	0
exposed	PMC3035602	45500	45507	O	-1	-1	0
to	PMC3035602	45508	45510	O	-1	-1	0
maternal	PMC3035602	45511	45519	O	-1	-1	0
cancer	PMC3035602	45520	45526	O	-1	-1	0
and	PMC3035602	45527	45530	O	-1	-1	0
cancer	PMC3035602	45531	45537	O	-1	-1	0
treatment	PMC3035602	45538	45547	O	-1	-1	0
in	PMC3035602	45548	45550	O	-1	-1	0
utero.68	PMC3035602	45551	45559	O	-1	-1	0
Maternal	PMC3035602	45560	45568	O	-1	-1	0
cancer	PMC3035602	45569	45575	O	-1	-1	0
may	PMC3035602	45576	45579	O	-1	-1	0
affect	PMC3035602	45580	45586	O	-1	-1	0
not	PMC3035602	45587	45590	O	-1	-1	0
only	PMC3035602	45591	45595	O	-1	-1	0
birth	PMC3035602	45596	45601	O	-1	-1	0
outcome	PMC3035602	45602	45609	O	-1	-1	0
,	PMC3035602	45609	45610	O	-1	-1	0
but	PMC3035602	45611	45614	O	-1	-1	0
also	PMC3035602	45615	45619	O	-1	-1	0
long	PMC3035602	45620	45624	O	-1	-1	0
-	PMC3035602	45624	45625	O	-1	-1	0
term	PMC3035602	45625	45629	O	-1	-1	0
health	PMC3035602	45630	45636	O	-1	-1	0
,	PMC3035602	45636	45637	O	-1	-1	0
as	PMC3035602	45638	45640	O	-1	-1	0
a	PMC3035602	45641	45642	O	-1	-1	0
consequence	PMC3035602	45643	45654	O	-1	-1	0
of	PMC3035602	45655	45657	O	-1	-1	0
intra	PMC3035602	45658	45663	O	-1	-1	0
-	PMC3035602	45663	45664	O	-1	-1	0
uterine	PMC3035602	45664	45671	O	-1	-1	0
programming	PMC3035602	45672	45683	O	-1	-1	0
.	PMC3035602	45683	45684	O	-1	-1	0

Thus	PMC3035602	45685	45689	O	-1	-1	0
,	PMC3035602	45689	45690	O	-1	-1	0
large	PMC3035602	45691	45696	O	-1	-1	0
cohort	PMC3035602	45697	45703	O	-1	-1	0
studies	PMC3035602	45704	45711	O	-1	-1	0
with	PMC3035602	45712	45716	O	-1	-1	0
long	PMC3035602	45717	45721	O	-1	-1	0
term	PMC3035602	45722	45726	O	-1	-1	0

follow	PMC3035602	45727	45733	O	-1	-1	0
-	PMC3035602	45733	45734	O	-1	-1	0
up	PMC3035602	45734	45736	O	-1	-1	0
are	PMC3035602	45737	45740	O	-1	-1	0
needed	PMC3035602	45741	45747	O	-1	-1	0
to	PMC3035602	45748	45750	O	-1	-1	0
evaluate	PMC3035602	45751	45759	O	-1	-1	0
the	PMC3035602	45760	45763	O	-1	-1	0
entire	PMC3035602	45764	45770	O	-1	-1	0
spectrum	PMC3035602	45771	45779	O	-1	-1	0
of	PMC3035602	45780	45782	O	-1	-1	0
adverse	PMC3035602	45783	45790	O	-1	-1	0
effects	PMC3035602	45791	45798	O	-1	-1	0
of	PMC3035602	45799	45801	O	-1	-1	0
cancer	PMC3035602	45802	45808	O	-1	-1	0
or	PMC3035602	45809	45811	O	-1	-1	0
cancer	PMC3035602	45812	45818	O	-1	-1	0
treatment	PMC3035602	45819	45828	O	-1	-1	0
on	PMC3035602	45829	45831	O	-1	-1	0
offspring	PMC3035602	45832	45841	O	-1	-1	0
of	PMC3035602	45842	45844	O	-1	-1	0
the	PMC3035602	45845	45848	O	-1	-1	0
patients	PMC3035602	45849	45857	O	-1	-1	0
.	PMC3035602	45857	45858	O	-1	-1	0


	PMC3035602	45858	45860	O	-1	-1	0

Disclosure	PMC3035602	45860	45870	O	-1	-1	0

The	PMC3035602	45871	45874	O	-1	-1	0
contents	PMC3035602	45875	45883	O	-1	-1	0
of	PMC3035602	45884	45886	O	-1	-1	0
this	PMC3035602	45887	45891	O	-1	-1	0
review	PMC3035602	45892	45898	O	-1	-1	0
have	PMC3035602	45899	45903	O	-1	-1	0
previously	PMC3035602	45904	45914	O	-1	-1	0
been	PMC3035602	45915	45919	O	-1	-1	0
included	PMC3035602	45920	45928	O	-1	-1	0
in	PMC3035602	45929	45931	O	-1	-1	0
a	PMC3035602	45932	45933	O	-1	-1	0
PhD	PMC3035602	45934	45937	O	-1	-1	0
thesis	PMC3035602	45938	45944	O	-1	-1	0
.	PMC3035602	45944	45945	O	-1	-1	0


	PMC3035602	45945	45947	O	-1	-1	0

References	PMC3035602	45947	45957	O	-1	-1	0


	PMC3035602	45957	45959	O	-1	-1	0
1	PMC3035602	45959	45960	O	-1	-1	0
.	PMC3035602	45960	45961	O	-1	-1	0

Dow	PMC3035602	45962	45965	O	-1	-1	0
KH	PMC3035602	45966	45968	O	-1	-1	0
,	PMC3035602	45968	45969	O	-1	-1	0
Harris	PMC3035602	45970	45976	O	-1	-1	0
JR	PMC3035602	45977	45979	O	-1	-1	0
,	PMC3035602	45979	45980	O	-1	-1	0
Roy	PMC3035602	45981	45984	O	-1	-1	0
C.	PMC3035602	45985	45987	O	-1	-1	0
Pregnancy	PMC3035602	45988	45997	O	-1	-1	0
after	PMC3035602	45998	46003	O	-1	-1	0
breast	PMC3035602	46004	46010	O	-1	-1	0
-	PMC3035602	46010	46011	O	-1	-1	0
conserving	PMC3035602	46011	46021	O	-1	-1	0
surgery	PMC3035602	46022	46029	O	-1	-1	0
and	PMC3035602	46030	46033	O	-1	-1	0
radiation	PMC3035602	46034	46043	O	-1	-1	0
therapy	PMC3035602	46044	46051	O	-1	-1	0
for	PMC3035602	46052	46055	O	-1	-1	0
breast	PMC3035602	46056	46062	O	-1	-1	0
cancer	PMC3035602	46063	46069	O	-1	-1	0
.	PMC3035602	46069	46070	O	-1	-1	0

J	PMC3035602	46071	46072	O	-1	-1	0
Natl	PMC3035602	46073	46077	O	-1	-1	0
Cancer	PMC3035602	46078	46084	O	-1	-1	0
Inst	PMC3035602	46085	46089	O	-1	-1	0
Monogr	PMC3035602	46090	46096	O	-1	-1	0
.	PMC3035602	46096	46097	O	-1	-1	0

1994	PMC3035602	46098	46102	O	-1	-1	0
;	PMC3035602	46102	46103	O	-1	-1	0
(	PMC3035602	46104	46105	O	-1	-1	0
16):131–137	PMC3035602	46105	46116	O	-1	-1	0
.	PMC3035602	46116	46117	O	-1	-1	0

2	PMC3035602	46118	46119	O	-1	-1	0
.	PMC3035602	46119	46120	O	-1	-1	0

Statistics	PMC3035602	46121	46131	O	-1	-1	0
Denmark	PMC3035602	46132	46139	O	-1	-1	0
.	PMC3035602	46139	46140	O	-1	-1	0

FOD11	PMC3035602	46141	46146	O	-1	-1	0
:	PMC3035602	46146	46147	O	-1	-1	0

Mean	PMC3035602	46148	46152	O	-1	-1	0
age	PMC3035602	46153	46156	O	-1	-1	0
of	PMC3035602	46157	46159	O	-1	-1	0
Danish	PMC3035602	46160	46166	O	-1	-1	0
women	PMC3035602	46167	46172	O	-1	-1	0
at	PMC3035602	46173	46175	O	-1	-1	0
first	PMC3035602	46176	46181	O	-1	-1	0
­delivery	PMC3035602	46182	46191	O	-1	-1	0
.	PMC3035602	46191	46192	O	-1	-1	0

http://www.statistikbanken.dk/FOD11/.	PMC3035602	46193	46230	O	-1	-1	0

Accessed	PMC3035602	46231	46239	O	-1	-1	0
Mar	PMC3035602	46240	46243	O	-1	-1	0
15	PMC3035602	46244	46246	O	-1	-1	0
2010	PMC3035602	46247	46251	O	-1	-1	0
.	PMC3035602	46251	46252	O	-1	-1	0

3	PMC3035602	46253	46254	O	-1	-1	0
.	PMC3035602	46254	46255	O	-1	-1	0

Nye	PMC3035602	46256	46259	O	-1	-1	0
tal	PMC3035602	46260	46263	O	-1	-1	0
fra	PMC3035602	46264	46267	O	-1	-1	0
Sundhedsstyrelsen	PMC3035602	46268	46285	O	-1	-1	0
2009	PMC3035602	46286	46290	O	-1	-1	0
:	PMC3035602	46290	46291	O	-1	-1	0
Cancerregisteret	PMC3035602	46292	46308	O	-1	-1	0
2008	PMC3035602	46309	46313	O	-1	-1	0
.	PMC3035602	46313	46314	O	-1	-1	0

http://www	PMC3035602	46315	46325	O	-1	-1	0
.	PMC3035602	46325	46326	O	-1	-1	0

sst.dk/publ/Publ2009/DOKU/cancerreg/cancerregisteret_2008.pdf	PMC3035602	46327	46388	O	-1	-1	0
.	PMC3035602	46388	46389	O	-1	-1	0

Accessed	PMC3035602	46390	46398	O	-1	-1	0
Mar	PMC3035602	46399	46402	O	-1	-1	0
15	PMC3035602	46403	46405	O	-1	-1	0
2010	PMC3035602	46406	46410	O	-1	-1	0
.	PMC3035602	46410	46411	O	-1	-1	0

4	PMC3035602	46412	46413	O	-1	-1	0
.	PMC3035602	46413	46414	O	-1	-1	0

Fisher	PMC3035602	46415	46421	O	-1	-1	0
PM	PMC3035602	46422	46424	O	-1	-1	0
,	PMC3035602	46424	46425	O	-1	-1	0
Hancock	PMC3035602	46426	46433	O	-1	-1	0
BW	PMC3035602	46434	46436	O	-1	-1	0
.	PMC3035602	46436	46437	O	-1	-1	0

Hodgkin	PMC3035602	46438	46445	O	-1	-1	0
’s	PMC3035602	46445	46447	O	-1	-1	0
disease	PMC3035602	46448	46455	O	-1	-1	0
in	PMC3035602	46456	46458	O	-1	-1	0
the	PMC3035602	46459	46462	O	-1	-1	0
pregnant	PMC3035602	46463	46471	O	-1	-1	0
patient	PMC3035602	46472	46479	O	-1	-1	0
.	PMC3035602	46479	46480	O	-1	-1	0

Br	PMC3035602	46481	46483	O	-1	-1	0
J	PMC3035602	46484	46485	O	-1	-1	0
Hosp	PMC3035602	46486	46490	O	-1	-1	0
Med	PMC3035602	46491	46494	O	-1	-1	0
.	PMC3035602	46494	46495	O	-1	-1	0

1996;56(10):529–532	PMC3035602	46496	46515	O	-1	-1	0
.	PMC3035602	46515	46516	O	-1	-1	0

5	PMC3035602	46517	46518	O	-1	-1	0
.	PMC3035602	46518	46519	O	-1	-1	0

Koren	PMC3035602	46520	46525	O	-1	-1	0
G	PMC3035602	46526	46527	O	-1	-1	0
,	PMC3035602	46527	46528	O	-1	-1	0
Lishner	PMC3035602	46529	46536	O	-1	-1	0
M	PMC3035602	46537	46538	O	-1	-1	0
,	PMC3035602	46538	46539	O	-1	-1	0
Zemlickis	PMC3035602	46540	46549	O	-1	-1	0
D.	PMC3035602	46550	46552	O	-1	-1	0
Cancer	PMC3035602	46553	46559	O	-1	-1	0
in	PMC3035602	46560	46562	O	-1	-1	0
pregnancy	PMC3035602	46563	46572	O	-1	-1	0
:	PMC3035602	46572	46573	O	-1	-1	0
identification	PMC3035602	46574	46588	O	-1	-1	0
of	PMC3035602	46589	46591	O	-1	-1	0
unanswered	PMC3035602	46592	46602	O	-1	-1	0
questions	PMC3035602	46603	46612	O	-1	-1	0
on	PMC3035602	46613	46615	O	-1	-1	0
maternal	PMC3035602	46616	46624	O	-1	-1	0
and	PMC3035602	46625	46628	O	-1	-1	0
fetal	PMC3035602	46629	46634	O	-1	-1	0
risks	PMC3035602	46635	46640	O	-1	-1	0
.	PMC3035602	46640	46641	O	-1	-1	0

In	PMC3035602	46642	46644	O	-1	-1	0
:	PMC3035602	46644	46645	O	-1	-1	0
Koren	PMC3035602	46646	46651	O	-1	-1	0
G	PMC3035602	46652	46653	O	-1	-1	0
,	PMC3035602	46653	46654	O	-1	-1	0
Lishner	PMC3035602	46655	46662	O	-1	-1	0
M	PMC3035602	46663	46664	O	-1	-1	0
,	PMC3035602	46664	46665	O	-1	-1	0
Farine	PMC3035602	46666	46672	O	-1	-1	0
D	PMC3035602	46673	46674	O	-1	-1	0
,	PMC3035602	46674	46675	O	-1	-1	0
editors	PMC3035602	46676	46683	O	-1	-1	0
.	PMC3035602	46683	46684	O	-1	-1	0

Cancer	PMC3035602	46685	46691	O	-1	-1	0
in	PMC3035602	46692	46694	O	-1	-1	0
pregnancy	PMC3035602	46695	46704	O	-1	-1	0
:	PMC3035602	46704	46705	O	-1	-1	0
Maternal	PMC3035602	46706	46714	O	-1	-1	0
and	PMC3035602	46715	46718	O	-1	-1	0
fetal	PMC3035602	46719	46724	O	-1	-1	0
risks	PMC3035602	46725	46730	O	-1	-1	0
.	PMC3035602	46730	46731	O	-1	-1	0

Cambridge	PMC3035602	46732	46741	O	-1	-1	0
:	PMC3035602	46741	46742	O	-1	-1	0

Cambridge	PMC3035602	46743	46752	O	-1	-1	0
University	PMC3035602	46753	46763	O	-1	-1	0
Press	PMC3035602	46764	46769	O	-1	-1	0
;	PMC3035602	46769	46770	O	-1	-1	0
1996:3–14	PMC3035602	46771	46780	O	-1	-1	0
.	PMC3035602	46780	46781	O	-1	-1	0

6	PMC3035602	46782	46783	O	-1	-1	0
.	PMC3035602	46783	46784	O	-1	-1	0

Rørth	PMC3035602	46785	46790	O	-1	-1	0
M	PMC3035602	46791	46792	O	-1	-1	0
,	PMC3035602	46792	46793	O	-1	-1	0
Storm	PMC3035602	46794	46799	O	-1	-1	0
H.	PMC3035602	46800	46802	O	-1	-1	0
Kræftsygdomme	PMC3035602	46803	46816	O	-1	-1	0
.	PMC3035602	46816	46817	O	-1	-1	0

Onkologi	PMC3035602	46818	46826	O	-1	-1	0
.	PMC3035602	46826	46827	O	-1	-1	0

Ringborg	PMC3035602	46828	46836	O	-1	-1	0
U	PMC3035602	46837	46838	O	-1	-1	0
,	PMC3035602	46838	46839	O	-1	-1	0
­Henriksson	PMC3035602	46840	46851	O	-1	-1	0
R	PMC3035602	46852	46853	O	-1	-1	0
,	PMC3035602	46853	46854	O	-1	-1	0
Friberg	PMC3035602	46855	46862	O	-1	-1	0
S	PMC3035602	46863	46864	O	-1	-1	0
,	PMC3035602	46864	46865	O	-1	-1	0
editors	PMC3035602	46866	46873	O	-1	-1	0
.	PMC3035602	46873	46874	O	-1	-1	0

2004	PMC3035602	46875	46879	O	-1	-1	0
.	PMC3035602	46879	46880	O	-1	-1	0

7	PMC3035602	46881	46882	O	-1	-1	0
.	PMC3035602	46882	46883	O	-1	-1	0

Kroman	PMC3035602	46884	46890	O	-1	-1	0
N	PMC3035602	46891	46892	O	-1	-1	0
,	PMC3035602	46892	46893	O	-1	-1	0
Jensen	PMC3035602	46894	46900	O	-1	-1	0
MB	PMC3035602	46901	46903	O	-1	-1	0
,	PMC3035602	46903	46904	O	-1	-1	0
Melbye	PMC3035602	46905	46911	O	-1	-1	0
M	PMC3035602	46912	46913	O	-1	-1	0
,	PMC3035602	46913	46914	O	-1	-1	0
Wohlfahrt	PMC3035602	46915	46924	O	-1	-1	0
J	PMC3035602	46925	46926	O	-1	-1	0
,	PMC3035602	46926	46927	O	-1	-1	0
Mouridsen	PMC3035602	46928	46937	O	-1	-1	0
HT	PMC3035602	46938	46940	O	-1	-1	0
.	PMC3035602	46940	46941	O	-1	-1	0

Should	PMC3035602	46942	46948	O	-1	-1	0
women	PMC3035602	46949	46954	O	-1	-1	0
be	PMC3035602	46955	46957	O	-1	-1	0
advised	PMC3035602	46958	46965	O	-1	-1	0
against	PMC3035602	46966	46973	O	-1	-1	0
pregnancy	PMC3035602	46974	46983	O	-1	-1	0
after	PMC3035602	46984	46989	O	-1	-1	0
breast	PMC3035602	46990	46996	O	-1	-1	0
-	PMC3035602	46996	46997	O	-1	-1	0
cancer	PMC3035602	46997	47003	O	-1	-1	0
treatment	PMC3035602	47004	47013	O	-1	-1	0
?	PMC3035602	47013	47014	O	-1	-1	0
Lancet	PMC3035602	47015	47021	O	-1	-1	0
.	PMC3035602	47021	47022	O	-1	-1	0

1997;350(9074):319–322	PMC3035602	47023	47045	O	-1	-1	0
.	PMC3035602	47045	47046	O	-1	-1	0


	PMC3035602	47046	47048	O	-1	-1	0

18	PMC3035602	47048	47050	O	-1	-1	0


	PMC3035602	47050	47052	O	-1	-1	0
submit	PMC3035602	47052	47058	O	-1	-1	0
your	PMC3035602	47059	47063	O	-1	-1	0
manuscript	PMC3035602	47064	47074	O	-1	-1	0
|	PMC3035602	47075	47076	O	-1	-1	0

www.dovepress.com	PMC3035602	47077	47094	O	-1	-1	0


	PMC3035602	47094	47096	O	-1	-1	0

Dovepress	PMC3035602	47096	47105	O	-1	-1	0


	PMC3035602	47105	47107	O	-1	-1	0

Dovepress	PMC3035602	47107	47116	O	-1	-1	0
8	PMC3035602	47117	47118	O	-1	-1	0
.	PMC3035602	47118	47119	O	-1	-1	0

Blakely	PMC3035602	47120	47127	O	-1	-1	0
LJ	PMC3035602	47128	47130	O	-1	-1	0
,	PMC3035602	47130	47131	O	-1	-1	0
Buzdar	PMC3035602	47132	47138	O	-1	-1	0
AU	PMC3035602	47139	47141	O	-1	-1	0
,	PMC3035602	47141	47142	O	-1	-1	0
Lozada	PMC3035602	47143	47149	O	-1	-1	0
JA	PMC3035602	47150	47152	O	-1	-1	0
,	PMC3035602	47152	47153	O	-1	-1	0
et	PMC3035602	47154	47156	O	-1	-1	0
al	PMC3035602	47157	47159	O	-1	-1	0
.	PMC3035602	47159	47160	O	-1	-1	0

Effects	PMC3035602	47161	47168	O	-1	-1	0
of	PMC3035602	47169	47171	O	-1	-1	0
pregnancy	PMC3035602	47172	47181	O	-1	-1	0
after	PMC3035602	47182	47187	O	-1	-1	0
treatment	PMC3035602	47188	47197	O	-1	-1	0
for	PMC3035602	47198	47201	O	-1	-1	0
breast	PMC3035602	47202	47208	O	-1	-1	0
carcinoma	PMC3035602	47209	47218	O	-1	-1	0
on	PMC3035602	47219	47221	O	-1	-1	0
survival	PMC3035602	47222	47230	O	-1	-1	0
and	PMC3035602	47231	47234	O	-1	-1	0
risk	PMC3035602	47235	47239	O	-1	-1	0
of	PMC3035602	47240	47242	O	-1	-1	0
recurrence	PMC3035602	47243	47253	O	-1	-1	0
.	PMC3035602	47253	47254	O	-1	-1	0
Cancer	PMC3035602	47255	47261	O	-1	-1	0
.	PMC3035602	47261	47262	O	-1	-1	0

2004;100(3):465–469	PMC3035602	47263	47282	O	-1	-1	0
.	PMC3035602	47282	47283	O	-1	-1	0

9	PMC3035602	47284	47285	O	-1	-1	0
.	PMC3035602	47285	47286	O	-1	-1	0

Kroman	PMC3035602	47287	47293	O	-1	-1	0
N	PMC3035602	47294	47295	O	-1	-1	0
,	PMC3035602	47295	47296	O	-1	-1	0
Jensen	PMC3035602	47297	47303	O	-1	-1	0
MB	PMC3035602	47304	47306	O	-1	-1	0
,	PMC3035602	47306	47307	O	-1	-1	0
Wohlfart	PMC3035602	47308	47316	O	-1	-1	0
J	PMC3035602	47317	47318	O	-1	-1	0
,	PMC3035602	47318	47319	O	-1	-1	0
Ejlertsen	PMC3035602	47320	47329	O	-1	-1	0
B	PMC3035602	47330	47331	O	-1	-1	0
;	PMC3035602	47331	47332	O	-1	-1	0
Danish	PMC3035602	47333	47339	O	-1	-1	0
Breast	PMC3035602	47340	47346	O	-1	-1	0
Cancer	PMC3035602	47347	47353	O	-1	-1	0

Cooperative	PMC3035602	47354	47365	O	-1	-1	0
Group	PMC3035602	47366	47371	O	-1	-1	0
.	PMC3035602	47371	47372	O	-1	-1	0

Pregnancy	PMC3035602	47373	47382	O	-1	-1	0
after	PMC3035602	47383	47388	O	-1	-1	0
treatment	PMC3035602	47389	47398	O	-1	-1	0
of	PMC3035602	47399	47401	O	-1	-1	0
breast	PMC3035602	47402	47408	O	-1	-1	0
cancer	PMC3035602	47409	47415	O	-1	-1	0
–	PMC3035602	47416	47417	O	-1	-1	0

a	PMC3035602	47418	47419	O	-1	-1	0
population	PMC3035602	47420	47430	O	-1	-1	0
-	PMC3035602	47430	47431	O	-1	-1	0
based	PMC3035602	47431	47436	O	-1	-1	0
study	PMC3035602	47437	47442	O	-1	-1	0
on	PMC3035602	47443	47445	O	-1	-1	0
behalf	PMC3035602	47446	47452	O	-1	-1	0
of	PMC3035602	47453	47455	O	-1	-1	0
Danish	PMC3035602	47456	47462	O	-1	-1	0
Breast	PMC3035602	47463	47469	O	-1	-1	0
Cancer	PMC3035602	47470	47476	O	-1	-1	0
Cooperative	PMC3035602	47477	47488	O	-1	-1	0
Group	PMC3035602	47489	47494	O	-1	-1	0
.	PMC3035602	47494	47495	O	-1	-1	0

Acta	PMC3035602	47496	47500	O	-1	-1	0
Oncol	PMC3035602	47501	47506	O	-1	-1	0
.	PMC3035602	47506	47507	O	-1	-1	0

2008;47(4):545–549	PMC3035602	47508	47526	O	-1	-1	0
.	PMC3035602	47526	47527	O	-1	-1	0

10	PMC3035602	47528	47530	O	-1	-1	0
.	PMC3035602	47530	47531	O	-1	-1	0

Arnon	PMC3035602	47532	47537	O	-1	-1	0
J	PMC3035602	47538	47539	O	-1	-1	0
,	PMC3035602	47539	47540	O	-1	-1	0
Meirow	PMC3035602	47541	47547	O	-1	-1	0
D	PMC3035602	47548	47549	O	-1	-1	0
,	PMC3035602	47549	47550	O	-1	-1	0
Lewis	PMC3035602	47551	47556	O	-1	-1	0
-	PMC3035602	47556	47557	O	-1	-1	0
Roness	PMC3035602	47557	47563	O	-1	-1	0
H	PMC3035602	47564	47565	O	-1	-1	0
,	PMC3035602	47565	47566	O	-1	-1	0
Ornoy	PMC3035602	47567	47572	O	-1	-1	0
A.	PMC3035602	47573	47575	O	-1	-1	0
Genetic	PMC3035602	47576	47583	O	-1	-1	0
and	PMC3035602	47584	47587	O	-1	-1	0
teratogenic	PMC3035602	47588	47599	O	-1	-1	0

effects	PMC3035602	47600	47607	O	-1	-1	0
of	PMC3035602	47608	47610	O	-1	-1	0
cancer	PMC3035602	47611	47617	O	-1	-1	0
treatments	PMC3035602	47618	47628	O	-1	-1	0
on	PMC3035602	47629	47631	O	-1	-1	0
gametes	PMC3035602	47632	47639	O	-1	-1	0
and	PMC3035602	47640	47643	O	-1	-1	0
embryos	PMC3035602	47644	47651	O	-1	-1	0
.	PMC3035602	47651	47652	O	-1	-1	0

Hum	PMC3035602	47653	47656	O	-1	-1	0
Reprod	PMC3035602	47657	47663	O	-1	-1	0

Update	PMC3035602	47664	47670	O	-1	-1	0
.	PMC3035602	47670	47671	O	-1	-1	0

2001;7(4):394–403	PMC3035602	47672	47689	O	-1	-1	0
.	PMC3035602	47689	47690	O	-1	-1	0

11	PMC3035602	47691	47693	O	-1	-1	0
.	PMC3035602	47693	47694	O	-1	-1	0

Kroman	PMC3035602	47695	47701	O	-1	-1	0
NT	PMC3035602	47702	47704	O	-1	-1	0
,	PMC3035602	47704	47705	O	-1	-1	0
Lidegaard	PMC3035602	47706	47715	O	-1	-1	0
O	PMC3035602	47716	47717	O	-1	-1	0
,	PMC3035602	47717	47718	O	-1	-1	0
Kvistgaard	PMC3035602	47719	47729	O	-1	-1	0
ME	PMC3035602	47730	47732	O	-1	-1	0
.	PMC3035602	47732	47733	O	-1	-1	0

Breast	PMC3035602	47734	47740	O	-1	-1	0
cancer	PMC3035602	47741	47747	O	-1	-1	0
–	PMC3035602	47748	47749	O	-1	-1	0
a	PMC3035602	47750	47751	O	-1	-1	0
lifestyle	PMC3035602	47752	47761	O	-1	-1	0
disease	PMC3035602	47762	47769	O	-1	-1	0
?	PMC3035602	47769	47770	O	-1	-1	0
.	PMC3035602	47770	47771	O	-1	-1	0

Ugeskr	PMC3035602	47772	47778	O	-1	-1	0
Laeger	PMC3035602	47779	47785	O	-1	-1	0
.	PMC3035602	47785	47786	O	-1	-1	0

2005;167(49):4636–4641	PMC3035602	47787	47809	O	-1	-1	0
.	PMC3035602	47809	47810	O	-1	-1	0

12	PMC3035602	47811	47813	O	-1	-1	0
.	PMC3035602	47813	47814	O	-1	-1	0

Weisz	PMC3035602	47815	47820	O	-1	-1	0
B	PMC3035602	47821	47822	O	-1	-1	0
,	PMC3035602	47822	47823	O	-1	-1	0
Meirow	PMC3035602	47824	47830	O	-1	-1	0
D	PMC3035602	47831	47832	O	-1	-1	0
,	PMC3035602	47832	47833	O	-1	-1	0
Schiff	PMC3035602	47834	47840	O	-1	-1	0
E	PMC3035602	47841	47842	O	-1	-1	0
,	PMC3035602	47842	47843	O	-1	-1	0
Lishner	PMC3035602	47844	47851	O	-1	-1	0
M.	PMC3035602	47852	47854	O	-1	-1	0
Impact	PMC3035602	47855	47861	O	-1	-1	0
and	PMC3035602	47862	47865	O	-1	-1	0
treatment	PMC3035602	47866	47875	O	-1	-1	0
of	PMC3035602	47876	47878	O	-1	-1	0
cancer	PMC3035602	47879	47885	O	-1	-1	0
during	PMC3035602	47886	47892	O	-1	-1	0
pregnancy	PMC3035602	47893	47902	O	-1	-1	0
.	PMC3035602	47902	47903	O	-1	-1	0

Expert	PMC3035602	47904	47910	O	-1	-1	0
Rev	PMC3035602	47911	47914	O	-1	-1	0
Anticancer	PMC3035602	47915	47925	O	-1	-1	0
Ther	PMC3035602	47926	47930	O	-1	-1	0
.	PMC3035602	47930	47931	O	-1	-1	0

2004;4(5):889–902	PMC3035602	47932	47949	O	-1	-1	0
.	PMC3035602	47949	47950	O	-1	-1	0

13	PMC3035602	47951	47953	O	-1	-1	0
.	PMC3035602	47953	47954	O	-1	-1	0

Bevona	PMC3035602	47955	47961	O	-1	-1	0
C	PMC3035602	47962	47963	O	-1	-1	0
,	PMC3035602	47963	47964	O	-1	-1	0
Sober	PMC3035602	47965	47970	O	-1	-1	0
AJ	PMC3035602	47971	47973	O	-1	-1	0
.	PMC3035602	47973	47974	O	-1	-1	0

Melanoma	PMC3035602	47975	47983	O	-1	-1	0
incidence	PMC3035602	47984	47993	O	-1	-1	0
trends	PMC3035602	47994	48000	O	-1	-1	0
.	PMC3035602	48000	48001	O	-1	-1	0

Dermatol	PMC3035602	48002	48010	O	-1	-1	0
Clin	PMC3035602	48011	48015	O	-1	-1	0
.	PMC3035602	48015	48016	O	-1	-1	0

2002	PMC3035602	48017	48021	O	-1	-1	0
;	PMC3035602	48021	48022	O	-1	-1	0
20(4):589–595	PMC3035602	48023	48036	O	-1	-1	0
,	PMC3035602	48036	48037	O	-1	-1	0
vii	PMC3035602	48038	48041	O	-1	-1	0
.	PMC3035602	48041	48042	O	-1	-1	0

14	PMC3035602	48043	48045	O	-1	-1	0
.	PMC3035602	48045	48046	O	-1	-1	0

Van	PMC3035602	48047	48050	O	-1	-1	0
der	PMC3035602	48051	48054	O	-1	-1	0
Horst	PMC3035602	48055	48060	O	-1	-1	0
M	PMC3035602	48061	48062	O	-1	-1	0
,	PMC3035602	48062	48063	O	-1	-1	0
Winther	PMC3035602	48064	48071	O	-1	-1	0
JF	PMC3035602	48072	48074	O	-1	-1	0
,	PMC3035602	48074	48075	O	-1	-1	0
Olsen	PMC3035602	48076	48081	O	-1	-1	0
JH	PMC3035602	48082	48084	O	-1	-1	0
.	PMC3035602	48084	48085	O	-1	-1	0

Cancer	PMC3035602	48086	48092	O	-1	-1	0
incidence	PMC3035602	48093	48102	O	-1	-1	0
in	PMC3035602	48103	48105	O	-1	-1	0
the	PMC3035602	48106	48109	O	-1	-1	0
age	PMC3035602	48110	48113	O	-1	-1	0
range	PMC3035602	48114	48119	O	-1	-1	0
0–34	PMC3035602	48120	48124	O	-1	-1	0
years	PMC3035602	48125	48130	O	-1	-1	0
:	PMC3035602	48130	48131	O	-1	-1	0
historical	PMC3035602	48132	48142	O	-1	-1	0
and	PMC3035602	48143	48146	O	-1	-1	0
actual	PMC3035602	48147	48153	O	-1	-1	0
status	PMC3035602	48154	48160	O	-1	-1	0
in	PMC3035602	48161	48163	O	-1	-1	0
Denmark	PMC3035602	48164	48171	O	-1	-1	0
.	PMC3035602	48171	48172	O	-1	-1	0

Int	PMC3035602	48173	48176	O	-1	-1	0
J	PMC3035602	48177	48178	O	-1	-1	0
Cancer	PMC3035602	48179	48185	O	-1	-1	0
.	PMC3035602	48185	48186	O	-1	-1	0

2006;118(11):2816–2826	PMC3035602	48187	48209	O	-1	-1	0
.	PMC3035602	48209	48210	O	-1	-1	0

15	PMC3035602	48211	48213	O	-1	-1	0
.	PMC3035602	48213	48214	O	-1	-1	0

Lishner	PMC3035602	48215	48222	O	-1	-1	0
M.	PMC3035602	48223	48225	O	-1	-1	0
Cancer	PMC3035602	48226	48232	O	-1	-1	0
in	PMC3035602	48233	48235	O	-1	-1	0
pregnancy	PMC3035602	48236	48245	O	-1	-1	0
.	PMC3035602	48245	48246	O	-1	-1	0

Ann	PMC3035602	48247	48250	O	-1	-1	0
Oncol	PMC3035602	48251	48256	O	-1	-1	0
.	PMC3035602	48256	48257	O	-1	-1	0

2003;14	PMC3035602	48258	48265	O	-1	-1	0
Suppl	PMC3035602	48266	48271	O	-1	-1	0
3	PMC3035602	48272	48273	O	-1	-1	0
:	PMC3035602	48273	48274	O	-1	-1	0
iii31–iii36	PMC3035602	48275	48286	O	-1	-1	0
.	PMC3035602	48286	48287	O	-1	-1	0

16	PMC3035602	48288	48290	O	-1	-1	0
.	PMC3035602	48290	48291	O	-1	-1	0

Melbye	PMC3035602	48292	48298	O	-1	-1	0
M	PMC3035602	48299	48300	O	-1	-1	0
,	PMC3035602	48300	48301	O	-1	-1	0
Adami	PMC3035602	48302	48307	O	-1	-1	0
H	PMC3035602	48308	48309	O	-1	-1	0
-	PMC3035602	48309	48310	O	-1	-1	0
O.	PMC3035602	48310	48312	O	-1	-1	0
Hodgkin	PMC3035602	48313	48320	O	-1	-1	0
’s	PMC3035602	48320	48322	O	-1	-1	0
lymphoma	PMC3035602	48323	48331	O	-1	-1	0
.	PMC3035602	48331	48332	O	-1	-1	0

In	PMC3035602	48333	48335	O	-1	-1	0
:	PMC3035602	48335	48336	O	-1	-1	0
Adami	PMC3035602	48337	48342	O	-1	-1	0
H	PMC3035602	48343	48344	O	-1	-1	0
-	PMC3035602	48344	48345	O	-1	-1	0
O	PMC3035602	48345	48346	O	-1	-1	0
,	PMC3035602	48346	48347	O	-1	-1	0
Hunter	PMC3035602	48348	48354	O	-1	-1	0
D	PMC3035602	48355	48356	O	-1	-1	0
,	PMC3035602	48356	48357	O	-1	-1	0
Trichopoulos	PMC3035602	48358	48370	O	-1	-1	0
D	PMC3035602	48371	48372	O	-1	-1	0
,	PMC3035602	48372	48373	O	-1	-1	0
editors	PMC3035602	48374	48381	O	-1	-1	0
.	PMC3035602	48381	48382	O	-1	-1	0

Textbook	PMC3035602	48383	48391	O	-1	-1	0
of	PMC3035602	48392	48394	O	-1	-1	0
Cancer	PMC3035602	48395	48401	O	-1	-1	0
Epidemiology	PMC3035602	48402	48414	O	-1	-1	0
.	PMC3035602	48414	48415	O	-1	-1	0

New	PMC3035602	48416	48419	O	-1	-1	0
York	PMC3035602	48420	48424	O	-1	-1	0
:	PMC3035602	48424	48425	O	-1	-1	0
Oxford	PMC3035602	48426	48432	O	-1	-1	0
University	PMC3035602	48433	48443	O	-1	-1	0
Press	PMC3035602	48444	48449	O	-1	-1	0
;	PMC3035602	48449	48450	O	-1	-1	0
2002:520–534	PMC3035602	48451	48463	O	-1	-1	0
.	PMC3035602	48463	48464	O	-1	-1	0
17	PMC3035602	48465	48467	O	-1	-1	0
.	PMC3035602	48467	48468	O	-1	-1	0

Cancer	PMC3035602	48469	48475	O	-1	-1	0
incidens	PMC3035602	48476	48484	O	-1	-1	0

i	PMC3035602	48485	48486	O	-1	-1	0
Danmark	PMC3035602	48487	48494	O	-1	-1	0
2000	PMC3035602	48495	48499	O	-1	-1	0
.	PMC3035602	48499	48500	O	-1	-1	0

Sundhedsstyrelsen	PMC3035602	48501	48518	O	-1	-1	0
.	PMC3035602	48518	48519	O	-1	-1	0

2004	PMC3035602	48520	48524	O	-1	-1	0
.	PMC3035602	48524	48525	O	-1	-1	0

http://www	PMC3035602	48526	48536	O	-1	-1	0
.	PMC3035602	48536	48537	O	-1	-1	0

sst.dk/publ/tidsskrifter/nyetal/pdf/2004/17_04.pdf	PMC3035602	48538	48588	O	-1	-1	0
.	PMC3035602	48588	48589	O	-1	-1	0

Accessed	PMC3035602	48590	48598	O	-1	-1	0
Mar	PMC3035602	48599	48602	O	-1	-1	0
15	PMC3035602	48603	48605	O	-1	-1	0
2010	PMC3035602	48606	48610	O	-1	-1	0
.	PMC3035602	48610	48611	O	-1	-1	0

18	PMC3035602	48612	48614	O	-1	-1	0
.	PMC3035602	48614	48615	O	-1	-1	0

Smith	PMC3035602	48616	48621	O	-1	-1	0
LH	PMC3035602	48622	48624	O	-1	-1	0
,	PMC3035602	48624	48625	O	-1	-1	0
Dalrymple	PMC3035602	48626	48635	O	-1	-1	0
JL	PMC3035602	48636	48638	O	-1	-1	0
,	PMC3035602	48638	48639	O	-1	-1	0
Leiserowitz	PMC3035602	48640	48651	O	-1	-1	0
GS	PMC3035602	48652	48654	O	-1	-1	0
,	PMC3035602	48654	48655	O	-1	-1	0
Danielsen	PMC3035602	48656	48665	O	-1	-1	0
B	PMC3035602	48666	48667	O	-1	-1	0
,	PMC3035602	48667	48668	O	-1	-1	0
Gilbert	PMC3035602	48669	48676	O	-1	-1	0
WM	PMC3035602	48677	48679	O	-1	-1	0
.	PMC3035602	48679	48680	O	-1	-1	0

Obstetrical	PMC3035602	48681	48692	O	-1	-1	0
deliveries	PMC3035602	48693	48703	O	-1	-1	0
associated	PMC3035602	48704	48714	O	-1	-1	0
with	PMC3035602	48715	48719	O	-1	-1	0
maternal	PMC3035602	48720	48728	O	-1	-1	0
malignancy	PMC3035602	48729	48739	O	-1	-1	0
in	PMC3035602	48740	48742	O	-1	-1	0
California	PMC3035602	48743	48753	O	-1	-1	0
,	PMC3035602	48753	48754	O	-1	-1	0
1992	PMC3035602	48755	48759	O	-1	-1	0
through	PMC3035602	48760	48767	O	-1	-1	0
1997	PMC3035602	48768	48772	O	-1	-1	0
.	PMC3035602	48772	48773	O	-1	-1	0

Am	PMC3035602	48774	48776	O	-1	-1	0
J	PMC3035602	48777	48778	O	-1	-1	0
Obstet	PMC3035602	48779	48785	O	-1	-1	0
Gynecol	PMC3035602	48786	48793	O	-1	-1	0
.	PMC3035602	48793	48794	O	-1	-1	0

2001;184(7):1504–1512	PMC3035602	48795	48816	O	-1	-1	0
.	PMC3035602	48816	48817	O	-1	-1	0

19	PMC3035602	48818	48820	O	-1	-1	0
.	PMC3035602	48820	48821	O	-1	-1	0

Lishner	PMC3035602	48822	48829	O	-1	-1	0
M	PMC3035602	48830	48831	O	-1	-1	0
,	PMC3035602	48831	48832	O	-1	-1	0
Zemlickis	PMC3035602	48833	48842	O	-1	-1	0
D	PMC3035602	48843	48844	O	-1	-1	0
,	PMC3035602	48844	48845	O	-1	-1	0
Degendorfer	PMC3035602	48846	48857	O	-1	-1	0
P	PMC3035602	48858	48859	O	-1	-1	0
,	PMC3035602	48859	48860	O	-1	-1	0
Panzarella	PMC3035602	48861	48871	O	-1	-1	0
T	PMC3035602	48872	48873	O	-1	-1	0
,	PMC3035602	48873	48874	O	-1	-1	0
Sutcliffe	PMC3035602	48875	48884	O	-1	-1	0
SB	PMC3035602	48885	48887	O	-1	-1	0
,	PMC3035602	48887	48888	O	-1	-1	0
Koren	PMC3035602	48889	48894	O	-1	-1	0
G.	PMC3035602	48895	48897	O	-1	-1	0
Maternal	PMC3035602	48898	48906	O	-1	-1	0
and	PMC3035602	48907	48910	O	-1	-1	0
foetal	PMC3035602	48911	48917	O	-1	-1	0
outcome	PMC3035602	48918	48925	O	-1	-1	0
following	PMC3035602	48926	48935	O	-1	-1	0
Hodgkin	PMC3035602	48936	48943	O	-1	-1	0
’s	PMC3035602	48943	48945	O	-1	-1	0
disease	PMC3035602	48946	48953	O	-1	-1	0
in	PMC3035602	48954	48956	O	-1	-1	0
pregnancy	PMC3035602	48957	48966	O	-1	-1	0
.	PMC3035602	48966	48967	O	-1	-1	0

Br	PMC3035602	48968	48970	O	-1	-1	0
J	PMC3035602	48971	48972	O	-1	-1	0
Cancer	PMC3035602	48973	48979	O	-1	-1	0
.	PMC3035602	48979	48980	O	-1	-1	0

1992;65(1):114–117	PMC3035602	48981	48999	O	-1	-1	0
.	PMC3035602	48999	49000	O	-1	-1	0

20	PMC3035602	49001	49003	O	-1	-1	0
.	PMC3035602	49003	49004	O	-1	-1	0

Savitz	PMC3035602	49005	49011	O	-1	-1	0
DA	PMC3035602	49012	49014	O	-1	-1	0
,	PMC3035602	49014	49015	O	-1	-1	0
Hertz	PMC3035602	49016	49021	O	-1	-1	0
-	PMC3035602	49021	49022	O	-1	-1	0
Picciotto	PMC3035602	49022	49031	O	-1	-1	0
I	PMC3035602	49032	49033	O	-1	-1	0
,	PMC3035602	49033	49034	O	-1	-1	0
Poole	PMC3035602	49035	49040	O	-1	-1	0
C	PMC3035602	49041	49042	O	-1	-1	0
,	PMC3035602	49042	49043	O	-1	-1	0
Olshan	PMC3035602	49044	49050	O	-1	-1	0
AF	PMC3035602	49051	49053	O	-1	-1	0
.	PMC3035602	49053	49054	O	-1	-1	0

Epidemiologic	PMC3035602	49055	49068	O	-1	-1	0
measures	PMC3035602	49069	49077	O	-1	-1	0
of	PMC3035602	49078	49080	O	-1	-1	0
the	PMC3035602	49081	49084	O	-1	-1	0
course	PMC3035602	49085	49091	O	-1	-1	0
and	PMC3035602	49092	49095	O	-1	-1	0
outcome	PMC3035602	49096	49103	O	-1	-1	0
of	PMC3035602	49104	49106	O	-1	-1	0
pregnancy	PMC3035602	49107	49116	O	-1	-1	0
.	PMC3035602	49116	49117	O	-1	-1	0

Epidemiol	PMC3035602	49118	49127	O	-1	-1	0
Rev.	PMC3035602	49128	49132	O	-1	-1	0
2002;24(2):91–101	PMC3035602	49133	49150	O	-1	-1	0
.	PMC3035602	49150	49151	O	-1	-1	0

21	PMC3035602	49152	49154	O	-1	-1	0
.	PMC3035602	49154	49155	O	-1	-1	0

Sutton	PMC3035602	49156	49162	O	-1	-1	0
R	PMC3035602	49163	49164	O	-1	-1	0
,	PMC3035602	49164	49165	O	-1	-1	0
Buzdar	PMC3035602	49166	49172	O	-1	-1	0
AU	PMC3035602	49173	49175	O	-1	-1	0
,	PMC3035602	49175	49176	O	-1	-1	0
Hortobagyi	PMC3035602	49177	49187	O	-1	-1	0
GN	PMC3035602	49188	49190	O	-1	-1	0
.	PMC3035602	49190	49191	O	-1	-1	0

Pregnancy	PMC3035602	49192	49201	O	-1	-1	0
and	PMC3035602	49202	49205	O	-1	-1	0
offspring	PMC3035602	49206	49215	O	-1	-1	0
after	PMC3035602	49216	49221	O	-1	-1	0
adjuvant	PMC3035602	49222	49230	O	-1	-1	0
chemotherapy	PMC3035602	49231	49243	O	-1	-1	0
in	PMC3035602	49244	49246	O	-1	-1	0
breast	PMC3035602	49247	49253	O	-1	-1	0
cancer	PMC3035602	49254	49260	O	-1	-1	0
patients	PMC3035602	49261	49269	O	-1	-1	0
.	PMC3035602	49269	49270	O	-1	-1	0

Cancer	PMC3035602	49271	49277	O	-1	-1	0
.	PMC3035602	49277	49278	O	-1	-1	0

1990;65(4	PMC3035602	49279	49288	O	-1	-1	0
)	PMC3035602	49288	49289	O	-1	-1	0
:	PMC3035602	49289	49290	O	-1	-1	0

847–850	PMC3035602	49291	49298	O	-1	-1	0
.	PMC3035602	49298	49299	O	-1	-1	0

22	PMC3035602	49300	49302	O	-1	-1	0
.	PMC3035602	49302	49303	O	-1	-1	0

Malamos	PMC3035602	49304	49311	O	-1	-1	0
NA	PMC3035602	49312	49314	O	-1	-1	0
,	PMC3035602	49314	49315	O	-1	-1	0
Stathopoulos	PMC3035602	49316	49328	O	-1	-1	0
GP	PMC3035602	49329	49331	O	-1	-1	0
,	PMC3035602	49331	49332	O	-1	-1	0
Keramopoulos	PMC3035602	49333	49345	O	-1	-1	0
A	PMC3035602	49346	49347	O	-1	-1	0
,	PMC3035602	49347	49348	O	-1	-1	0
Papadiamantis	PMC3035602	49349	49362	O	-1	-1	0
J	PMC3035602	49363	49364	O	-1	-1	0
,	PMC3035602	49364	49365	O	-1	-1	0
Vassilaros	PMC3035602	49366	49376	O	-1	-1	0
S.	PMC3035602	49377	49379	O	-1	-1	0
Pregnancy	PMC3035602	49380	49389	O	-1	-1	0
and	PMC3035602	49390	49393	O	-1	-1	0
offspring	PMC3035602	49394	49403	O	-1	-1	0
after	PMC3035602	49404	49409	O	-1	-1	0
the	PMC3035602	49410	49413	O	-1	-1	0
appearance	PMC3035602	49414	49424	O	-1	-1	0
of	PMC3035602	49425	49427	O	-1	-1	0
breast	PMC3035602	49428	49434	O	-1	-1	0
cancer	PMC3035602	49435	49441	O	-1	-1	0
.	PMC3035602	49441	49442	O	-1	-1	0

Oncology	PMC3035602	49443	49451	O	-1	-1	0
.	PMC3035602	49451	49452	O	-1	-1	0

1996;53(6):471–475	PMC3035602	49453	49471	O	-1	-1	0
.	PMC3035602	49471	49472	O	-1	-1	0

23	PMC3035602	49473	49475	O	-1	-1	0
.	PMC3035602	49475	49476	O	-1	-1	0

Langagergaard	PMC3035602	49477	49490	O	-1	-1	0
V	PMC3035602	49491	49492	O	-1	-1	0
,	PMC3035602	49492	49493	O	-1	-1	0
Gislum	PMC3035602	49494	49500	O	-1	-1	0
M	PMC3035602	49501	49502	O	-1	-1	0
,	PMC3035602	49502	49503	O	-1	-1	0
Skriver	PMC3035602	49504	49511	O	-1	-1	0
MV	PMC3035602	49512	49514	O	-1	-1	0
,	PMC3035602	49514	49515	O	-1	-1	0
et	PMC3035602	49516	49518	O	-1	-1	0
al	PMC3035602	49519	49521	O	-1	-1	0
.	PMC3035602	49521	49522	O	-1	-1	0

Birth	PMC3035602	49523	49528	O	-1	-1	0
outcome	PMC3035602	49529	49536	O	-1	-1	0
in	PMC3035602	49537	49539	O	-1	-1	0
women	PMC3035602	49540	49545	O	-1	-1	0
with	PMC3035602	49546	49550	O	-1	-1	0
breast	PMC3035602	49551	49557	O	-1	-1	0
cancer	PMC3035602	49558	49564	O	-1	-1	0
.	PMC3035602	49564	49565	O	-1	-1	0

Br	PMC3035602	49566	49568	O	-1	-1	0
J	PMC3035602	49569	49570	O	-1	-1	0
Cancer	PMC3035602	49571	49577	O	-1	-1	0
.	PMC3035602	49577	49578	O	-1	-1	0

2006:94(1):142–146	PMC3035602	49579	49597	O	-1	-1	0
.	PMC3035602	49597	49598	O	-1	-1	0

24	PMC3035602	49599	49601	O	-1	-1	0
.	PMC3035602	49601	49602	O	-1	-1	0

Dalberg	PMC3035602	49603	49610	O	-1	-1	0
K	PMC3035602	49611	49612	O	-1	-1	0
,	PMC3035602	49612	49613	O	-1	-1	0
Eriksson	PMC3035602	49614	49622	O	-1	-1	0
J	PMC3035602	49623	49624	O	-1	-1	0
,	PMC3035602	49624	49625	O	-1	-1	0
Holmberg	PMC3035602	49626	49634	O	-1	-1	0
L.	PMC3035602	49635	49637	O	-1	-1	0
Birth	PMC3035602	49638	49643	O	-1	-1	0
outcome	PMC3035602	49644	49651	O	-1	-1	0
in	PMC3035602	49652	49654	O	-1	-1	0
women	PMC3035602	49655	49660	O	-1	-1	0
with	PMC3035602	49661	49665	O	-1	-1	0
previously	PMC3035602	49666	49676	O	-1	-1	0
treated	PMC3035602	49677	49684	O	-1	-1	0
breast	PMC3035602	49685	49691	O	-1	-1	0
cancer	PMC3035602	49692	49698	O	-1	-1	0
–	PMC3035602	49699	49700	O	-1	-1	0
a	PMC3035602	49701	49702	O	-1	-1	0
population	PMC3035602	49703	49713	O	-1	-1	0
-	PMC3035602	49713	49714	O	-1	-1	0
based	PMC3035602	49714	49719	O	-1	-1	0
cohort	PMC3035602	49720	49726	O	-1	-1	0
study	PMC3035602	49727	49732	O	-1	-1	0
from	PMC3035602	49733	49737	O	-1	-1	0
Sweden	PMC3035602	49738	49744	O	-1	-1	0
.	PMC3035602	49744	49745	O	-1	-1	0

PLoS	PMC3035602	49746	49750	O	-1	-1	0
Med	PMC3035602	49751	49754	O	-1	-1	0
.	PMC3035602	49754	49755	O	-1	-1	0

2006;3(9):e336	PMC3035602	49756	49770	O	-1	-1	0
.	PMC3035602	49770	49771	O	-1	-1	0

25	PMC3035602	49772	49774	O	-1	-1	0
.	PMC3035602	49774	49775	O	-1	-1	0

Zemlickis	PMC3035602	49776	49785	O	-1	-1	0
D	PMC3035602	49786	49787	O	-1	-1	0
,	PMC3035602	49787	49788	O	-1	-1	0
Lishner	PMC3035602	49789	49796	O	-1	-1	0
M	PMC3035602	49797	49798	O	-1	-1	0
,	PMC3035602	49798	49799	O	-1	-1	0
Degendorfer	PMC3035602	49800	49811	O	-1	-1	0
P	PMC3035602	49812	49813	O	-1	-1	0
,	PMC3035602	49813	49814	O	-1	-1	0
et	PMC3035602	49815	49817	O	-1	-1	0
al	PMC3035602	49818	49820	O	-1	-1	0
.	PMC3035602	49820	49821	O	-1	-1	0

Maternal	PMC3035602	49822	49830	O	-1	-1	0
and	PMC3035602	49831	49834	O	-1	-1	0
fetal	PMC3035602	49835	49840	O	-1	-1	0
outcome	PMC3035602	49841	49848	O	-1	-1	0
after	PMC3035602	49849	49854	O	-1	-1	0
breast	PMC3035602	49855	49861	O	-1	-1	0
cancer	PMC3035602	49862	49868	O	-1	-1	0
in	PMC3035602	49869	49871	O	-1	-1	0
pregnancy	PMC3035602	49872	49881	O	-1	-1	0
.	PMC3035602	49881	49882	O	-1	-1	0

Am	PMC3035602	49883	49885	O	-1	-1	0
J	PMC3035602	49886	49887	O	-1	-1	0
Obstet	PMC3035602	49888	49894	O	-1	-1	0
Gynecol	PMC3035602	49895	49902	O	-1	-1	0
.	PMC3035602	49902	49903	O	-1	-1	0

1992	PMC3035602	49904	49908	O	-1	-1	0
;	PMC3035602	49908	49909	O	-1	-1	0
166(3):781–787	PMC3035602	49910	49924	O	-1	-1	0
.	PMC3035602	49924	49925	O	-1	-1	0

26	PMC3035602	49926	49928	O	-1	-1	0
.	PMC3035602	49928	49929	O	-1	-1	0

Cardonick	PMC3035602	49930	49939	O	-1	-1	0
E	PMC3035602	49940	49941	O	-1	-1	0
,	PMC3035602	49941	49942	O	-1	-1	0
Iacobucci	PMC3035602	49943	49952	O	-1	-1	0
A.	PMC3035602	49953	49955	O	-1	-1	0
Use	PMC3035602	49956	49959	O	-1	-1	0
of	PMC3035602	49960	49962	O	-1	-1	0
chemotherapy	PMC3035602	49963	49975	O	-1	-1	0
during	PMC3035602	49976	49982	O	-1	-1	0
human	PMC3035602	49983	49988	O	-1	-1	0
­pregnancy	PMC3035602	49989	49999	O	-1	-1	0
.	PMC3035602	49999	50000	O	-1	-1	0

Lancet	PMC3035602	50001	50007	O	-1	-1	0
Oncol	PMC3035602	50008	50013	O	-1	-1	0
.	PMC3035602	50013	50014	O	-1	-1	0

2004;5(5):283–291	PMC3035602	50015	50032	O	-1	-1	0
.	PMC3035602	50032	50033	O	-1	-1	0

27	PMC3035602	50034	50036	O	-1	-1	0
.	PMC3035602	50036	50037	O	-1	-1	0

Berry	PMC3035602	50038	50043	O	-1	-1	0
DL	PMC3035602	50044	50046	O	-1	-1	0
,	PMC3035602	50046	50047	O	-1	-1	0
Theriault	PMC3035602	50048	50057	O	-1	-1	0
RL	PMC3035602	50058	50060	O	-1	-1	0
,	PMC3035602	50060	50061	O	-1	-1	0
Holmes	PMC3035602	50062	50068	O	-1	-1	0
FA	PMC3035602	50069	50071	O	-1	-1	0
,	PMC3035602	50071	50072	O	-1	-1	0
et	PMC3035602	50073	50075	O	-1	-1	0
al	PMC3035602	50076	50078	O	-1	-1	0
.	PMC3035602	50078	50079	O	-1	-1	0

Management	PMC3035602	50080	50090	O	-1	-1	0
of	PMC3035602	50091	50093	O	-1	-1	0
breast	PMC3035602	50094	50100	O	-1	-1	0
cancer	PMC3035602	50101	50107	O	-1	-1	0
during	PMC3035602	50108	50114	O	-1	-1	0
pregnancy	PMC3035602	50115	50124	O	-1	-1	0
using	PMC3035602	50125	50130	O	-1	-1	0
a	PMC3035602	50131	50132	O	-1	-1	0
standardized	PMC3035602	50133	50145	O	-1	-1	0
protocol	PMC3035602	50146	50154	O	-1	-1	0
.	PMC3035602	50154	50155	O	-1	-1	0

J	PMC3035602	50156	50157	O	-1	-1	0
Clin	PMC3035602	50158	50162	O	-1	-1	0
Oncol	PMC3035602	50163	50168	O	-1	-1	0
.	PMC3035602	50168	50169	O	-1	-1	0

1999;17(3):855–861	PMC3035602	50170	50188	O	-1	-1	0
.	PMC3035602	50188	50189	O	-1	-1	0

28	PMC3035602	50190	50192	O	-1	-1	0
.	PMC3035602	50192	50193	O	-1	-1	0

Ring	PMC3035602	50194	50198	O	-1	-1	0
AE	PMC3035602	50199	50201	O	-1	-1	0
,	PMC3035602	50201	50202	O	-1	-1	0
Smith	PMC3035602	50203	50208	O	-1	-1	0
IE	PMC3035602	50209	50211	O	-1	-1	0
,	PMC3035602	50211	50212	O	-1	-1	0
Jones	PMC3035602	50213	50218	O	-1	-1	0
A	PMC3035602	50219	50220	O	-1	-1	0
,	PMC3035602	50220	50221	O	-1	-1	0
Shannon	PMC3035602	50222	50229	O	-1	-1	0
C	PMC3035602	50230	50231	O	-1	-1	0
,	PMC3035602	50231	50232	O	-1	-1	0
Galani	PMC3035602	50233	50239	O	-1	-1	0
E	PMC3035602	50240	50241	O	-1	-1	0
,	PMC3035602	50241	50242	O	-1	-1	0
Ellis	PMC3035602	50243	50248	O	-1	-1	0
PA	PMC3035602	50249	50251	O	-1	-1	0
.	PMC3035602	50251	50252	O	-1	-1	0
­C	PMC3035602	50253	50255	O	-1	-1	0
hemotherapy	PMC3035602	50256	50267	O	-1	-1	0
for	PMC3035602	50268	50271	O	-1	-1	0
breast	PMC3035602	50272	50278	O	-1	-1	0
cancer	PMC3035602	50279	50285	O	-1	-1	0
during	PMC3035602	50286	50292	O	-1	-1	0
pregnancy	PMC3035602	50293	50302	O	-1	-1	0
:	PMC3035602	50302	50303	O	-1	-1	0

an	PMC3035602	50304	50306	O	-1	-1	0
18-year	PMC3035602	50307	50314	O	-1	-1	0
­experience	PMC3035602	50315	50326	O	-1	-1	0
from	PMC3035602	50327	50331	O	-1	-1	0
five	PMC3035602	50332	50336	O	-1	-1	0
London	PMC3035602	50337	50343	O	-1	-1	0
teaching	PMC3035602	50344	50352	O	-1	-1	0
hospitals	PMC3035602	50353	50362	O	-1	-1	0
.	PMC3035602	50362	50363	O	-1	-1	0

J	PMC3035602	50364	50365	O	-1	-1	0
Clin	PMC3035602	50366	50370	O	-1	-1	0
Oncol	PMC3035602	50371	50376	O	-1	-1	0
.	PMC3035602	50376	50377	O	-1	-1	0

2005	PMC3035602	50378	50382	O	-1	-1	0
;	PMC3035602	50382	50383	O	-1	-1	0
23(18):4192–4197	PMC3035602	50384	50400	O	-1	-1	0
.	PMC3035602	50400	50401	O	-1	-1	0

29	PMC3035602	50402	50404	O	-1	-1	0
.	PMC3035602	50404	50405	O	-1	-1	0

Hansen	PMC3035602	50406	50412	O	-1	-1	0
D	PMC3035602	50413	50414	O	-1	-1	0
,	PMC3035602	50414	50415	O	-1	-1	0
Moller	PMC3035602	50416	50422	O	-1	-1	0
H	PMC3035602	50423	50424	O	-1	-1	0
,	PMC3035602	50424	50425	O	-1	-1	0
Olsen	PMC3035602	50426	50431	O	-1	-1	0
J.	PMC3035602	50432	50434	O	-1	-1	0
Severe	PMC3035602	50435	50441	O	-1	-1	0
periconceptional	PMC3035602	50442	50458	O	-1	-1	0
life	PMC3035602	50459	50463	O	-1	-1	0
events	PMC3035602	50464	50470	O	-1	-1	0
and	PMC3035602	50471	50474	O	-1	-1	0
the	PMC3035602	50475	50478	O	-1	-1	0
sex	PMC3035602	50479	50482	O	-1	-1	0
ratio	PMC3035602	50483	50488	O	-1	-1	0
in	PMC3035602	50489	50491	O	-1	-1	0
offspring	PMC3035602	50492	50501	O	-1	-1	0
:	PMC3035602	50501	50502	O	-1	-1	0
follow	PMC3035602	50503	50509	O	-1	-1	0
up	PMC3035602	50510	50512	O	-1	-1	0
study	PMC3035602	50513	50518	O	-1	-1	0
based	PMC3035602	50519	50524	O	-1	-1	0
on	PMC3035602	50525	50527	O	-1	-1	0
five	PMC3035602	50528	50532	O	-1	-1	0
national	PMC3035602	50533	50541	O	-1	-1	0
registers	PMC3035602	50542	50551	O	-1	-1	0
.	PMC3035602	50551	50552	O	-1	-1	0
BMJ	PMC3035602	50553	50556	O	-1	-1	0
.	PMC3035602	50556	50557	O	-1	-1	0

1999;319(7209):548–549	PMC3035602	50558	50580	O	-1	-1	0
.	PMC3035602	50580	50581	O	-1	-1	0

30	PMC3035602	50582	50584	O	-1	-1	0
.	PMC3035602	50584	50585	O	-1	-1	0

Nagarajan	PMC3035602	50586	50595	O	-1	-1	0
R	PMC3035602	50596	50597	O	-1	-1	0
,	PMC3035602	50597	50598	O	-1	-1	0
Robison	PMC3035602	50599	50606	O	-1	-1	0
LL	PMC3035602	50607	50609	O	-1	-1	0
.	PMC3035602	50609	50610	O	-1	-1	0

Pregnancy	PMC3035602	50611	50620	O	-1	-1	0
outcomes	PMC3035602	50621	50629	O	-1	-1	0
in	PMC3035602	50630	50632	O	-1	-1	0
survivors	PMC3035602	50633	50642	O	-1	-1	0
of	PMC3035602	50643	50645	O	-1	-1	0
­childhood	PMC3035602	50646	50656	O	-1	-1	0
cancer	PMC3035602	50657	50663	O	-1	-1	0
.	PMC3035602	50663	50664	O	-1	-1	0

J	PMC3035602	50665	50666	O	-1	-1	0
Natl	PMC3035602	50667	50671	O	-1	-1	0
Cancer	PMC3035602	50672	50678	O	-1	-1	0
Inst	PMC3035602	50679	50683	O	-1	-1	0
Monogr	PMC3035602	50684	50690	O	-1	-1	0
.	PMC3035602	50690	50691	O	-1	-1	0

2005;(34):72–76	PMC3035602	50692	50707	O	-1	-1	0
.	PMC3035602	50707	50708	O	-1	-1	0

31	PMC3035602	50709	50711	O	-1	-1	0
.	PMC3035602	50711	50712	O	-1	-1	0

Byrne	PMC3035602	50713	50718	O	-1	-1	0
J	PMC3035602	50719	50720	O	-1	-1	0
,	PMC3035602	50720	50721	O	-1	-1	0
Rasmussen	PMC3035602	50722	50731	O	-1	-1	0
SA	PMC3035602	50732	50734	O	-1	-1	0
,	PMC3035602	50734	50735	O	-1	-1	0
Steinhorn	PMC3035602	50736	50745	O	-1	-1	0
SC	PMC3035602	50746	50748	O	-1	-1	0
,	PMC3035602	50748	50749	O	-1	-1	0
et	PMC3035602	50750	50752	O	-1	-1	0
al	PMC3035602	50753	50755	O	-1	-1	0
.	PMC3035602	50755	50756	O	-1	-1	0

Genetic	PMC3035602	50757	50764	O	-1	-1	0
disease	PMC3035602	50765	50772	O	-1	-1	0
in	PMC3035602	50773	50775	O	-1	-1	0
offspring	PMC3035602	50776	50785	O	-1	-1	0
of	PMC3035602	50786	50788	O	-1	-1	0
long	PMC3035602	50789	50793	O	-1	-1	0
-	PMC3035602	50793	50794	O	-1	-1	0
term	PMC3035602	50794	50798	O	-1	-1	0
survivors	PMC3035602	50799	50808	O	-1	-1	0
of	PMC3035602	50809	50811	O	-1	-1	0
childhood	PMC3035602	50812	50821	O	-1	-1	0
and	PMC3035602	50822	50825	O	-1	-1	0
adolescent	PMC3035602	50826	50836	O	-1	-1	0
cancer	PMC3035602	50837	50843	O	-1	-1	0
.	PMC3035602	50843	50844	O	-1	-1	0

Am	PMC3035602	50845	50847	O	-1	-1	0

J	PMC3035602	50848	50849	O	-1	-1	0
Hum	PMC3035602	50850	50853	O	-1	-1	0

Genet	PMC3035602	50854	50859	O	-1	-1	0
.	PMC3035602	50859	50860	O	-1	-1	0

1998;62(1):45–52	PMC3035602	50861	50877	O	-1	-1	0
.	PMC3035602	50877	50878	O	-1	-1	0


	PMC3035602	50878	50880	O	-1	-1	0

Clinical	PMC3035602	50880	50888	O	-1	-1	0
Epidemiology	PMC3035602	50889	50901	O	-1	-1	0
2011:3	PMC3035602	50902	50908	O	-1	-1	0


	PMC3035602	50908	50910	O	-1	-1	0

Dovepress	PMC3035602	50910	50919	O	-1	-1	0
32	PMC3035602	50920	50922	O	-1	-1	0
.	PMC3035602	50922	50923	O	-1	-1	0

Hawkins	PMC3035602	50924	50931	O	-1	-1	0
MM	PMC3035602	50932	50934	O	-1	-1	0
.	PMC3035602	50934	50935	O	-1	-1	0

Is	PMC3035602	50936	50938	O	-1	-1	0
there	PMC3035602	50939	50944	O	-1	-1	0
evidence	PMC3035602	50945	50953	O	-1	-1	0
of	PMC3035602	50954	50956	O	-1	-1	0
a	PMC3035602	50957	50958	O	-1	-1	0
therapy	PMC3035602	50959	50966	O	-1	-1	0
-	PMC3035602	50966	50967	O	-1	-1	0
related	PMC3035602	50967	50974	O	-1	-1	0
increase	PMC3035602	50975	50983	O	-1	-1	0
in	PMC3035602	50984	50986	O	-1	-1	0
germ	PMC3035602	50987	50991	O	-1	-1	0
cell	PMC3035602	50992	50996	O	-1	-1	0
mutation	PMC3035602	50997	51005	O	-1	-1	0
among	PMC3035602	51006	51011	O	-1	-1	0
childhood	PMC3035602	51012	51021	O	-1	-1	0
cancer	PMC3035602	51022	51028	O	-1	-1	0
survivors	PMC3035602	51029	51038	O	-1	-1	0
?	PMC3035602	51038	51039	O	-1	-1	0

J	PMC3035602	51040	51041	O	-1	-1	0
Natl	PMC3035602	51042	51046	O	-1	-1	0
Cancer	PMC3035602	51047	51053	O	-1	-1	0
Inst	PMC3035602	51054	51058	O	-1	-1	0
.	PMC3035602	51058	51059	O	-1	-1	0

1991;83(22):1643–1650	PMC3035602	51060	51081	O	-1	-1	0
.	PMC3035602	51081	51082	O	-1	-1	0

33	PMC3035602	51083	51085	O	-1	-1	0
.	PMC3035602	51085	51086	O	-1	-1	0

Winther	PMC3035602	51087	51094	O	-1	-1	0
JF	PMC3035602	51095	51097	O	-1	-1	0
,	PMC3035602	51097	51098	O	-1	-1	0
Boice	PMC3035602	51099	51104	O	-1	-1	0
JD	PMC3035602	51105	51107	O	-1	-1	0
Jr	PMC3035602	51108	51110	O	-1	-1	0
,	PMC3035602	51110	51111	O	-1	-1	0
Thomsen	PMC3035602	51112	51119	O	-1	-1	0
BL	PMC3035602	51120	51122	O	-1	-1	0
,	PMC3035602	51122	51123	O	-1	-1	0
Schull	PMC3035602	51124	51130	O	-1	-1	0
WJ	PMC3035602	51131	51133	O	-1	-1	0
,	PMC3035602	51133	51134	O	-1	-1	0
Stovall	PMC3035602	51135	51142	O	-1	-1	0
M	PMC3035602	51143	51144	O	-1	-1	0
,	PMC3035602	51144	51145	O	-1	-1	0
Olsen	PMC3035602	51146	51151	O	-1	-1	0
JH	PMC3035602	51152	51154	O	-1	-1	0
.	PMC3035602	51154	51155	O	-1	-1	0

Sex	PMC3035602	51156	51159	O	-1	-1	0
ratio	PMC3035602	51160	51165	O	-1	-1	0
among	PMC3035602	51166	51171	O	-1	-1	0
offspring	PMC3035602	51172	51181	O	-1	-1	0
of	PMC3035602	51182	51184	O	-1	-1	0
childhood	PMC3035602	51185	51194	O	-1	-1	0
cancer	PMC3035602	51195	51201	O	-1	-1	0
survivors	PMC3035602	51202	51211	O	-1	-1	0
treated	PMC3035602	51212	51219	O	-1	-1	0
with	PMC3035602	51220	51224	O	-1	-1	0
radiotherapy	PMC3035602	51225	51237	O	-1	-1	0
.	PMC3035602	51237	51238	O	-1	-1	0

Br	PMC3035602	51239	51241	O	-1	-1	0
J	PMC3035602	51242	51243	O	-1	-1	0
Cancer	PMC3035602	51244	51250	O	-1	-1	0
.	PMC3035602	51250	51251	O	-1	-1	0

2003;88(3):382–387	PMC3035602	51252	51270	O	-1	-1	0
.	PMC3035602	51270	51271	O	-1	-1	0

34	PMC3035602	51272	51274	O	-1	-1	0
.	PMC3035602	51274	51275	O	-1	-1	0

Langagergaard	PMC3035602	51276	51289	O	-1	-1	0
V	PMC3035602	51290	51291	O	-1	-1	0
,	PMC3035602	51291	51292	O	-1	-1	0
Puho	PMC3035602	51293	51297	O	-1	-1	0
EH	PMC3035602	51298	51300	O	-1	-1	0
,	PMC3035602	51300	51301	O	-1	-1	0
Lash	PMC3035602	51302	51306	O	-1	-1	0
TL	PMC3035602	51307	51309	O	-1	-1	0
,	PMC3035602	51309	51310	O	-1	-1	0
Nørgård	PMC3035602	51311	51318	O	-1	-1	0
B	PMC3035602	51319	51320	O	-1	-1	0
,	PMC3035602	51320	51321	O	-1	-1	0
Sørensen	PMC3035602	51322	51330	O	-1	-1	0
HT	PMC3035602	51331	51333	O	-1	-1	0
.	PMC3035602	51333	51334	O	-1	-1	0

Birth	PMC3035602	51335	51340	O	-1	-1	0
outcome	PMC3035602	51341	51348	O	-1	-1	0
in	PMC3035602	51349	51351	O	-1	-1	0
Danish	PMC3035602	51352	51358	O	-1	-1	0
women	PMC3035602	51359	51364	O	-1	-1	0
with	PMC3035602	51365	51369	O	-1	-1	0
cutaneous	PMC3035602	51370	51379	O	-1	-1	0
malignant	PMC3035602	51380	51389	O	-1	-1	0
melanoma	PMC3035602	51390	51398	O	-1	-1	0
.	PMC3035602	51398	51399	O	-1	-1	0

Melanoma	PMC3035602	51400	51408	O	-1	-1	0
Res	PMC3035602	51409	51412	O	-1	-1	0
.	PMC3035602	51412	51413	O	-1	-1	0

2007;17(1):31–36	PMC3035602	51414	51430	O	-1	-1	0
.	PMC3035602	51430	51431	O	-1	-1	0

35	PMC3035602	51432	51434	O	-1	-1	0
.	PMC3035602	51434	51435	O	-1	-1	0

O’Meara	PMC3035602	51436	51443	O	-1	-1	0
AT	PMC3035602	51444	51446	O	-1	-1	0
,	PMC3035602	51446	51447	O	-1	-1	0
Cress	PMC3035602	51448	51453	O	-1	-1	0
R	PMC3035602	51454	51455	O	-1	-1	0
,	PMC3035602	51455	51456	O	-1	-1	0
Xing	PMC3035602	51457	51461	O	-1	-1	0
G	PMC3035602	51462	51463	O	-1	-1	0
,	PMC3035602	51463	51464	O	-1	-1	0
Danielsen	PMC3035602	51465	51474	O	-1	-1	0
B	PMC3035602	51475	51476	O	-1	-1	0
,	PMC3035602	51476	51477	O	-1	-1	0
Smith	PMC3035602	51478	51483	O	-1	-1	0
LH	PMC3035602	51484	51486	O	-1	-1	0
.	PMC3035602	51486	51487	O	-1	-1	0

Malignant	PMC3035602	51488	51497	O	-1	-1	0
melanoma	PMC3035602	51498	51506	O	-1	-1	0
in	PMC3035602	51507	51509	O	-1	-1	0
pregnancy	PMC3035602	51510	51519	O	-1	-1	0
.	PMC3035602	51519	51520	O	-1	-1	0

A	PMC3035602	51521	51522	O	-1	-1	0
population	PMC3035602	51523	51533	O	-1	-1	0
-	PMC3035602	51533	51534	O	-1	-1	0
based	PMC3035602	51534	51539	O	-1	-1	0
evaluation	PMC3035602	51540	51550	O	-1	-1	0
.	PMC3035602	51550	51551	O	-1	-1	0

Cancer	PMC3035602	51552	51558	O	-1	-1	0
.	PMC3035602	51558	51559	O	-1	-1	0

2005	PMC3035602	51560	51564	O	-1	-1	0
;	PMC3035602	51564	51565	O	-1	-1	0

103(6):1217–1226	PMC3035602	51566	51582	O	-1	-1	0
.	PMC3035602	51582	51583	O	-1	-1	0

36	PMC3035602	51584	51586	O	-1	-1	0
.	PMC3035602	51586	51587	O	-1	-1	0

Ravid	PMC3035602	51588	51593	O	-1	-1	0
M	PMC3035602	51594	51595	O	-1	-1	0
,	PMC3035602	51595	51596	O	-1	-1	0
Lishner	PMC3035602	51597	51604	O	-1	-1	0
M	PMC3035602	51605	51606	O	-1	-1	0
,	PMC3035602	51606	51607	O	-1	-1	0
Zemlickis	PMC3035602	51608	51617	O	-1	-1	0
D	PMC3035602	51618	51619	O	-1	-1	0
,	PMC3035602	51619	51620	O	-1	-1	0
Koren	PMC3035602	51621	51626	O	-1	-1	0
G.	PMC3035602	51627	51629	O	-1	-1	0
Malignant	PMC3035602	51630	51639	O	-1	-1	0
melanoma	PMC3035602	51640	51648	O	-1	-1	0
and	PMC3035602	51649	51652	O	-1	-1	0
pregnancy	PMC3035602	51653	51662	O	-1	-1	0
.	PMC3035602	51662	51663	O	-1	-1	0

In	PMC3035602	51664	51666	O	-1	-1	0
:	PMC3035602	51666	51667	O	-1	-1	0
Koren	PMC3035602	51668	51673	O	-1	-1	0
G	PMC3035602	51674	51675	O	-1	-1	0
,	PMC3035602	51675	51676	O	-1	-1	0
Lishner	PMC3035602	51677	51684	O	-1	-1	0
M	PMC3035602	51685	51686	O	-1	-1	0
,	PMC3035602	51686	51687	O	-1	-1	0
Farine	PMC3035602	51688	51694	O	-1	-1	0
D	PMC3035602	51695	51696	O	-1	-1	0
,	PMC3035602	51696	51697	O	-1	-1	0
editors	PMC3035602	51698	51705	O	-1	-1	0
.	PMC3035602	51705	51706	O	-1	-1	0

Cancer	PMC3035602	51707	51713	O	-1	-1	0
in	PMC3035602	51714	51716	O	-1	-1	0
­Pregnancy	PMC3035602	51717	51727	O	-1	-1	0
:	PMC3035602	51727	51728	O	-1	-1	0

Maternal	PMC3035602	51729	51737	O	-1	-1	0
and	PMC3035602	51738	51741	O	-1	-1	0
Fetal	PMC3035602	51742	51747	O	-1	-1	0
Risks	PMC3035602	51748	51753	O	-1	-1	0
.	PMC3035602	51753	51754	O	-1	-1	0

Cambridge	PMC3035602	51755	51764	O	-1	-1	0
:	PMC3035602	51764	51765	O	-1	-1	0

Cambridge	PMC3035602	51766	51775	O	-1	-1	0
­University	PMC3035602	51776	51787	O	-1	-1	0
Press	PMC3035602	51788	51793	O	-1	-1	0
;	PMC3035602	51793	51794	O	-1	-1	0
1996:134–142	PMC3035602	51795	51807	O	-1	-1	0
.	PMC3035602	51807	51808	O	-1	-1	0

37	PMC3035602	51809	51811	O	-1	-1	0
.	PMC3035602	51811	51812	O	-1	-1	0

Janov	PMC3035602	51813	51818	O	-1	-1	0
AJ	PMC3035602	51819	51821	O	-1	-1	0
,	PMC3035602	51821	51822	O	-1	-1	0
Anderson	PMC3035602	51823	51831	O	-1	-1	0
J	PMC3035602	51832	51833	O	-1	-1	0
,	PMC3035602	51833	51834	O	-1	-1	0
Cella	PMC3035602	51835	51840	O	-1	-1	0
DF	PMC3035602	51841	51843	O	-1	-1	0
,	PMC3035602	51843	51844	O	-1	-1	0
Zuckerman	PMC3035602	51845	51854	O	-1	-1	0
E	PMC3035602	51855	51856	O	-1	-1	0
,	PMC3035602	51856	51857	O	-1	-1	0
Kornblith	PMC3035602	51858	51867	O	-1	-1	0
AB	PMC3035602	51868	51870	O	-1	-1	0
,	PMC3035602	51870	51871	O	-1	-1	0
­Holland	PMC3035602	51872	51880	O	-1	-1	0

JC	PMC3035602	51881	51883	O	-1	-1	0
,	PMC3035602	51883	51884	O	-1	-1	0
et	PMC3035602	51885	51887	O	-1	-1	0

al	PMC3035602	51888	51890	O	-1	-1	0
.	PMC3035602	51890	51891	O	-1	-1	0

Pregnancy	PMC3035602	51892	51901	O	-1	-1	0
outcome	PMC3035602	51902	51909	O	-1	-1	0
in	PMC3035602	51910	51912	O	-1	-1	0
survivors	PMC3035602	51913	51922	O	-1	-1	0
of	PMC3035602	51923	51925	O	-1	-1	0
advanced	PMC3035602	51926	51934	O	-1	-1	0
Hodgkin	PMC3035602	51935	51942	O	-1	-1	0
disease	PMC3035602	51943	51950	O	-1	-1	0
.	PMC3035602	51950	51951	O	-1	-1	0

Cancer	PMC3035602	51952	51958	O	-1	-1	0
.	PMC3035602	51958	51959	O	-1	-1	0

1992;70(3):688–692	PMC3035602	51960	51978	O	-1	-1	0
.	PMC3035602	51978	51979	O	-1	-1	0

38	PMC3035602	51980	51982	O	-1	-1	0
.	PMC3035602	51982	51983	O	-1	-1	0

Swerdlow	PMC3035602	51984	51992	O	-1	-1	0
AJ	PMC3035602	51993	51995	O	-1	-1	0
,	PMC3035602	51995	51996	O	-1	-1	0
Jacobs	PMC3035602	51997	52003	O	-1	-1	0
PA	PMC3035602	52004	52006	O	-1	-1	0
,	PMC3035602	52006	52007	O	-1	-1	0
Marks	PMC3035602	52008	52013	O	-1	-1	0
A	PMC3035602	52014	52015	O	-1	-1	0
,	PMC3035602	52015	52016	O	-1	-1	0
et	PMC3035602	52017	52019	O	-1	-1	0
al	PMC3035602	52020	52022	O	-1	-1	0
.	PMC3035602	52022	52023	O	-1	-1	0

Fertility	PMC3035602	52024	52033	O	-1	-1	0
,	PMC3035602	52033	52034	O	-1	-1	0
reproductive	PMC3035602	52035	52047	O	-1	-1	0
­outcomes	PMC3035602	52048	52057	O	-1	-1	0
,	PMC3035602	52057	52058	O	-1	-1	0
and	PMC3035602	52059	52062	O	-1	-1	0
health	PMC3035602	52063	52069	O	-1	-1	0
of	PMC3035602	52070	52072	O	-1	-1	0
offspring	PMC3035602	52073	52082	O	-1	-1	0
,	PMC3035602	52082	52083	O	-1	-1	0
of	PMC3035602	52084	52086	O	-1	-1	0
patients	PMC3035602	52087	52095	O	-1	-1	0
treated	PMC3035602	52096	52103	O	-1	-1	0
for	PMC3035602	52104	52107	O	-1	-1	0
Hodgkin	PMC3035602	52108	52115	O	-1	-1	0
’s	PMC3035602	52115	52117	O	-1	-1	0

disease	PMC3035602	52118	52125	O	-1	-1	0
:	PMC3035602	52125	52126	O	-1	-1	0

an	PMC3035602	52127	52129	O	-1	-1	0
investigation	PMC3035602	52130	52143	O	-1	-1	0
including	PMC3035602	52144	52153	O	-1	-1	0
chromosome	PMC3035602	52154	52164	O	-1	-1	0
examinations	PMC3035602	52165	52177	O	-1	-1	0
.	PMC3035602	52177	52178	O	-1	-1	0

Br	PMC3035602	52179	52181	O	-1	-1	0
J	PMC3035602	52182	52183	O	-1	-1	0
Cancer	PMC3035602	52184	52190	O	-1	-1	0
.	PMC3035602	52190	52191	O	-1	-1	0

1996;74(2):291–296	PMC3035602	52192	52210	O	-1	-1	0
.	PMC3035602	52210	52211	O	-1	-1	0

39	PMC3035602	52212	52214	O	-1	-1	0
.	PMC3035602	52214	52215	O	-1	-1	0

Holmes	PMC3035602	52216	52222	O	-1	-1	0
GE	PMC3035602	52223	52225	O	-1	-1	0
,	PMC3035602	52225	52226	O	-1	-1	0
Holmes	PMC3035602	52227	52233	O	-1	-1	0
FF	PMC3035602	52234	52236	O	-1	-1	0
.	PMC3035602	52236	52237	O	-1	-1	0

Pregnancy	PMC3035602	52238	52247	O	-1	-1	0
outcome	PMC3035602	52248	52255	O	-1	-1	0
of	PMC3035602	52256	52258	O	-1	-1	0
patients	PMC3035602	52259	52267	O	-1	-1	0
treated	PMC3035602	52268	52275	O	-1	-1	0
for	PMC3035602	52276	52279	O	-1	-1	0
Hodgkin	PMC3035602	52280	52287	O	-1	-1	0
’s	PMC3035602	52287	52289	O	-1	-1	0
disease	PMC3035602	52290	52297	O	-1	-1	0
:	PMC3035602	52297	52298	O	-1	-1	0
a	PMC3035602	52299	52300	O	-1	-1	0
controlled	PMC3035602	52301	52311	O	-1	-1	0
study	PMC3035602	52312	52317	O	-1	-1	0
.	PMC3035602	52317	52318	O	-1	-1	0

Cancer	PMC3035602	52319	52325	O	-1	-1	0
.	PMC3035602	52325	52326	O	-1	-1	0

1978;41(4):1317–1322	PMC3035602	52327	52347	O	-1	-1	0
.	PMC3035602	52347	52348	O	-1	-1	0

40	PMC3035602	52349	52351	O	-1	-1	0
.	PMC3035602	52351	52352	O	-1	-1	0

Signorello	PMC3035602	52353	52363	O	-1	-1	0
LB	PMC3035602	52364	52366	O	-1	-1	0
,	PMC3035602	52366	52367	O	-1	-1	0
Cohen	PMC3035602	52368	52373	O	-1	-1	0
SS	PMC3035602	52374	52376	O	-1	-1	0
,	PMC3035602	52376	52377	O	-1	-1	0
Bosetti	PMC3035602	52378	52385	O	-1	-1	0
C	PMC3035602	52386	52387	O	-1	-1	0
,	PMC3035602	52387	52388	O	-1	-1	0
et	PMC3035602	52389	52391	O	-1	-1	0
al	PMC3035602	52392	52394	O	-1	-1	0
.	PMC3035602	52394	52395	O	-1	-1	0

Female	PMC3035602	52396	52402	O	-1	-1	0
survivors	PMC3035602	52403	52412	O	-1	-1	0
of	PMC3035602	52413	52415	O	-1	-1	0
childhood	PMC3035602	52416	52425	O	-1	-1	0
cancer	PMC3035602	52426	52432	O	-1	-1	0
:	PMC3035602	52432	52433	O	-1	-1	0
preterm	PMC3035602	52434	52441	O	-1	-1	0
birth	PMC3035602	52442	52447	O	-1	-1	0
and	PMC3035602	52448	52451	O	-1	-1	0
low	PMC3035602	52452	52455	O	-1	-1	0
birth	PMC3035602	52456	52461	O	-1	-1	0
weight	PMC3035602	52462	52468	O	-1	-1	0
among	PMC3035602	52469	52474	O	-1	-1	0
their	PMC3035602	52475	52480	O	-1	-1	0
children	PMC3035602	52481	52489	O	-1	-1	0
.	PMC3035602	52489	52490	O	-1	-1	0

J	PMC3035602	52491	52492	O	-1	-1	0
Natl	PMC3035602	52493	52497	O	-1	-1	0
Cancer	PMC3035602	52498	52504	O	-1	-1	0
Inst	PMC3035602	52505	52509	O	-1	-1	0
.	PMC3035602	52509	52510	O	-1	-1	0

2006;98(20):1453–1461	PMC3035602	52511	52532	O	-1	-1	0
.	PMC3035602	52532	52533	O	-1	-1	0

41	PMC3035602	52534	52536	O	-1	-1	0
.	PMC3035602	52536	52537	O	-1	-1	0

Green	PMC3035602	52538	52543	O	-1	-1	0
DM	PMC3035602	52544	52546	O	-1	-1	0
,	PMC3035602	52546	52547	O	-1	-1	0
Whitton	PMC3035602	52548	52555	O	-1	-1	0
JA	PMC3035602	52556	52558	O	-1	-1	0
,	PMC3035602	52558	52559	O	-1	-1	0
Stovall	PMC3035602	52560	52567	O	-1	-1	0
M	PMC3035602	52568	52569	O	-1	-1	0
,	PMC3035602	52569	52570	O	-1	-1	0
et	PMC3035602	52571	52573	O	-1	-1	0
al	PMC3035602	52574	52576	O	-1	-1	0
.	PMC3035602	52576	52577	O	-1	-1	0

Pregnancy	PMC3035602	52578	52587	O	-1	-1	0
outcome	PMC3035602	52588	52595	O	-1	-1	0
of	PMC3035602	52596	52598	O	-1	-1	0
female	PMC3035602	52599	52605	O	-1	-1	0
survivors	PMC3035602	52606	52615	O	-1	-1	0
of	PMC3035602	52616	52618	O	-1	-1	0
childhood	PMC3035602	52619	52628	O	-1	-1	0
cancer	PMC3035602	52629	52635	O	-1	-1	0
:	PMC3035602	52635	52636	O	-1	-1	0

a	PMC3035602	52637	52638	O	-1	-1	0
report	PMC3035602	52639	52645	O	-1	-1	0
from	PMC3035602	52646	52650	O	-1	-1	0
the	PMC3035602	52651	52654	O	-1	-1	0
Childhood	PMC3035602	52655	52664	O	-1	-1	0
Cancer	PMC3035602	52665	52671	O	-1	-1	0
Survivor	PMC3035602	52672	52680	O	-1	-1	0
Study	PMC3035602	52681	52686	O	-1	-1	0
.	PMC3035602	52686	52687	O	-1	-1	0

Am	PMC3035602	52688	52690	O	-1	-1	0
J	PMC3035602	52691	52692	O	-1	-1	0
Obstet	PMC3035602	52693	52699	O	-1	-1	0
Gynecol	PMC3035602	52700	52707	O	-1	-1	0
.	PMC3035602	52707	52708	O	-1	-1	0

2002;187(4):1070–1080	PMC3035602	52709	52730	O	-1	-1	0
.	PMC3035602	52730	52731	O	-1	-1	0

42	PMC3035602	52732	52734	O	-1	-1	0
.	PMC3035602	52734	52735	O	-1	-1	0

Langagergaard	PMC3035602	52736	52749	O	-1	-1	0
V	PMC3035602	52750	52751	O	-1	-1	0
,	PMC3035602	52751	52752	O	-1	-1	0
Horvath	PMC3035602	52753	52760	O	-1	-1	0
-	PMC3035602	52760	52761	O	-1	-1	0
Puho	PMC3035602	52761	52765	O	-1	-1	0
E	PMC3035602	52766	52767	O	-1	-1	0
,	PMC3035602	52767	52768	O	-1	-1	0
Nørgaard	PMC3035602	52769	52777	O	-1	-1	0
M	PMC3035602	52778	52779	O	-1	-1	0
,	PMC3035602	52779	52780	O	-1	-1	0
Nørgård	PMC3035602	52781	52788	O	-1	-1	0
B	PMC3035602	52789	52790	O	-1	-1	0
,	PMC3035602	52790	52791	O	-1	-1	0
Sørensen	PMC3035602	52792	52800	O	-1	-1	0
HT	PMC3035602	52801	52803	O	-1	-1	0
.	PMC3035602	52803	52804	O	-1	-1	0

Hodgkin	PMC3035602	52805	52812	O	-1	-1	0
’s	PMC3035602	52812	52814	O	-1	-1	0
disease	PMC3035602	52815	52822	O	-1	-1	0
and	PMC3035602	52823	52826	O	-1	-1	0
birth	PMC3035602	52827	52832	O	-1	-1	0
outcome	PMC3035602	52833	52840	O	-1	-1	0
:	PMC3035602	52840	52841	O	-1	-1	0
a	PMC3035602	52842	52843	O	-1	-1	0
Danish	PMC3035602	52844	52850	O	-1	-1	0
­nationwide	PMC3035602	52851	52862	O	-1	-1	0
cohort	PMC3035602	52863	52869	O	-1	-1	0
study	PMC3035602	52870	52875	O	-1	-1	0
.	PMC3035602	52875	52876	O	-1	-1	0

Br	PMC3035602	52877	52879	O	-1	-1	0
J	PMC3035602	52880	52881	O	-1	-1	0
Cancer	PMC3035602	52882	52888	O	-1	-1	0
.	PMC3035602	52888	52889	O	-1	-1	0

2008;98:183–188	PMC3035602	52890	52905	O	-1	-1	0
.	PMC3035602	52905	52906	O	-1	-1	0

43	PMC3035602	52907	52909	O	-1	-1	0
.	PMC3035602	52909	52910	O	-1	-1	0

Lambe	PMC3035602	52911	52916	O	-1	-1	0
M	PMC3035602	52917	52918	O	-1	-1	0
,	PMC3035602	52918	52919	O	-1	-1	0
Ekbom	PMC3035602	52920	52925	O	-1	-1	0
A.	PMC3035602	52926	52928	O	-1	-1	0
Cancers	PMC3035602	52929	52936	O	-1	-1	0
coinciding	PMC3035602	52937	52947	O	-1	-1	0
with	PMC3035602	52948	52952	O	-1	-1	0
childbearing	PMC3035602	52953	52965	O	-1	-1	0
:	PMC3035602	52965	52966	O	-1	-1	0
delayed	PMC3035602	52967	52974	O	-1	-1	0
diagnosis	PMC3035602	52975	52984	O	-1	-1	0
during	PMC3035602	52985	52991	O	-1	-1	0
pregnancy	PMC3035602	52992	53001	O	-1	-1	0
?	PMC3035602	53001	53002	O	-1	-1	0

BMJ	PMC3035602	53003	53006	O	-1	-1	0
.	PMC3035602	53006	53007	O	-1	-1	0

1995;311(7020):1607–1608	PMC3035602	53008	53032	O	-1	-1	0
.	PMC3035602	53032	53033	O	-1	-1	0

44	PMC3035602	53034	53036	O	-1	-1	0
.	PMC3035602	53036	53037	O	-1	-1	0

Zhu	PMC3035602	53038	53041	O	-1	-1	0
JL	PMC3035602	53042	53044	O	-1	-1	0
,	PMC3035602	53044	53045	O	-1	-1	0
Basso	PMC3035602	53046	53051	O	-1	-1	0
O	PMC3035602	53052	53053	O	-1	-1	0
,	PMC3035602	53053	53054	O	-1	-1	0
Hasle	PMC3035602	53055	53060	O	-1	-1	0
H	PMC3035602	53061	53062	O	-1	-1	0
,	PMC3035602	53062	53063	O	-1	-1	0
Winther	PMC3035602	53064	53071	O	-1	-1	0
JF	PMC3035602	53072	53074	O	-1	-1	0
,	PMC3035602	53074	53075	O	-1	-1	0
Olsen	PMC3035602	53076	53081	O	-1	-1	0
JH	PMC3035602	53082	53084	O	-1	-1	0

,	PMC3035602	53084	53085	O	-1	-1	0
Olsen	PMC3035602	53086	53091	O	-1	-1	0
J.	PMC3035602	53092	53094	O	-1	-1	0
Do	PMC3035602	53095	53097	O	-1	-1	0
parents	PMC3035602	53098	53105	O	-1	-1	0
of	PMC3035602	53106	53108	O	-1	-1	0
children	PMC3035602	53109	53117	O	-1	-1	0
with	PMC3035602	53118	53122	O	-1	-1	0
congenital	PMC3035602	53123	53133	O	-1	-1	0
malformations	PMC3035602	53134	53147	O	-1	-1	0
have	PMC3035602	53148	53152	O	-1	-1	0
a	PMC3035602	53153	53154	O	-1	-1	0
higher	PMC3035602	53155	53161	O	-1	-1	0
cancer	PMC3035602	53162	53168	O	-1	-1	0
risk	PMC3035602	53169	53173	O	-1	-1	0
?	PMC3035602	53173	53174	O	-1	-1	0

A	PMC3035602	53175	53176	O	-1	-1	0
nationwide	PMC3035602	53177	53187	O	-1	-1	0
study	PMC3035602	53188	53193	O	-1	-1	0
in	PMC3035602	53194	53196	O	-1	-1	0
Denmark	PMC3035602	53197	53204	O	-1	-1	0
.	PMC3035602	53204	53205	O	-1	-1	0

Br	PMC3035602	53206	53208	O	-1	-1	0
J	PMC3035602	53209	53210	O	-1	-1	0
Cancer	PMC3035602	53211	53217	O	-1	-1	0
.	PMC3035602	53217	53218	O	-1	-1	0

2002;87(5):524–528	PMC3035602	53219	53237	O	-1	-1	0
.	PMC3035602	53237	53238	O	-1	-1	0

45	PMC3035602	53239	53241	O	-1	-1	0
.	PMC3035602	53241	53242	O	-1	-1	0

Chambers	PMC3035602	53243	53251	O	-1	-1	0
CD	PMC3035602	53252	53254	O	-1	-1	0
,	PMC3035602	53254	53255	O	-1	-1	0
Johnson	PMC3035602	53256	53263	O	-1	-1	0
KA	PMC3035602	53264	53266	O	-1	-1	0
,	PMC3035602	53266	53267	O	-1	-1	0
Dick	PMC3035602	53268	53272	O	-1	-1	0
LM	PMC3035602	53273	53275	O	-1	-1	0
,	PMC3035602	53275	53276	O	-1	-1	0
Felix	PMC3035602	53277	53282	O	-1	-1	0
RJ	PMC3035602	53283	53285	O	-1	-1	0
,	PMC3035602	53285	53286	O	-1	-1	0
Jones	PMC3035602	53287	53292	O	-1	-1	0
KL	PMC3035602	53293	53295	O	-1	-1	0
.	PMC3035602	53295	53296	O	-1	-1	0
­Maternal	PMC3035602	53297	53306	O	-1	-1	0
fever	PMC3035602	53307	53312	O	-1	-1	0
and	PMC3035602	53313	53316	O	-1	-1	0
birth	PMC3035602	53317	53322	O	-1	-1	0
outcome	PMC3035602	53323	53330	O	-1	-1	0
:	PMC3035602	53330	53331	O	-1	-1	0
a	PMC3035602	53332	53333	O	-1	-1	0
prospective	PMC3035602	53334	53345	O	-1	-1	0
study	PMC3035602	53346	53351	O	-1	-1	0
.	PMC3035602	53351	53352	O	-1	-1	0

Teratology	PMC3035602	53353	53363	O	-1	-1	0
.	PMC3035602	53363	53364	O	-1	-1	0

1998	PMC3035602	53365	53369	O	-1	-1	0
;	PMC3035602	53369	53370	O	-1	-1	0
58(6):251–257	PMC3035602	53371	53384	O	-1	-1	0
.	PMC3035602	53384	53385	O	-1	-1	0

46	PMC3035602	53386	53388	O	-1	-1	0
.	PMC3035602	53388	53389	O	-1	-1	0

Tikkanen	PMC3035602	53390	53398	O	-1	-1	0
J	PMC3035602	53399	53400	O	-1	-1	0
,	PMC3035602	53400	53401	O	-1	-1	0
Heinonen	PMC3035602	53402	53410	O	-1	-1	0
OP	PMC3035602	53411	53413	O	-1	-1	0
.	PMC3035602	53413	53414	O	-1	-1	0

Maternal	PMC3035602	53415	53423	O	-1	-1	0
hyperthermia	PMC3035602	53424	53436	O	-1	-1	0
during	PMC3035602	53437	53443	O	-1	-1	0
pregnancy	PMC3035602	53444	53453	O	-1	-1	0
and	PMC3035602	53454	53457	O	-1	-1	0
cardiovascular	PMC3035602	53458	53472	O	-1	-1	0
malformations	PMC3035602	53473	53486	O	-1	-1	0
in	PMC3035602	53487	53489	O	-1	-1	0
the	PMC3035602	53490	53493	O	-1	-1	0
offspring	PMC3035602	53494	53503	O	-1	-1	0
.	PMC3035602	53503	53504	O	-1	-1	0

Eur	PMC3035602	53505	53508	O	-1	-1	0
J	PMC3035602	53509	53510	O	-1	-1	0
Epidemiol	PMC3035602	53511	53520	O	-1	-1	0
.	PMC3035602	53520	53521	O	-1	-1	0

1991;7(6):628–635	PMC3035602	53522	53539	O	-1	-1	0
.	PMC3035602	53539	53540	O	-1	-1	0

47	PMC3035602	53541	53543	O	-1	-1	0
.	PMC3035602	53543	53544	O	-1	-1	0

Wu	PMC3035602	53545	53547	O	-1	-1	0
G	PMC3035602	53548	53549	O	-1	-1	0
,	PMC3035602	53549	53550	O	-1	-1	0
Bazer	PMC3035602	53551	53556	O	-1	-1	0
FW	PMC3035602	53557	53559	O	-1	-1	0
,	PMC3035602	53559	53560	O	-1	-1	0
Cudd	PMC3035602	53561	53565	O	-1	-1	0
TA	PMC3035602	53566	53568	O	-1	-1	0
,	PMC3035602	53568	53569	O	-1	-1	0
Meininger	PMC3035602	53570	53579	O	-1	-1	0
CJ	PMC3035602	53580	53582	O	-1	-1	0
,	PMC3035602	53582	53583	O	-1	-1	0
Spencer	PMC3035602	53584	53591	O	-1	-1	0
TE	PMC3035602	53592	53594	O	-1	-1	0
.	PMC3035602	53594	53595	O	-1	-1	0

Maternal	PMC3035602	53596	53604	O	-1	-1	0
­nutrition	PMC3035602	53605	53615	O	-1	-1	0
and	PMC3035602	53616	53619	O	-1	-1	0
fetal	PMC3035602	53620	53625	O	-1	-1	0
development	PMC3035602	53626	53637	O	-1	-1	0
.	PMC3035602	53637	53638	O	-1	-1	0

J	PMC3035602	53639	53640	O	-1	-1	0
Nutr	PMC3035602	53641	53645	O	-1	-1	0
.	PMC3035602	53645	53646	O	-1	-1	0

2004;134(9):2169–2172	PMC3035602	53647	53668	O	-1	-1	0
.	PMC3035602	53668	53669	O	-1	-1	0

48	PMC3035602	53670	53672	O	-1	-1	0
.	PMC3035602	53672	53673	O	-1	-1	0

McIntire	PMC3035602	53674	53682	O	-1	-1	0
DD	PMC3035602	53683	53685	O	-1	-1	0
,	PMC3035602	53685	53686	O	-1	-1	0
Bloom	PMC3035602	53687	53692	O	-1	-1	0
SL	PMC3035602	53693	53695	O	-1	-1	0
,	PMC3035602	53695	53696	O	-1	-1	0
Casey	PMC3035602	53697	53702	O	-1	-1	0
BM	PMC3035602	53703	53705	O	-1	-1	0
,	PMC3035602	53705	53706	O	-1	-1	0
Leveno	PMC3035602	53707	53713	O	-1	-1	0
KJ	PMC3035602	53714	53716	O	-1	-1	0
.	PMC3035602	53716	53717	O	-1	-1	0

Birth	PMC3035602	53718	53723	O	-1	-1	0
weight	PMC3035602	53724	53730	O	-1	-1	0
in	PMC3035602	53731	53733	O	-1	-1	0
­relation	PMC3035602	53734	53743	O	-1	-1	0
to	PMC3035602	53744	53746	O	-1	-1	0
morbidity	PMC3035602	53747	53756	O	-1	-1	0
and	PMC3035602	53757	53760	O	-1	-1	0
mortality	PMC3035602	53761	53770	O	-1	-1	0
among	PMC3035602	53771	53776	O	-1	-1	0
newborn	PMC3035602	53777	53784	O	-1	-1	0
infants	PMC3035602	53785	53792	O	-1	-1	0
.	PMC3035602	53792	53793	O	-1	-1	0

N	PMC3035602	53794	53795	O	-1	-1	0
Engl	PMC3035602	53796	53800	O	-1	-1	0
J	PMC3035602	53801	53802	O	-1	-1	0
Med	PMC3035602	53803	53806	O	-1	-1	0
.	PMC3035602	53806	53807	O	-1	-1	0

1999;340(16):1234–1238	PMC3035602	53808	53830	O	-1	-1	0
.	PMC3035602	53830	53831	O	-1	-1	0

49	PMC3035602	53832	53834	O	-1	-1	0
.	PMC3035602	53834	53835	O	-1	-1	0

Barker	PMC3035602	53836	53842	O	-1	-1	0
DJP	PMC3035602	53843	53846	O	-1	-1	0
.	PMC3035602	53846	53847	O	-1	-1	0

Fetal	PMC3035602	53848	53853	O	-1	-1	0
origins	PMC3035602	53854	53861	O	-1	-1	0
of	PMC3035602	53862	53864	O	-1	-1	0
coronary	PMC3035602	53865	53873	O	-1	-1	0
heart	PMC3035602	53874	53879	O	-1	-1	0
disease	PMC3035602	53880	53887	O	-1	-1	0
.	PMC3035602	53887	53888	O	-1	-1	0

BMJ	PMC3035602	53889	53892	O	-1	-1	0
.	PMC3035602	53892	53893	O	-1	-1	0

1995	PMC3035602	53894	53898	O	-1	-1	0

;	PMC3035602	53898	53899	O	-1	-1	0
311(6998):171–174	PMC3035602	53900	53917	O	-1	-1	0
.	PMC3035602	53917	53918	O	-1	-1	0

50	PMC3035602	53919	53921	O	-1	-1	0
.	PMC3035602	53921	53922	O	-1	-1	0

Hedegaard	PMC3035602	53923	53932	O	-1	-1	0
M	PMC3035602	53933	53934	O	-1	-1	0
,	PMC3035602	53934	53935	O	-1	-1	0
Henriksen	PMC3035602	53936	53945	O	-1	-1	0
TB	PMC3035602	53946	53948	O	-1	-1	0
,	PMC3035602	53948	53949	O	-1	-1	0
Sabroe	PMC3035602	53950	53956	O	-1	-1	0
S	PMC3035602	53957	53958	O	-1	-1	0
,	PMC3035602	53958	53959	O	-1	-1	0
Secher	PMC3035602	53960	53966	O	-1	-1	0
NJ	PMC3035602	53967	53969	O	-1	-1	0
.	PMC3035602	53969	53970	O	-1	-1	0

Psychological	PMC3035602	53971	53984	O	-1	-1	0
distress	PMC3035602	53985	53993	O	-1	-1	0
in	PMC3035602	53994	53996	O	-1	-1	0
pregnancy	PMC3035602	53997	54006	O	-1	-1	0
and	PMC3035602	54007	54010	O	-1	-1	0
preterm	PMC3035602	54011	54018	O	-1	-1	0
delivery	PMC3035602	54019	54027	O	-1	-1	0
.	PMC3035602	54027	54028	O	-1	-1	0

BMJ	PMC3035602	54029	54032	O	-1	-1	0
.	PMC3035602	54032	54033	O	-1	-1	0

1993;307(6898):234–239	PMC3035602	54034	54056	O	-1	-1	0
.	PMC3035602	54056	54057	O	-1	-1	0

51	PMC3035602	54058	54060	O	-1	-1	0
.	PMC3035602	54060	54061	O	-1	-1	0

Hedegaard	PMC3035602	54062	54071	O	-1	-1	0
M	PMC3035602	54072	54073	O	-1	-1	0
,	PMC3035602	54073	54074	O	-1	-1	0
Henriksen	PMC3035602	54075	54084	O	-1	-1	0
TB	PMC3035602	54085	54087	O	-1	-1	0
,	PMC3035602	54087	54088	O	-1	-1	0
Secher	PMC3035602	54089	54095	O	-1	-1	0
NJ	PMC3035602	54096	54098	O	-1	-1	0
,	PMC3035602	54098	54099	O	-1	-1	0
Hatch	PMC3035602	54100	54105	O	-1	-1	0
MC	PMC3035602	54106	54108	O	-1	-1	0
,	PMC3035602	54108	54109	O	-1	-1	0

Sabroe	PMC3035602	54110	54116	O	-1	-1	0
S.	PMC3035602	54117	54119	O	-1	-1	0
Do	PMC3035602	54120	54122	O	-1	-1	0

stressful	PMC3035602	54123	54132	O	-1	-1	0
life	PMC3035602	54133	54137	O	-1	-1	0
events	PMC3035602	54138	54144	O	-1	-1	0
affect	PMC3035602	54145	54151	O	-1	-1	0
duration	PMC3035602	54152	54160	O	-1	-1	0
of	PMC3035602	54161	54163	O	-1	-1	0
gestation	PMC3035602	54164	54173	O	-1	-1	0
and	PMC3035602	54174	54177	O	-1	-1	0
risk	PMC3035602	54178	54182	O	-1	-1	0
of	PMC3035602	54183	54185	O	-1	-1	0
preterm	PMC3035602	54186	54193	O	-1	-1	0
delivery	PMC3035602	54194	54202	O	-1	-1	0
?	PMC3035602	54202	54203	O	-1	-1	0

Epidemiology	PMC3035602	54204	54216	O	-1	-1	0
.	PMC3035602	54216	54217	O	-1	-1	0

1996;7(4):339–345	PMC3035602	54218	54235	O	-1	-1	0
.	PMC3035602	54235	54236	O	-1	-1	0

Clinical	PMC3035602	54237	54245	O	-1	-1	0
Epidemiology	PMC3035602	54246	54258	O	-1	-1	0


	PMC3035602	54258	54260	O	-1	-1	0

Publish	PMC3035602	54260	54267	O	-1	-1	0
your	PMC3035602	54268	54272	O	-1	-1	0
work	PMC3035602	54273	54277	O	-1	-1	0
in	PMC3035602	54278	54280	O	-1	-1	0
this	PMC3035602	54281	54285	O	-1	-1	0
journal	PMC3035602	54286	54293	O	-1	-1	0

Clinical	PMC3035602	54294	54302	O	-1	-1	0
Epidemiology	PMC3035602	54303	54315	O	-1	-1	0
is	PMC3035602	54316	54318	O	-1	-1	0
an	PMC3035602	54319	54321	O	-1	-1	0
international	PMC3035602	54322	54335	O	-1	-1	0
,	PMC3035602	54335	54336	O	-1	-1	0
peer	PMC3035602	54337	54341	O	-1	-1	0
-	PMC3035602	54341	54342	O	-1	-1	0
reviewed	PMC3035602	54342	54350	O	-1	-1	0
,	PMC3035602	54350	54351	O	-1	-1	0
open	PMC3035602	54352	54356	O	-1	-1	0
access	PMC3035602	54357	54363	O	-1	-1	0
journal	PMC3035602	54364	54371	O	-1	-1	0
focusing	PMC3035602	54372	54380	O	-1	-1	0
on	PMC3035602	54381	54383	O	-1	-1	0
disease	PMC3035602	54384	54391	O	-1	-1	0
and	PMC3035602	54392	54395	O	-1	-1	0
drug	PMC3035602	54396	54400	O	-1	-1	0
epidemiology	PMC3035602	54401	54413	O	-1	-1	0
,	PMC3035602	54413	54414	O	-1	-1	0
identification	PMC3035602	54415	54429	O	-1	-1	0
of	PMC3035602	54430	54432	O	-1	-1	0
risk	PMC3035602	54433	54437	O	-1	-1	0
factors	PMC3035602	54438	54445	O	-1	-1	0
and	PMC3035602	54446	54449	O	-1	-1	0
screening	PMC3035602	54450	54459	O	-1	-1	0
procedures	PMC3035602	54460	54470	O	-1	-1	0
to	PMC3035602	54471	54473	O	-1	-1	0
develop	PMC3035602	54474	54481	O	-1	-1	0
optimal	PMC3035602	54482	54489	O	-1	-1	0
preventative	PMC3035602	54490	54502	O	-1	-1	0
initiatives	PMC3035602	54503	54514	O	-1	-1	0
and	PMC3035602	54515	54518	O	-1	-1	0
programs	PMC3035602	54519	54527	O	-1	-1	0
.	PMC3035602	54527	54528	O	-1	-1	0

Specific	PMC3035602	54529	54537	O	-1	-1	0
topics	PMC3035602	54538	54544	O	-1	-1	0
include	PMC3035602	54545	54552	O	-1	-1	0
:	PMC3035602	54552	54553	O	-1	-1	0
diagnosis	PMC3035602	54554	54563	O	-1	-1	0
,	PMC3035602	54563	54564	O	-1	-1	0
prognosis	PMC3035602	54565	54574	O	-1	-1	0
,	PMC3035602	54574	54575	O	-1	-1	0
treatment	PMC3035602	54576	54585	O	-1	-1	0
,	PMC3035602	54585	54586	O	-1	-1	0
screening	PMC3035602	54587	54596	O	-1	-1	0
,	PMC3035602	54596	54597	O	-1	-1	0
prevention	PMC3035602	54598	54608	O	-1	-1	0
,	PMC3035602	54608	54609	O	-1	-1	0
risk	PMC3035602	54610	54614	O	-1	-1	0
factor	PMC3035602	54615	54621	O	-1	-1	0
modification	PMC3035602	54622	54634	O	-1	-1	0
,	PMC3035602	54634	54635	O	-1	-1	0
systematic	PMC3035602	54636	54646	O	-1	-1	0


	PMC3035602	54646	54648	O	-1	-1	0

Birth	PMC3035602	54648	54653	O	-1	-1	0
outcome	PMC3035602	54654	54661	O	-1	-1	0
in	PMC3035602	54662	54664	O	-1	-1	0
women	PMC3035602	54665	54670	O	-1	-1	0
with	PMC3035602	54671	54675	O	-1	-1	0
cancer	PMC3035602	54676	54682	O	-1	-1	0

52	PMC3035602	54683	54685	O	-1	-1	0
.	PMC3035602	54685	54686	O	-1	-1	0

Hansen	PMC3035602	54687	54693	O	-1	-1	0
D	PMC3035602	54694	54695	O	-1	-1	0
,	PMC3035602	54695	54696	O	-1	-1	0
Lou	PMC3035602	54697	54700	O	-1	-1	0
HC	PMC3035602	54701	54703	O	-1	-1	0
,	PMC3035602	54703	54704	O	-1	-1	0
Olsen	PMC3035602	54705	54710	O	-1	-1	0
J.	PMC3035602	54711	54713	O	-1	-1	0
Serious	PMC3035602	54714	54721	O	-1	-1	0
life	PMC3035602	54722	54726	O	-1	-1	0
events	PMC3035602	54727	54733	O	-1	-1	0
and	PMC3035602	54734	54737	O	-1	-1	0
congenital	PMC3035602	54738	54748	O	-1	-1	0
­malformations	PMC3035602	54749	54763	O	-1	-1	0
:	PMC3035602	54763	54764	O	-1	-1	0
a	PMC3035602	54765	54766	O	-1	-1	0
national	PMC3035602	54767	54775	O	-1	-1	0
study	PMC3035602	54776	54781	O	-1	-1	0
with	PMC3035602	54782	54786	O	-1	-1	0
complete	PMC3035602	54787	54795	O	-1	-1	0
follow	PMC3035602	54796	54802	O	-1	-1	0
-	PMC3035602	54802	54803	O	-1	-1	0
up	PMC3035602	54803	54805	O	-1	-1	0
.	PMC3035602	54805	54806	O	-1	-1	0

Lancet	PMC3035602	54807	54813	O	-1	-1	0
.	PMC3035602	54813	54814	O	-1	-1	0

2000	PMC3035602	54815	54819	O	-1	-1	0
;	PMC3035602	54819	54820	O	-1	-1	0

356(9233):875–880	PMC3035602	54821	54838	O	-1	-1	0
.	PMC3035602	54838	54839	O	-1	-1	0

53	PMC3035602	54840	54842	O	-1	-1	0
.	PMC3035602	54842	54843	O	-1	-1	0

Moran	PMC3035602	54844	54849	O	-1	-1	0
BJ	PMC3035602	54850	54852	O	-1	-1	0
,	PMC3035602	54852	54853	O	-1	-1	0
Yano	PMC3035602	54854	54858	O	-1	-1	0
H	PMC3035602	54859	54860	O	-1	-1	0
,	PMC3035602	54860	54861	O	-1	-1	0
Al	PMC3035602	54862	54864	O	-1	-1	0
Zahir	PMC3035602	54865	54870	O	-1	-1	0
N	PMC3035602	54871	54872	O	-1	-1	0
,	PMC3035602	54872	54873	O	-1	-1	0
et	PMC3035602	54874	54876	O	-1	-1	0
al	PMC3035602	54877	54879	O	-1	-1	0
.	PMC3035602	54879	54880	O	-1	-1	0

Conflicting	PMC3035602	54881	54892	O	-1	-1	0
priorities	PMC3035602	54893	54903	O	-1	-1	0
in	PMC3035602	54904	54906	O	-1	-1	0
­surgical	PMC3035602	54907	54916	O	-1	-1	0
intervention	PMC3035602	54917	54929	O	-1	-1	0
for	PMC3035602	54930	54933	O	-1	-1	0
cancer	PMC3035602	54934	54940	O	-1	-1	0
in	PMC3035602	54941	54943	O	-1	-1	0
pregnancy	PMC3035602	54944	54953	O	-1	-1	0
.	PMC3035602	54953	54954	O	-1	-1	0

Lancet	PMC3035602	54955	54961	O	-1	-1	0
Oncol	PMC3035602	54962	54967	O	-1	-1	0
.	PMC3035602	54967	54968	O	-1	-1	0

2007;8(6	PMC3035602	54969	54977	O	-1	-1	0
)	PMC3035602	54977	54978	O	-1	-1	0

:	PMC3035602	54978	54979	O	-1	-1	0

536–544	PMC3035602	54980	54987	O	-1	-1	0
.	PMC3035602	54987	54988	O	-1	-1	0

54	PMC3035602	54989	54991	O	-1	-1	0
.	PMC3035602	54991	54992	O	-1	-1	0

Weisz	PMC3035602	54993	54998	O	-1	-1	0
B	PMC3035602	54999	55000	O	-1	-1	0
,	PMC3035602	55000	55001	O	-1	-1	0
Schiff	PMC3035602	55002	55008	O	-1	-1	0
E	PMC3035602	55009	55010	O	-1	-1	0
,	PMC3035602	55010	55011	O	-1	-1	0
Lishner	PMC3035602	55012	55019	O	-1	-1	0
M.	PMC3035602	55020	55022	O	-1	-1	0
Cancer	PMC3035602	55023	55029	O	-1	-1	0
in	PMC3035602	55030	55032	O	-1	-1	0
pregnancy	PMC3035602	55033	55042	O	-1	-1	0
:	PMC3035602	55042	55043	O	-1	-1	0
maternal	PMC3035602	55044	55052	O	-1	-1	0
and	PMC3035602	55053	55056	O	-1	-1	0
fetal	PMC3035602	55057	55062	O	-1	-1	0
implications	PMC3035602	55063	55075	O	-1	-1	0
.	PMC3035602	55075	55076	O	-1	-1	0

Hum	PMC3035602	55077	55080	O	-1	-1	0
Reprod	PMC3035602	55081	55087	O	-1	-1	0
Update	PMC3035602	55088	55094	O	-1	-1	0
.	PMC3035602	55094	55095	O	-1	-1	0

2001;7(4):384–393	PMC3035602	55096	55113	O	-1	-1	0
.	PMC3035602	55113	55114	O	-1	-1	0

55	PMC3035602	55115	55117	O	-1	-1	0
.	PMC3035602	55117	55118	O	-1	-1	0

Nisce	PMC3035602	55119	55124	O	-1	-1	0
LZ	PMC3035602	55125	55127	O	-1	-1	0
,	PMC3035602	55127	55128	O	-1	-1	0
Tome	PMC3035602	55129	55133	O	-1	-1	0
MA	PMC3035602	55134	55136	O	-1	-1	0
,	PMC3035602	55136	55137	O	-1	-1	0
He	PMC3035602	55138	55140	O	-1	-1	0
S	PMC3035602	55141	55142	O	-1	-1	0
,	PMC3035602	55142	55143	O	-1	-1	0
Lee	PMC3035602	55144	55147	O	-1	-1	0
BJ	PMC3035602	55148	55150	O	-1	-1	0
III	PMC3035602	55151	55154	O	-1	-1	0
,	PMC3035602	55154	55155	O	-1	-1	0
Kutcher	PMC3035602	55156	55163	O	-1	-1	0
GJ	PMC3035602	55164	55166	O	-1	-1	0
.	PMC3035602	55166	55167	O	-1	-1	0

Management	PMC3035602	55168	55178	O	-1	-1	0
of	PMC3035602	55179	55181	O	-1	-1	0
coexisting	PMC3035602	55182	55192	O	-1	-1	0
Hodgkin	PMC3035602	55193	55200	O	-1	-1	0
’s	PMC3035602	55200	55202	O	-1	-1	0
disease	PMC3035602	55203	55210	O	-1	-1	0
and	PMC3035602	55211	55214	O	-1	-1	0
pregnancy	PMC3035602	55215	55224	O	-1	-1	0
.	PMC3035602	55224	55225	O	-1	-1	0

Am	PMC3035602	55226	55228	O	-1	-1	0
J	PMC3035602	55229	55230	O	-1	-1	0
Clin	PMC3035602	55231	55235	O	-1	-1	0
Oncol	PMC3035602	55236	55241	O	-1	-1	0
.	PMC3035602	55241	55242	O	-1	-1	0

1986	PMC3035602	55243	55247	O	-1	-1	0
;	PMC3035602	55247	55248	O	-1	-1	0
9(2):146–151	PMC3035602	55249	55261	O	-1	-1	0
.	PMC3035602	55261	55262	O	-1	-1	0

56	PMC3035602	55263	55265	O	-1	-1	0
.	PMC3035602	55265	55266	O	-1	-1	0

Kal	PMC3035602	55267	55270	O	-1	-1	0
HB	PMC3035602	55271	55273	O	-1	-1	0
,	PMC3035602	55273	55274	O	-1	-1	0
Struikmans	PMC3035602	55275	55285	O	-1	-1	0
H.	PMC3035602	55286	55288	O	-1	-1	0
Radiotherapy	PMC3035602	55289	55301	O	-1	-1	0
during	PMC3035602	55302	55308	O	-1	-1	0
pregnancy	PMC3035602	55309	55318	O	-1	-1	0
:	PMC3035602	55318	55319	O	-1	-1	0
fact	PMC3035602	55320	55324	O	-1	-1	0
and	PMC3035602	55325	55328	O	-1	-1	0
fiction	PMC3035602	55329	55336	O	-1	-1	0
.	PMC3035602	55336	55337	O	-1	-1	0

Lancet	PMC3035602	55338	55344	O	-1	-1	0
Oncol	PMC3035602	55345	55350	O	-1	-1	0
.	PMC3035602	55350	55351	O	-1	-1	0

2005;6(5):328–333	PMC3035602	55352	55369	O	-1	-1	0
.	PMC3035602	55369	55370	O	-1	-1	0

57	PMC3035602	55371	55373	O	-1	-1	0
.	PMC3035602	55373	55374	O	-1	-1	0

Woo	PMC3035602	55375	55378	O	-1	-1	0
SY	PMC3035602	55379	55381	O	-1	-1	0
,	PMC3035602	55381	55382	O	-1	-1	0
Fuller	PMC3035602	55383	55389	O	-1	-1	0
LM	PMC3035602	55390	55392	O	-1	-1	0
,	PMC3035602	55392	55393	O	-1	-1	0
Cundiff	PMC3035602	55394	55401	O	-1	-1	0
JH	PMC3035602	55402	55404	O	-1	-1	0
,	PMC3035602	55404	55405	O	-1	-1	0
et	PMC3035602	55406	55408	O	-1	-1	0
al	PMC3035602	55409	55411	O	-1	-1	0
.	PMC3035602	55411	55412	O	-1	-1	0

Radiotherapy	PMC3035602	55413	55425	O	-1	-1	0
during	PMC3035602	55426	55432	O	-1	-1	0
pregnancy	PMC3035602	55433	55442	O	-1	-1	0
for	PMC3035602	55443	55446	O	-1	-1	0
clinical	PMC3035602	55447	55455	O	-1	-1	0
stages	PMC3035602	55456	55462	O	-1	-1	0

IA	PMC3035602	55463	55465	O	-1	-1	0
-	PMC3035602	55465	55466	O	-1	-1	0
IIA	PMC3035602	55466	55469	O	-1	-1	0
Hodgkin	PMC3035602	55470	55477	O	-1	-1	0
’s	PMC3035602	55477	55479	O	-1	-1	0
disease	PMC3035602	55480	55487	O	-1	-1	0
.	PMC3035602	55487	55488	O	-1	-1	0

Int	PMC3035602	55489	55492	O	-1	-1	0
J	PMC3035602	55493	55494	O	-1	-1	0
Radiat	PMC3035602	55495	55501	O	-1	-1	0

Oncol	PMC3035602	55502	55507	O	-1	-1	0
Biol	PMC3035602	55508	55512	O	-1	-1	0
Phys	PMC3035602	55513	55517	O	-1	-1	0
.	PMC3035602	55517	55518	O	-1	-1	0

1992;23(2):407–412	PMC3035602	55519	55537	O	-1	-1	0
.	PMC3035602	55537	55538	O	-1	-1	0

58	PMC3035602	55539	55541	O	-1	-1	0
.	PMC3035602	55541	55542	O	-1	-1	0

Li	PMC3035602	55543	55545	O	-1	-1	0
FP	PMC3035602	55546	55548	O	-1	-1	0
,	PMC3035602	55548	55549	O	-1	-1	0
Gimbrere	PMC3035602	55550	55558	O	-1	-1	0
K	PMC3035602	55559	55560	O	-1	-1	0
,	PMC3035602	55560	55561	O	-1	-1	0
Gelber	PMC3035602	55562	55568	O	-1	-1	0
RD	PMC3035602	55569	55571	O	-1	-1	0
,	PMC3035602	55571	55572	O	-1	-1	0
et	PMC3035602	55573	55575	O	-1	-1	0
al	PMC3035602	55576	55578	O	-1	-1	0
.	PMC3035602	55578	55579	O	-1	-1	0

Outcome	PMC3035602	55580	55587	O	-1	-1	0
of	PMC3035602	55588	55590	O	-1	-1	0
pregnancy	PMC3035602	55591	55600	O	-1	-1	0
in	PMC3035602	55601	55603	O	-1	-1	0
survivors	PMC3035602	55604	55613	O	-1	-1	0
of	PMC3035602	55614	55616	O	-1	-1	0
Wilms	PMC3035602	55617	55622	O	-1	-1	0
’	PMC3035602	55622	55623	O	-1	-1	0
tumor	PMC3035602	55624	55629	O	-1	-1	0
.	PMC3035602	55629	55630	O	-1	-1	0

JAMA	PMC3035602	55631	55635	O	-1	-1	0
.	PMC3035602	55635	55636	O	-1	-1	0

1987;257(2):216–219	PMC3035602	55637	55656	O	-1	-1	0
.	PMC3035602	55656	55657	O	-1	-1	0

59	PMC3035602	55658	55660	O	-1	-1	0
.	PMC3035602	55660	55661	O	-1	-1	0

Chiarelli	PMC3035602	55662	55671	O	-1	-1	0
AM	PMC3035602	55672	55674	O	-1	-1	0
,	PMC3035602	55674	55675	O	-1	-1	0
Marrett	PMC3035602	55676	55683	O	-1	-1	0
LD	PMC3035602	55684	55686	O	-1	-1	0
,	PMC3035602	55686	55687	O	-1	-1	0
Darlington	PMC3035602	55688	55698	O	-1	-1	0
GA	PMC3035602	55699	55701	O	-1	-1	0
.	PMC3035602	55701	55702	O	-1	-1	0

Pregnancy	PMC3035602	55703	55712	O	-1	-1	0
outcomes	PMC3035602	55713	55721	O	-1	-1	0
in	PMC3035602	55722	55724	O	-1	-1	0
females	PMC3035602	55725	55732	O	-1	-1	0
after	PMC3035602	55733	55738	O	-1	-1	0
treatment	PMC3035602	55739	55748	O	-1	-1	0
for	PMC3035602	55749	55752	O	-1	-1	0
childhood	PMC3035602	55753	55762	O	-1	-1	0
cancer	PMC3035602	55763	55769	O	-1	-1	0
.	PMC3035602	55769	55770	O	-1	-1	0

Epidemiology	PMC3035602	55771	55783	O	-1	-1	0
.	PMC3035602	55783	55784	O	-1	-1	0

2000	PMC3035602	55785	55789	O	-1	-1	0
;	PMC3035602	55789	55790	O	-1	-1	0
11(2):161–166	PMC3035602	55791	55804	O	-1	-1	0
.	PMC3035602	55804	55805	O	-1	-1	0

60	PMC3035602	55806	55808	O	-1	-1	0
.	PMC3035602	55808	55809	O	-1	-1	0

Boice	PMC3035602	55810	55815	O	-1	-1	0
JD	PMC3035602	55816	55818	O	-1	-1	0
Jr	PMC3035602	55819	55821	O	-1	-1	0
,	PMC3035602	55821	55822	O	-1	-1	0
Tawn	PMC3035602	55823	55827	O	-1	-1	0
EJ	PMC3035602	55828	55830	O	-1	-1	0
,	PMC3035602	55830	55831	O	-1	-1	0
Winther	PMC3035602	55832	55839	O	-1	-1	0
JF	PMC3035602	55840	55842	O	-1	-1	0
,	PMC3035602	55842	55843	O	-1	-1	0
et	PMC3035602	55844	55846	O	-1	-1	0
al	PMC3035602	55847	55849	O	-1	-1	0
.	PMC3035602	55849	55850	O	-1	-1	0

Genetic	PMC3035602	55851	55858	O	-1	-1	0
effects	PMC3035602	55859	55866	O	-1	-1	0
of	PMC3035602	55867	55869	O	-1	-1	0
radiotherapy	PMC3035602	55870	55882	O	-1	-1	0
for	PMC3035602	55883	55886	O	-1	-1	0
childhood	PMC3035602	55887	55896	O	-1	-1	0
cancer	PMC3035602	55897	55903	O	-1	-1	0
.	PMC3035602	55903	55904	O	-1	-1	0

Health	PMC3035602	55905	55911	O	-1	-1	0
Phys	PMC3035602	55912	55916	O	-1	-1	0
.	PMC3035602	55916	55917	O	-1	-1	0

2003;85(1):65–80	PMC3035602	55918	55934	O	-1	-1	0
.	PMC3035602	55934	55935	O	-1	-1	0

61	PMC3035602	55936	55938	O	-1	-1	0
.	PMC3035602	55938	55939	O	-1	-1	0

Winther	PMC3035602	55940	55947	O	-1	-1	0
JF	PMC3035602	55948	55950	O	-1	-1	0
,	PMC3035602	55950	55951	O	-1	-1	0
Boice	PMC3035602	55952	55957	O	-1	-1	0
Jr	PMC3035602	55958	55960	O	-1	-1	0
JD	PMC3035602	55961	55963	O	-1	-1	0
,	PMC3035602	55963	55964	O	-1	-1	0
Frederiksen	PMC3035602	55965	55976	O	-1	-1	0
K	PMC3035602	55977	55978	O	-1	-1	0
,	PMC3035602	55978	55979	O	-1	-1	0
et	PMC3035602	55980	55982	O	-1	-1	0
al	PMC3035602	55983	55985	O	-1	-1	0
.	PMC3035602	55985	55986	O	-1	-1	0

Radiotherapy	PMC3035602	55987	55999	O	-1	-1	0
for	PMC3035602	56000	56003	O	-1	-1	0
childhood	PMC3035602	56004	56013	O	-1	-1	0
cancer	PMC3035602	56014	56020	O	-1	-1	0
and	PMC3035602	56021	56024	O	-1	-1	0
risk	PMC3035602	56025	56029	O	-1	-1	0
for	PMC3035602	56030	56033	O	-1	-1	0
congenital	PMC3035602	56034	56044	O	-1	-1	0
malformations	PMC3035602	56045	56058	O	-1	-1	0
in	PMC3035602	56059	56061	O	-1	-1	0
offspring	PMC3035602	56062	56071	O	-1	-1	0
:	PMC3035602	56071	56072	O	-1	-1	0
a	PMC3035602	56073	56074	O	-1	-1	0
populationbased	PMC3035602	56075	56090	O	-1	-1	0
cohort	PMC3035602	56091	56097	O	-1	-1	0
study	PMC3035602	56098	56103	O	-1	-1	0
.	PMC3035602	56103	56104	O	-1	-1	0

Clin	PMC3035602	56105	56109	O	-1	-1	0
Genet	PMC3035602	56110	56115	O	-1	-1	0
.	PMC3035602	56115	56116	O	-1	-1	0

2009;75:50–56	PMC3035602	56117	56130	O	-1	-1	0
.	PMC3035602	56130	56131	O	-1	-1	0

62	PMC3035602	56132	56134	O	-1	-1	0
.	PMC3035602	56134	56135	O	-1	-1	0

Schull	PMC3035602	56136	56142	O	-1	-1	0
WJ	PMC3035602	56143	56145	O	-1	-1	0
,	PMC3035602	56145	56146	O	-1	-1	0
Neel	PMC3035602	56147	56151	O	-1	-1	0
JV	PMC3035602	56152	56154	O	-1	-1	0
.	PMC3035602	56154	56155	O	-1	-1	0

Radiation	PMC3035602	56156	56165	O	-1	-1	0
and	PMC3035602	56166	56169	O	-1	-1	0
the	PMC3035602	56170	56173	O	-1	-1	0
sex	PMC3035602	56174	56177	O	-1	-1	0
ratio	PMC3035602	56178	56183	O	-1	-1	0
in	PMC3035602	56184	56186	O	-1	-1	0
man	PMC3035602	56187	56190	O	-1	-1	0
.	PMC3035602	56190	56191	O	-1	-1	0

Science	PMC3035602	56192	56199	O	-1	-1	0
.	PMC3035602	56199	56200	O	-1	-1	0

1958	PMC3035602	56201	56205	O	-1	-1	0
;	PMC3035602	56205	56206	O	-1	-1	0

128(3320):343–348	PMC3035602	56207	56224	O	-1	-1	0
.	PMC3035602	56224	56225	O	-1	-1	0

63	PMC3035602	56226	56228	O	-1	-1	0
.	PMC3035602	56228	56229	O	-1	-1	0

Hawkins	PMC3035602	56230	56237	O	-1	-1	0
MM	PMC3035602	56238	56240	O	-1	-1	0
,	PMC3035602	56240	56241	O	-1	-1	0
Smith	PMC3035602	56242	56247	O	-1	-1	0
RA	PMC3035602	56248	56250	O	-1	-1	0
.	PMC3035602	56250	56251	O	-1	-1	0

Pregnancy	PMC3035602	56252	56261	O	-1	-1	0
outcomes	PMC3035602	56262	56270	O	-1	-1	0
in	PMC3035602	56271	56273	O	-1	-1	0
childhood	PMC3035602	56274	56283	O	-1	-1	0
cancer	PMC3035602	56284	56290	O	-1	-1	0
survivors	PMC3035602	56291	56300	O	-1	-1	0
:	PMC3035602	56300	56301	O	-1	-1	0
probable	PMC3035602	56302	56310	O	-1	-1	0
effects	PMC3035602	56311	56318	O	-1	-1	0
of	PMC3035602	56319	56321	O	-1	-1	0
abdominal	PMC3035602	56322	56331	O	-1	-1	0
irradiation	PMC3035602	56332	56343	O	-1	-1	0
.	PMC3035602	56343	56344	O	-1	-1	0

Int	PMC3035602	56345	56348	O	-1	-1	0
J	PMC3035602	56349	56350	O	-1	-1	0
Cancer	PMC3035602	56351	56357	O	-1	-1	0
.	PMC3035602	56357	56358	O	-1	-1	0

1989	PMC3035602	56359	56363	O	-1	-1	0
;	PMC3035602	56363	56364	O	-1	-1	0
43(3):399–402	PMC3035602	56365	56378	O	-1	-1	0
.	PMC3035602	56378	56379	O	-1	-1	0

64	PMC3035602	56380	56382	O	-1	-1	0
.	PMC3035602	56382	56383	O	-1	-1	0

Winther	PMC3035602	56384	56391	O	-1	-1	0
JF	PMC3035602	56392	56394	O	-1	-1	0
,	PMC3035602	56394	56395	O	-1	-1	0
Boice	PMC3035602	56396	56401	O	-1	-1	0
Jr	PMC3035602	56402	56404	O	-1	-1	0
JD	PMC3035602	56405	56407	O	-1	-1	0
,	PMC3035602	56407	56408	O	-1	-1	0
Svendsen	PMC3035602	56409	56417	O	-1	-1	0
AL	PMC3035602	56418	56420	O	-1	-1	0
,	PMC3035602	56420	56421	O	-1	-1	0
et	PMC3035602	56422	56424	O	-1	-1	0
al	PMC3035602	56425	56427	O	-1	-1	0
.	PMC3035602	56427	56428	O	-1	-1	0

Spontaneous	PMC3035602	56429	56440	O	-1	-1	0
abortion	PMC3035602	56441	56449	O	-1	-1	0
in	PMC3035602	56450	56452	O	-1	-1	0
a	PMC3035602	56453	56454	O	-1	-1	0
Danish	PMC3035602	56455	56461	O	-1	-1	0
population	PMC3035602	56462	56472	O	-1	-1	0
-	PMC3035602	56472	56473	O	-1	-1	0
based	PMC3035602	56473	56478	O	-1	-1	0
cohort	PMC3035602	56479	56485	O	-1	-1	0
of	PMC3035602	56486	56488	O	-1	-1	0
childhood	PMC3035602	56489	56498	O	-1	-1	0
cancer	PMC3035602	56499	56505	O	-1	-1	0
survivors	PMC3035602	56506	56515	O	-1	-1	0
.	PMC3035602	56515	56516	O	-1	-1	0

J	PMC3035602	56517	56518	O	-1	-1	0
Clin	PMC3035602	56519	56523	O	-1	-1	0
Oncol	PMC3035602	56524	56529	O	-1	-1	0
.	PMC3035602	56529	56530	O	-1	-1	0

2008;26:4340–4346	PMC3035602	56531	56548	O	-1	-1	0
.	PMC3035602	56548	56549	O	-1	-1	0

65	PMC3035602	56550	56552	O	-1	-1	0
.	PMC3035602	56552	56553	O	-1	-1	0

Meirow	PMC3035602	56554	56560	O	-1	-1	0
D	PMC3035602	56561	56562	O	-1	-1	0
,	PMC3035602	56562	56563	O	-1	-1	0
Nugent	PMC3035602	56564	56570	O	-1	-1	0
D.	PMC3035602	56571	56573	O	-1	-1	0

The	PMC3035602	56574	56577	O	-1	-1	0
effects	PMC3035602	56578	56585	O	-1	-1	0
of	PMC3035602	56586	56588	O	-1	-1	0
radiotherapy	PMC3035602	56589	56601	O	-1	-1	0
and	PMC3035602	56602	56605	O	-1	-1	0
chemotherapy	PMC3035602	56606	56618	O	-1	-1	0
on	PMC3035602	56619	56621	O	-1	-1	0
female	PMC3035602	56622	56628	O	-1	-1	0
reproduction	PMC3035602	56629	56641	O	-1	-1	0
.	PMC3035602	56641	56642	O	-1	-1	0

Hum	PMC3035602	56643	56646	O	-1	-1	0
Reprod	PMC3035602	56647	56653	O	-1	-1	0
Update	PMC3035602	56654	56660	O	-1	-1	0
.	PMC3035602	56660	56661	O	-1	-1	0

2001;7(6):535–543	PMC3035602	56662	56679	O	-1	-1	0
.	PMC3035602	56679	56680	O	-1	-1	0

66	PMC3035602	56681	56683	O	-1	-1	0
.	PMC3035602	56683	56684	O	-1	-1	0

Schmidt	PMC3035602	56685	56692	O	-1	-1	0
KL	PMC3035602	56693	56695	O	-1	-1	0
,	PMC3035602	56695	56696	O	-1	-1	0
Andersen	PMC3035602	56697	56705	O	-1	-1	0
CY	PMC3035602	56706	56708	O	-1	-1	0
,	PMC3035602	56708	56709	O	-1	-1	0
Loft	PMC3035602	56710	56714	O	-1	-1	0
A	PMC3035602	56715	56716	O	-1	-1	0
,	PMC3035602	56716	56717	O	-1	-1	0
Byskov	PMC3035602	56718	56724	O	-1	-1	0
AG	PMC3035602	56725	56727	O	-1	-1	0
,	PMC3035602	56727	56728	O	-1	-1	0
Ernst	PMC3035602	56729	56734	O	-1	-1	0
E	PMC3035602	56735	56736	O	-1	-1	0
,	PMC3035602	56736	56737	O	-1	-1	0
Andersen	PMC3035602	56738	56746	O	-1	-1	0
AN	PMC3035602	56747	56749	O	-1	-1	0
.	PMC3035602	56749	56750	O	-1	-1	0

Follow	PMC3035602	56751	56757	O	-1	-1	0
-	PMC3035602	56757	56758	O	-1	-1	0
up	PMC3035602	56758	56760	O	-1	-1	0
of	PMC3035602	56761	56763	O	-1	-1	0
ovarian	PMC3035602	56764	56771	O	-1	-1	0
function	PMC3035602	56772	56780	O	-1	-1	0
post	PMC3035602	56781	56785	O	-1	-1	0
-	PMC3035602	56785	56786	O	-1	-1	0
chemotherapy	PMC3035602	56786	56798	O	-1	-1	0

following	PMC3035602	56799	56808	O	-1	-1	0
ovarian	PMC3035602	56809	56816	O	-1	-1	0
cryopreservation	PMC3035602	56817	56833	O	-1	-1	0
and	PMC3035602	56834	56837	O	-1	-1	0
transplantation	PMC3035602	56838	56853	O	-1	-1	0
.	PMC3035602	56853	56854	O	-1	-1	0

Hum	PMC3035602	56855	56858	O	-1	-1	0
Reprod	PMC3035602	56859	56865	O	-1	-1	0
.	PMC3035602	56865	56866	O	-1	-1	0

2005;20(12):3539–3546	PMC3035602	56867	56888	O	-1	-1	0
.	PMC3035602	56888	56889	O	-1	-1	0

67	PMC3035602	56890	56892	O	-1	-1	0
.	PMC3035602	56892	56893	O	-1	-1	0

Doll	PMC3035602	56894	56898	O	-1	-1	0
DC	PMC3035602	56899	56901	O	-1	-1	0
,	PMC3035602	56901	56902	O	-1	-1	0
Ringenberg	PMC3035602	56903	56913	O	-1	-1	0
QS	PMC3035602	56914	56916	O	-1	-1	0
,	PMC3035602	56916	56917	O	-1	-1	0
Yarbro	PMC3035602	56918	56924	O	-1	-1	0
JW	PMC3035602	56925	56927	O	-1	-1	0
.	PMC3035602	56927	56928	O	-1	-1	0

Antineoplastic	PMC3035602	56929	56943	O	-1	-1	0
agents	PMC3035602	56944	56950	O	-1	-1	0
and	PMC3035602	56951	56954	O	-1	-1	0
­pregnancy	PMC3035602	56955	56965	O	-1	-1	0
.	PMC3035602	56965	56966	O	-1	-1	0

Semin	PMC3035602	56967	56972	O	-1	-1	0
Oncol	PMC3035602	56973	56978	O	-1	-1	0
.	PMC3035602	56978	56979	O	-1	-1	0

1989;16(5):337–346	PMC3035602	56980	56998	O	-1	-1	0
.	PMC3035602	56998	56999	O	-1	-1	0

68	PMC3035602	57000	57002	O	-1	-1	0
.	PMC3035602	57002	57003	O	-1	-1	0

Aviles	PMC3035602	57004	57010	O	-1	-1	0
A	PMC3035602	57011	57012	O	-1	-1	0
,	PMC3035602	57012	57013	O	-1	-1	0
Neri	PMC3035602	57014	57018	O	-1	-1	0
N.	PMC3035602	57019	57021	O	-1	-1	0
Hematological	PMC3035602	57022	57035	O	-1	-1	0
malignancies	PMC3035602	57036	57048	O	-1	-1	0
and	PMC3035602	57049	57052	O	-1	-1	0
pregnancy	PMC3035602	57053	57062	O	-1	-1	0
:	PMC3035602	57062	57063	O	-1	-1	0
a	PMC3035602	57064	57065	O	-1	-1	0
final	PMC3035602	57066	57071	O	-1	-1	0
report	PMC3035602	57072	57078	O	-1	-1	0
of	PMC3035602	57079	57081	O	-1	-1	0
84	PMC3035602	57082	57084	O	-1	-1	0
children	PMC3035602	57085	57093	O	-1	-1	0
who	PMC3035602	57094	57097	O	-1	-1	0
received	PMC3035602	57098	57106	O	-1	-1	0
chemotherapy	PMC3035602	57107	57119	O	-1	-1	0
in	PMC3035602	57120	57122	O	-1	-1	0
utero	PMC3035602	57123	57128	O	-1	-1	0
.	PMC3035602	57128	57129	O	-1	-1	0

Clin	PMC3035602	57130	57134	O	-1	-1	0
­Lymphoma	PMC3035602	57135	57144	O	-1	-1	0
.	PMC3035602	57144	57145	O	-1	-1	0

2001;2(3):173–177	PMC3035602	57146	57163	O	-1	-1	0
.	PMC3035602	57163	57164	O	-1	-1	0

69	PMC3035602	57165	57167	O	-1	-1	0
.	PMC3035602	57167	57168	O	-1	-1	0

Bath	PMC3035602	57169	57173	O	-1	-1	0
LE	PMC3035602	57174	57176	O	-1	-1	0
,	PMC3035602	57176	57177	O	-1	-1	0
Wallace	PMC3035602	57178	57185	O	-1	-1	0
WH	PMC3035602	57186	57188	O	-1	-1	0
,	PMC3035602	57188	57189	O	-1	-1	0
Critchley	PMC3035602	57190	57199	O	-1	-1	0
HO	PMC3035602	57200	57202	O	-1	-1	0
.	PMC3035602	57202	57203	O	-1	-1	0

Late	PMC3035602	57204	57208	O	-1	-1	0
effects	PMC3035602	57209	57216	O	-1	-1	0
of	PMC3035602	57217	57219	O	-1	-1	0
the	PMC3035602	57220	57223	O	-1	-1	0
treatment	PMC3035602	57224	57233	O	-1	-1	0
of	PMC3035602	57234	57236	O	-1	-1	0
childhood	PMC3035602	57237	57246	O	-1	-1	0
cancer	PMC3035602	57247	57253	O	-1	-1	0
on	PMC3035602	57254	57256	O	-1	-1	0
the	PMC3035602	57257	57260	O	-1	-1	0
female	PMC3035602	57261	57267	O	-1	-1	0
reproductive	PMC3035602	57268	57280	O	-1	-1	0
system	PMC3035602	57281	57287	O	-1	-1	0
and	PMC3035602	57288	57291	O	-1	-1	0
the	PMC3035602	57292	57295	O	-1	-1	0
potential	PMC3035602	57296	57305	O	-1	-1	0
for	PMC3035602	57306	57309	O	-1	-1	0
fertility	PMC3035602	57310	57319	O	-1	-1	0
preservation	PMC3035602	57320	57332	O	-1	-1	0
.	PMC3035602	57332	57333	O	-1	-1	0

BJOG	PMC3035602	57334	57338	O	-1	-1	0
.	PMC3035602	57338	57339	O	-1	-1	0

2002;109(2):107–114	PMC3035602	57340	57359	O	-1	-1	0
.	PMC3035602	57359	57360	O	-1	-1	0

70	PMC3035602	57361	57363	O	-1	-1	0
.	PMC3035602	57363	57364	O	-1	-1	0

Lo	PMC3035602	57365	57367	O	-1	-1	0
PA	PMC3035602	57368	57370	O	-1	-1	0
,	PMC3035602	57370	57371	O	-1	-1	0
Ruvolo	PMC3035602	57372	57378	O	-1	-1	0
G	PMC3035602	57379	57380	O	-1	-1	0
,	PMC3035602	57380	57381	O	-1	-1	0
Gancitano	PMC3035602	57382	57391	O	-1	-1	0
RA	PMC3035602	57392	57394	O	-1	-1	0
,	PMC3035602	57394	57395	O	-1	-1	0

Cittadini	PMC3035602	57396	57405	O	-1	-1	0
E.	PMC3035602	57406	57408	O	-1	-1	0
Ovarian	PMC3035602	57409	57416	O	-1	-1	0
function	PMC3035602	57417	57425	O	-1	-1	0
­following	PMC3035602	57426	57436	O	-1	-1	0
radiation	PMC3035602	57437	57446	O	-1	-1	0
and	PMC3035602	57447	57450	O	-1	-1	0
chemotherapy	PMC3035602	57451	57463	O	-1	-1	0
for	PMC3035602	57464	57467	O	-1	-1	0
cancer	PMC3035602	57468	57474	O	-1	-1	0
.	PMC3035602	57474	57475	O	-1	-1	0

Eur	PMC3035602	57476	57479	O	-1	-1	0
J	PMC3035602	57480	57481	O	-1	-1	0
Obstet	PMC3035602	57482	57488	O	-1	-1	0
Gynecol	PMC3035602	57489	57496	O	-1	-1	0
Reprod	PMC3035602	57497	57503	O	-1	-1	0
Biol	PMC3035602	57504	57508	O	-1	-1	0
.	PMC3035602	57508	57509	O	-1	-1	0

2004;113(Suppl	PMC3035602	57510	57524	O	-1	-1	0
1):S33–S40	PMC3035602	57525	57535	O	-1	-1	0
.	PMC3035602	57535	57536	O	-1	-1	0

71	PMC3035602	57537	57539	O	-1	-1	0
.	PMC3035602	57539	57540	O	-1	-1	0

Tewari	PMC3035602	57541	57547	O	-1	-1	0
K	PMC3035602	57548	57549	O	-1	-1	0
,	PMC3035602	57549	57550	O	-1	-1	0
Bonebrake	PMC3035602	57551	57560	O	-1	-1	0
RG	PMC3035602	57561	57563	O	-1	-1	0
,	PMC3035602	57563	57564	O	-1	-1	0
Asrat	PMC3035602	57565	57570	O	-1	-1	0
T	PMC3035602	57571	57572	O	-1	-1	0
,	PMC3035602	57572	57573	O	-1	-1	0
Shanberg	PMC3035602	57574	57582	O	-1	-1	0
AM	PMC3035602	57583	57585	O	-1	-1	0
.	PMC3035602	57585	57586	O	-1	-1	0

Ambiguous	PMC3035602	57587	57596	O	-1	-1	0
genitalia	PMC3035602	57597	57606	O	-1	-1	0
in	PMC3035602	57607	57609	O	-1	-1	0
infant	PMC3035602	57610	57616	O	-1	-1	0
exposed	PMC3035602	57617	57624	O	-1	-1	0
to	PMC3035602	57625	57627	O	-1	-1	0
tamoxifen	PMC3035602	57628	57637	O	-1	-1	0
in	PMC3035602	57638	57640	O	-1	-1	0
utero	PMC3035602	57641	57646	O	-1	-1	0
.	PMC3035602	57646	57647	O	-1	-1	0

Lancet	PMC3035602	57648	57654	O	-1	-1	0
.	PMC3035602	57654	57655	O	-1	-1	0

1997	PMC3035602	57656	57660	O	-1	-1	0

;	PMC3035602	57660	57661	O	-1	-1	0
350(9072):183	PMC3035602	57662	57675	O	-1	-1	0
.	PMC3035602	57675	57676	O	-1	-1	0


	PMC3035602	57676	57678	O	-1	-1	0

Dovepress	PMC3035602	57678	57687	O	-1	-1	0
reviews	PMC3035602	57688	57695	O	-1	-1	0
,	PMC3035602	57695	57696	O	-1	-1	0
risk	PMC3035602	57697	57701	O	-1	-1	0
&	PMC3035602	57702	57703	O	-1	-1	0
safety	PMC3035602	57704	57710	O	-1	-1	0
of	PMC3035602	57711	57713	O	-1	-1	0
medical	PMC3035602	57714	57721	O	-1	-1	0
interventions	PMC3035602	57722	57735	O	-1	-1	0
,	PMC3035602	57735	57736	O	-1	-1	0
epidemiology	PMC3035602	57737	57749	O	-1	-1	0
&	PMC3035602	57750	57751	O	-1	-1	0
biostatical	PMC3035602	57752	57763	O	-1	-1	0
methods	PMC3035602	57764	57771	O	-1	-1	0
,	PMC3035602	57771	57772	O	-1	-1	0
evaluation	PMC3035602	57773	57783	O	-1	-1	0
of	PMC3035602	57784	57786	O	-1	-1	0
guidelines	PMC3035602	57787	57797	O	-1	-1	0
,	PMC3035602	57797	57798	O	-1	-1	0
translational	PMC3035602	57799	57812	O	-1	-1	0
medicine	PMC3035602	57813	57821	O	-1	-1	0
,	PMC3035602	57821	57822	O	-1	-1	0
health	PMC3035602	57823	57829	O	-1	-1	0
policies	PMC3035602	57830	57838	O	-1	-1	0
&	PMC3035602	57839	57840	O	-1	-1	0
economic	PMC3035602	57841	57849	O	-1	-1	0
evaluations	PMC3035602	57850	57861	O	-1	-1	0
.	PMC3035602	57861	57862	O	-1	-1	0

The	PMC3035602	57863	57866	O	-1	-1	0
manuscript	PMC3035602	57867	57877	O	-1	-1	0
management	PMC3035602	57878	57888	O	-1	-1	0
system	PMC3035602	57889	57895	O	-1	-1	0
is	PMC3035602	57896	57898	O	-1	-1	0
completely	PMC3035602	57899	57909	O	-1	-1	0
online	PMC3035602	57910	57916	O	-1	-1	0
and	PMC3035602	57917	57920	O	-1	-1	0
includes	PMC3035602	57921	57929	O	-1	-1	0
a	PMC3035602	57930	57931	O	-1	-1	0
very	PMC3035602	57932	57936	O	-1	-1	0
quick	PMC3035602	57937	57942	O	-1	-1	0
and	PMC3035602	57943	57946	O	-1	-1	0
fair	PMC3035602	57947	57951	O	-1	-1	0
peer	PMC3035602	57952	57956	O	-1	-1	0
-	PMC3035602	57956	57957	O	-1	-1	0
review	PMC3035602	57957	57963	O	-1	-1	0
system	PMC3035602	57964	57970	O	-1	-1	0
,	PMC3035602	57970	57971	O	-1	-1	0
which	PMC3035602	57972	57977	O	-1	-1	0
is	PMC3035602	57978	57980	O	-1	-1	0
all	PMC3035602	57981	57984	O	-1	-1	0
easy	PMC3035602	57985	57989	O	-1	-1	0
to	PMC3035602	57990	57992	O	-1	-1	0
use	PMC3035602	57993	57996	O	-1	-1	0
.	PMC3035602	57996	57997	O	-1	-1	0


	PMC3035602	57997	57999	O	-1	-1	0

Submit	PMC3035602	57999	58005	O	-1	-1	0
your	PMC3035602	58006	58010	O	-1	-1	0
manuscript	PMC3035602	58011	58021	O	-1	-1	0
here	PMC3035602	58022	58026	O	-1	-1	0
:	PMC3035602	58026	58027	O	-1	-1	0

http://www.dovepress.com/clinical-epidemiology-journal	PMC3035602	58028	58082	O	-1	-1	0


	PMC3035602	58082	58084	O	-1	-1	0

Clinical	PMC3035602	58084	58092	O	-1	-1	0
Epidemiology	PMC3035602	58093	58105	O	-1	-1	0
2011:3	PMC3035602	58106	58112	O	-1	-1	0


	PMC3035602	58112	58114	O	-1	-1	0
submit	PMC3035602	58114	58120	O	-1	-1	0
your	PMC3035602	58121	58125	O	-1	-1	0
manuscript	PMC3035602	58126	58136	O	-1	-1	0
|	PMC3035602	58137	58138	O	-1	-1	0

www.dovepress.com	PMC3035602	58139	58156	O	-1	-1	0


	PMC3035602	58156	58158	O	-1	-1	0

Dovepress	PMC3035602	58158	58167	O	-1	-1	0


	PMC3035602	58167	58169	O	-1	-1	0
19	PMC3035602	58169	58171	O	-1	-1	0


	PMC3035602	58171	58173	O	-1	-1	0

